Canine leishmaniasis: the role of hepatocytes and Kupffer cells during Leishmania infantum infection by RODRIGUES, Maria Armanda Viana
  
  
Universidade Nova de Lisboa 
Instituto de Higiene e Medicina Tropical 
Canine leishmaniasis: the role of hepatocytes and Kupffer  
cells during Leishmania infantum infection 
Maria Armanda Viana Rodrigues 
DISSERTATION IN SUPPORT OF A CANDIDATURE FOR A DOCTORATE DEGREE IN  
BIOMEDICAL SCIENCES, SPECIALIZATION IN CELLULAR AND MOLECULAR BIOLOGY, 




Universidade Nova de Lisboa 
Instituto de Higiene e Medicina Tropical 
Canine leishmaniasis: the role of hepatocytes and Kupffer  
cells during Leishmania infantum infection 
  
Author: Maria Armanda Viana Rodrigues 
Degree in Cellular Biology and Biotechnology (FCUL) 
Master in Cellular Biology and Biotechnology (FCUL) 
 
Supervisor: Prof. Dr. Gabriela Santos-Gomes (IHMT/UNL) 
Co-supervisors:  Prof. Dr. Isabel Pereira da Fonseca (FMV/ULisboa) 
Prof. Dr. Joana Miranda (FF/ULisboa) 
 
 
Dissertation in support of a candidature for a Doctorate degree in Biomedical Sciences, 
specialization in Cellular and Molecular Biology, by Universidade Nova de Lisboa, Instituto de 
Higiene e Medicina Tropical, under supervision of Prof. Dr. Gabriela Santos-Gomes. 
Financial support by PhD scholarship SFRH/BD/73386/2010 and projects 
PTDC/CVT/113121/2009 and PTDC/CVT/118566/2010, funded by the Portuguese Foundation 




Communications and publications performed in 
dissertation context   
Papers in preparation 
Rodrigues A, Santos-Mateus D, Alexandre-Pires G, Valério-Bolas A, 
Rafael-Fernandes M, Alves-Azevedo R, Ligeiro D, Pereira M, Nunes T, Pereira da 
Fonseca I, Santos-Gomes G. Canine hepatocytes activate innate immune receptors 
against Leishmania infantum. 
Rodrigues A, Alexandre-Pires G, Santos-Mateus D, Ligeiro D, Valério-Bolas A, 
Martins C, Rafael-Fernandes M, Pereira M, Pereira da Fonseca I, Santos-Gomes G. 
Innate immune receptors of canine Kupffer cells sense Leishmania infantum differently 
from blood monocytes. 
Rodrigues A, Santos-Mateus D, Valério-Bolas A, Claro M, Martins C, 
Alexandre-Pires G, Santos-Gomes G. Analysis of cell memory in liver of mice infected 
with Leishmania infantum.  
National scientific meetings 
Poster presentation 
Rodrigues A, Alexandre-Pires G, Santos-Mateus D, Aires-Pereira M, 
Valério-Bolas A, Rafael-Fernandes M, Silva-Pedrosa R, Pereira da Fonseca I, 
Santos-Gomes G. A exposição a Leishmania infantum causa alterações metabólicas nos 
hepatócitos caninos. V Jornadas Científicas do Instituto de Higiene e Medicina 
Tropical. Lisbon, Portugal, 12
th
 December 2014.  
Claro M, Rodrigues A, Santos-Mateus D, Valério-Bolas A, Martins C, 
Alexandre-Pires G, Santos-Gomes G. Analysis of cell memory in liver of mice infected 
with Leishmania infantum. Fundação Astrazeneca Innovate Competition, iMed 5.0 
Conference. Rectory of Universidade NOVA de Lisboa, 12-13 October 2013. 
 
ii 
Rodrigues A, Santos-Mateus D, Valério-Bolas A, Pereira M, Alexandre-Pires G, 
Pereira-da-Fonseca I, Santos-Gomes G. Isolation of primary dog hepatocytes.  





Rodrigues A, Alexandre-Pires G, Santos-Mateus D, Pereira MA, Valério-Bolas 
A, Rafael-Fernandes M, Marques C, Pereira da Fonseca I, Santos-Gomes G. Impacto na 
função metabólica e na resposta imunitária de hepatócitos de cão expostos a Leishmania 
infantum. IV Jornadas Cientificas do Instituto de Higiene e Medicina Tropical, Lisbon 
11
th
 December 2013. 
International scientific meetings 
Poster presentation 
Rodrigues A, Alexandre-Pires G, Santos-Mateus D, Ligeiro D, Valério-Bolas A, 
Rafael-Fernandes M, Pereira M, Pereira da Fonseca I, Santos-Gomes G. 3D canine 
hepatocyte culture system modeling the Leishmania infantum liver infection.  
XXIV International Symposium on Morphological Sciences, Istanbul, Turkey, 2-6 
September, 2015. Anatomy, Vol. 9 / Suppl 2 S132. 
[http://www.anatomy.org.tr/issue/2015s2/pdf/04.pdf] 
Rodrigues A, Alexandre-Pires G, Santos-Mateus D, Ligeiro D, Valério-Bolas A, 
Martins C, Rafael-Fernandes M, Pereira M, Pereira da Fonseca I, Santos-Gomes G. 
Innate immune receptors of canine Kupffer cells sense Leishmania infantum.  
4th European Congress of Immunology, Vienna, Austria, September 6-9, 2015. Abstract 





Rodrigues A, Alexandre-Pires G, Santos-Mateus D, Valério-Bolas A, 
Rafael-Fernandes M, Aires-Pereira M, Pereira da Fonseca I, Santos-Gomes G.  
Impact on cell metabolism of dog hepatocytes when exposed to Leishmania infantum.  
Congress of the European Association of Veterinary Anatomists. Cluj-Napoca, 
Romania, July 23-26, 2014. Anatomia, Histologia, Embryologia, Journal of Veterinary 
Medicine C, 43, Supl. 1: pp. 80-81.  
[http://onlinelibrary.wiley.com/doi/10.1111/ahe.12127/epdf ] 
Rodrigues A, Alexandre-Pires G, Santos-Mateus D, Marques, C. Valério-Bolas 
A, Rafael-Fernandes M, Fonseca I, Santos-Gomes G. Impact on the metabolic function 
and immune activity of dog hepatocytes when exposed to Leishmania infantum. EMBO 
young scientists’ forum. Lisbon 15-16 July, 2013. Instituto de Medicina Molecular 
(IMM). 
Oral presentation 
Rodrigues A, Santos-Mateus D, Alexandre-Pires G, Valério-Bolas A, 
Rafael-Fernandes M, Alves-Azevedo R, Ligeiro D, Pereira M, Nunes T, Pereira da 
Fonseca I, Santos-Gomes, G. Leishmania infantum modulates the metabolism of dog 
hepatocyte. XIX Congreso de la Sociedad Espanola de Parasitología, II Encuentro 
Internacional de Parasitólogos de Espanha, Francia, Italia y Portugal. Vitoria-Gasteiz, 
Spain, 23-25 July 2015. Abstract book pp H5. 
[http://www.congresoparasitologia.org/info/H.pdf] 
Rodrigues A, Teixeira F, Martins C, Santos-Mateus D, Carvalho S, 
Alexandre-Pires G, Lopes R, Gaspar M, Cruz E, Tomás A, Santos-Gomes G.  
Zoonotic visceral leishmaniasis - New insights in the dynamics of cellular memory. 










Near this Spot 
are deposited the Remains of one 
who possessed Beauty without Vanity, 
Strength without Insolence, 
Courage without Ferocity, 
and all the virtues of Man without his Vices. 
 
This praise, which would be unmeaning Flattery 
if inscribed over human Ashes, 
is but a just tribute to the Memory of 
Boatswain, a Dog 
 














Dedicated to the most important persons in my life: 
Tiago and my Parents, 






To Professor Gabriela Santos-Gomes, from Instituto de Higiene e Medicina 
Tropical (IHMT), Universidade Nova de Lisboa (UNL), for receiving me at the 
laboratory (some years ago) and for the magnificent scientific guidance, for 
encouraging me to take this adventure and accomplish this project. Thank you for being 
more than just my thesis supervisor, thank you for being a friend. You are a great 
scientist and an amazing person. Thank you for the revision of the thesis, 
encouragement when it was needed and for ever being present throughout this journey, 
with a scientific advice or just to talk. Thank you for the good experiences of teaching 
on the other side of the Atlantic, those were also great adventures. 
To Professor Isabel Fonseca, from Faculdade de Medicina Veterinária, 
Universidade Técnica de Lisboa, for having accepted to be co-supervisor of the present 
work. Thank you for being available whenever it was needed and for the revision of the 
present thesis.  
To Researcher Joana Miranda, from Faculdade de Farmácia da Universidade de 
Lisboa (FFUL), Research institute for medicines (iMed), for having accepted to 
participate in this project and for maintaining a friendship and always being available 
for any advice or just to talk. 
To Professor Graça Pires, from Faculdade de Medicina Veterinária, 
Universidade Técnica de Lisboa, for accepted to be part of this project. Thank you for 
your good humor, patience, and never-ending availability to embrace our new crazy 
ideas. Without your assistance this project would not be the same. Thank you for 
performing the flow cytometry analysis, fluorescent confocal microscopy and scan 
electron microscopy photos that were so important for this work.  
To Researcher Fátima Nogueira, from IHMT, UNL and Researcher Manuela 
Colla Carvalheiro, from iMed, FFUL, for accepted to be my tutorial commission. Thank 
you for your availability to read my work reports and attend the meetings. 




Many thanks to Professor Marcelo Silva for the utilization of the inverted 
microscope and plate reader whenever I needed and my thanks to Professor Celso 
Cunha for sharing his laboratory equipment with me when it was most needed. These 
demonstrate the spirit of cooperation of IHMT. 
To Professor Ana Tomás, from Instituto Biologia Molecular e Celular (IBMC), 
for providing the GFP-L. infantum transformed parasites and recombinant proteins used 
in this study. Thank you for your important collaboration.  
To Researcher Luiz Filipe Passero and Researcher João Lago, from Faculdade 
de Medicina da Universidade de Sao Paulo, Brazil, for providing the ursolic acid, tested 
in the present work for its leishmanicidal activity. Thank you for your important 
collaboration. 
To Professor Bartira Rossi Bergmann, from Instituto de Biofísica Carlos Chagas 
Filho, UFRJ, Rio de Janeiro, Brazil, for providing the Chalcone-8 and Quercetin tested 
in the present work for its leishmanicidal activity. Thank you for this important 
collaboration. 
To Dr. Pedro Faísca, from Universidade Lusófona, for your availability to 
process the mice histological preparations. My thanks also to technician Susana Dias for 
the patience explaining all the process and protocols involved.  
To Dr. Sância Ramos, director of Anatomia Patológica do Centro Hospitalar 
Ocidental E.P.E – Hospital Santa Cruz, for the availability demonstrated when help was 
asked. To technician Armandina Manuel for the patience in explaining and teaching all 
about histological cuts and coloration, and also for the interest demonstrated in the 
present work. 
To Researcher Dário Ligeiro from IPST - Instituto Português do Sangue e da 
Transplantação - Centro do Sangue e da Transplantação de Lisboa, for the collaboration 
on obtaining the confocal fluorescence microscopy images. Thank you for the 
availability demonstrated when help was asked. 
To Researcher Telmo Nunes from Faculty of Sciences, Microscopy Center, 
Universidade de Lisboa, for preparation of samples for scan electron microscopy. Thank 
you for the fruitful collaboration 
 
vii 
To Researcher Dinora Lopes and technicians Victor Santos and Rosário Tito 
from the animal facilities of IHMT. My thanks for the immense collaboration in mice 
inoculation and treatment. 
 
 
To Portuguese Foundation for Science and Technology (FCT), for funding my 
PhD scholarship SFRH/BD/73386/2010. 
 
 
To my “half-brain” David Santos-Mateus. Thank you for being present since the 
first “liver-day” to the last one. You are a great scientific and bad-tempered mind! 
Thank you for being such a friend. My “gigantic” thanks also to Ana Valerio-Bolas, 
Mariana Rafael-Fernandes, Débora Almeida, Mafalda Claro, Ana Rita Pedrosa, Joana 
Cavaco Silva and Maria de Aires - my “companion in situation”. It was your presence, 
your aid, your friendship that helping me to overcome the bad lad-days. Thank you for 
always help me in the “liver-days”. Thank you for all the scientific and less scientific 
discussions. Thank you for all the good times in the lab, the “family” lunches and all 
coffee-times. I know that this lab, during these four years had very special people and 
now I have very special friends for life. 
My thanks also to Cátia Marques and Marcos Santos, for performing the analysis 
for the dogs used in the present study and always respond to my questions and doubts.  
To Cíntia Philipon for your friendship and for many interesting talks. Thank you 
for loaning the compounds.  
To Jéssica de Jesus, thank you for your friendship, joy, and help with the RT-
PCR. It was a very important help in a stressful time.  
To Sara Ventura and Raquel Azevedo, those who were not frightened by RNA 
extraction in “massive” scale. Your help was priceless in the “final run”. 
 
viii 
To Pedro Ruas and João Tabanez, for keeping a good lab ambience and always 
be helpful. To Áurea Gabriela and Joana Monteiro for your friendship and precious help 
with the microscope scales. 
 
To my parents for all their love and care. For their presence in everything in my 
life and for helping me be who I am and be where I am now.  To my grandmother. You 
always will be an example for me with your strength and good advices.   
And at last, to Tiago. Thank you for your love and patience. Thank you for pick 
me up at IHMT so many times at “evil” hours and for cooking and waiting me to have 
dinner. Thank you for making me feel so special. Thank you for your support in 
everything in my life. Thank you for your interest in biology and for have accepted the 




Estudo da resposta imunitária exibida pelo fígado de cão 
infetado por Leishmania infantum 
Maria Armanda Viana Rodrigues 
PALAVRAS-CHAVE: Leishmaniose canina; Hepatócitos; Células de Kupffer; Imunidade 
inata; Memória celular. 
A leishmaniose canina (LCan) é uma doença zoonótica causada por Leishmania 
infantum, um parasita protozoário transmitido por flébotomos. O fígado constitui um 
órgão vital e de grande importância metabólica, sendo também um alvo preferencial 
para L. infantum. Apesar do complexo metabolismo, o fígado apresenta mecanismos 
efetores que podem contribuir para a direta eliminação do parasita de forma ainda não 
completamente compreendida. Assim, este estudo tem por objetivo analisar o papel dos 
hepatócitos e das células de Kupffer (CK) na infeção por L. infantum. A resposta imune 
orquestrada pelo cão contra L. infantum é constituída por um largo espetro de respostas 
de imunidade inata e adquirida. Estudos em cães infetados demonstraram que a 
imunidade ao parasita é órgão-específica. Para analisar a interação entre L. infantum e 
os hepatócitos, no presente estudo, hepatócitos e CK foram isolados de cães saudáveis e 
cultivadas em dois sistemas de cultura diferentes. O sistema 2D consiste na clássica 
cultura em placa e o sistema 3D tira partido da tendência dos hepatócitos para agregar e 
permite às células recriar a organização natural existente no órgão. L. infantum 
apresentou um claro tropismo para os hepatócitos, aderindo fortemente à membrana 
celular. No entanto, não é claro se o parasita entrou nos hepatócitos. Estas interações 
levaram a uma ativação da imunidade inata, aumentando a expressão génica dos 
receptores NOD1 e NOD2, bem como TLR2, em sinergia com a diferenciação de um 
perfil misto de citocinas anti- e pro-inflamatórias, que conduziu à diminuição de 
atividade das CYPs450. Três novos compostos com reconhecida atividade 
anti-leishmanial (ácido ursólico, chalcona-8 e quercetina) foram testados e comparados 
com o fármaco classicamente utilizado no tratamento da leishmaniose. Os compostos 
experimentais apresentaram boa atividade leishmanicida e não afetaram a viabilidade 
dos hepatócitos, diminuíram a inflamação celular e restauraram a atividade das 
CTPs450, havendo ainda a hipótese de serem metabolizados em parte pelas referidas 
enzimas. As CK mostraram-se permissivas a amastigotas e promastigotas e elevaram a 
expressão de NOD1 e TLR2 na presença do parasita. No entanto, L. infantum é capaz de 
regular a resposta imunitária nas CK, evitando a ação de citocinas anti e 
pró-inflamatórias e do stress oxidativo, aumentando, por outro, lado a síntese de ureia. 
A adição de antimoniato de meglumina permitiu às CK recuperar a ativação e expressão 
de recetores de imunidade inata e produção de citocinas. A co-cultura de CK infetadas 
com hepatócitos revelou que as células em conjunto foram capazes de ativar a 
imunidade inata. Os hepatócitos evidenciaram, assim, um papel interessante na 
orquestração de uma resposta imune sinergética com as CK contra L. infantum. Foram 
 
x 
ainda observadas diferenças entre a resposta imune exibida por macrófagos do sangue 
(MØ) e CK infetados por L. infantum. A análise da memória linfocitária hepática, 
realizada em modelo murino de leishmaniose visceral, demonstrou que o tratamento 
com antimoniato de meglumina elevou os níveis de memória e o número de células 
efetoras, melhorando a resposta imunitária do fígado, salientando o seu papel como 
órgão imunitário. As proteínas recombinantes de L. infantum, LirCyp1 e LirSOD foram 
reconhecidas pelas células de memória de animais infetados e tratados, indiciando que 
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Canine leishmaniasis (CanL) is a zoonotic disease caused by Leishmania 
infantum, a protozoan parasite transmitted by sand flies. The liver is a vital and major 
metabolic organ which also constitutes a L. infantum preferential target. Despite the 
complex metabolism, liver possesses effector mechanisms that can contribute to direct 
elimination of Leishmania in a not yet defined way. Thus, this study aimed to assess the 
role of hepatocytes and Kupffer cells (KC) in the canine liver infected by L. infantum. A 
wide spectrum of innate and acquired immune responses is orchestrated by the canine 
host when facing L. infantum infection. CanL infection studies have indicated that 
parasite immunity is organ-specific. In the present study, canine hepatocytes and KCs 
were isolated from healthy stray dogs and two different culture systems were used to 
analyze the interaction of L. infantum with hepatocytes. The 2D-culture system consists 
in the classical plate culture and the 3D-culture system takes advantage of the natural 
aggregation properties of hepatocytes and allows cells to recreate some of the natural 
tissue architecture. L. infantum exhibited evident tropism to hepatocytes and strongly 
attached to the cells in both cultures system. However, it was not clear if parasites 
entered the hepatocytes. These interactions lead to activation of innate immunity by 
increasing the gene expression of NOD1 and NOD2 receptors in synergy with the 
increase in TLR2 expression. TNF-α cytokine expression was increased creating a pro-
inflammatory cellular microenvironment and, as consequence, decreasing the CYP450 
activity. This downregulation of CYPs may increase toxicity of clinical drugs in some 
cases. Three new potential leishmanicidal drugs were tested, ursolic acid, chalcone-8 
and quercetin in comparison to the standard meglumine antimoniate. Experimental 
drugs revealed good leishmanicidal activity and did not reduce hepatocyte viability. The 
addition of leishmanicidal drugs decreased the inflammation and restored the CYP450 
activity, which were also probable involved in the metabolization of the tested 
compounds. Regarding KCs, these cells were permissive to L. infantum amastigotes and 
promastigotes. KCs increased expression of NOD1 and TLR2 innate immune receptors. 
Even so, the parasite regulates KC immune response, avoiding the generation of pro- 
and anti-inflammatory cytokines and the oxidative burst, increasing the synthesis of 
urea. The addition of meglumine antimoniate allowed KC to activate, increasing the 
expression of innate immune receptors and of pro-inflammatory cytokines, breaking the 
silencing imposed by the parasite. The addition of L. infantum infected KCs to canine 
hepatocytes in a co-culture, was able to activate cells innate immunity. Hepatocyte 
seemed to have an interesting role in orchestrating a synergistic immune response 
against L. infantum parasites. Major differences were also found between the immune 
response exhibited by blood derivate macrophages (MØ) and liver KC, when facing 
 
xii 
infection by L. infantum. The assessment of the liver lymphocyte memory performed in 
the murine model of visceral leishmaniasis demonstrated that the treatment with 
antimoniate meglumine increases the levels of memory and effector T cells, enhancing 
liver immune response. The liver has higher levels of immune memory T cells, 
evidencing its role as an immunological organ. The recombinant proteins LirCyp1 and 
LirSOD, are strongly recognized by memory cells from infected and treated mice, 
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1 General Introduction 
1.1. Leishmaniasis 
Leishmaniases constitutes a group of diseases caused by an intracellular 
protozoan of the genus Leishmania that parasites a large range of mammalian hosts 
including humans, dogs and rodents. Leishmaniasis is caused by more than 20 
Leishmania species that can be transmitted to humans by the bite of infected female 
sand flies. 
Traditionally, wild canids and especially the domestic dog are the hosts 
responsible for the persistence of the disease and the source of infection for the vector. 
The domestic dogs are good reservoirs of the parasite, as they have high parasite 
burdens in the skin and a chronic and long lasting disease (João et al., 2006). In 
humans, leishmaniasis covers a large spectrum of clinical symptoms, ranging from 
self-healing cutaneous infections (CL) to visceral leishmaniasis (VL) also known as 
kala-azar, which can be fatal if not treated. The outcome of infection in humans and 
dogs depends on both the parasite species involved and its virulence and on the host 
immune response (Goto and Lindoso, 2004). The need to better understand the immune 
response generated against Leishmania infection, the development of better 
anti-leishmanial drugs and of complementary strategies of treatment and, the 
development of an affordable vaccine are the main goals set for leishmaniasis research. 
1.2. Biology of Leishmania 
1.2.1. Leishmania morphology and life cycle 
Leishmania ssp. are unicellular digenetic parasites, whose life cycle involves 
two hosts, a vertebrate and an invertebrate. During life cycle, Leishmania has two basic 
body forms: the amastigote, an intracellular form that occurs in the vertebrate host and 
the promastigote, an extracellular flagellated/mobile form in the sand fly (Phlebotomus 
ssp. and Lutzomyia ssp.) vector. Amastigotes are taken up from the blood of an infected 
vertebrate host when the female sand fly gets a blood meal. During digestion in the sand 
fly gut, amastigotes are released to extracellular environment and differentiate into 
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promastigote form. In the gut of the female sand fly, promastigotes attach to the 
midgut-hindgut epithelium microvilli and divide by binary fission.  
Promastigotes possess a number of single-copy organelles with defined 
sub-cellular locations. Morphologically, presents an elongated form of about 10-30 μm 
long and 2.5-5 μm width depending on the species, a central nucleus, Golgi apparatus, 
mitochondria, which incorporates the kinetoplast, a region of highly condensed 
chromatin, the basal body and a long external flagellum that emerges from the anterior 
part of the cell, via the flagellar pocket, and confers motility (Figure 1A and B). After 
initial ingestion of blood meal from the host (Figure 2), promastigotes development in 
the sand fly takes 8-20 days and, followed by multiplication in the midgut-hindgut, they 
move forward to the pharynx where they produce a partial or complete blockage of the 
sucking apparatus (Dhingra and Satapathy, 2014).  
 
Figure 1: Leishmania ssp. morphological forms.  
A) Schematic representation of the main intracellular organelles of Leishmania promastigote (left) or 
amastigote (right) forms. The flagellar pocket marks the anterior end of the cell (adapted from Besteiro et 
al., 2007). B) Electron scanning of Leishmania infantum cultured promastigote. C) Intracellular 
amastigotes (black arrow) under optical microscopy inside a macrophage (magnification 400x). 
Due to the impairment of sucking mechanism, to feed again the sand fly needs to 
bite the vertebrate host and regurgitating metacyclic promastigotes that are introduced 
into the bite wound allowing the natural transmission of Leishmania to occur. 
Metacycle promastigote forms are resistant to complement attack and quickly invade 
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local phagocytes, subsequently transforming into amastigotes inside the host cells 
(Cupolillo et al., 1995). Although the deposition of promastigotes in the vertebrate 
dermis includes sand fly saliva, the salivary glands are not usually infected as in the 
case of the African trypanosomes in the tsetse fly or the Plasmodium in the mosquito. 
The amastigote (meaning “without a flagellum”) is the intracellular non-motile 
form in the vertebrate host. Although the amastigote is not really devoid of a flagellum, 
it is merely that the flagellum does not protrude beyond the cell surface and cannot be 
seen by light microscopy (Figure 1A and C). Intracellular amastigote exhibits a round or 
oval shape of around 2-6 μm of diameter. This morphological form also presents a 
nucleus, the Golgi apparatus and mitochondria with the kinetoplast. Inside the 
parasitophorous vacuole of the host cell amastigote form replicates by longitudinal 
binary fission. Promastigotes can be grown in vitro at 24-27 ºC in several axenic culture 
mediums, such as NNN medium, which is constituted by a solid phase of blood agar 
and a liquid phase containing a physiologic salt solution, or in different available liquid 
media (e.g., Scheneider insect drosophila medium, RPMI, D-MEM, Glasgow minimal 
essential medium) sera supplemented. Amastigotes usually are grown in vitro in 
cultured cells and can also be grown in axenic liquid media at 37 ºC under special 
conditions.  
In cutaneous leishmaniasis (CL), the parasite stays in the skin, causing lesions 
that can ulcerate or evaluate to spontaneous cure, depending on the species of 
Leishmania and on the immune response of the host. The mechanisms which determine 
the dissemination of the parasite from the initial site of infection to mucosal tissues and 
cartilages, as in the case of mucocutaneous leishmaniasis (MCL) or to internal organs 
(e.g. spleen, liver and bone marrow), as in visceral leishmaniasis (VL) are not yet clear 
(Murray et al., 2002). Organ-specific immunity has been described in various 
experimental VL studies in mouse and dog models (Santos-Gomes et al., 2002; 
Alexandre-Pires et al., 2010). 




Figure 2: Leishmania ssp. life cycle. 
Transmission of Leishmania occurs during the blood meal of phlebotomine female sand flies (1), which 
introduces metacyclic infective promastigotes into the vertebrate host dermis. Parasites are phagocyted by 
macrophages (2) and in the interior vacuoles transformed into amastigotes (3). Amastigotes replicate 
inside the cells (4) and infected macrophages may be retained on the skin (CL and MCL) or migrate to the 
inner organs, visceralizing the infection (VL). During another blood meal, the phlebotomine female ingest 
the infected macrophages (5) and in the midgut the amastigote leaves the cells (6) and matures to virulent 
and infective promastigotes (7) ready to be injected in the next mammal host (8). Image released into the 
public domain by Mariana Ruiz Villarreal and adapted 
1.2.1.1. Leishmania in the vector: co-evolution of parasite and vector 
Phlebotomine sand flies are dipteran insects belonging to the family 
Psychodidae and approximately 700 species have been described to date. Of these, 
evidence of Leishmania vectorial capacity has been demonstrated for about 30 species. 
Currently there are two groups of Leishmania parasites that are classified into different 
subgenera, according with the part of the sand fly gut that are colonized by the parasite. 
Indeed, the original division of mammal infective Leishmania into the subgenera 
Leishmania and Viannia by Lainson and Shaw (1977) was largely based on this 
character, a separation which has been subsequently confirmed by DNA sequence based 
phylogenetic analyses (Croan et al., 1997; Noyes et al., 2002). Female sand flies 
(Phlebotomus spp. in the Old World, Lutzomyia spp. in the New World) acquire 
Leishmania parasites when feed on an infected mammal host. Sand flies are 
Telmophages, meaning they insert their saw-like mouthparts into the skin and agitate 
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them to produce a small wound into which the blood flows from superficial capillaries. 
It is this damaged tissue that activates and attracts skin macrophages into the blood 
pool, enabling their subsequent uptake by the sand fly. The change in environmental 
conditions, from the mammalian host to the sand flies midgut, mainly characterized by a 
decrease in temperature and an increase in pH, triggers the parasite transformation in 
the motile promastigote form in the vector (Bates and Rogers, 2004). In the vector, the 
amastigote give rise to the procyclic promastigote, the first promastigote stage  
(Figure 3). This is a slow motile and active replication form that promotes a fast and 
exponential increase in parasite numbers.  
In Leishmania subgenus, the initial parasite phase is confined by the peritrophic 
matrix, a chitin and protein mesh secreted by the midgut epithelium that encloses the 
blood meal, while digesting it (Secundino et al., 2005). After a few days, the 
nectomonad parasites begin to differentiate into the elongate, strongly motile 
promastigotes. These are migratory forms that accumulate at the anterior end of the 
peritrophic matrix and break out of the blood meal from the action of a parasite secreted 
chitinase (Shakarian and Dwyer, 2000). Then, the parasites moves towards the anterior 
midgut, most of them attaching to the microvilli of the midgut epithelium, were 
replicate actively. Parasites that result from the replicative process reach the stomodeal 
valve that guards the junction between foregut and midgut. The existence of this 
intermediate phase of promastigote form is a mark of a true vector, since the parasite 
persists beyond the blood meal, avoiding expulsion during defecation. The ability to 
attach is an important property of Leishmania promastigotes (Sacks and Kamhawi, 
2001). Lipophosphoglycan (LPG), the major parasite surface glycoconjugate, binds to 
galectin on the sand fly gut epithelium of some species, establishing a key 
parasite-vector interaction, such as Leishmania major in Phlebotomus papatasi 
(Pimenta et al., 1992). However, more recent findings indicate that non-LPG mediated 
attachment can also be used by some Leishmania species (Myskova et al., 2007). Once 
reached the stomodeal valve, the nectomonad promastigotes transform into leptomonad 
promastigotes, shorter forms that continue to replicate. These are responsible for the 
secretion of promastigote secretory gel (PSG), which plays a key role in transmission. 
Nectomonad/leptomonad promastigotes attach themselves to the cuticle lined surface of 
the valve and differentiate into haptomonad promastigotes (Killick-Kendrick et al., 
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1974). This form of attachment is mechanistically different to that seen in the midgut 
epithelium and is mediated by the expansion of the flagellar tip into 
hemidesmosome-like structures (Wakid and Bates, 2004). Finally, some of the 
leptomonads promastigotes differentiate into metacyclic promastigotes, the mammal 
infective stage. These parasites are deposited in the skin of a new mammalian host when 
the sand fly gets another blood meal, leading to the transmission of the parasite. 
 
Figure 3: Leishmania (Leishmania) inside the sand flies vector. 
1) Amastigotes ingested with the blood meal are transformed into weakly motile procyclic promastigotes; 
2) Four hours after the blood meal, the blood is enclosed in the peritrophic matrix made of chitin and 
proteins secreted by the midgut, which protects the promastigotes from the enzymatic activity. 3) Within 
48-72 h the peritrophic matrix is degraded, releasing the elongated and highly motile nectomonad 
promastigote that migrates to the anterior midgut. 4) The nectomonads transform into leptomonad 
promastigotes and release the promastigote secretory gel. This gel fills the anterior midgut  
into the foregut. 5) At the foregut the non-infectious procyclic promastigotes transform  
into the infective metacyclic promastigotes. 6) The sand flies regurgitate and expel  
the metacyclic promastigotes when taking a new blood meal in a mammal. (Adapted from  
http://dna.kdna.ucla.edu/parasite_course-old/leish_files/subchapters/morphology%20and%20life%20cycl
e.htm) 
Parasites of the subgenus Viannia are only found in the New World and 
therefore all the vectors are of Lutzomyia (Lu.) spp. The initial parasite events are 
similar to those described for the subgenus Leishmania. Amastigotes are taken up and 
transformed into the replicative procyclic promastigotes. However, the majority of the 
parasites can be found in the pyloric region of the hindgut (Nieves and Pimenta, 2000), 
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a defining feature of this subgenus. After the hindgut phase, there is a forward migration 
followed by parasite accumulation at the anterior midgut, PSG secretion and 
differentiation of metacyclic promastigotes. The detailed kinetics of this anterior 
migration has not been fully explored. Although the route is slightly different and the 
parasite stages involved have not been well defined the final development goal is 
similar in both subgenus, resulting in an effective capacity of infect new host and 
propagate the parasite (Bates, 2007). 
It is also of interest to look at the fitness cost of the fly vector by sustaining the 
development of infective Leishmania and by transmitting the infection. For example, 
the deviation of nutrient resources to parasite growth associated with the considerable 
distension of the gut by the gel-like plug produced by the parasite, damaging the 
stomodeal valves have the potential for causing injuries to sand flies. Roger and Bates 
(2007) examined the effect of infection on the longevity of L. longipalpis. Both L. 
mexicana and L. infantum infections were found to significantly reduce longevity under 
normal laboratory conditions (average of 11 days of life for non-infected controls and of 
9 days for both L. mexicana and L. infantum infected sand flies. Although little is 
known regarding the survival of flies in nature, it is recognized that some respects of the 
natural environment can be more stressful and hazardous than the conditions 
experienced in laboratory insectaries. Curiously, Leishmania infections do not 
significantly impact on immediate reproductive fitness of the sand fly. An interesting 
balance occurs in the Leishmania-sand fly relationship. In fact, more aggressive and 
quickly developing infections will lead to increased accumulation of PSG by metacyclic 
promastigotes, thereby increasing the probability of transmission. On the other hand, 
this fast developing infection will also exert a greater fitness cost on the vector, thus 
reducing the probability of transmission. Thus, any alteration of feeding behavior by the 
parasite will independently increase the probability of transmission and this will be a 
clear selective advantage. Such behavior might include factors encouraging the sand fly 
to find a host and begin feeding and those leading the sand fly to prolong the feed or 
re-feed. Therefore, the timing of vector feeding with respect to parasite development is 
crucial, since successful transmission of parasites is dependent on vector survival. The 
vectors should survive long enough to assure the complete development of the parasite, 
reaching the infective stage (Rogers and Bates, 2007).  
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Thus Leishmania transmission results of a combination of several factors: (i) the 
PSG physical blockage of the stomodeal valve, ensuring enhanced regurgitation of 
infective forms, (ii) the subsequent exacerbation of infection in the mammalian host by 
the PSG action in association with the components of vector saliva as adjuvant and, (iii) 
the manipulation of feeding behavior according with the presence of infective forms 
available for transmission. All together, the above elicited issues highlight the close 
co-evolution of Leishmania parasites and their own sand fly vectors (Rogers et al., 
2002; Rogers and Bates, 2007). 
1.2.2. Parasite virulence factors 
During the blood meal, the insect vector deposits metacyclic promastigotes in 
the skin of the host. These promastigotes, the virulent form of Leishmania, are able to 
initiate an infection. Once in the dermis, the parasites are exposed to new hostile 
environments, such as the extra-cellular matrix (ECM) of connective tissue or the innate 
immune system and must interact with a variety of obstacles, to establish the infection 
within macrophage phagolysosomes. It is widely accepted that the distinct leishmaniasis 
clinical manifestations are a consequence of the interaction of the parasite (depending 
on parasite species) and the host’s immune system.  
Some parasite components are characterized as virulence factors, enabling the 
parasite to invade and establish infection in the mammalian host, contributing to 
Leishmania pathogenesis. The most known and described virulence factors from 
Leishmania include glycoinositol phospholipids (GIPL), lipophosphoglycan (LPG), 
proteophosphoglycan (PPG), the 11 kDa kinetoplastid membrane protein (KMP-11), 
several proteinases and metalloproteinases. Although the exact impact of these 
Leishmania components on the mammalian host’s immune system is not yet totally 
clarified there are evidences that these components modulate the interactions between 
the parasite and the host immune cells, favoring infection outcome (Silva-Almeida et 
al., 2012). GIPL were reported to help Leishmania (L.) major to survive inside 
macrophages by inhibiting nitric oxide synthase and protein kinase C (Zufferey et al., 
2013). LPG is a macrophage ligand that is directly involved in the initial stages of the 
infection. Assays carried out with a mutant strain of L. major deficient in the gene lpg1 
(lpg1
-
) showed that the mutant parasites appear to attenuate virulence during the 
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infection of murine macrophages, despite presenting no other phenotypical changes. 
The lpg1
-
 promastigotes were highly susceptible to the complement system and to the 
oxidants produced by host cells. In addition, these parasites lost their ability to inhibit 
phagolysosome fusion, leading to their own destruction inside macrophages. It has also 
been reported that Lmajorlpg2 null mutants (lpg2
-
) were unable to survive in sand flies 
or in mammalian host cells. These highly altered parasites lacked all the 
phosphoglycans, including LPG and proteophosphoglycans (Svárovská et al., 2010). 
Interestingly, Leishmania LPG has been shown to inhibit the nuclear translocation of 
NF-κB in monocytes, leading to a subsequent diminution of IL-12 production 
(Argueta-Donohué et al., 2008) and can also influence the host’s early immune 
responses by modulating the activity of dendritic cells, inhibiting antigen presentation 
and promoting an early IL-4 release (Liu et al., 2009). All together, these actions 
promote the parasite establishment and survival.  
Proteophosphoglycans are highly glycosylated polypeptides with functions not 
entirely clear. It is speculated that its long chain that covers the plasma membrane of the 
parasite could play some role in binding to macrophage receptors. Within macrophages, 
the secretion of modified PPG by parasites appears to contribute to the maintenance of 
the parasitophorous vacuole (Peters et al., 1997).  
KMP-11 is a hydrophobic protein that has been described to be associated with 
LPG. This protein presents immune regulatory properties and is able to induce the 
expression of IL-10 in cells of human patients with cutaneous and mucocutaneous 
leishmaniases (Carvalho et al., 2005). However, the mechanism that supports this 
regulation remains unclear. 
Proteases are also important virulence factors, as they are enzymes that 
hydrolyze peptide bonds and have the potential to degrade peptides and proteins. As so, 
they are potentially involved in a broad range of biological functions, including the 
infection process. Proteases are usually classified based on the catalytic domain. They 
can be serine-, threonine-, aspartyl-, metallo- or cysteine-proteases. Among these, only 
the aspartyl-, metallo- and cysteine-protease classes have been extensively studied in 
Leishmania species (Silva-Almeida et al., 2012). There are several parasite proteases 
known to be involved in pathogenesis and playing important roles in parasite invasion 
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and migration through host tissues, degradation of immune related proteins, immune 
evasion and activation of inflammation (McKerrow et al., 2006). The most known 
protease is the gp63, a metalloproteinase that covers the body surface of Leishmania. 
This protease belongs to the metzincin class (peptidase family M8) and is abundantly 
expressed on the surface of Leishmania ssp. and related to other trypanosomatid 
protozoan (Etges et al., 1986). Gp63 has a very important biological role, associated 
with the parasite protection against the action of enzymes of the vector midgut and from 
the phagolysosomes of host macrophages. Additionally, when inside the mammalian 
host gp63 is required to assure the resistance of promastigotes to lysis mediated by the 
complement, as the presence of this active protease greatly reduced the fixation of the 
terminal complement components on parasite surface by increasing the conversion of 
C3b to its inactive form, the C3bi (Yao et al., 2003). 
Produced by the leptomonad promastigotes, a virulence factor highly important 
in the establishment of infection on the mammalian host is the PSG, mainly constituted 
by a high molecular weight glycoprotein called filamentous proteophosphoglycan 
(fPPG) (Ilg et al., 1999). The identification of PSG in the sand flies brings a new 
recognition of the blocked fly hypothesis. The gel-forming properties of fPPG could fill 
and distend the anterior midgut of the sand fly, extending through the stomodeal valve 
into the foregut. Although fPPG is clearly the major component of PSG and a critical 
element of transmission and disease exacerbation, other products secreted by the 
parasite or by the sand fly present in the plug could have as yet undescribed biological 
effects. When co-inoculated with metacyclic promastigotes has been shown that PSG 
cause disease exacerbation, leading to an enhancement of pathology and of a parasite 
load increase (Bates and Rogers, 2004). It should also be noted that the PSG plug 
obstructing the anterior midgut is packed with promastigotes. Essentially, the plug is 
constituted by a pellet of promastigotes embedded in PSG. When observed in situ by 
microscopy, PSG plug has little evidence of life, as the cells appear immobile. 
However, when dissected out into culture medium, the PSG readily dissolves and 
releases promastigotes that regain their motility. The majority of these parasites are 
leptomonad promastigotes, one of the main pieces of evidence that this stage is 
responsible for the secretion of PSG. The other life cycle stages associated with the plug 
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are metacyclic promastigotes. Interestingly, these are mainly located at the poles of the 
plug, at ideal positions for transmission.  
Some of the virulence factors are intrinsic to the parasite forms, but it is widely 
discussed that also the components of the vector can be directly linked with the 
virulence of the parasite. Vector’s saliva is a potent pharmacological active fluid that 
directly affects the hemostasis, release of inflammatory mediators and cell immune 
activity of vertebrate hosts. These actions are crucial for a successful blood meal and the 
modifications on host physiology caused by pharmacologically active molecules may 
favor the transmission of Leishmania parasites that colonize the digestive tract of the 
sand fly (Andrade et al., 2007). Sand fly saliva is a well-established disease 
exacerbation factor. To achieve a successful blood meal, sand flies must overcome 
host’s hemostasis system, which includes blood coagulation cascade, vasoconstriction 
mediators, fibrinolysis and platelet aggregation. Besides hemostasis, sand flies must 
also evade the host’s innate and acquired immune responses. To overcome these 
obstacles, sand flies develop a salivary secretion with an array of potent 
pharmacological components, such as anticoagulants, anti-platelet, vasodilators and, 
notably, immunomodulatory and anti-inflammatory molecules (Kamhawi, 2000). These 
biological active mediators with redundant and synergize activities generate a proper 
environment for a successful blood feeding and also for parasite establishment. Most of 
the existing knowledge concerning resistance and susceptibility to Leishmania infection 
was built based on experimental models. Titus and Ribeiro (1988) first demonstrated 
that saliva from Lu. longipalpis enhanced L. major infection when the parasite was 
co-inoculated with the sand fly  salivary gland sonicate (SGS) in mice. Although not in 
its natural vector, the addition of san fly saliva enhanced lesion size and raised parasite 
burden in the lesions. Similar findings were further reported with other Leishmania 
species (Andrade et al., 2007). 
In murine models of leishmaniasis, resistance to infection is associated with the 
expression of interferon (IFN)-γ and interleukin (IL) -12 driving a CD4
+
 Th1 immune 
response, while susceptibility is related to production of IL-4 and the development of a 
CD4
+
Th2 response. Saliva from L. longipalpis seems to drive, by an unknown 
mechanism, the host immune response to a Th2 type, less effective in terms of parasite 
clearance, allowing parasite persistence. In endemic areas where potential host is highly 
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exposed to sand fly bites and saliva inoculation, the salivary components also seem to 
display an immune response in the host, leading to antibody production and cell 
mediated immune activation. However, the specific role of antibodies against sand fly 
saliva in the outcome of Leishmania infection is not fully known. Experimental studies, 
together with clinical data, suggest a potential transmission blocking mechanism. 
BALB⁄c mice repeatedly exposed to L. longipalpis bits produced high levels of 
anti-salivary antibodies, with predominance of the IgG1 subclass (Belkaid et al., 1988). 
Total serum IgG from these animals recognized predominantly bands of 45, 44 and  
16 kDa, displaying some similarity to human anti-saliva humoral responses, that 
recognize most of the bands. These proteins were also the major targets of the human 
antibody response in an endemic area (Barral et al., 2000). As these proteins are widely 
recognized, they are natural candidates to be used as markers of exposure to L. 
longipalpis bits. Besides antibody production, an intense cellular infiltrate of 
neutrophils, eosinophils and macrophages at the site of sand fly bites also occurs. 
Moreover, mice pre-exposure to P. papatasi SGS or immunized with SP15, a protein 
present in P. papatasi saliva, were able to block the establishment of L. major infection 
(Andrade et al., 2007). Also in humans, the response generated by sand fly saliva seems 
to exert a direct effect on human antigen presenting cells. L. longipalpis SGS inhibit the 
production of IL-10 and tumor necrosis factor (TNF)-α, but induce IL-6, IL-8 and 
IL-12p40 release by lipopolysaccharide-stimulated monocytes and dendritic cells. 
Besides cytokine production, sand fly saliva also interfered with the expression of 
monocytes/macrophages co-stimulatory molecules. In vitro, the saliva effect on human 
immune cells can be reverted by incubation with anti-SGS antibodies, revealing the 
importance of a specific humoral response for the neutralization of sand fly saliva 
harmful effects on the human immune system (Costa et al., 2004). 
The combination of experimental data indicates that the components of sand fly 
saliva can be used in a combined vaccine with Leishmania antigens to enhance 
protection. Furthermore, as sand flies feed on many other animals besides humans, 
immune approaches that target specific salivary components may enable protection 
against leishmaniasis in different vertebrate species, as in the case of CanL. 
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1.2.3. Evolution and taxonomy of Leishmania 
Leishmania infections in humans have a long history, dating back as far as the 
first century AD. Evidencies of leishmaniasis have been found in mummies in anchient 
Egipt and in upper Nubia (Albert et al., 2006).  Pre-Incan pottery from Ecuador and 
Peru displayed skin lesions and facial deformities that are typical of cutaneous and 




 centuries and accounts 
from Spanish conquistadors noted the presence of skin lesions on agricultural workers. 
These ulcers, similar to leprosy lesions were named “white leprosy”, “Andean sickness” 
or “valley sickness.” Detailed descriptions of the “Balkh sore” were written by Arab 
physicians in the 10
th
 century. Indian physicians also described “kala-azar” or “black 
fever” disease now known as visceral leishmaniasis. The disease became known as 
leishmaniasis after William Leishman, a Glaswegian doctor serving with the British 
Army in India. In 1901, Leishman developed one of the earliest stains of Leishmania. In 
Dum Dum (India), Leishman discovered ovoid bodies in the spleen of a British soldier 
who was experiencing high fever, anemia, muscular atrophy and swelling of the spleen. 
Leishman described this illness as “dum dum fever” and published his findings in 1903. 
Charles Donovan also recognized these symptoms in other kala-azar patients and 
published his discovery a few weeks after Leishman. After Donovan described the oval 
bodies using Leishman's stain, these forms became known as Leishman-Donovan 
bodies and officially this parasite turn out to be known as Leishmania donovani (Bari, 
2006). By linking this protozoan with kala-azar, Leishman and Donovan had discovered 
the genus, Leishmania.  
Leishmania organisms have been assigned to different species primarily based 
on clinical, biological, geographical and epidemiological criteria and, later, 
immunological, biochemical and genomic data. Hierarchical taxonomic schemes have 
been proposed using the subgenus, complex of species and species. The concept of 
species complexes for grouping the Leishmania species initially proposed based on 
biological and biochemical characteristics has been revised and modified (Schönian et 
al., 2010). In order to access the true risk associated with leishmaniasis, it is of the 
highest importance to know the distribution of Leishmania species and the evolutionary 
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relations between them. As a morphological distinction of Leishmania species is 
impractical, DNA-based criteria are now used to identify the different species.  
Leishmania belongs to the phylum Kinetoplastida, which lacks a fossil record. 
Molecular studies have shown that kinetoplastids are probably related with the 
euglenids (Dooijes et al., 2000). Kinetoplastids and euglenids are included in the 
eukaryote super group Excavata, whose fossil register point out for their emergence 
during the Ordovician period (Roger and Hug, 2006). Since Leishmania is a digenetic 
parasite it is difficult to consider the emergence of the current genus Leishmania before 
the appearance of adequate hosts, in particular the vector. The first fossil member of the 
genus Leishmania, designed as Paleoleishmania proterus, a trypanosomatid associated 
with a blood-filled female sand fly in Cretaceous Burmese amber and described by 
Poinar and Poinar (2004). This fossil dates from the Early Cretaceous and brought new 
insights regarding transmission. The discovery of a sand fly larvae, which develop in 
habitats containing free living flagellates with trypanosomatid characteristics raise the 
hypothesis that these flagellates were ingested by the sand fly larvae and probably 
multiplied inside them. Once in an adult sand fly, the flagellates could be transmitted to 
a vertebrate, thus establishing a continuing cycle between vectors and vertebrates. These 
events took place before the appearance of placental mammals during the Paleocene. It 
was after this period that Phlebotomus, the current vector of Leishmania, appeared.  
The evolution of Leishmania has been explained by two major hypotheses 
related to a Neotropical or Palaearctic origin (Figure 4). Regardless its origin, the 
dissemination of Leishmania followed the migration of vectors and vertebrate hosts 
(Perrotey et al., 2005). The definitive host of primitive Leishmania may have been 
reptiles or ancient mammals. Mainly based on the published gene sequence phylogenies 
and in the form of a number of rooted phylogenetic trees which place Neotropical 
species at the root and Palaearctic at the crown of the tree, Harry Noyes in 1998 has 
renewed the hypothesis of a Neotropical origin for the genus Leishmania. According to 
this hypothesis, Sauroleishmania subsequently evolved from mammalian parasites in 
the Palaearctic regions (Noyes et al., 2000). Additionally, the earliest fossil of sand flies 
was found at the south of the Tethys Sea, in Lebanon and was from the Cretaceous 
period, thus lived in Gondwana at 120 million years ago. Before this, Phlebotomine 
sand flies probably had lived for a long time in Pangaea from where separate lineages 
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could have developed in the Neotropics, such as the Old World sand flies species 
(Noyes et al., 2000). However, this hypothesis was contested by Kerr (2000) which 
defended a Palaearctic origin for Leishmania. From biochemical and molecular 
evidences, Kerr argues that the phylogenetic trees indicating that subgenus Viannia and 
the genus Endotrypanum are ancestral to subgenus Leishmania are un-rooted and based 
on the assumption of a constant evolutionary rate, which led to the underestimation of 
Sauroleishmania and Leishmania antiquity. This approach suggests that 
Sauroleishmania was originated in Cretaceous reptiles of the Palaearctic region. As 
reptiles declined the phlebotomine ancestral species adapted to feeding on emerging 
rodents rather than reptiles. Leishmania, along with its phlebotomine vector and a 
rodent reservoir may have evolved in the Palaearctic and at the end of the Eocene 
dispersed to the Nearctic. The fossil record of sand flies, although very scarce, provides 
evidence for the separation of Phlebotomus and Lutzomyia during the Oligocene, 
coinciding with a break in the land connection of the Palaearctic with the Nearctic. 
After the formation of the Panamanian Land Bridge, about 3 million years ago, the 
dissemination of sigmodontine rodents, Leishmania and Lutzomyia accelerated rapidly. 
A variety of mammals of South American origin, such as echimyid rodents, porcupines, 
sloths and opossums, lacking prior exposure to Leishmania, may have been particularly 
susceptible to the parasite. Furthermore, an adaptation to new mammalian hosts in 
response to climatic changes might have greatly accelerated the rate of speciation of 
Leishmania. A third Leishmania phylogeny hypothesis based on the major divisions 
within the genus is discussed by Momen and Cupolillo (2000). In this hypothesis a 
Neotropic origin is recalled for the subgenus Viannia and Paraleishmania, while an 
African origin is proposed for the subgenus Leishmania and possibly also to 
Sauroleishmania. The current distribution of Leishmania in the New World regions is 
explained as the product of multiple introductions of Leishmania parasites into 
Neotropics. Altogether, molecular trees, fossil records, historical events and 
biogeographical, entomological and ecological data need yet to be consolidated, 
supporting one hypothesis regarding the origin of Leishmania and the resulting human 
disease (Tuon et al., 2008). 




Figure 4: Map of the world in the late Cretaceous. 
Red bar shows the isolation of the Neotropics from the Palaearctic. The land bridge of Panama did not 
reconnect the two continents until 3 million years ago in the Pliocene. Light blue indicate shallow seas 
that covered large parts of the Palaearctic and Nearctic during the Mesozoic and Cenozoic. (Adapted from 
Ron Blakey, NAU Geology, in http://cpgeosystems.com/globaltext2.html) 
The most accepted standard procedure for the characterization and identification 
of strains of Leishmania is the multilocus enzyme electrophoresis (MLEE). This 
technique was firstly used in 1990 by Rioux and co-workers to classifying the  
Leishmania genus. However, the disadvantages of MLEE, as it is a very demanding and 
time consuming technique and has a moderated discriminatory power, have restricted its 
usage, being substituted by other methodologies for species discrimination using 
molecular markers. The development of new molecular techniques provided additional 
information for phylogenetic analyses. Several molecular markers have been described 
and used to investigate phylogenetic relationships within the entire genus. Some of 
these markers are: the internal transcribed spacer (ITS) 1 and 2 of the ribosomal DNA 
array (Cupolillo et al., 1995, Dávila and Momen, 2000, Berzunza-Cruz et al., 2002, 
Kuhls et al., 2005, Villinski et al., 2008), the repetitive DNA sequence (Piarroux et al., 
1995), the gene for the catalytic polypeptide of DNA polymerase α (Croan et al., 1997), 
the gene encoding the largest subunit of RNA polymerase II (Croan and Ellis, 1996), 
the cytochrome oxidase II gene (Ibrahim and Barker, 2001), the glycoprotein 63 gene 
(Mauricio et al., 2007), cysteine protease B genes (Hide et al., 2008), the mini-exon 
(Sukmee et al., 2008), 7SL RNA (Zelazny et al., 2005), the cytochrome B gene 
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(Luyo-Acero et al., 2004; Asato et al., 2009). Also, multilocus microsatellite typing 
(MLMT) fragment analysis, coding and noncoding DNA sequences of nuclear or 
mitochondrial origin, random amplified polymorphic DNA (RAPD) and multilocus 
sequencing typing (MLST), which targets conserved genes, have been used (Lukes et 
al., 2007). Most of these studies include only species of either the New or Old World, or 
isolates from one particular geographic region. Although, many molecular methods 
have been introduced to unravel the Leishmania taxonomy, defining Leishmania species 
or accepting all of the described species is still controversial. The application of 
numerical taxonomy and cladistics techniques for the analysis of electrophoretic data 
results in the current classification system (Table 1).  
At present, about 30 species of Leishmania that infect mammals have been 
described. Species of both subgenera Leishmania and Viannia can be pathogenic to 
humans and produce diverse clinical manifestations. The species within the subgenera 
were established by MLEE (Rioux, et al., 1990). The validity of the taxonomic 
classification scheme has been questioned several times, and the debate centers on the 
species status of L. (V.) panamensis, L. (V.) peruviana, L. (L.) infantum, L. (L.) chagasi, 
L. (L.) archibaldi, L. (L.) garnhami, L. (L.) pifanoi and L. (V.) lainsoni (Bañuls et al., 
2007). Cupolillo et al. (2000), by analogy with a similar division in Trypanosoma, 
proposed the separation of the genus Leishmania into two divisions, Euleishmania and 
Paraleishmania. The Euleishmania comprised the subgenera Leishmania and Viannia 
as described by Lainson and Shaw (1977) and the Paraleishmania included L. hertigi, 
L. deanei, L. colombiensis, L. equatorensis, L. herreri and the Endotrypanum strains. 
Using molecular criteria, the Paraleishmania can also be further sub-divided: one group 
formed by parasites of hystricomorph rodents (porcupines) which includes L. hertigi 
and L. deanei and the other group constituted by the remaining species which are 
principally parasites of sloths. Endotrypanum are unique among Trypanosomatidae, as 
they are able to infect erythrocytes in the mammalian host. Strains of Endotrypanum 
currently maintained in laboratory collections form a polyphyletic group within the 
Paraleishmania. Currently there are only two Endotrypanum species described, E. 
schaudinni and E. monterogeii. These species are included in Paraleishmania from 
which they are currently indistinguishable and the name Endotrypanumis is reserved for 
the true intraerythrocytic parasite of sloths (Momen and Cupolillo 2000). Also the 
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taxonomic position and phylogenetic relationship of lizard infecting Leishmania 
remains uncertain, as a number of lizards infecting parasites previously classified as 
Leishmania but apparently undergoing peripylarian development in sand flies, have 
been placed into the genus Sauroleishmania. 
Table 1: Simplified classification of Leishmania species. 
The genus Leishmania consists of the subgenera Leishmania, Viannia and Sauroleishmania, the latter 
corresponding to lizard parasites. These subgenera match the Euleishmania section. Species not classified 
in any of these subgenera were included in the Paraleishmania section. Table based on MLEE and 
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1.2.4. Distribution and epidemiology 
Leishmaniases are geographically widespread diseases with potential to increase 
their incidence worldwide. The intensification of travel and population migration, such 
as immunological naive populations in endemic areas and the movement of infected 
people into non-endemic countries may contribute to increasing leishmaniasis incidence 
worldwide. Global warming and other environmental factors may also be held into 
account as potential sources of increasing incidence (Lukes et al., 2007; Aagaard-Hanse 
et al., 2010). Leishmaniases are prevalent in 98 countries on the five continents. 
Approximately 1.3 million new cases occur annually, of which 300 000 are VL, mainly 
occurring in Bangladesh, Brazil, Ethiopia, India, Nepal, South Sudan and Sudan. 
Moreover, one million of CL are reported by Afghanistan, Algeria, Brazil, Colombia, 
the Islamic Republic of Iran, Pakistan, Peru, Saudi Arabia, the Syrian Arab Republic 
and Tunisia, and of MCL are occurring in Brazil, Peru and in the Plurinational State of 
Bolivia (WHO, 2015) (Figure 5). Although, as reporting is mandatory in only 33 out of 
98 affected countries, the true dimension of leishmaniasis remains unknown.  
Apart from the absence of consensus about the distinctiveness of some 
Leishmania species that causes disease in humans, a situation well described by the 
impasse in the classification of New World L. chagasi or the classification of L. 
archibaldi and L. killicki. Now is widely accepted that L. chagasi is a synonym of L. 
infantum, but still considered by some Latin American authors as two distinct species. 
Similar controversy is found in the classification of L. archibaldi and L. killicki as 
distinct from the closely related species L. donovani and L. tropica, respectively. From 
the 15 Leishmania species known to cause disease in humans 13 have a zoonotic nature 
(Table 2). In this case the reservoir of the parasite is sylvatic animals with habitats 
where humans are accidental hosts. Only two species of Leishmania are considered as 
having an exclusive or predominant anthroponotic transmission pattern, L. donovani 
(including L. archibaldi) and L. tropica (including L. killicki), meaning that it is mainly 
transmitted between people, who act as the reservoir hosts. Even for those species a 
presence of an animal reservoir has been indicated in several endemic settings. Several 
other Leishmania species have been found in animals but not in humans: Leishmania 
gerbilli, Leishmania turanica and Leishmania arabica from Old World rodents, 
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Leishmania equatoriensis from arboreal mammals in Ecuador and Leishmania sp. from 
red kangaroo (Gramiccia and Gradoni, 2005). 
 
Figure 5: Leishmaniasis global distribution. 
A) Global distribution of visceral leishmaniasis (VL); B) Global distribution of cutaneous leishmaniasis 
(CL) (WHO, 2013). Images available at: 
http://gamapserver.who.int/mapLibrary/Files/Maps/Leishmaniasis_2013_VL.pngand 
http://gamapserver.who.int/mapLibrary/Files/Maps/Leishmaniasis_2013_CL.png 
Zoonotic visceral leishmaniasis (ZVL) is the most widespread zoonotic 
leishmaniasis caused by a single parasite species, L. infantum. It is a life threatening 
disease, as the parasite multiplies in the macrophages of the reticuloendothelial system, 
resulting in generalized signs and symptoms like fever, splenomegaly and pancytopenia. 
This disease occurs in the Mediterranean basin, several countries of Central and South 
America (especially in Brazil) and also in Asia. Sporadic cases of localized cutaneous 
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leishmaniasis (LCL) due to dermotropic L. infantum variants are also found in the same 
endemic areas. The vector in the New World is L. longipalpis but in the Old World 
several species are involved, mainly belonging to the genus Phlebotomus (P. 
perniciosus, P. ariasi, P. neglectus and others). In ZVL can be distinguished two types 
of reservoirs, the domestic reservoir mainly constituted by the domestic dog and the 
sylvatic reservoir mainly constituted by foxes, jackals and wolves. In the Mediterranean 
basin L. infantum asymptomatic infections are common in healthy populations and 
clinical disease is associated with age, being children under 2 years the most affected 
(Šiško-Kraljević et al., 2013). Malnutrition and immunosuppression (e.g. HIV 
co-infection, immunosuppressive drugs and immunocompetence decline) are other risk 
factors of disease development (Gramiccia and Gradoni, 2005). 
Cutaneous leishmaniasis (CL), also considered generally a zoonotic disease, is 
found in Africa, Asia and in most Latin American countries, caused by different 
Leishmania species. Depending on parasite species and of the competence of the host 
immune system, the clinical features of CL are localized nodules, ulcerative lesions that 
can self-healing multiple lesions or even disfiguring lesions. In the Old World, L. major, 
L. aethiopica and dermotropic L. infantum variants are the agents for CL. In the New 
World, there are several species causing CL namely: L. braziliensis, L. guyanensis, L. 
lainsoni, L. naiffi, L. panamensis, L. peruviana, L. shawi, L. mexicana, L. amazonensis, 
L. venezuelensis (Gramiccia and Gradoni, 2005). Rarely these infections may evolve 
toward a diffuse CL [L. aethiopica (OW), L. ganhami (NW) and L. pifanoi (NW)] with 
multiple, not ulcerating nodules distributed over large areas of the skin, or to MCL [L. 
braziliensis (NW) and L. panamensis (NW)] that progresses to severe ulceration of 
oronasopharyngeal mucosa and cartilages, causing disfiguring lesions. 
Zoonotic cutaneous leishmaniasis (ZCL) is mainly caused by L. major and L. 
aethiopica and occurs in most part of the Central Asia, Middle East and North Africa. 
The transmission of the parasite through the vector is maintained by wild rodent (gerbil 
colonies). The risk of ZCL may be increased when agricultural projects are 
implemented and irrigation systems extended. These types of man-made ecological 
changes are accompanied by the intrusion of large numbers of non-immune immigrants 
in areas where leishmaniasis sylvatic cycle occurs (Dawit et al., 2013). 
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Table 2: Co-relation of zoonotic Leishmania species, human disease, geographical distribution and 
the main reservoir 
(Adapted from Gramiccia and Gradoni, 2005). 
 
Despite this widespread geographic distribution and the involvement of different 
rodent hosts, L. major appears genetically uniform by MLEE typing, even though that is 
a phonogram constructed by Rioux and coworkers (1990) shows some geographical 
subdivision. In the New World, CL are originally considered sylvatic zoonoses. Several 
species of Leishmania host’s have shown a remarkable potential to adapt to 
environmental changes introduced by man and can show a synanthropic distribution, as 
seen in tropical rain forest, secondary forests or peri-urban areas. Urban leishmaniasis 
has been identified as an increasing problem in Latin American (Mott et al., 1990). 
Zoonotic forms of the disease are influenced by human activities, mainly the migration 
from rural to urban areas, deforestation, environmental changes and ecological 
modifications that might have important consequences in the distribution of vectors and 
reservoirs and of the respective population size (Gil et al., 2010). CL, once a typical 
rural disease, is spreading into urban and peri-urban areas of countries worldwide. 
Temporary population movement due to conflicts and famine can contribute to the 
generation of new epidemic foci of disease. Non-immune populations migrated into 
endemic areas and on their return imported the parasite into a previously non-endemic 
area. Other factors contributing to new foci of LV are the high prevalence of 
malnutrition and the lack of access to diagnostic as well as treatment facilities (Collin et 
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al., 2004). Displaced populations exposed to loss of assets and subsequent famine may 
face extremely high mortality.  
Anthroponotic leishmaniasis may also occur in high densely populated urban 
settings, as in Afghanistan, Islamic Republic of Iran, Morocco and Syrian Arab 
Republic. L. tropica is the mainly anthroponotic species in the old world responsible for 
the anthroponotic cutaneous leishmaniasis (ACL) (Reithinger et al., 2003). L. donovani 
is the major agent for the anthroponotic cutaneous leishmaniasis (ACL) in the old world 
and infects people of all ages. Also, anthroponotic visceral leishmaniasis (AVL) should 
be susceptible to elimination with rapid case detection and treatment combined with 
local vector control. However, one of the most important interventions may well be the 
socio economic development. L. donovani is only found in the Old World where is 
notoriously associated with AVL of rural poor populations living in the northeast of the 
Indian subcontinent and with AVL of displaced persons in East Africa (Ready, 2014).  
Post-kala-azar dermal leishmaniasis (PKDL) may occur after recovery in some 
cases of VL caused by L. donovani. This syndrome is characterized by a maculopapular, 
macular or nodular rash around the mouth, which spreads for the entire body. In Africa, 
where PKLD is common, the disease usually occurs within 6 months of after VL 
treatment. PKDL patients are thought to be a reservoir for transmission of VL and may 
be difficult to treat, especially in some patients in East Africa who suffer from a severe 
form of PKDL. In South Asia, this syndrome is relatively rare, may occur several years 
after VL has been cured and required prolonged treatment. In India, PKLD is seen in 
1-3% of successfully treated cases of VL. PKDL is characterized by lesions rich in 
parasites, which favors anthroponotic transmission in Africa as well as in India (Musa et 
al., 2013). 
In Brazil, Colombia and Venezuela, migration, urbanization and deforestation 
largely contributed to ZVL increases as a public health problem (WHO, 2002). In 
Brazil, a country that accounts for more than 90% of all ZVL cases reported worldwide, 
has registered an increase in the incidence of the disease in the last 40 years. During this 
period, a massive migration occurred from the rural areas in large cities. Migrants 
settled in the surroundings of the main cities, building at the edges of the cities, closing 
of forested area. This may have established a link between the urban areas and the 
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sylvatic cycles, bringing humans closer to vector breeding sites and facilitating vector 
adjustment to peridomestic habitats. Furthermore, the presence of dogs in the 
households may amplify the cycle of infection and disease (Costa et al., 1990; Costa et 
al., 1995). 
In Europe there are only two transmission cycles with proven long-term 
endemism: ZVL and CL both caused by L. infantum throughout the Mediterranean 
region and, ACL caused by L. tropica now occurring sporadically in Greece (Ready, 
2010). Also in Europe climatic changes, as global warming, maybe in the origin of L. 
infantum expansion to northern countries, where normally the vector could not survive 
to transmit the parasite due to the long duration of the lower temperatures. In Italy, a 
study made by Capelli and co-workers in 2004 indicates a spread of CanL, to 
non-endemic areas in the northern part of the country. These studies indicate that the 
parasite L. infantum is advancing, as well as its vector, into non-endemic areas, which 
poses a problem to veterinarian and public health authorities. There are also evidences 
indicating a northward expansion of the parasite, as in Germany and in France, where a 
novel CanL focus has been identified outside the traditional leishmaniasis endemic 
range (Bogdan et al., 2001). The domestic dog is the only reservoir host of major 
veterinary importance and, in Europe, there is a large market for prophylactic drugs and 
treatment of CanL also caused by L. infantum. Domestic cats might be secondary 
reservoir hosts of L. infantum in southern Europe, because they are experimentally 
infectious to sand flies and natural infections can be associated with feline retroviruses 
(Maroli et al., 2007). 
Also HIV infection appears to increase susceptibility to VL affecting its 
epidemiology. In places where the access to antiretroviral therapy is limited, the 
prevalence of VL is rising. In northern Ethiopia, the rate of co-infected patients 
increased from 19% during 1998–1999 to 34% during 2006–2007 (Alvar et al., 2008; 
WHO, 2013). Starting from the early 1990s, the impact of Leishmania-HIV 
co-infections was recognized as an alarming problem by international health authorities 
(Desjeux, 1996). Cases were reported from 35 countries world-wide, but most have 
been recorded in southwestern Europe namely France, Italy, Portugal (Campino et al., 
1994) and Spain, showing a deadly overlapping between HIV and ZVL. The strong 
influence of the HIV-associated immunosuppression on the virulence of L. infantum 
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infection did not occur for other agents of zoonotic leishmaniasis, such as L. major in 
tropical Africa (Guiguemdé et al., 2003) or New World CL agents. However, by the end 
of the 1990s, several reports indicated that the L. infantum/HIV epidemic peak was 
over, fact that was attributable to the introduction of the highly active antiretroviral 
therapy (HAART). Currently, very few HIV-infected individuals with clinical VL are 
annually recorded in southern Europe. Records are mainly from AIDS patients 
unresponsive to HAART. Analogously, the feared Leishmania-HIV epidemic in 
endemic countries of Latin America such as Brazil, which was expected because of the 
increasing overlap of the two infections, has not occurred thanks to the free and 
universal distribution of antiretroviral drugs. At the same time the prevalence of both 
HIV and L. infantum infections have remained unchanged or even increased in overlap 
areas. Because the current benefic effect of HAART on the outcome of VL disease 
could be reversed by the emergence of HIV drug resistance, current surveillance 
activities on leishmanial infections in asymptomatic HIV-infected individuals should be 
continued (Gramiccia and Gradoni, 2005). On the other hand, VL is being reported with 
increasing frequency in transplant recipients, with several cases reported thus far. The 
most likely pathogenetic mechanisms of VL in transplant patients are either primary 
infection acquired by immunosuppressed subjects traveling in regions of endemicity or 
reactivation of a preexisting asymptomatic infection in the recipient, while acquisition 
through either an infected graft or blood transfusion probably represents an uncommon 
situation (Biglino et al., 2009). Nevertheless, the risk of transfusion-transmitted 
leishmaniasis should not be completed dismissed as demonstrated in a study by Luz et 
al., (1997), where a significantly higher seroprevalence was observed among 
multiply-transfused patients than among voluntary blood donors in regions of high 
endemicity, pointing out the need to control the blood transfusion donor and receptors.  
As leishmaniasis is distributed through the world and with potential to increase, 
the development of new therapeutic targets and drugs and the development of 
affordable and effective vaccine, are the major challenges of controlling the 
dissemination of these parasite diseases. However, in parallel this has to be 
accompanied by the improvement of sanitary conditions on precarious population 
settlements. 
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1.2.5. Control strategies 
1.2.5.1. Diagnosis 
The clinical diagnosis of leishmaniasis is complex because its clinical features 
are common to others frequently occurring diseases in the same geographic area, such 
as malaria, typhoid and tuberculosis in case of VL or leprosy, fungal or bacterial 
infections, tuberculosis or syphilis in the case of CL and MCL, among many other 
diseases. Also, many of these diseases can be present along with VL, in cases of 
co-infection.  
The natural sequestration of the parasite in the spleen, liver, bone marrow or 
lymph nodes difficult parasite isolation and further complicates the diagnostic. 
Laboratory diagnosis of leishmaniasis can be made by the following procedures: (i) 
demonstration of parasite presence in tissues of relevance by light microscopy with the 
examination of the stained specimen, followed by in vitro culture, or animal 
inoculation; (ii) detection of parasite DNA in tissue samples; (iii) immunodiagnosis by 
detection of parasite antigen in tissue, blood or urine samples or (iv) by specific 
detection of antileishmanial antibodies (immunoglobulins) (Sundar and Rai, 2002).  
The commonly used method for VL diagnosis has been the identification of 
parasites in splenic or bone marrow aspirate. The confirmed presence of parasites in 
aspirate biopsy specimens or in the peripheral blood buffy coat attests for a positive 
diagnosis. However, the procedure to obtain a spleen aspirate may be life threatening 
due to the risk of internal hemorrhage. Besides the Giemsa and Leishman stain, 
Leishmania can also be detected in tissue samples using fluorescent antibodies specific 
to the surface receptors of the parasite. Fluorescein isothiocyanate isomer or rhodamide 
B isothiocyanate conjugated antiserum is usually used for this purpose. Fluorescent 
monoclonal antibodies are also used for identification of the parasite specie. Culture of 
parasites can improve the sensitivity of detection, but Leishmania culture in routine 
clinical practice is time consuming and an expensive procedure. However, cultures are 
required for an accurate diagnosis of the infection, as a supplement to other methods or 
to provide a diagnosis when routine methods have failed.  
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Leishmania strains can be maintained as promastigotes in artificial culture 
medium. The culture media used may be monophasic (Schneider’s insect medium, 
M199, Glasgow medium, RPMI or Grace’s insect medium) or diphasic 
(Novy-McNeal-Nicolle medium and Evans' modified Tobie's medium). Culture tubes 
are inoculated with bone marrow, lymph node or splenic aspirate and incubated at a 
temperature between 22º and 27°C. The tubes are followed weekly, during 4 weeks, by 
microscopy to detect promastigotes presence. After this period are discarded as 
negative. If promastigotes are present, they are maintained by weekly passage to fresh 
medium. Blood can also be used to isolate the parasite, from the cellular deposit after a 
centrifugation, but the method is slow and takes longer. In areas of endemicity of the 
disease, recognition of Leishmania species is not usually performed. However, 
identification of an organism to the species level is epidemiologically helpful and is also 
important in the treatment and prognosis of travelers, which usually are highly 
susceptible to the parasite and tend to develop unusual manifestations of the disease 
(Boelaert et al., 2004). Due to the limitations inherent to the classic techniques used for 
detection of parasites and sometimes dependent on their isolation, new approaches for 
parasite detection have been attempted since the early 1980s.  
The development of PCR has provided a powerful approach to the application of 
molecular biology techniques to the diagnosis of leishmaniasis. There are different 
target sequences used, which include ribosomal RNA genes, kinetoplast DNA (kDNA), 
miniexon-derived RNA (medRNA) and the β-tubulina gene region. Species level 
identification can be achieved by analysis of amplified kDNA using primers from 
conserved regions of different Leishmania species kDNA minicircles (Singh et al., 
1999). PCR analysis could be used to detect the presence of Leishmania in spleen, liver, 
lymph node and bone marrow aspirates, whole blood and buffy coat of suspected VL 
patients. Several other PCR based techniques had been developed in order to create 
more specific techniques, with potential to identify the parasite species and to be 
performed with whole blood from potential patients. A PCR–ELISA technique was 
developed and is based on the PCR amplification and labeling of target amplicons and 
their hybridization with target specific probes, capture of labeled hybrids into a 
microplate or tube and subsequent detection by immunoassay. The generated amplicons 
are usually labeled with digoxigenin molecules and are easy to detect using 
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anti-digoxigenin antibodies. This PCR-ELISA technique presents a high sensitivity 
inVL diagnosis using peripheral blood samples (Singh and Sivakumar, 2003). More 
recently, an evaluation of an oligochromatography-PCR for diagnosis of VL, CL and 
PKDL, showed a high sensitivity (> 95%) on lymph, blood and bone marrow samples 
from confirmed VL patients (Saad et al., 2010). Another interesting approach is a rapid 
fluorogenic PCR technique. Wortmann et al., (2001) used a fluorescent DNA probe for 
a conserved rRNA gene that is amplified using flanking primers with great sensitivity 
and specificity demonstrated in clinical samples. The real-time PCR has the advantage 
of being quantitative, which could be useful in the follow up of treatment, allowing the 
assessment of the parasite burden (Bossolasco et al., 2003; Mary et al., 2004). PCR 
could also prove to be an important tool in assessing the success of VL treatment. 
Studies using PCR analyzed VL patients who tested negative by PCR with lymph node 
tissue, none relapsed or developed PKDL. However, more than half of patients who 
tested positive by PCR with lymph node tissue either relapsed from VL or developed 
PKDL after apparent cure of disease following supervised treatment. Though, the role 
of PCR as defining technique to describe the patient status or the prognosis is still 
debated, as a substantial number of patients, who tested positive by PCR, after apparent 
cure, did not relapse or develop PKDL. These results elucidate the limitation of PCR in 
deciding the end point of treatment. The PCR positivity observed in these patients may 
be due to the presence of non-viable parasites. Similarly, PCR analysis performed on 
healthy inhabitants of endemic areas may result positive (Elmahallawy et al., 2014), 
which may lead to the erroneous conclusion that they suffer from VL. In these cases, a 
combination of techniques may be helpful in defining the status of these patients, using 
direct agglutination test (DAT), which shows low titers in healthy endemic controls and 
PCR. However, PCR techniques remain complex and expensive and, in most 
leishmaniasis endemic countries, they are restricted to a few hospitals and research 
centers. 
Several studies have demonstrated the presence of leishmanial antigens in the 
urine of VL patients. The antigen is detected quite early during the infection and the 
results of animal experiments suggest that the amount of detectable antigen tends to 
decline rapidly following therapy. It has been developed a latex agglutination test 
(KAtex, Kalon Biological, UK) for detecting leishmanial antigen in urine of patients 
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with VL has showing high specificity from 82% to 100%, but moderate sensitivity. This 
method is nowadays useful in the diagnosis of disease in cases where there is a deficient 
antibody production as in immunocompromised patients. In summary, the latex 
agglutination test is simple, easy to perform, inexpensive, rapid and can be used as a 
screening test. Because it promises to be a test of cure in populations of developing 
areas, efforts have been made to improve the performance of this technique (Srivastava 
et al., 2011).  
The human body makes an attempt to fight against VL by producing the highest 
levels of antibodies. This is due to polyclonal activation of the B cells, resulting in 
marked elevation of immunoglobulin M (IgM) and IgG against various nonspecific 
proteins. The consistent presence of high levels of antibodies against parasite antigens 
can simplify VL diagnosis. Several serological techniques are based on detection of 
these antibodies. Current serological tests are based on four principal formats: indirect 
fluorescent antibody (IFA), enzyme-linked immunosorbent assay (ELISA), western blot 
and direct agglutination test (DAT). The sensitivity depends upon the assay and its 
methodology, but the specificity depends on the antigen rather than the serological 
format used. IFA shows acceptable sensitivity (87%–100%) and specificity (77%–
100%) (Boelaert et al., 2004). Promastigote forms should be the antigen of choice for 
VL diagnosis of by the IFA because they minimize cross-reactivity with trypanosomal 
sera. However, the need for a sophisticate fluorescence microscope leaves the IFA test 
to the reference laboratories. DAT is based on direct specific agglutination of 
Leishmania promastigotes by serum anti-Leishmania antibodies. Trypsinized 
coomassie-stained promastigotes can be used either as a suspension or in freeze-dried 
form that can be stored at room temperature for at least two years, facilitating its use in 
the field (Oskam et al., 1999). Although DAT showed a high degree of repeatability 
within the centers, its reproducibility across the centers was quite weak (WHO, 2014). 
Moreover, difficult field conditions, time consuming incubations, the fragility of 
aqueous antigen, the lack of cold chain and batch-to-batch variations in the antigen, 
along with the non-standardization of test readings, have severely limited its 
applicability in regions of endemicity. Two DAT procedures are available, the 
EasyDAT described in 2003 with the same sensitivity, specificity and durability as the 
traditional DAT antigen method, offering the additional advantage of cost reduction and 
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standardization (Gómez-Ochoa et al., 2003) and the fast agglutination screening test 
(FAST) developed by Schoone et al., (2001) with an incubation time reduced to only 
3 h, mainly indicated for screening large populations. However, anti-Leishmania 
antibodies may persist for several years after treatment, leading to positive DAT titers in 
cured patients. Although DAT results should be carefully analyzed DAT remains the 
serological test of choice as well as the first antibody detection test for VL used in the 
field. The latex agglutination test (LAT) is one of the recently developed rapid 
diagnostic tests for detection of anti-Leishmania antibodies against the A2 protein 
derived from the amastigote form, as well as those against crude antigens derived from 
promastigotes of an Iranian strain of L. infantum. Both antigens were selected using dot 
blotting of positive and negative pooled sera and used to sensitize 0.9-μm latex beads. 
Tests were carried out in serum of human patients with VL (confirmed with 
parasitological isolation), health controls and patients with other non-leishmaniasis 
disease. Canine serum was also tested from dogs with confirmed CanL and healthy. 
Compared with the controls, human sera from DAT-confirmed patients yielded a 
sensitivity of 88.4% and specificity of 93.5% on A2-LAT (amastigote). A good degree 
of agreement was found between A2-LAT and DAT, with the advantage of LAT being 
a test much faster to complete (Ghatei et al., 2009; Akhoundi et al., 2013). 
ELISA has been used as a potential serodiagnostic tool for almost all infectious 
diseases, including leishmaniasis. The technique is highly sensitive, but its specificity 
depends upon the antigen used. Several ELISA have been devolved using different 
antigens. The commonly used antigen is a crude soluble antigen (CSA). It is prepared 
by repeated freezing and thawing of a suspension of promastigotes in 
phosphate-buffered saline, followed by centrifugation. The supernatant is used as 
soluble antigen and is used to coat ELISA plates. The sensitivity of CSA-ELISA ranges 
from 80% to 100% and specificity from 84% to 95% (Ryan et al., 2002). However, 
cross-reactivity with sera from patients with tuberculosis, trypanosomiasis and 
toxoplasmosis has been reported (Bray, 1976; Smrkovski and Larson, 1977). A cloned 
of a conserved portion of a L. chagasi kinesin-related protein used as a recombinant 
antigen (rK39) has been reported to be highly reactive to sera from human VL and 
CanL when run in an ELISA format (Burns et al., 1993). Using this recombinant 
antigen, 99% specificity and sensitivity were reported in immunocompetent patients 
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with clinical VL. Because of the conditions prevailing in areas of endemicity, any 
sophisticated method cannot be employed on a wider scale. Other recombinant 
hydrophilic L. chagasi antigens rk9 and rk26 have been tested, leading to an increase in 
the list of available antigens for serodiagnosis of VL (Mohapatra et al., 2010). 
Moreover, heat shock proteins HPS70 or histones proteins H2A, H2B, H3 and H4 may 
have potential use for VL serodiagnosis. Furthermore, when lipid-binding proteins 
(LBP) were used as antigens have shown high sensitivity and absence of cross-reactions 
with sera of patients with other diseases (Brito et al., 2000). A rapid test, based on rK39 
antigen, has been developed in the form of a ready-to-use immunochromatographic strip 
test. The recombinant antigen is immobilized on a nitrocellulose band membrane. 
However filed testing results show that the sensitivity of the test is not constant, as it 
can change with the geographical area of the test. These differences in sensitivity may 
be due to differences in the antibody responses observed in different ethnic groups and 
so it can be useful as preliminary diagnostic tool, but a confirmatory diagnosis is needed 
in the positive cases. It has been noted that all antibody detection tests share the same 
drawbacks; the antibodies remain positive for many months after the patient has been 
cured and do not differentiate between current and past infection. In endemic regions, 
asymptomatic infected people can also be positive in these tests (Elmahallawy et al., 
2014). 
Immunoblotting, also known as western blot, can also be used to identify LV 
positive patients. For this type of testing, promastigotes are cultured, lysed and the 
proteins are separated on sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE). The separated proteins are electrotransferred onto a nitrocellulose 
membrane and incubated with the patient serum. The western blot technique provides 
detailed antibody responses to various leishmanial antigens (Brito et al., 2000; 
Santos-Gomes et al., 2000) and has been found to be more sensitive than the IFA test 
and ELISA, in particular for HIV patients with VL, but is time consuming and requires 
specialized equipment and technicians, thus limiting its use to research laboratories and 
not in diagnose. 
Diagnosis confirmation of CL and MCL is usually performed in the laboratory 
by direct identification of amastigotes in Giemsa-stained lesion smears of biopsies, 
scrapings, or impression smears. Amastigotes are observed as round or oval bodies, 2–4 
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μm in diameter, with the characteristic nucleus and kinetoplast. As for CL diagnosis, 
different procedures are used to isolate the parasite from the lesions. This can be 
achieved by scraping the lesion, after application of anesthetic in order to collect 
material to microscope slides to stain and examine under optical microscopy. A tissue 
biopsy is also used to collect tissue for processing to microscope observation or for PCR 
detection. An aspirative biopsy performed with a needle in a syringe with phosphate 
saline buffer may also be used to isolate the parasite, as this exudate can be used to 
initiate a culture. Both tissue biopsy and needle aspirate can lead to the parasite species 
identification. Seroimmunological tests for detection of specific anti-Leishmania 
antibodies, as described above, can also be performed. However, these methods are not 
commonly used because antibodies tend to be undetectable or presented in low titers 
due to poor humoral response (Amaral et al., 2000; Romero et al., 2005). Although 
parasite isolation by culture and parasite DNA detection by PCR are sensitive methods 
are not currently used in developing countries. 
In case of CanL it is also necessary to have tools that allow a correct diagnosis. 
Diagnosis of CanL is based on the presence of clinical signs together with positive 
specific antibody assay. Infection can be confirmed by demonstration the presence of 
amastigotes on stained slides or in cultures of biopsy aspirates of the bone marrow or 
lymph nodes or, even of healthy skin biopsy specimens. Diagnostic antibody tests 
available for veterinarian use include IFA, DAT and ELISA. These tests vary in 
sensitivity and specificity, and although they detected a specific humoral immune 
response, they do not prove or rule out active infection. These assays may give 
false-positive reactions with sera of dogs imported from endemic areas that have been 
vaccinated against Leishmania ssp. and in dogs infected by Trypanosoma cruzi, another 
protozoan that sometimes infects dogs in the Americas. However, the rK39 dipstick 
immunoassay does not cross-react with T. cruzi or Babesia. PCR and real time PCR 
assays are also available at few veterinary diagnostic laboratories and can be helpful in 
confirming infection in individual patients and as part of an overall control program 
(Solano-Gallego et al., 2011). 
  




Leishmaniases are considered by the World Health Organization (WHO) one of 
the main neglected diseases in the world, affecting primarily the poor population in 
underdevelopment countries with great social-economic impact. However, the 
commercial interest from pharmaceutical companies in developing new compounds to 
treat leishmaniasis and other tropical neglect diseases is limited. These limitations arise 
from the fact that the treatments have to be affordable, to ensure their access from the 
affected poor populations.  
None of the currently available drugs can be considered ideal due to several 
factors such as considerable toxicity, severe adverse reactions, long treatment duration 
or high costs. On the other hand, our understanding of Leishmania biology has not yet 
been translated into effective new drugs, with only a few new alternative drugs 
emerging in the past years (Menezes et al., 2015).  
Antimony compounds constitute the first line of treatment for all forms of 
leishmaniasis for more than 70 years. However, only in recent years its chemical 
structure and mechanism of action has been defined. Also in the recent years, a 
large-scale increase in clinical resistance to pentavalent antimonials has been reported, 
mainly in India, where 65% of patients treated for the first time failing to respond to 
treatment (Murray, 2005). The second line of drugs includes pentamidine and 
amphoterin B, but severe side effects combined with high costs, limit their use. 
Miltefosine (hexadecylphosphocholine), originally developed as an anticancer agent, is 
now approved and used as an oral drug for the VL treatment However, problems with 
costs and long half-life are being raised.  
CL was usually treated with local therapy. At the end of the 19th century in 
Tashkent (Uzbekistan), pure lactic acid was applied to the lesions to cauterize it. Other 
cauterizing agents, including copper sulfate, old battery acid, plant extracts and heating 
of the lesions, were also applied (Olliaro and Bryceson, 1993). Antimony has been used 
as a drug for several centuries, but the modern use of it began only in 1905 when 
Plimmer and Thompson showed the activities of sodium and potassium tartrate against 
trypanosomes. This discovery leads to the subsequent use of this drug in the treatment 
of human trypanosomiasis in Africa. Then, the use of trivalent antimony was spread to 
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countries affected by leishmaniasis. However, later on this drug was found to be highly 
toxic as well as very unstable in a tropical climate, evidencing a suboptimal treatment in 
terms of clinical, resistance and relapses. The development of a less toxic pentavalent 
antimonial led to the synthesis of antimony gluconate (Solustibosan) and sodium 
stibogluconate (Pentostam) (Menezes et al., 2015). Now a days the most commonly 
used organic compounds of antimony (Sb) are sodium stibogluconate and meglumine 
antimoniate. Pentavalent antimonial has been the most frequently used drug for VL and 
CL treatment despite their variable effectiveness. Antimonials can cause serious adverse 
effects, as it can be accumulated in tissues, causing severe cardiotoxicity, pancreatitis 
and nephrotoxicity that require hospitalization and close monitoring of patients. The 
adverse effects and the lengthy treatment period lead to treatment noncompliance and 
abandonment, favoring the emergence of resistant Leishmania in India. However, 
antimonial still are used as the first-line treatment in the endemic areas world-wide 
(Haldar et al., 2011). Sensitivity of different Leishmania species to antimonials varies 
differently. For example Navin et al., (1992) published a study were L. brazilensis 
showed to be more sensitive to sodium stibogluconate (Pentostam) than L. mexicana, 
highlighting the importance of a specific approach in the treatment of leishmaniasis. 
Resistance is associated with host factors such as decreased drug uptake, increased 
efflux mechanism, reduced concentration inside the parasite, inhibition of drug 
activation, inactivation of active drug and gene amplification. The role of ATP-Binding 
Cassette Transporters (ABC) transporters, such as P-glycoprotein and multidrug 
resistance (MDR)-related protein, in drug resistance was proven in laboratory isolates of 
Leishmania ssp. (Haldar et al., 2011). However, its role in the field isolates is still not 
clear. 
Amphotericin B is an antifungal agent extracted from the filamentous bacteria 
Streptomyces nodusus. It is used as the second line drug in patients with leishmaniasis. 
Amphotericin B formulations, such as lipid complex, colloidal form or the liposomal 
form, were developed to reduce adverse effects caused by the pure amphotericin B 
solution and improve pharmacokinetics and bioavailability. Despite proven less toxic, 
these alternative formulations of amphotericin B have limitations for use in developing 
countries: they have high costs and are unstable at higher temperatures, requiring 
cooling chain to be maintained. Although amphotericin B has been proven as a 
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successful therapeutic agent for patients with leishmaniasis, there are few reports 
indicating the emergence of resistance. Despite the mechanism of resistance of 
amphotericin B is not yet clear a resistance increase could be expected because of the 
high frequency of its use, mainly in India (Mohapatra, 2014). More recently, Purkait 
and coworkers (2012) demonstrated the generation of amphotericin B resistant parasites 
associated with a molecular mechanism that leads to changes in membrane composition, 
conducting to a decreased in amphotericin B binding and reduced uptake by the 
parasite. Also MDR1 gene in the ABC transporters of promastigotes seems to be 
responsible for the drug efflux mechanism and subsequently leads to resistance. 
Pentamidine, other alternative drug currently used for leishmaniasis treatment, is 
highly toxic and triggers important adverse effects, such as diabetes mellitus, severe 
hypoglycemia, hypotension, myocarditis, renal toxicity and can, ultimately, cause death. 
Nowadays, due to the appearance of resistance cases, high toxicity and low efficacy, 
this drug is less used (Singh et al., 2012a). Currently, pentamidine are mainly used in 
combined therapeutic protocols.  
Paromomycin is a broad spectrum antibiotic extracted from the bacteria 
Streptomyces rimosus subsp. paromomycinus. It is active against several parasites and 
constitutes an alternative drug for leishmaniasis treatment. Low cost, fewer side-effects 
than other drugs, better efficacy and shorter duration of administration make this drug 
popular and thought to be a candidate for the first line therapy for VL patients. 
However, parenteral formulations still cause serious adverse reactions, including 
nephrotoxicity and hepatotoxicity and it is likely the acquisition of resistance in 
monotherapy. To combat these problems, newer formulations like paromomycin loaded 
with albumin microsphere and paromomycin with liposome formulation have been 
developed exhibiting better results (Wiwanitkit, 2012, Mohapatra, 2014). 
Miltefosine (hexadecylphosphocholine) is the first oral drug for VL treatment 
and exhibits a high cure rate (Sundar et al., 2002). It also had shown good results 
against antimony resistant VL and PKDL cases and in India, it is proposed to be the 
first-line drug in the kala-azar elimination program. The mechanism of action of this 
drug is not yet fully understood and because of anthroponotic transmission in the Indian 
subcontinent, the misuse of the drug and its longer half-life are the two factors that may 
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lead to a rapid acquisition of resistance to this drug (Bhandari et al., 2012). More 
recently, there are reports of miltefosine resistant cases from Nepal (Pandey et al., 
2012). The proposed mechanism of Leishmania resistance to miltefosine was 
inactivation of genes responsible for drug uptake, but several other factors may be also 
responsible for the mechanism of resistance of miltefosine apart from point mutation. 
Depending on the country, there are various protocols for CanL treatment, but 
the combination of antileishmanial drugs like meglumine antimoniate together with 
allopurinol, a well-known leishmaniostatical drug, is the most frequently chosen 
protocol. The duration of the treatment depends on the severity of the disease, 
individual tolerance to drugs and side effects, as well as clinical response. As in 
humans, there are also several side effects when these drugs are used in dogs. 
Meglumine antimoniate can induce nephrotoxicity and miltefosine can give origin to 
gastrointestinal problems. For each dog, it is important to determine CanL clinical stage 
before starting treatment in order to apply the most adequate treatment, potentiating a 
better prognosis. Nevertheless, parasitological cure is rarely achieved and relapses are 
common. Once leishmaniasis is diagnosed, dogs should have a close follow up after the 
first month of treatment, including a thorough physical examination, serum biochemical 
analysis and urinalysis. Subsequently, every six months, the patient should be 
reevaluated and serology against Leishmania repeated. If available, real-time PCR 
evaluation should also be done. Dogs in a more advanced disease stage should be 
evaluated every 1–2 months during treatment with particular emphasis on the analysis 
of functional parameters of the most susceptible organs, like kidneys and liver (Kaszak 
et al., 2015). 
The current available treatments for leishmaniasis present several challenges as 
they can have high toxicity and be used for a long term, causing severe adverse 
reactions. This often leads to treatment, abandonment and failure. In addition, many 
current antileishmanial drugs do not completely eliminate the parasites from infected 
individuals, leading to future relapses. Alternative protocols, such as the rational 
combination of drugs to combat the resistance developed in monotherapy, or 
combinations of immunotherapy and antileishmanial drugs are now being developed, as 
they can reduce individual doses, treatment duration and adverse effects (Menezes et 
al., 2015). Recently, a trial was carried out in East Africa for the treatment of VL, 
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comparing a lower dose of paromomycin in association with sodium stibogluconate 
during 17 consecutive days and, with sodium stibogluconate in monotherapy for 30 
consecutive days. The combination of paromomycin and sodium stibogluconate showed 
efficacy and safety similar to sodium stibogluconate, suggesting that this drug 
combination is suitability for VL treatment in East Africa, as it reduces the time needed 
for treatment (Musa et al., 2012). Other studies are being conducted in order to evaluate 
the safety and efficiency of several antileishmanial drug combinations. Controlled 
release systems, such as liposomes and nanoparticles, provide a greater efficacy and 
safety, as drugs are more target driven, reducing the dose and adverse reactions of 
conventional formulations. Another strategy to improve antileishmanial treatment is the 
identification of new targets both in parasites and in host cells. Potential new targets for 
drugs have been identified in molecular and biochemical studies and some are being 
validated. Studies designed to better understand the biology of host-parasite interactions 
would facilitate the design of more effective drugs against Leishmania infection 
(Menezes et al., 2015). 
1.2.5.3. Reservoir and vector control 
Leishmaniases are emerging diseases caused by a parasite with ability to adapt 
to changing environments, spreading into new geographical regions. Constant 
epidemics and the military importance of the disease, along with the lack of a human 
vaccine or chemoprophylaxis, have increased the interest in the biology and control of 
phlebotomine sand flies and also driven attention to the reservoirs, in particular to the 
VL peridomestic reservoir, the dog. The importance of CanL as a possible measure of 
human disease risk was demonstrated in Brazil, where a rise in the number of human 
cases was preceded by an increase in CanL prevalence (Miró et al., 2008). 
Primary available strategy to control the dissemination of leishmaniasis includes 
control of reservoir populations and vectors. A study by Kassi et al., (2008) 
demonstrated that in order to reduce CL risk significantly a reservoir population should 
be eliminated in a 500 m radius of a protected area. However, the imposition of this 
kind of measures is questionable and other alternatives are proposed to control the 
vector population. The interventions selected would then depend on the incidence of 
disease in that particular area, the population being targeted, the reservoir, the particular 
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vector, the environment, the acceptability of the intervention and the availability of 
funds. Most of adult sand fly control techniques can be placed in the following 
categories: (i) application of long-lasting insecticides to surfaces, often interior walls, to 
either kill or repel sand flies or as space-sprays that kill the sand flies within a treated 
space, (ii) barriers and treated netting/clothing and use of topical repellents on the skin. 
Of these techniques, residual spraying of houses and animal shelters is probably the 
most useful and the most used, with several insecticides available for use. A study 
performed by Tatreault et al., (2001) tested the susceptibility of four species of sand 
flies from the Middle East (P. bergeroti, P. langeroni, P. papatasi and P. sergenti) to 
various insecticides. This study indicated that DDT (an organochlorine) and malathion 
(an organophosphate) exhibited less sand fly-specific toxicity than the pyrethroid 
insecticides, including resmethrin and cyfluthrin. DDT was the first insecticide used on 
a large scale for control of sand flies. It was applied in large amounts in India, the 
former Soviet Union, Brazil and China, causing some reduction in sand fly populations. 
However, biological questions as whether the reduction in the number of insects has a 
direct impact on disease risk and on insect biodiversity were raised (Lane, 1991). The 
use of residual sprays is limited by several environmental factors, including high 
summer temperatures, strong radiation and the accumulation of dust. These conditions 
may reduce insecticide toxicity or efficacy. In Brazil, the interior and exterior 
applications of deltamethrin were accomplished by a significant reduction of sand fly 
populations inside the house, but the exterior spraying were ineffective. The long-term 
effect on morbidity due to leishmaniasis, however, was not assessed. Deltamethrin 
application in other geographic areas often had similar results (Falcão et al., 1991). 
In some ways, phlebotomine vector control is similar to that performed for 
malaria vectors. The exception is the larval control, as most larval control techniques 
used against mosquitoes, are inappropriate for sand fly because the aqueous habitat of 
the mosquito larva is different from the highly organic soil required by the sand fly 
immature stages. However, the use of Bacillus sphaericus for sand fly larval control is 
possible. In this innovative technique, bait-fed adult sand flies were used to carry the 
bacteria control agent to larval habitats in animal burrows, resulting in larval mortality 
(Robert et al., 1997). Adult sand fly and mosquito vectors share characteristics that 
make control for one similar to the control for the other. In fact, some researchers 
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believe that a reason for leishmaniasis resurgence is a reduction in the use of 
insecticides for malaria control (Lane, 1991). Reductions in leishmaniasis were also 
noted with antimalarial programs that relied on interior residual sprays in Italy, Iran, 
Bangladesh and Peru (Alexander and Maroli, 2003). 
Other alternative insecticides are the space sprays which do not leave significant 
residues in the habitat and have also been part of some sand fly control programs. These 
sprays can be used in the interior or exterior and are aimed at the insects present in the 
environment at spraying-time (usually the flying insects). Although the efficacy of this 
measure is still debated, as sand flies are very small insects and the insecticides used are 
short-lived, interior fogs are still a part of some vector control programs and can provide 
temporary relief from insect bites. It is also important to notice that the repellency and 
contact irritancy of space sprays makes more important protecting humans from 
exposure to vectors than is the lethal effect of the insecticide. A new class of chemicals 
with repellent properties, including neem oil, citronella, linalool and geraniol, has also 
been tested against sand flies showing diverse levels of effectiveness (Muller et al., 
2008). The inconsistent results obtained from interior residual sprays and the continued 
development of insect resistance to the insecticides of choice, including DDT, increase 
the importance of the use of insecticide-treated nets (ITN) as a measure of sand fly 
control. The ITN can provide considerable protection against the local indoor feeding 
sand flies. ITN are very attractive as they can be effective, relatively cheap and 
sustainable. In addition, the pyrethroid insecticides used to treat the nets have relatively 
low mammalian toxicity and good insecticide activity (Alexander and Maroli, 2003). 
Nevertheless, the results of large-scale ITN programs have been inconsistent as they are 
dependent on individual behave. Trials in Iran and Syria had disappointing results. 
However, in Sudan a significant VL reduction was observed following the mass 
distribution of fine-mesh ITN (Ritmeijer et al., 2007). 
Although certain wild animal species may be involved in ZVL epidemiology, 
domestic dogs appear to be the principal reservoir host of L. infantum throughout the 
world. Much of the focus on ZVL control is currently placed on these animals, 
particularly in ZVL screening, vaccination and protection with collars impregnated with 
insecticides such as deltamethrin. Killick-Kendrick et al., (1997) were the first 
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demonstrating that such collars (Scalibor® Protector Bands) exerted a potent repellent 
and anti-feeding effect on P. perniciosus, killing up to 60% of the insects within 2 h of 
exposure. Collars also killed about 50% of sand flies exposed to protected dogs during 
the same period. Based on laboratory evaluations, it has been suggested that, at least in 
the Mediterranean and Middle East sub-regions, this measure could be expected to 
protect dogs from most sand fly bites, retaining a protective and killing effect for a 
complete biting season (Killick-Kendrick et al., 1997). It has also been suggested that 
given the long-term effect of collars (up to 34 weeks), supplying them to the majority of 
dogs in a L. infantum focus would reduce contact between vectors and reservoirs 
sufficient to diminish the risk of infection for both dogs and humans. 
In the absence of a human vaccine, disease prevention will continue to focus on 
vector control, amplified by other measures such as reservoir culling (measure yet not 
proved to be efficacious in the reduction of leishmaniasis incidence), serological 
screening and personal protection. The adaptability of the parasites and the vectors has 
permitted the disease to spread into new environments, including suburban and urban 
environments. In order to address the continued spread of this disease, increased efforts 
in the fields of urban entomology, civil engineering, disease surveillance and tropical 
urban ecology are required (Claborn, 2010). More focalized measures may require 
increased community participation and education in preventative measures against 
leishmaniasis. Improved information on sand fly biting behavior, resting and breeding 
sites would make delivery of existing compounds more efficient, resulting in lower 
costs of interventions, higher efficacy and fewer detrimental effects to the environment 
(Alexander and Maroli, 2003). 
1.2.5.4. Vaccines 
The possibility of achieving a vaccine for leishmaniasis is encouraged by the 
well described fact that most individuals, who have been infected with Leishmania and 
recover from the infection, become resistant to later re-infection. Also, the ancient 
practice of leishmanization can be seen as further proof of biological feasibility of 
vaccine development, at least for CL. Widely practiced in the Middle East and Central 
Asia, individuals, mainly the girls, was deliberately exposed to the parasite in a similar 
process to vaccination, using thorns or sharp instruments to introduce live parasites and 
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artificially simulate a cutaneous infection, in an unexposed site on the body to prevent 
the risk of facial lesions through natural infection. Leishmanization have been 
empirically developed and were in use in various countries (former Soviet Union, 
Central Asia, Israel and Iran), remaining the only group of human leishmaniasis 
vaccines to show real efficacy (Nagill and Kaur, 2011; Beaumier et al., 2013). 
However, issues relating to the biological safety of such live vaccine were raised, 
mainly about dose control of and strain used as well as the difficulty of getting a 
standardized vaccine product. Together with the occurrence of persistent lesions, lead to 
the limitation of its use. 
Despite different Leishmania species causing a range of clinical manifestations, 
genomic analysis indicates a large degree of sequence homology between species, 
suggesting it may be possible to generate broadly effective vaccines against different 
clinical diseases. Up to this time, several strategies have been followed in an attempt to 
mimic the effect of leishmanization in a safer way. Whole-killed (autoclaved) 
Leishmania promastigotes were also tested as vaccines against CL and VL. Killed L. 
major parasite as vaccines against CL with BCG as adjuvant, was tested in Iran and 
showed that this approach was considered safe with no evidence of an exacerbating 
response following natural infection. However, low in immunogenicity was reported 
being considered multiple doses or other adjuvants applications to increase its 
immunogenicity and achieve the goal of reduce the incidence of CL (Momeni et al., 
1999). Similar trials were conducted in Colombia with L. amazonensis with positive 
results. The administration of killed parasites was able to significantly increase 
Leishmania-antigen lymphocyte proliferation (Vélez et al., 2000). However, concerns 
remain regarding the feasibility of developing killed, whole-parasite vaccines, including 
the variation in results obtained from different fields and clinical trial sites in the past 
and potential difficulties in producing such a product to good clinical manufacturing 
standards. 
Various attenuated parasites have also been tested in animal models. These 
parasites are generally taken up by host cells in a similar way to virulent parasites and 
persist for some time without replicating. This allows the host immune system to 
respond to the parasite antigens. Radio-attenuated and biochemically altered parasites 
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without adjuvant have proven to confer good protection in mice and hamsters (Rivier et 
al., 1999). Although concerns regarding back conversion to virulence make the latter 
option questionable for human use. Genetically modified Leishmania parasites lacking 
essential virulence genes, such as dyhydrofolate reductase, biopterin reductase or 
cysteine proteases, may overcome this problem and could produce attractive vaccine 
candidates against leishmaniasis (Veras et al., 1999, Kumar and Engwerda, 2014). 
Development of drug-sensitive Leishmania mutants to be used as vaccines alone or with 
adjuvant has been proposed as a mechanism to induce anti-leishmanial immunity 
(Muyombwe et al., 1997). Based on the large degree of sequence homology between 
species, it has also been proposed the use of non-human pathogenic Leishmania species 
like L. tarantolae, which can stimulate protection against virulent L. donovani strains 
(Breton et al., 2005). However, the main problem with using killed or attenuated 
parasites are the concerns relating to safety and feasibility for large-scale use in the 
field. 
The technological possibility to create recombinant proteins, conjugated to some 
degree of conservation between Leishmania species lead to several vaccine proposals 
either alone or combined with adjuvant or with bacteria/recombinant virus as a delivery 
vehicle. There have been significant efforts in recent time to identify recombinant 
antigens that can protect against Leishmania infection in experimental models. Some of 
these antigens include kinetoplastid membrane protein-11, sterol 24-c-methyltranferase, 
amastigote specific protein A2, cysteine proteinase B, promastigote surface antigen 2, 
nucleoside hydrolase and surface expressed glycoprotein gp63. Although most of these 
recombinant antigens have been tested in animal models for their immunogenicity and 
protective efficacy only a few have progressed to clinical trials in non-human primates, 
dogs or in preclinical human studies (Kumar et al., 2010; Singh et al., 2012b; Kumar 
and Engwerda, 2014). In recent years, liposomes have been developed as a delivery 
system for vaccine and as potent adjuvant. The gp63 Leishmania vaccine was analyzed  
in new studies with a liposomal formulation. It was authenticated that 
distearoyl-phosphatidylcholine (DSPC) liposome used with the immunodominant gp63 
of L. donovani promastigotes functions as adjuvant and were able to promote significant 
protection against progressive VL in susceptible BALB/c mice. The follow up of the 
study demonstrated that the control of disease progression and parasitic burden in mice 
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vaccinated with gp63 in cationic DSPC liposomes was promoted IFN-γ production and 
down regulation of IL-4. In addition, CD8
+
 T cell response was elicited by liposomic 
gp63, pointing to a long term protection (Bhowmick et al., 2008). The first candidate of 
this type of vaccines to make it into phase I and II clinical trials was LEISH-F1 from 
The Infectious Disease Research Institute (IDRI, USA). Recombinant Leishmania 
polyprotein LEISH-F1 (formerly known as Leish-111f) is constituted by three 
recombinant proteins derived from L. major and conserved across various Leishmania 
species, including L. donovani, L. chagasi and L. braziliensis. The three proteins 
included in the vaccine are: Leishmania elongation initiation factor (LeIF), 
thiol-specific antioxidant (TSA) and Leishmania major stress-inducible protein 1 
(LmSTI1) (Chakravarty et al., 2011). LEISH-F1 was administrated with an adjuvant 
monophosphoryl lipid A (MPL) plus squalene (SE) in the final vaccine formulation 
LEISH-F1+MPL-SE. Phase I clinical trials indicate that the vaccine is immunogenic, 
safe and well tolerated in populations with and without leishmaniasis history. 
Additionally, LEISH-F1 vaccine also has demonstrated some therapeutic significance in 
patients with MCL (Nascimento et al., 2010). Leish-111F/MPL-SE defined vaccine 
progressed to human phase-I and phase-II clinical trials in healthy volunteers from 
United States and Colombia were demonstrated safety and immunogenicity in healthy 
volunteers. Trials of the vaccine in subjects with CL in Brazil (Nascimento et al., 2010) 
and ML in Peru (Llanos-Cuentas et al., 2010) also showed that it was likewise 
well-tolerated. The last clinical trial showed that the LEISH-F1+MPL-SE vaccine is 
safe and immunogenic in healthy subjects with and without history of previous infection 
with Leishmania donovani in India (Chakravarty et al., 2011). With the great 
preliminary successes of the LEISH-F1 vaccine, IDRI redesigned the vaccine taking 
their new construct Leish-110f (LEISH-F2) through phase I and phase II clinical trial. 
The new Leish-110f includes a construct without the histidine tag on the N-terminus, as 
well as the replacement of Lys274 with Gln, in an effort to overcome possible 
regulatory concerns and to facilitate the manufacturing process. Leish-110f was 
administrated with adjuvant natural (MPL-SE) or synthetic (EM005) agonists of 
Toll-like receptor 4 (Bertholet et al., 2009). Positive findings related to immunogenicity 
indicate an immune response sufficient to control parasite multiplication upon primary 
infection and prevented disease. A newer LEISH-F3 vaccine, for use against VL, is in a 
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phase I trial of healthy adult volunteers in the USA. The LEISH-F3 vaccine is a fusion 
polypeptide made by linking in tandem two Leishmania proteins: residues 1-314 of the 
Leishmania infantum/donovani nonspecific nucleoside hydrolase (NH) protein and 
residues 2-353 of Leishmania infantum sterol 24-c-methyltransferase (SMT) protein 
(WHO, 2014). The LEISH-F3 vaccine is given with GLA-SE, a novel TLR-4-based 
adjuvant, and is compared to administration of LEISH-F3-MPL-SE adjuvant or just the 
vaccine. A second phase I trial is prewired to take place in India 
(https://clinicaltrials.gov/ct2/show/NCT01751048). 
 It is also believed that salivary proteins of sand fly vectors (Phlebotomus and 
Lutzomyia ssp.) have immunomodulatory properties, which may be good vaccine 
candidates. Salivary proteins, such as PpSP15, maxadilan, LJM17, LJM19 and LJM143, 
have been reported as potent immunogens, inducing lymphocytic infiltration with 
up-regulation of IFN-γ and IL-12 (Collin et al., 2009). However, this protection might 
be only transient. A study demonstrated that this protection is time-dependent and 
limited to a short-term exposure to sand flies immediately before infection. These 
results explained the persistence of leishmaniasis in endemic areas and should be taken 
into account when designing anti-Leishmania vaccines based on sand fly saliva 
(Rohousová et al., 2011).  
DNA vaccines to prevent leishmaniasis are also undergoing development and 
testing. This approach has several advantages, such as low costs of production, stability 
of materials, sustained expression of relevant antigens and efficient generation of 
effector and memory immune responses. Immunization with naked DNA is a relatively 
new approach in which single or multiple genes encoding various antigens are cloned 
into a mammalian expression vector. The administration through simple intramuscular 
injection and multiple plasmids can be combined to yield multivalent vaccines. The 
mechanism by which DNA vaccination generates potent immune responses appears to 
be induced by the inherent adjuvant activity of non-methylated DNA sequences that 
stimulate innate responses, then by replication within the host leading to the in situ 
expression of the encoded proteins (Duthie and Reed, 2014). Several studies have 
examined the use of experimental DNA vaccines against several Leishmania species. 
Mice vaccination with DNA encoding gp63 or LACK, antigens already identified as 
highly immunogenic, elicited antigen-specific Th1 responses and reduced lesion 
1 | General Introduction 
 
45 
development when challenged with L. major (Gurunathan et al., 1997; Walker et al., 
1998). A significant advance was described in a study by Guha et al. (2013) where the 
target antigen was the hemoglobin receptor (HbR) of the parasite. HbR is the receptor 
for hemoglobin endocytosis and also has hexokinase activity. It is expressed on the cell 
surface of the parasite and is conserved among different species. Using a DNA vaccine 
approach and tested it in an experimental model of VL the authors showed that 
HbR-DNA vaccination of mice stimulated the production of antigen-specific IgG2a 
antibodies and promoted the generation of antigen-specific T-cell responses that were 
able to produce multiple Th1-related cytokines simultaneously. In hamster model, 
vaccination with HbR-DNA protected animals from virulent L. donovani challenge, 
allowing them to survive the infection. As the results were obtained in the absence of 
adjuvant they are very encouraging. However, DNA vaccines have shown great promise 
in animal models, but have not yet proven their utility in humans. There have been no 
clinical trials beyond phase II to test DNA vaccines in humans. The major challenge for 
DNA vaccine candidates remains the demonstration of safety and efficacy in humans in 
both clinical trials and field settings (Kumar and Engwerda, 2014). 
Another strategy for the development of a vaccine for VL is known as 
heterologous DNA-prime protein-boost (HPB) and has been used with several antigens 
such as ORFF, cysteine proteinases or gp63. These had also shown some success but 
are yet to reach the level of clinical trials. Ramiro et al. (2003) observed 60% protection 
in dogs immunized with a plasmid carrying the gene for the LACK antigen from 
Leishmania infantum (LACK-DNA), followed by a second immunization with the 
recombinant vaccinia virus (rVV) containing the same gene (rVV-LACK), followed by 
L. infantum challenge. Since the immune response in a canine model differs 
significantly from murine and human hosts Dondji et al. (2005) and Tewary et al. 
(2005) conducted similar studies using the murine model for VL and found comparable 
levels of protection. The success of vaccine development depends upon understanding 
the immunobiology of pathogen/host interactions, selection of appropriate vaccine 
candidates and choosing the right adjuvant or delivery vehicle. In addition, the vaccine 
must be able to generate long-lasting immunity, be efficient and safe as well as 
affordable. The development of a vaccine against leishmaniasis has been slow, but the 
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increasing knowledge gained in recent years is opening the way for renewed efforts to 
create and test new vaccines for preventing and or treat leishmaniasis. 
The development of an effective vaccine for CanL represents a cost-effective 
tool for interrupting the transmission cycle and controlling ZVL in the human 
populations. Canines, particularly domestic dogs, are the main reservoir for VL species 
and are considered the main source of zoonotic transmission to humans. As previously 
discussed, treatment of CanL has low efficacy with drugs successfully used in human 
VL treatment, rarely achieving a cure state (Baneth and Shaw, 2002). Prevention has 
been, so far, the best way to prevent CanL transmission with the use of insecticide 
impregnated collars in domestic dogs to reduce the risk of contracting CanL. The 
culling of seropositive dogs has long been recommended in Brazil, but had not led to a 
reduction in the number of human VL cases and may be of limited value (Courtenay et 
al., 2002). Consequently, the development of vaccines against CanL is an attractive 
approach to controlling infection in dogs, reducing the parasite reservoir and 
consequently diminishing the risk of parasite transmission to human populations. 
Immunological characterization of CanL reveals cellular and humoral immune 
responses similar to human infection, including immune deregulation and increased 
IL-10, associated with disease manifestation and progression. Disease resistance is 
linked to strong Th1 immune responses, including IFN-γ expression. Therefore, like in 
human VL vaccine, an effective CanL vaccine needs to induce strong and long lasting 
cell mediated immunity. Adjuvant choice must be carefully considered for CanL 
interventions, as live BCG is not an appropriate adjuvant for commercial application 
due to safety problems in dogs and the identification of appropriate and effective 
adjuvants are essential for safe and effective CanL vaccines (Poot et al., 2009). In 
addition to adjuvant and also similar to the research to obtain a human VL vaccine, sand 
fly salivary components are being considered for inclusion in CanL vaccine. Evaluation 
of a killed Leishmania vaccine containing sand fly saliva extract indicated that the 
vaccine is highly immunogenic and provided support for further development of saliva 
components as candidates for incorporation in an anti-VL vaccine (Giunchetti et al., 
2007; Giunchetti et al., 2008). This is supported by vaccination studies using the 
hamster VL model, showing that the salivary protein LJM19 was able to protect 
hamsters from fatal infection with L. infantum (Gomes et al., 2008). Currently, there are 
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two commercially available CanVL vaccines, Leishmune® and Leish-tec® in Brazil. 
But the search for new vaccines continues under development, including recombinant 
antigen vaccines and both live and killed whole-cell vaccines. The Leishmune® vaccine 
produced by Fort Dodge Animal Health was the first commercially licensed vaccine for 
CanL. This vaccine consists of the fucose mannose ligand (FML) isolated from L. 
donovani plus a saponin adjuvant. It corresponds to a surface antigen present throughout 
the parasite life cycle, and antibodies raised in vaccinated dogs prevented the binding of 
procyclic promastigotes to the sand fly midgut (Saraiva et al., 2006). This vaccine 
induced a significant and strong protective effect during phase III trials in dogs living in 
ZVL endemic area in Brazil, with a protective efficacy as high as 80%. This protection 
lasted up to 3.5 years following vaccination, indicating the induction of a long-lasting 
immunity (da Silva et al., 2000; Borja-Cabrera et al., 2002). Since Leishmune® 
vaccinated dogs showed a complete absence of parasites, they are noninfectious and this 
contributes to the breakdown of the zoonotic transmission cycle. During phase III trials 
of Leishmune® there was a concomitant reduction in human ZVL cases in districts 
where dogs were vaccinated, indicating that Leishmune® vaccination interrupts parasite 
transmission to humans (Silva et al., 2000). A decrease in the incidence of human and 
canine visceral leishmaniasis was registered in endemic areas of Brazil after dog’s 
vaccination (Palatnik-de-Sousa et al., 2009). Thus, Leishmune® acts as a transmission 
blocking vaccine by clearing parasites from the animal reservoir and preventing the 
survival of the parasite in the sand fly vector. Currently, this prophylactic vaccine is 
recommended for healthy, non-infected dogs. Nevertheless, studies performed showed 
that Leishmune® is also effective as a therapeutic vaccine for naturally infected dogs, 
particularly when given in combination with leishmanicidal drugs (Borja-Cabrera et al., 
2004). An amastigote specific antigen, the recombinant A2 antigen (rA2) constitutes the 
base of the vaccine Leish-Tec®. This vaccine applied with saponin as adjuvant could 
induce type 1 immune response. The first clinical trial performed showed that 
vaccinated animals produced significantly increased levels of total IgG and IgG2 
anti-A2 antibodies and remained negative in conventional leishmaniasis serodiagnostic 
methods. A significantly increased of IFN-γ and low IL-10 levels were detected in 
vaccinated animals before and after challenge, as compared to control animals. 
Immunization with rA2 was immunogenic and conferred partial protection to dogs, 
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allowing the serological differentiation between vaccinated and infected animals, an 
important requirement for a CanL vaccine (Fernandes et al., 2008). Leish-Tec® is now 
commercially available and there are no significant differences in the rates of 
seroconversion, clinical signs or parasite transmission to the vector between dogs 
immunized with Leishmune® or Leish-Tec® (Fernandes et al., 2014). Together, these 
studies indicate that rA2 is an important CanL vaccine and future studies should report 
the impact of this intervention on both canine and human VL infections. As many of the 
clinical and immunological features of CanL are similar to those observed in human 
VL, experimental challenge in dogs represents a useful system for evaluating the 
efficacy of vaccine candidates. The Leish-111f + MPL-SE vaccine, discussed above, is 
a leading vaccine candidate for human VL that also has shown therapeutic efficacy in 
CanL trials (Trigo et al., 2010). A third CanL vaccine has been recently licensed in 
Europe, the CaniLeish®, from Virbac Animal Health. This vaccine is constituted by 
excreted/secreted antigens purified from the culture supernatant of L. infantum 
promastigotes (LiESAP) with muramyl dipeptide (MDP) as adjuvant (LiESP/QA-21). 
In the field conducted trials, dogs were kept outdoors, exposed to sand flies in an 
endemic region of the south of France. Vaccinated dogs’ antibody reactivity to the 
antigen by immunofluorescence antibody (IFA) test showed a strong reaction after two 
seasons of sand flies activity. Moreover, strong vaccine efficacy (92%) was seen based 
on leishmanial DNA and parasite detection in bone marrow aspirate. Besides the in 
vitro study of T cell immune response showed high IFN-γ production in vaccinated 
dogs in comparison to the control ones (Moreno et al., 2014). Other recombinant 
proteins are also being tested for a potential CanL vaccine and also the use of live 
attenuated parasite vaccines continues under exploration. However, the elimination of 
human VL will be difficult to achieve in the presence of persisting animal reservoirs 
and veterinary intervention is an important tool for reducing the global burden of this 
disease. The identification of measurable and reliable biomarkers of immunogenicity 
and protection induced by CanL vaccines may also be informative for human VL 
vaccine efforts. 
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1.3. Immunology of leishmaniasis 
Understanding the immunological events that result in failure or successful 
control of the infection by Leishmania parasites is fundamental for the design and 
evaluation of vaccines and therapies against leishmaniasis, both in humans, canine or 
experimental models of the disease. Control of Leishmania infection and disease 
progression has long been associated with generation of T helper (Th) 1 and Th2 
responses respectively. Although the Th1/Th2 paradigm is valid in several aspects, Th2 
polarization has never explained the severity of human disease and a number of other T 
cell subsets, including the generation of a regulatory T and Th17 cell response is not yet 
completed understood. Thus, all efforts to better understand the complex mechanisms 
behind the immune response generated by the host to Leishmania infection are of high 
importance, as it can lead to better strategies to control the infection. 
1.3.1. Host-parasite interaction in canine leishmaniasis 
Wild canines and domestic dogs are the main reservoirs of ZVL caused by L. 
infantum in the Mediterranean area, Middle-East, Asian countries and Latin America. 
The role of dogs as the main reservoir of ZVL has led to an increased interest in 
studying the immune response and finding Leishmania antigens implicated in protective 
cellular immunity. CanL is a multisystemic disease with variable clinical signs. 
Lymphadenomegaly, splenomegaly and hepatomegaly, weight loss, skin ulcers, 
alopecia, onychogryphosis, among other symptoms can be detected in Leishmania 
infected dogs. Typically it is possible to identify the presence of Leishmania 
amastigotes inside macrophages in the dog’s skin, spleen and liver, in a granulomatous 
inflammatory formation. A fraction of infected dogs develops symptomatic infection 
resulting in death, while others remain asymptomatic or develop one or more mild 
symptoms, classified as oligosymptomatic (Ciaramella et al., 1997). There are several 
evidences pointing to the importance of dog’s genetics in susceptibility or resistance to 
CanL. Studies performed on genetics of human VL have identified several genes 
involved in disease susceptibility. In the endemic area of VL in Sudan, where the 
infection is caused by L. donovani, 90% of people involved in the study showed 
immunological evidence of the infection, but only 30% developed human VL. 
Candidate gene to VL resistance revealed linkage to a polymorphism in the natural 
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resistance associated macrophage protein 1 (NRAMP1) gene, later named Slc11a1 gene 
(Bucheton et al., 2003). The Slc11a1 gene encodes a proton divalent cation antiporter 
with a role in regulating macrophage function, including upregulation of chemokine and 
cytokine genes, such as TNF and interkeukin-1(IL-1), as well as induction of nitric 
oxide synthase which are linked to anti-leishmanial immune mechanisms (Blackwell et 
al., 2001). Epidemiological studies also suggested a role for intrinsic factors in CanL 
resistance. Two genes have been identified and implicated in susceptibility to the 
disease. Quinnell et al. (2003) performed a study in a cohort of Brazilian mongrel dogs 
naturally infected with L. infantum to investigate the genetic variation of class II 
molecules of major histocompatibility complex (MHC II), termed ‘the dog leukocyte 
antigen (DLA) system’. It has detected a significant association between the presence of 
the DLA–DRB1*01502 allele and susceptibility to CanL, indicating that DLA-DRB1 
locus plays a major role in determining susceptibility. In another study performed in 
Spain, haplotypes of the canine Slc11a1 gene were found associated with CanL 
susceptibility (Altet et al., 2002). Single nucleotide polymorphism (SNP) mutations in 
the promoter region of Slc11a1 gene were also described and associated with 
susceptibility to human VL and CanL. The presence of haplotype TAG-8-141 has been 
related to the boxers’ predisposing to CanL (Sanchez-Robert et al., 2005). Despite these 
findings associate genetics with susceptibility to CanL, the individual dog’s natural 
resistance to Leishmania infection is probably determined by a more complex 
multigenic puzzle. Nevertheless, susceptibility to developing the disease is also 
influenced by non-genetic extrinsic factors such as nutritional status, concomitant 
infections and parasitism, parasite virulence and previous exposure to CanL (Baneth et 
al., 2008). 
A wide spectrum of innate and acquired immune responses is orchestrated by the 
canine host when facing a L. infantum infection. The two opposite poles of this 
spectrum are the protective immunity mediated by T cell activation and the 
susceptibility to the disease marked by the non-protective humoral immune response. It 
has long been known that dogs that remaining asymptomatic, exhibiting some resistance 
to infection progression were able to activate cell mediated immune response, 
presenting lower antibody titers to leishmanial antigens. However, symptomatic or 
susceptible animals failed to activate a cell mediated immune response, both in vitro 
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and in vivo, showing considerably higher serum antibodies to leishmanial antigens, 
which are not immunoprotective. It is also widely accepted that macrophages play a 
central role in controlling Leishmania infection. The main effector mechanism involved 
in the protective immune response of dogs infected with L. infantum is the activation of 
macrophages by IFN-γ, IL-2 and TNF-α to kill intracellular amastigotes via the 
L-arginine nitric oxide (NO) pathway. The pathway directing the production of this 
effector molecule has been identified as the main principal leishmanicidal mechanism 
present in macrophages and capable of intracellular killing of Leishmania amastigotes 
(Holzmuller et al., 2006). The emergence of the Th1/Th2 paradigm as opposing 
cytokine responses in the control of Leishmania infections was established by 
observations on experimental L. major infections of resistant mice. These mice develop 
a T cell response dominated by a CD4
+
 Th1 phenotype characterized by IFN-γ 
secretion, while the susceptible mice developed a dominant response with activation of 
CD4
+
 Th2 phenotype characterized by production of IL-4 and IL-5. Correlation between 
a polarized immune response and the infection outcome led to the concept that the 
balance of Th1/ Th2 immune response determines disease progression or by the 
contrary, infection control (Scott et al., 1988). Further studies on the immune response 
generated by resistant C57BL/6 and C3H/HeN mice or susceptible BALB/c mice to L. 
major infection revealed two distinct patterns. Infection of C3H/HeN mice was 
dominated by IL-12 production and CD4
+
 Th1 immune response accompanied by high 
levels of IFN-γ secreted by natural killer (NK) cells and no IL-4 (Scharton and Scott, 
1993). In contrast, progressive disease in susceptible BALB/c mice was characterized 
by the early IL-4 production, absence of IL-12 and a polarized Th2 response. 
Confirmation that the early IL-4 synthesis drives this Th2 response came from 
experiments performed in BALB/c mice genetically engineered to be IL-4 deficient and 
in mice treated with anti-IL-4 antibody, demonstrating that without IL-4 secretion these 
mice can heal L. major infection (Kopf et al., 1996). Julia et al. (1996) demonstrated 
that the cellular origin of IL-4 in BALB/c mice is confined to an oligoclonal CD4
+
 T 
cell population with a Vβ4Vα8 T cell receptor which recognizes the Leishmania 
homologue of the receptor for activated C kinase (LACK). Several other experiments 
lead to the conclusion of the critical importance of IL-12 in mediating a Th1 response 
and, therefore the resistance to Leishmania infection. IL-12 depletion increases 
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susceptibility of naturally resistant mice and, by the contrary, the conversion of 
susceptible BALB/c mice to a resistant phenotype is achieved after treatment with IL-12 
(Heinzel et al., 1993). It is now known that dendritic cells are the source of IL-12 
production, but the antigens responsible for triggering an IL-12 response and the exact 
mechanisms are not defined. Among other cytokines, the predominant expansion of 
IFN-γ producing-Th1 cells, which induces the synthesis of nitric oxide directed by the 
induced nitric oxide synthetase (iNOS), activates the microbicidal function of 
parasitized macrophages. In resistant C57BL/6 mice infected with a low dose of L. 
major, a clear role for CD8
+
 T cells in primary immunity is defined. Nevertheless, 
parasites persist even in resistant mice. Using this low-dose model, it was demonstrated 
that IL-10 played an essential role in parasite persistence. The sterile parasite cure was 
only achieved in IL-10 deficient and IL-4/IL-10 double deficient mice, demonstrating 
the requirement for IL-10 in establishing latency (Belkaid et al., 2001). A key study 





regulatory T cells (Treg) expressing high CTLA-4 is the source of IL-10, controlling L. 
major persistence and immunity in C57BL/6 mice (Belkaid et al., 2002). Treg constitute 
5–10% of CD4
+
 T cells in normal mice and humans, developing in the thymus where, 
following high-affinity recognition of self-peptides, they up regulate the transcription 
factor FoxP3 and the expression of the cell surface marker CD25, essential for their 
survival and a constitutive marker of Treg in the periphery. Two distinct 
sub-populations of Treg have been described, naturally occurring Treg involved in the 
maintenance of peripheral tolerance and antigen-specific T regulatory cells (Tr1) that 
encounter pathogen derived foreign antigen in the periphery (Roberts, 2006).  
Th1/Th2 dichotomy is well characterized in cutaneous leishmaniasis and in the 
murine model. In contrast, humans VL, CanL and experimentally infected rodents do 
not show a clear Th1/Th2 dichotomy pattern. Particularly in dogs, infection outcome is 
highly variable. It is now widely accepted that protective immunity against Leishmania 
parasites is mediated by CD4
+ 
Th1 cell immune response. The balance between L. 
infantum induced mixed Th1 and Th2 responses accounts for parasite replication 
control, disease progression or clinical cure (Baneth et al., 2008) (Figure 6). 




Figure 6: Schematic representation of the immune response generated by dogs to L. infantum 
infection. 
Resistance to CanL has been associated with the differentiation of IFN-γ, IL-2 
and TNF-α producing Th1 cells, leading to the activation of macrophages and NO 
production to kill intracellular amastigotes. Th2 response may lead to the polyclonal 
proliferation of B cells and the production of non-protective antibodies, leading to 
disease progression. Mix Th1/Th2 immune responses may also occur. T regulatory 
(Treg) cells constitute a natural occurring population of T cells with regulatory 
properties (Adapted from Barbiéri, 2006). 
Define the profile of cytokines expressed in CanL is a complex task because the 
broad spectrum of clinical manifestations, the different tissues analyzed and the 
differences between experimental and natural infection associated with the limited 
number of studies reported. Longitudinal experimental CanL infection studies have 
mostly indicated a mixed Th1 and Th2 pattern. In a follow up study Santos-Gomes et al. 
(2002) characterized the cytokine profile of L. infantum experimentally infected dogs. 
The animals showed an initial asymptomatic phase with an absence of or low 
expression of cytokines during a period of silent establishment of the parasite followed 
by a short-term production of Th1-type cytokines before the appearance of clinical 
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signs. In a third phase, animals presented clinical signs and reduced expression of 
cytokines. During these three phases, animals maintained specific humoral immune 
responses, immunosuppression of specific lymphocyte proliferation and the capacity to 
transmit the parasite, since its presence can be detected in the skin. The cellular basis 
and mechanisms for the development of T cell unresponsiveness in CanL are not fully 
understood. The majority of infected dogs are likely to develop specific cell mediated 
immunity expressed as proliferation of lymphocytes stimulated in vitro by Leishmania 
antigen or in vivo by a positive skin test early in infection. However, as the disease 
progresses in susceptible dogs, these responses diminish. During a longitudinal 
follow-up of experimentally infected dogs, blood parasite load and Leishmania specific 
cell mediated immunity were shown to be inversely correlated (Rodríguez-Cortés, et al., 
2007). It has been postulated that cell mediated immunity unresponsiveness in 
progressive disease is due to the decrease in peripheral CD4
+
 T cell numbers or the 
decreasing expression of co-stimulatory molecules, accompanied by the 
unresponsiveness of the remains cells and unprotective humoral responses which allow 
the dissemination and multiplication of L. infantum in different tissues. CanL is 
frequently associated with a marked humoral response, with production of high 
antibody titers, which is not protective and points to failure in the control of infection. 
The levels of Leishmania specific immunoglobulins of symptomatic dogs are greater 
than those found in infected, but asymptomatic dogs and a clear association was shown 
between these levels, the clinical status and tissue parasite density (Reis et al., 2006). 
The levels of canine IgG1 and IgG2 subclasses have been extensively studied in an 
attempt to establish a correlation between the subclass levels, the type of Th immune 
response and the clinical outcome of infection. A direct correlation between high levels 
of IgG1 anti-Leishmania antibody and the appearance of clinical symptoms was 
demonstrated in L. infantum infected dogs, while IgG2 antibodies were associated with 
asymptomatic infection (Nieto, et al., 1999). However, these results were not 
corroborated by other studies in which dogs with positive DTH skin reactions exhibited 
a polymorphic humoral immune response ranging from seronegative to positive levels 
of IgG1 or IgG2 (Bourdoiseau, et al., 1997). Studies evaluating IgG1 and IgG2 using 
polyclonal antibodies frequently have reached conflicting outcomes, possibly because 
of a lack of specificity of commercial reagents. Furthermore, studies employing 
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monoclonal antibodies to detect canine IgG1 and IgG2 have shown a steady increase in 
the production of both subclasses during natural and experimental CanL without 
indicating a practical use for these levels (Fujiwara, et al., 2005). Apart from the direct 
action of cytokines and immunoglobulins, the involvement of CD8
+
 lymphocytes in 
resistance to canine VL, has also been studied. These lymphocytes were detected in 
asymptomatic dogs experimentally infected with L. infantum, but not in symptomatic 
animals, suggesting that direct lysis of infected macrophages by cytotoxic T 
lymphocytes represents an additional effector mechanism in resistance to CanL (Pinelli 





populations was observed. These populations were partially restored after drug 
treatment (Bourdoiseau et al., 1997). 
For many years, it was thought that CD4
+
 T helper cells existed as a dichotomy 
of lineages Th1 and Th2, differentiated by cytokine expression patterns. However, 
recently it became apparent that the T helper cell population was not limited to these 
two subsets. Although it has long been appreciated that IL-17 (also known as IL-17A) 
production by T cells is required for protection against some pathogens, it was 
demonstrated that IL-17A was produced by a unique subset of T helper cells. 
Subsequently, it was definitively shown that T cells could differentiate into 
IL-17-producing cells in vitro and in vivo independently of Th1 or Th2 cell 
development thereby establishing Th17 cells as a unique T helper cell lineage. 
Functionally, Th17 cells play a role in host defense against extracellular pathogens in 
mediating the recruitment of neutrophils and macrophages to infected tissues. 
Moreover, it has become evident that aberrant regulation of Th17 cells may play a 
significant role in the pathogenesis of multiple inflammatory and autoimmune disorders 
(Korn et al., 2009). IL-22 is also produced by Th17 cells and is particularly involved in 
immunity in epithelial and mucosal surfaces. IL-17 and IL-22 are pro-inflammatory 
cytokines that play a protective role against intracellular parasites, such as Leishmania 
(Nascimento et al., 2015). However, the role of IL-17 and IL-22 during Leishmania 
infection remains controversial. In order to preserve host immunological balance 
(immune homeostasis), T regulatory lymphocytes (Tregs) have an important role in 
suppressing the immune response in human leishmaniasis (Rai et al., 2012), in murine 
leishmaniasis (Rodrigues et al., 2009) and, probably in CanL (Silva et al., 2014). Tregs 
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are characterized by the expression of CD4, CD25 and of the highly conserved 
transcription factor Forkhead box P3 (Foxp3), serving a pivotal role in stabilizing their 
regulatory properties. However, Th17 cytokine and FoxP3 have been poorly studied in 
CanL and not in the visceral organs, requiring further investigations (Hosein et al., 
2015). 
It is now widely accepted that in dogs, CanL resistance is associated with the 
differentiation of IFN-γ, IL-2 and TNF-α producing Th1 cell subset leading to the 
activation of macrophages and NO production to kill intracellular amastigotes. This 
profile has been seen in dogs that were observed after a successful chemotherapy for L. 
infantum infection, as well in canine macrophage cell line infected with L. infantum 
after incubation with IFN-γ, TNF-α and IL-2, or in macrophages from dogs immunized 
with killed L. infantum promastigotes. On the other hand, susceptibility is associated 
with high anti-Leishmania antibody titers, which are not immunoprotective and also an 
unresponsive T cell population. Our understanding of canine immunity has expanded 
and we now know that the immune response generated by the dog against Leishmania 
infection is a result of a complex interaction between the parasite virulence and the 
silencing imposing effect with genetics and immune status of the host. This complex 
interaction may lead to mix immune responses with no defined pattern. 
1.3.2. Innate immunity in leishmaniasis 
The mammalian immune system fights infection through the cooperation of two 
connected systems, the innate and adaptive immune systems. Adaptive immunity 
detects an invading agent through recognition of peptide antigens, using antigen 
receptors expressed on the surface of B and T cells. The recognition of an antigen by its 
receptor triggers clonal expansion and further development of antigen-specific response. 
Innate immunity was considered to be a less complex and flexible system until the mid 
1990s when Toll receptors were discovered in Drosophila species and its mammalian 
homologues, the Toll-like receptors (TLR) were found to mediate recognition of 
pathogens by the innate immune system. These findings led to the discovery of pattern 
recognition receptors (PRR) and their roles in regulation and coordination of the 
immune response. PRR recognize and respond to evolutionarily conserved microbe 
specific molecular patterns, the so called pathogen associated molecular patterns 
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(PAMP) and, therefore, play a critical role in host defense towards pathogenic 
organisms. The major innate immune cells that respond to Leishmania infection are 
neutrophils and macrophages. These cells are equipped with several PRR that allow 
them to screen the environment for invading pathogens. Several studies have 
demonstrated that the expression and activation of PRR in innate immune cells serve as 
an essential link between the innate and adaptive immune systems. Adaptive immunity 
is controlled by PRR induced signals at multiple checkpoints, dictating the initiation of 
a response, the type of response, the magnitude and duration of the response and the 
production of long term memory. There are several classes of PRR, the membrane 
bound TLR and C-type lectin receptors (CLR), cytoplasmic PRR that include NOD-like 
receptors (NLR), AIM2-like receptors, RIG-I-like receptors and several cytoplasmic 
DNA sensors (Gurung and Kanneganti, 2015). PRR can instruct the adaptive immune 
system on when and how to respond to a particular infection. This has been 
demonstrated in studies on PRR, in particular for TLR, which revealed that innate 
recognition of pathogens results not only in the expression of innate response genes 
directed to control or eliminate infectious agent, but also in the expression of 
chemokines and cytokines that promote and shape the subsequent immune reaction.  
One of the classical functions attributed to neutrophils is their capacity to 
phagocytose and kill microorganisms. However, Leishmania take advantage of this 
property and neutrophils provide a transient safe shelter for the parasites, prior to their 
entry into macrophages where they will replicate. To survival inside neutrophils, the 
parasite has developed several protective mechanisms including the prevention of the 
activation of an oxidative burst, thus avoiding the generation of highly toxic reactive 
oxygen species (ROS) (Laufs et al., 2002) and the ability to be targeted to non-lytic 
compartments of neutrophils, as reported for L. donovani (Gueirard et al., 2008). 
Neutrophils have a short lifespan and become rapidly apoptotic, leading to their 
phagocytosis by macrophages. However, following infection by Leishmania, their 
lifespan can be increased to several days as in the case of human neutrophils in vitro 
infected with L. major that increased their lifespan to two days, inhibiting the 
processing of procaspases in the infected cells (van Zandbergen et al., 2004). In 
addition to their phagocytic function, neutrophils contribute to the initiation of 
inflammation, a process which is recognized as essential in launching immunity. The 
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importance of neutrophils as decision shapers in the development of an immune 
response is recent and they have long been considered as short lived and non-dividing 
cells of poor interest. However, this view is changing and neutrophils are currently 
appearing not only as key components of the inflammatory response, but also as cells 
that display important immunoregulatory roles in different microbial infections 
(Charmoy et al., 2010). The continuation of immunological studies will improve the 
knowledge about the cross-talks between neutrophils and other cells immune and 
non-immune, that leads to the eventual resolution of the lesion, or on the contrary to 
unimpaired progression of the infection. In this case, factors related to the sand fly 
vector also need to be re-considered. Peters et al. (2009) showed that sand fly 
inoculation maintains a localized, prolonged neutrophilic response which is different 
from that observed after needle injection of the parasite. This neutrophilic response 
impaired protection given to the mice by vaccination with killed Leishmania and 
challenged by the bite of infected sand flies, while such mice exhibited resistance 
against challenge infection induced through needle inoculation of live parasites. 
Removal of the neutrophils promoted resistance against sand fly-induced infection, 
further pointing to the importance of neutrophils as a decisive parameter in shaping the 
outcome of infection by Leishmania parasites. 
One of the major problems with Leishmania infections is the ability of these 
parasites to evade and subvert host immune responses. These qualities allow these 
parasites to persist and establish chronic infections. When Leishmania parasites are 
inoculated by the sand fly, the first barrier that this parasite faces is the complement 
system. This system is constituted by a group of more than 30 soluble proteins of the 
plasma that are involved in rapidly clear pathogens from the body. The complement 
cascade can be activated by three possible ways: classical, lectins and alternative 
pathway. Antibodies binding to the pathogen initiate the classical pathway, whereas the 
binding of mannose binding lectin and ficolins activates lectin pathway. In contrast, 
alternative pathway does not require antibody or lectin binding and is directly activated 
by the pathogens. All of these pathways result in common activation of C3 convertase 
that cleaves C3 to generate C3b. C3b deposition onto the pathogen surface induces the 
deposition of C5b-C6-C7-C8-C9 (C5b-9 membrane attack complex, MAC) complex 
that promotes lysis of the target pathogen. In addition, C3b acts as an opsonin and 
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promotes phagocytosis of the pathogen by neutrophils and macrophages. In the case of 
Leishmania infection, the alternative pathway that is highly effective in the clearance of 
Leishmania parasites is activated (Hoover et al., 1985). In the case of normal human 
serum, parasite clearance was shown to be antibody or C4 independent, requiring the 
formation of the C5b-9 MAC complex (Mosser and Edelson, 1985). Activation of the 
classical pathway via IgM anti-Leishmania antibodies causes promastigotes agglutinate 
and eventually parasite killing (Navin et al., 1989). A tremendous selective pressure to 
survive to the action of complement-mediated killing has resulted in the evolution of 
several immune evasion strategies that are employed by Leishmania. The two major 
virulence factors of Leishmania are the glycocalyx component lipophosphoglycan 
(LPG) and the metalloprotease gp63. The glycocalyx (the glycoconjugate surface 
coat) acting as the interface between the parasite and the external environment is 
essential to the parasite survival as proven by several studies with parasites lacking the 
glycocalyx or presenting genetic deletions associated with the glycocalyx. In the first 
case, parasites are highly susceptible to complement killing (Späth et al., 2003a; Yao et 
al., 2013). In the second, although gp63 depleted L. major parasites exhibit a normal 
growth curve in culture medium and in the sand fly gut they are highly susceptible to 
complement killing (Joshi et al., 2002). More remarkably, L. major parasites deficient 
in either LPG (Lpg1
– / –
) or all phosphoglycans (Lpg2
– / –
) present attenuate virulence 
and therefore reduced ability to infect mice (Späth et al., 2000; Späth et al., 2003b). 
Furthermore, LPG deficient L. major also fails to survive within the sand fly’s gut, 
demonstrating their important role in parasite survival (Sacks et al., 2000). In 
metacyclic promastigotes, LPG is essential for resistance to elimination via complement 
system activation. LPG binds to C3b, initiating the assembly of C5b-9 complex. 
However, MAC does not reach the Leishmania membrane and is spontaneously 
vanished as soluble C5b-9 complex (Puentes et al., 1990). In a similar way, gp63 
facilitates C3 deposition on Leishmania surface, but inactivates C3b (iC3b), inhibiting 
the formation of subsequent C5b-9 MAC complex (Brittingham et al., 1995). All of the 
evasion mechanisms lead to LPG and gp63 facilitating C3b opsonization, which 
promotes phagocytosis through C3b receptor (CD11b) of neutrophils and macrophages, 
facilitating the entry of viable parasite in target cells. In addition, both LPG and gp63 
can directly bind to cell surface receptors such as mannose and fibronectin receptor and 
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promote their uptake. Thus, LPG and gp63 mediate the parasite entry into the host cells, 
protecting Leishmania from the deadly activity of complement cascade (Gurung and 
Kanneganti, 2015). This is supported by the study performed in CD11b receptor 
deficient-mice, which are more resistant to Leishmania infection (Carter et al., 2009) 
further substantiating the importance of CD11b in disease perpetuation. While rapid 
Leishmania phagocytosis via CD11b cell receptor is required for parasite persistence 
within the host, FcγR-dependent Leishmania phagocytosis is required for parasite 
clearance and disease protection (Woelbing et al., 2006). These studies highlight the 
constant evolutionary battle between the mammalian host and Leishmania to assure its 
survival. 
As for PRR, it was the identification of mammals TLR that made immunologists 
aware that innate immunity plays an important role in the detection and control of 
invading pathogens. TLR seem to be sufficient to control adaptive immunity at all 
checkpoints, leading to adaptive responses characterized by Th1 induction, 
immunoglobulin production, CD8
+
 T cell stimulation that culminates in/assure 
protection from re-infection (Palm and Medzhitov, 2009). So far, it has been identified 
10 functional TLR in humans and 12 TLR in mice, being TLR1–TLR9 conserved in 
both species. The members of TLR family are expressed on cell membranes of both 
innate immune cells (such as dendritic cells, neutrophils, macrophages, natural killer 
cells), adaptive immune cells (T and B lymphocytes) and non-immune cells (epithelial 
and endothelial cells), triggering the synthesis and secretion of cytokines and activation 
of other host defense programs that are necessary for innate or adaptive immune 
responses. TLR are type I trans-membrane glycoproteins consisting of an extracellular 
leucine-rich repeat (LRR) domain that mediate the recognition of PAMP, a 
trans-membrane domain and an intracellular Toll-interleukin-1 (IL-1) receptor (TIR) 
domain required for downstream signal transduction. These receptors are predominantly 
expressed in tissues involved in immune functions, such as the spleen and liver or the 
peripheral blood leukocytes, as well as those exposed to the external environment such 
as lungs and gastrointestinal tract. TLR are largely divided into two subgroups 
depending on their cellular localization and respective PAMP ligands. One group is 
composed of TLR1, TLR2, TLR4, TLR5, TLR6 and TLR11 that are expressed on cell 
surfaces and recognizes mainly microbial membrane components such as lipids, 
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lipoproteins and proteins. The other group includes TLR3, TLR7, TLR8 and TLR9 that 
are exclusively expressed in the membranes of intracellular vesicles, such as the 
endoplasmic reticulum (ER), endosomes, lysosomes and endolysosomes, recognizing 
microbial nucleic acids (Figure 7). The cellular localization of TLR is thought to be 
important for ligand accessibility, the maintenance of tolerance to self-molecules such 
as nucleic acids and also for downstream signal transduction (Akira et al., 2006). TLR 
signaling pathways were intensively studied after the discovery of the TIR domain–
containing adaptor molecule MyD88 (myeloid differentiation primary response gene 
88). The subsequent identification of additional TIR domain–containing adaptors has 
shown that individual TLR selectively recruit distinct adaptor molecules, providing 
specific immune responses accordingly with the infecting agent.  
Mice deficient in MyD88 is highly susceptible to L. major infections. Wild type 
C57BL/6 mice infected with L. major develop footpad lesions that heal by themselves 
after several weeks post infection. However, C57BL/6 mice deficient in MyD88 
develop non-healing footpad lesions that progressively worsen over the course of 
infection. The disease progression in the MyD88
– / –
 mice following L. major infection 
is comparable to the infection evolution in highly susceptible BALB/c mice (de Veer et 
al., 2003; Debus et al., 2003) and can be reverted by treatment with recombinant IL-12 
(Muraille et al., 2003). MyD88 dependent pathways appear essential for the 
development of the protective IL-12 mediated Th1 response against L. major. In 
absence of MyD88 protein, infected mice develop a non-protective Th2 response. LPG 
of several Leishmania ssp. induces mitogen-activated protein kinase and induces the 
production of IL-12 and TNF-α in a MyD88dependent process, identifying LPG as a 
potential ligand. In vitro studies carried out by L. donovani infected macrophages 
suggested that both TLR2 and TLR3 are involved in the immune responses, specifically 
signaling the production of TNF-α and NO, important for protective immunity against 
Leishmania (Flandin et al., 2006). Furthermore, transfection studies (293T cells 
transfected with different TLR) demonstrated that TLR2 is LPG receptor (de Veer et al., 
2003). More recently, it was shown that anti-TLR2 antibody in the presence of LPG 
could inhibit nuclear factor (NF)-κB signaling events, confirming LPG as the direct 
ligand of TLR2 (Srivastav et al., 2012). However, LPG-deficient L. donovani (Lpg1
– /–
) 
still activates macrophage in a TLR2 dependent manner suggesting TLR2 can also 
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recognize other phosphoglycan moieties on Leishmania. Interestingly, Tlr2
– /–
 mice are 
resistant to Leishmania infection as a result of increased IL-12 production (Guerra et al., 
2010). Altogether, these results indicate that Leishmania LPG utilizes TLR2 to evade 
host-immune response. 
 
Figure 7: Pattern Recognition Receptors (PRR). 
A) TLR2-TLR1 and TLR2-TLR6 heterodimers recognize triacylated and diacylated lipopeptides, 
respectively. TLR2-TLR1 and TLR2-TLR6 induce NF-κB activation through recruitment of TIRAP and 
MyD88 adaptors. B) TLR4 complexed with MD2 protein recognizes lipopolysaccharides (LPS). The 
generation of a multimeric receptor constituted by two copies of the TLR4-MD2-LPS complex signals the 
early-phase activation of NF-κB by recruiting the TIR domain–containing adaptors TIRAP and MyD88 
(MyD88-dependent pathway). The TLR4-MD2-LPS complex is internalized and triggers signal 
transduction by recruiting TRAM and TIR-domain-containing adapter-inducing interferon-β (TRIF), 
which directs the expression of interferon regulatory factor 3 (IRF3) giving rise to the late-phase of 
NF-κB and the induction of type I interferon (TRIF-dependent pathway). Both early- and late-phase 
activation of NF-κB is required for the induction of inflammatory cytokines. C) TLR5 recognizes 
flagellin and activates NF-κB through MyD88 (Adapted from Kawai and Akira, 2010). 
Based on their ability to induce effector proteins, such as reactive oxygen 
species and IL-12, L. donovani glycoproteins and glycosphingophospholipids have been 
suggested as potential ligands for TLR4 (Karmakar et al., 2012). Tlr4
– / –
 deficient mice 
are highly susceptible to Leishmania infection and show increased parasite load, 
indicating that TLR4 contributes to the effective control of Leishmania infection in vivo, 
through NO production (Kropf et al., 2004a; Kropf et al., 2004b). Interestingly, these 
Tlr4
– / –
 mice are able to ultimately clear the parasitic infection, suggesting possible roles 
for other TLR as well. Indeed, TLR9 has emerged as another important sensor involved 
A B C 
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in immunity against Leishmania infections. TLR9 recognizes Leishmania DNA, 
increasing IL-12 production and promoting target cell lysis by NK cell (Liese et al., 
2007, Schleicher et al., 2007). Moreover, Tlr9
–/–
 mice show increased susceptibility to 
Leishmania infection, presenting increased footpad lesion and high levels of 
antileishmanial antibody titers (Liese et al., 2007). Similar to Tlr4
– / –
 mice, the disease 
in Tlr9
– / –
 mice eventually resolves over time. These independent studies highlight the 
TLR redundancy that is involved in providing protection against Leishmania spp. 
infection. Some in vitro studies have insinuated a possible role for TLR3 in immunity 
against Leishmania (Flandin et al., 2006), but the in vivo studies with Tlr3
– / –
 mice were 
not yet being performed and probably will give interesting results, as TLR3 has a 
MyD88-independent activation. Although TLR3 requires its adaptor TRIF for signaling 
it has also been suggested to play redundant roles with MyD88 during in vitro 
Leishmania infections (Gallego et al., 2011). Schamber-Reis et al. (2013) showed that 
during Leishmania infection, nucleic acid sensing by multiple TLR is a major resistance 
factor, indicating the redundant and the essential role of nucleic acid sensing TLR3, 
TLR7 and TLR9, in inducing the IL-12 production and development of a Th1 response 
and resistance to L. major infection. TLR4 and TLR9 play an important role in 
immunity to recognize and respond against Leishmania. Interestingly, Leishmania 
hijacks TLR2, which evolved similarly as TLR4 and TLR9 to respond against 
Leishmania. Indeed, recognition of Leishmania LPG seems to promote parasite growth 
by inhibiting IL-12 production. Thus, during L. donovani infection blockade of TLR2 
signaling by anti-TLR2 antibody provides significant protection by reducing the 
parasite burden (Murray et al., 2013). L. donovani induces a robust expression of A20 
(a deubiquitinating enzyme). A20 blocks TRAF6 Lys63 ubiquitination and signaling 
through TLR2 (Srivastav et al., 2012). Moreover, Leishmania LPG signaling through 
TLR2 inhibits TLR9 expression and anti-Leishmanial responses (Srivastava et al., 
2013). Leishmania also utilizes several other host proteins to regulate TLR signaling 
and control the immune response in the host. A study performed by Gupta et al. (2014) 
shows that L. donovani inhibits TRAF3 degradation, which is an important step 
required for TLR4 signaling. In addition, L. amazonensis negatively regulates TLR4 
signaling by degrading intracellular proteins such as STAT1/STAT2, ERK1/2 and IRF1 
(Xin et al., 2008), while L. major inhibitor of serine peptidase 2 has been revealed to 
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inhibit TLR4 activation through neutrophil elastase (Faria et al., 2011). Toll-like 
receptors serve as the first line defense for innate immune cells and are critically 
important for protection against Leishmania infections. Therefore, Leishmania has 
evolved to evade and manipulate the immune system, overcoming these immune 
responses to survive within the host. 
While TLR guard the extracellular environment and endosomal compartments, 
cytoplasmic PRR patrol the danger in the cytoplasm. The cytosolic PRR can be 
separated into two classes based on their mechanism of activation. The first class of 
cytosolic PRR, which includes the nucleotide binding oligomerization domain 
containing (NOD)-like receptor (NLR) family members NOD1 and NOD2, the retinoic 
acid inducible gene I (RIG-I)-like helicases (RLH) and, presumably, the IFN stimulator 
DNA (ISD) sensor, directly detects cytosolic PAMP and activates several signaling 
cascades. The second class is constituted by members of the NLR family that are 
involved in the formation and activation of large, multimeric protein complexes, 
referred to as inflammasomes, controlling the activation of caspase-1 and the secretion 
of caspase-1-dependent cytokines such as IL-1β (Meylan, et al., 2006; Palm and 
Medzhitov, 2009). The role of cytosolic PRR in controlling adaptive immunity is just 
beginning to emerge. Cytosolic PRR, unlike transmembrane PRR, can distinguish 
between intracellular and extracellular infections and may even distinguish pathogenic 
from harmless, commensal microorganisms and danger associated molecular patterns. 
The NLR proteins are a family of 22 mammalian genes that have diverse functions in 
innate immunity and inflammation. However, one of the most important discoveries 
relating to NLR has been the discovery of inflammasomes. NLRP1b, NLRP3 and 
NLRC4 have been shown to form a multimeric protein complex along with common 
adaptor molecule, containing a CARD domain and cysteine protease caspase-1called the 
inflammasomes. Inflammasomes are known to act as cytosolic sensors and regulate 
cytokine secretion and cell death pathways. The family shares common structural 
motifs: a central nucleotide-binding domain (NACHT), a C-terminal leucine-rich-repeat 
(LRR) domain that has been implicated in ligand sensing and an N-terminal effector 
domain that is either a CARD (caspase-1 activation and recruitment), BIR (baculovirus 
inhibitor of apoptosis protein repeat) domain or a PYD (pyrin) domain. The NLRP 
group members contain a PYD, the NAIP include a BIR domain and the NLRC group 
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proteins contain a CARD domain (Clay et al., 2014). The formation of multiprotein 
inflammasome complexes constitutes a major pro-inflammatory pathway of the innate 
immune system. Signals that trigger activation are unique to each of the NLR proteins. 
Upon activation by the appropriate ligand, NLR is activated and cleave the precursors 
of IL-1β and IL-18 into their mature secreted forms. The release of these cytokines 
leads to further inflammatory cascades in the host. Other NLR (NOD1, NOD2) are 
known to regulate inflammatory immune responses, whereas the molecular functions of 
many NLR proteins have yet to be discovered. Inflammasomes are central for cleavage 
and activation of pyrogenic cytokines, IL-1β and IL-18. NLR and inflammasomes are 
linked to several autoimmune and inflammatory diseases as well as to infections (Davis 
et al., 2014). However, the knowledge about the roles of NLR in immunity against 
Leishmania infections is just beginning to be explored in models of the many species 
and varieties of leishmaniasis. Several NLR, including some of the 
non-inflammasome-activating NLR, play crucial roles in the host adaptive response to 
pathogens, regulating cellular migration, goblet cell-induced mucous secretion and 
negative regulation of inflammatory pathways. There has been one report indicating that 
at least one species of Leishmania is capable of activating the NLRP3 inflammasome in 
macrophages in vitro and, in vivo, there are evidences that NLRP3 inflammasomes 
influence the course of murine cutaneous or visceral disease. Knockout mice lacking 
NLRP3, ASC or caspase-1 infected with L. amazonensis developed enlarged lesion size 
and augmented parasite burden compared to wild type control mice, evidencing that 
NLRP3 and inflammasome components limit the intracellular growth of L. amazonensis 
in macrophages. Although controversial in some points, in vitro data demonstrated that 
IL-1β released by macrophages infected with L. amazonensis, L. braziliensis and L. 
mexicana require the expression of NLRP3, ASC and caspase-1. (Fettelschoss et al., 
2011; Lima-Junior et al., 2013). Overall, these experiments suggest a protective role for 
the NLRP3 inflammasome against Leishmania parasite load, increasing host resistance 
to a high parasite load. But also there are evidences of conflict, suggesting that 
inflammasome assembly or IL-1β could actually exacerbate the lesions, stressing that 
the underlying mechanisms need further exploration. Regarding the non-inflammasome 
NLR, little is known about any role for NOD1/2 proteins in leishmaniasis disease, 
despite their importance in inflammation and in developing adaptive immunity, 
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highlighting the possible importance of these pathways. The first report of mammalian 
NLR sensing cytoplasmic microbial PAMP refers to NOD1 and NOD2, which have one 
and two N-terminal CARD effector domains, respectively and recognize peptidoglycan 
fragments (Figure 8).  
  
Figure 8: Non-inflammasome NLR, NOD1 and NOD2. 
These cytosolic sensors of pathogens and danger-associated molecules have one (NOD1) or two (NOD2) 
N-terminal CARD effector domains and recognize peptidoglycan fragments (Adapted from Strober et al., 
2006). 
NOD1 recognizes the peptide γ-d-glutamyl-meso-diaminopimelic acid and 
chiefly acts as a sensor for gram-negative bacteria, whereas NOD2 recognizes muramyl 
dipeptide (MDP) and represents a general sensor for most bacteria. Ligand recognition 
by NOD induces the recruitment of CARD-containing serine/threonine kinase RICK 
(also called RIP2) to the receptor via CARD-CARD interactions, which eventually 
leads to NF-κB activation (Inohara et al., 2005; Lee and Kim, 2007). Although several 
potential regulators of NF-κB activity in the NOD-dependent pathways (TAK1, TRIP-6, 
GRIM-19 and ERBIN) have been identified (Werts et al., 2006) their mode of action 
and the in vivo physiological importance remain to be determined. Recent experiments 
have shown that specific activation of NOD1 in the absence of ligands for other PRR is 
sufficient to induce Th2 and B cell response. NOD1 stimulation was able to potentiate 
Th1, Th2 and Th17 responses initiated in cooperation with TLR ligands either during 
immunization or infection with Helicobacter pylori. It is thus suggested that when 
acting coordinated with TLR ligands, NOD1 potentiates and may shape adaptive 
immunity. Because NOD1 stimulation potentiates all Th responses it is unclear whether 
this sensor is involved in controlling the type of response induced (Fritz et al., 2007). 
1.3.3. Organ specific immune response in leishmaniasis 
Visceral leishmaniasis (VL) is caused by the intracellular parasites Leishmania 
donovani and Leishmania infantum. In the VL mouse model, there is a distinct 
organ-specific pattern of parasite growth during the disease establishment. In humans 
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and genetically susceptible mice, the liver, the spleen and the bone marrow are major 
sites of parasite growth and pathology. Although there is some evidence regarding the 
immune response of target organs against Leishmania parasites from murine models, 
little is known of the specific immune responses occurring in these organs in both 
human and canine leishmaniasis. 
 One remarkable aspect of murine VL is the unlike growth rate of parasites in 
infected organs. Infection in the liver is characterized by a rapid increase in the parasite 
burden in the first 4 weeks of infection followed by clearance of the parasite within 6–8 
weeks. This self-curing mechanism in the liver is attributed to the development 
granulomatous response Th1 dominated immune environment (Stern et al., 1988) 
characterized by high IFN-γ production by CD4
+
 T cells. Despite these local responses, 
the parasite is able to disseminate and produce symptomatic VL. In contrast, infection in 
the spleen has serious consequences demonstrated by increased parasite burden, 
disruption of splenic microarchitecture and impaired immune responses resulting in the 
infection persistence (Ato et al., 2002). Although the exact mechanism by which the 
parasite establishes chronic infections in the spleen still remains obscure it is now 
becoming evident that the parasite targets and alters the functions of the host immune 
system for evasion. Some of the altered mechanisms include suppression of host 
protective Th1 responses, generation of defective CD8
+
 T cells and inhibition of 
dendritic cell (DC) function (Ato et al., 2006). In addition to modifying DC and T-cell 
function, the parasite also modulates B-cell function for its survival. Furthermore, by 
directly interacting with different cell subsets, the parasite also generates an 
immunosuppressive environment by inducing IL-10 production thus favoring its 
survival in the host. 
Ahmed et al., (2003) addressed the question of parasite tropism, using mice 
infected intradermally with L. infantum or L. donovani. Parasites were found to persiste 
in spleen and draining lymph nodes and were initially cleared from liver and skin. This 
course of infection appears to be representative of subclinical canine and human VL. 
The tissue site-specific parasite clearance or persistence appears to reflect different local 
immune responses. This indicates that parasites do not accommodate in the first organ 
they encounter after intravenous inoculation, evidencing a pattern of infection. Thus, the 
liver apparently serves as site for initial parasite expansion and the spleen may serve as 
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a safer organ for the long term persistence of the visceralizing Leishmania ssp. 
Resolution of disease in the livers of mice infected with L. donovani or L. infantum 
correlates with the local formation of granulomas. Amastigotes are first observed in 
Kupffer cells, ensuring parasite survival (Figure 9A). Early parasite replication in the 
liver and in the spleen is associated with low IFN-γ and IL-12-producing cells (Wilson 
et al., 2005). Furthermore, infection dynamics are similar in wild type and IL-12p40 
knockout C57BL/6 mice, suggesting that IL-12 mediated Th1 response does not 
influence disease progression until a posterior phase of infection (Wilson et al., 2002).  
Resolution of liver infection is attributed to the development of a Th1 dominated 
granulomatous response, characterized by high IFN-γ production mainly due to CD4
+
 T 
cells. This response is initiated by IL-12 secreted-DCs (Gorak et al., 1998). IL-12 is an 
essential cytokine in the development of protective immunity against L. donovani. IL-12 
blocking reduced both IFN-γ production and granuloma formation in the liver of 
infected mice (Murray, 1997) and, by the contrary, supplementation with exogenous 
IL-12 early decreased liver parasite burden (Murray and Hariprashad, 1995). CD8
+
 T 
cells also have an essential role in the hepatic parasite clearance. Indeed, depletion of 
CD8
+
 T cells inhibits granulomatous response, resulting in disease exacerbation 
(Bankoti and Stäger, 2012). In addition to the adaptive T cell response, TNF production 
and expression of inducible nitric oxide synthase (iNOS) by macrophages help parasite 
elimination. Indeed, granulomas are poorly formed in the immunodeficient murine 
model and in humans with progressive visceral leishmaniasis, which do not develop 
mature granulomas. In VL, hepatic resistance is also attributed to the generation of 
reactive nitrogen and oxygen intermediates, both playing a non-negligible role in 
restraining of parasite growth during the early stages of infection (Murray and Nathan, 
1999). These might in turn be related to the T cell dependent recruitment of monocytes 
at the early phase of infection. At a later stage of infection, regulation of iNOS plays an 
important role in NO generation, pointing to T cell dependent macrophage activation 
(Cervia et al., 1993). 
During a challenge, there is a fast generation of granulomas enriched in CD8
+ 
cells, underlying the importance of CD8
+
 cells for the development of long term 
immunity to VL, a finding also observed during L. major infection (Müller, 1992). The 
livers of asymptomatic dogs showed an effective immunity with well-organized 
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granulomas able to isolate and restring parasite spreading in an immune environment of 
activated effector T cells, dendritic cells (DCs) and central memory cells. In contrast, 
liver of symptomatic dogs showed a non-organized and ineffective infiltrate of T cells 
and heavily parasitized Kupffer cells (Sanchez et al., 2004). Furthermore, the highest 
proportion of activated effector T cells was also observed in the liver of asymptomatic 
dogs, correlating with an effective immune response against the parasite. Interestingly, 
many naive T cells were observed in the liver of symptomatic dogs. Apparently, central 
memory T cells sensitized against L. infantum may migrate to peripheral tissues, 
providing protection at these vulnerable sites. In contrast, naive T cells migrate almost 
exclusively to lymphoid organs, which are designed for receiving migrating cells and 
antigen sampling (Mackay, et al., 1990; Mackay, et al., 1992). Therefore, it is possible 
that the high proportion of naive T cells found in the liver of symptomatic dogs 
correspond to a resident mixed T cell subset associated with tolerance or nonspecific 
activation similar to that described in mice (O’Farrelly et al., 1999). Nevertheless, the 
role of naive T cells in the liver of infected dogs remains to be defined. Establishment 
and functioning of liver granulomas in dog is not yet fully characterized as in VL 
murine model.  
In the spleen, where amastigotes can persist throughout the life of the animal, 
parasite replication begins later and remains at a low level. Spleen and bone marrow are 
sites of chronic inflammation, characterized by parasite persistence. Chronic spleen 
infection is associated with splenomegaly and changes in the splenic microarchitecture 
(Ato et al., 2002; Stanley and Engwerda, 2007) which have consequences on the 
development of a specific immune response. Paradoxically, pro-inflammatory and 
inhibitory cytokines are co-expressed in splenic cultures (Wilson et al., 1996). Although 
IL-10, IL-12, IFN-γ and TGF-β are detected by immunohistochemistry in the spleens of 
L. donovani infected BALB/c mice, IL-4 remained absent (Melby et al., 2001). 
Typically, following an encounter with the antigen, DCs migrate from the marginal 
zone (MZ) of the spleen to the T cell rich area known as periarteriolar lymphoid sheaths 
(PALS) (Figure 9B-C). At PALS DCs interact with T cells, resulting in the induction of 
an antigen-specific T cell response (Gorak et al., 1998). 




Figure 9: Organ-specific immune response in VL. 
A) The ability of the liver to resolve infection is dependent on the formation of inflammatory foci around 
infected Kupffer cells, consisting of lymphocytes and monocytes, which allow fusion of infected cells and 
killing of amastigotes by infiltrating activated blood monocytes. B) Schematic representation of a 
mammalian spleen highlighting the localization of the periarteriolar lymphoid sheaths (PALS) and 
marginal zone in the white pulp. C) Schematic magnification of a follicle with the distribution of DCs and 
macrophages in the marginal zone. These cells migrate to the rich T cell area of the periarteriolar 
lymphoid sheaths (PALS) presenting Leishmania antigens, giving origin to an immune reaction. IFN-γ, 
interferon-γ; IL-12, interleukin 12; IL-2, interleukin 2; NO, nitric oxide; ROI, reactive oxygen 
intermediates; TNF-α, tumor necrosis factor α; DC, Dendritic cells; MZ, marginal zone. (Adapted from 
Cyster, 2000; Engwerda and Kaye, 2000 and http://bodterms.weebly.com/pals.html) 
During chronic L. donovani infection, increase production of TNF by 
macrophages causes the disruption of splenic MZ (Engwerda et al., 2002). As a 
consequence of this disruption, DCs and naive T-cells fail to migrate to the PALS, 
which may result in diminished T cells priming. This impaired migratory capacity also 
directs the down regulation of important co-stimulatory molecules and the increase 
expression of DCs inhibitory molecules (Josh et al., 2009), leading to the hypothesis 
that DC functions are diminished at later stages of infection. This hypothesis is 
supported by the study conducted by Stäger et al., (2006), where bone marrow-derived 
DCs LPS-activated were adoptive transferred into mice at a later L. donovani, infection 
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stage resulting in a significant reduction of the splenic parasite burden and possibly in 
the induction of a protective T cell response.  
Splenomegaly is also associated with destruction of the follicular network and 
the fibroblastic reticular network of DCs (Smelt et al., 1997). In the spleen, the immune 
responses of symptomatic and asymptomatic dogs were very similar. However, the 




 T cells in the spleen of asymptomatic dogs 
is highly suggestive of an efficient cellular response, involving the recruitment of 
parasite-specific CD4
+
 T cells meant to migrate to target organs (Sanchez et al., 2004).  
Culture of spleen cells during L. infantum infection showed that there are antigen 
specific lymphocytes producing IFN-γ even at the peak of liver infection (Murray et al., 
2002). IFN-γ stimulates macrophages to produce nitric oxide, a final effector molecule 
necessary for intracellular parasite elimination. Therefore, it is not immediately 
apparent why parasites survive in the spleen.  
The answer may lay in studies of the trafficking of amastigotes and DCs within 
the spleen. During a normal antigen specific response in the spleen, DCs migrate from 
the marginal zone to PALS, a zone containing mainly T cells. At PALS, DCs interact 
with T cells and initiate antigen specific response. Chemokines CCL21 and CCL19 
induce migration of mature DCs, expressing CCR7 at surface (Balazs et al., 2002). 
During the first few hours of L. donovani infection, parasites are localized in marginal 
zone macrophages (MZMs) of the splenic white pulp, which is lacking mature DCs and 
T cells. After a week, parasites are found in the red pulp, a macrophage rich area, and 
DCs failed to move to PALS marginal zone where the antigen-specific response occurs. 
The cause of this anergy are associated with DCs failing in express surface CCR7 due to 
increased levels of IL-10 and TNF-α that mediates a decrease of CCL21 and CCL19 
release from PALS’ cells. The consequence of the mis-localization of parasite 
antigen-expressing DCs is the failure to interact and activate a T cell specific response. 
Late in L. donovani infection, the splenic architecture is disrupted, losing MZMs 
expressing normal amounts of TNF-α. Progressive destruction of follicular DCs and the 
eventual loss of germinal centers occurred (Balazs et al., 2002; Bankoti and Stäger, 
2012). This pattern differs from chronic L. major infection, causing CL, in which 
dendritic cells localize normally. In addition, these changes could affect the reactivity of 
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B cells and, consequently compromise antibody production, which are known to be 
deregulated during VL (Ronet et al., 2008). 
1.3.3.1. Liver structure and immunology 
The liver is the largest organ in the mammalian body and it performs a 
remarkable number of tasks that support the function of other organs and impacts all 
physiologic systems. The main essential functions of the liver are related to protein 
synthesis and metabolism, including the metabolism of amino acids, carbohydrates, 
lipids and vitamins. Also the degradation of toxins, xenobiotics and waste products are 
essential functions performed by the liver. Nevertheless, the liver is also responsible for 
several immunological functions as the removal of pathogens and exogenous antigens 
from the systemic circulation. The anatomic position of the liver and its distinctive 
vasculature accounts for its unique ability to continuously exchange immunological 
information. 
To accomplish its multiple tasks, the liver is constituted by diverse cell 
populations sub-divided in parenchymal and non-parenchymal cells (Figure 10).  
 
Figure 10: Liver cell constitution. 
Numbers indicate cell frequency estimated for a healthy human liver (Adapted from Racanelli and 
Rehermann, 2006). 
Most of the liver volume is occupied by parenchymal cells (hepatocytes) that 
occupy approximately 78–80% of the total hepatic tissue. Non-parenchymal cells 
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correspond barely to 5–6% of the total organ (Blouin et al., 1977). The 
non-parenchymal cells consist of diverse types of cells, including liver sinusoidal 
endothelial cells (LSEC), Kupffer cells (KC) and hepatic stellate cells (HSC). The liver 
can be considered to have two separate anatomic areas, the parenchyma and the portal 
tracts. Structurally, the liver can be further subdivided into five systems comprising the 
vascular system, the hepatic lobule, the hepatic sinusoidal system, the biliary system 
and the stroma. Each of these systems directly or indirectly plays an important role in 
the homeostasis of the innate and adaptive immune system. 
Liver structural organization has profound implications in its immune functions 
(Figure 11). The blood supply depends on: a conventional arterial system from the 
abdominal aorta that supports predominantly bile ducts and other tissues in the portal 
tracts, and of two venous systems that includes a minor system from the arterial plexus 
within portal tracts (peribiliary plexus) and a major system from the splanchnic organs 
(Racanelli and Rehermann, 2006). Blood enters the hepatic parenchyma mainly via 
terminal portal vessels and then passes through a network of liver sinusoids, leaving the 
parenchyma via the central hepatic veins (Figure 11B). About 30% of the total blood 
passes through the liver every minute, carrying peripheral blood lymphocytes, dendritic 
cells and potential harmful microbes or antigens (Sheth and Bankey, 2001). Due to the 
small diameter of sinusoids, minimal increases in systemic venous pressure and 
perturbations of sinusoidal flow result in stasis, which lengthens the contact between 
lymphocytes and antigen presenting cells and promotes lymphocyte extravasations. 
Blood rich in antigens flowing through the liver sinusoids is actively screened by a 
complex network of conventional and non-conventional antigen presenting cells (APC) 
(Thomson and Knolle, 2010). Lymphocyte extravasations is further facilitated by 
fenestrations in the monolayer of sinusoidal endothelial cells (LSEC) that give 
lymphocyte access to the space of Disse via cytoplasmic extensions and allow 
interaction with the underlying extracellular matrix, stellate cells and hepatocytes 
(Wisse, 1970).  
The role of the liver as the main metabolic organ increases the rate of exposure 
to newly produced potential antigens and enhances the inherited risk of over activation 
of components of the immune system with potentially harmful consequences for 
individual homeostasis. Thus, the immune system developed mechanisms to promote 
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tolerance, but is also able to trigger a responsive state at any given time (Kita et al., 
2001).  
Hepatocytes constitute the majority of the hepatic cells and although the primary 
roles of these cells are of metabolic nature, such as protein production and toxin 
neutralization, these parenchymal cells of the liver can also detect pathogens and aid the 
host immune response. Hepatocytes express innate immune receptors and in many cases 
have been demonstrated that these cells recognize pathogen associated ligands and 
display an innate immune response. Zhang et al. (2009) reported that TLR3 and TLR4 
activation lead the attenuation of viral replication inside hepatocytes and the secretion 
of inflammatory cytokines such as IFN-α and IFN-γ.  
 
Figure 11: The canine liver, as model for the mammal liver. 
A) Morphology of the canine liver; B) Longitudinal cut of canine liver. The arrow indicates the flow of 
the blood from the portal tract to the central vein. C) Localization of the liver in the canine body 
surrounded by the adjacent organs. D) Magnification of a hepatic lobule. The arrow indicates the flow of 
the blood from the portal tract to the central vein. Notice the localization in the space of Disse of Kupffer 
cells and stellate cells (Adapted from http://www.hillspet.com/dog-care/dog-disease-liver-disease.html, 
Frevert et al., 2005 and https://bio.mox.polimi.it/nanomedicine/perfusion-characteristics-liver-tissue/). 
In addition to their role in innate immunity, hepatocytes have also been 
implicated in the initiation of the adaptive immune response. Hepatocytes express 
MHCI and CD1 on the cell surface allowing them to present antigens to both T and 
natural killer T cells (NKT). However, the lack of expression of co-stimulatory 
molecules and CD40 skews this process towards tolerance rather than activation (Li and 
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Tian, 2013). Under inflammatory conditions, some hepatocytes can be induced to 
express MHCII (Franco et al., 1988). Apparently, MHCII-expressing hepatocytes 
induce Th2 cell differentiation of uncommitted CD4
+
 T cells and annul the ability of 
previously differentiated Th1 to secrete IFN-γ, even in the presence of 
pro-inflammatory microbial signals. The suppression of Th1 responses by hepatocytes 
is associated with poor expression levels of Th1-promoting Delta-like Notch ligands. 
These processes lead to chronic infections (Wiegard et al., 2007).  
Hepatocytes can also induce antigen-specific Tregs cells, which prevent 
autoimmune diseases (Lüth et al., 2008) and regulates NK cell via NKG2A-Qa-1b 
receptor, resulting in increased IL-10 and decreased IFN-γ production by NK cells 
(Jinushi et al., 2007). When encountering type I IFN-secreting NKT cells, hepatocytes 
can stimulate IL-10-expressing CD8
+ 
T cells, which also exhibit regulatory function. 
Electron microscopy has revealed that hepatocytes and naive T cells physically interact 
in an ICAM-1–and MHC-dependent fashion (Warren et al., 2006). Taken together, 
these studies provide strong evidence of a role for hepatocytes in the activation of T 
cells, however the ability of hepatocyte-mediated activation of T cells remains, given 
the presence of other APC (LSEC, KCs and DC) in the liver microenvironment.  
Hepatocytes are also responsible for the production of most acute-phase proteins 
and complement components. These two soluble elements of the innate immune system 
represent an evolutionarily conserved first line of defense against pathogens. 
Acute-phase proteins such as C-reactive protein can bind to specific microbial surfaces 
and alert the immune system to the presence of these pathogens. Likewise, components 
of the complement system such as C3 protein and the mannose-binding lectin directly 
bind microbial surfaces, triggering the immune system (Sarma and Ward, 2011). 
Through the production of these critical innate immune proteins, the hepatocyte can 
extend its role in pathogen detection far beyond the anatomical limits of the liver. 
KC are resident stationary cells located in the vasculature are adherent to LSEC 
and directly exposed to the contents of blood circulating through the liver tissue (Figure 
11D). This contrasts with other monocytic and macrophage cell populations located in 
diverse/different tissues that actively crawl through the tissue searching for pathogens. 
KC express an array of scavenger receptors, TLR, complement receptors and antibody 
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receptors, molecules that allow KC to detect, bind and internalize pathogens. 
Expressing MHC I, MHC II and costimulatory molecules needed for T cell activation, 
KC are important APC. Furthermore, these receptors drive in part the activation of KC, 
which leads to production of cytokines and chemokines and allows KC to function as 
immune sentinels, alerting other components of the immune system to the presence of 
harmful microbes (Bilzer et al., 2006). Although capable of activating T cells under 
basal conditions KC are poor activators of the adaptive immune response, preventing 
reactions to common gut-derived antigen present in the portal circulation. Following 
TLR activation or when in the presence of inflammatory cytokines, KC can be 
converted from normally tolerogenic cells into potent APC capable of robust activation 
of T cells. KC are also extremely effective in activating the invariant NKT (iNKT) cells 
that live and patrol the sinusoids of the liver, quickly controlling a potential infection 
(Jenne and Kubes, 2013).  
Hepatic stellate cells (HSC), also designated Ito cells, are star-shaped cells that 
reside in the space of Disse, between hepatocytes and LSEC comprise a minor fraction 
(5–8%) of total liver cells. Under normal conditions, HSC have a central role in vitamin 
A and lipid storage, but in a chronic liver damage scenario, HSC transdifferentiate into 
a fibrinogenic pro-liferating cell leading to liver fibrosis. In addition to their well 
defined roles in lipid storage and fibrinogenesis, evidences also suggest that HSC act as 
immune sentinels in the liver (Winau et al., 2008). HSC express molecules required for 
antigen presentation (MHC I, MHC II, CD80 and CD86) and fluorescent microscopy 
studies have revealed direct contact between these cells and lymphocytes, supporting 
the hypothesis that HSC can directly activate naive lymphocytes (Muhanna et al., 
2007). However, the ability of HSC to directly activate lymphocytes has been 
questioned given their low abundance of MHC and of costimulatory molecules. 
Analysis of the expression of key molecules required for antigen presentation (MHC II, 
CD80, CD86) performed in fresh isolated HSC did not detect those molecules, but low 
abundance of others (CD1d) molecules were identified (Ichikawa, et al., 2011). 
Although, some of these molecules were upregulated after cell culture in the presence of 
pro-inflammatory cytokines, it appears that under basal conditions HSC do not express 
the key molecules needed for antigen presentation to lymphocytes. The role suggested 
for HSC, as regulatory bystanders, promoting Tregs and suppressing Th17 
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differentiation might represent key players in the mechanism that drives liver-induced 
tolerance. As a result, these cells may be important in disease progression and in the 
damage resolution of the liver. 
In addition to LSEC, KC and HSC, the liver also contains several populations of 
dendritic cells (DC). Tissue-resident DCs are present in most tissues with considerable 
functional and phenotypic heterogeneity amongst DC populations. DC appears to enter 
the liver predominantly via the portal blood supply, maturing as they transit from the 
portal circulation to the central vein. DCs are sparsely distributed through the liver and 
immunohistochemical studies of patient liver biopsies, indicate that they are primarily 
found in the portal regions and occasionally in the parenchyma (Rahman and Aloman, 
2013). Liver DC can internalize antigens derived from the blood and transport these 
antigens to a regional lymph node. Under steady state conditions, liver DCs in both 
mice and humans can be divided into two major functional classes: classical DCs 
(cDCs) and plasmacytoid DCs (pDCs). cDCs express high levels of MHCII and 
function as highly-efficient professional antigen presenting cells. In contrast, pDCs 
express relatively lower levels of MHCII and have a relatively limited capacity to 
capture and present tissue antigens and instead function as major producers of type I 
IFNs in response to nucleic acids in the setting of viral infection (Pillarisetty et al., 
2004). Normally poor activators of T cell immunity, liver DC, under the proper 
conditions, can be transformed into potent APC by IL-10 blocking or by activation 
through pathogen-associated molecules  
Despite the DC subpopulations mentioned above, another cell population that 
appears to have characteristics of both DC and NK cells has been identified in the 
mouse liver (Pillarisetty et al., 2005). NK-DC express both NK cell markers (NK1.1) 
and DC markers (CD11c) and are present in several tissues but are enriched among the 
CD11c
+
liver fraction. NK-DC can both directly lyse target tumor cells and efficiently 
present antigen, activating naive T cells. Additionally, NK-DC can produce large 
quantities of cytokines, such as IFN-γ, further potentiating the cytotoxic immune 
response.  
Hepatic leukocyte populations differ from those of other tissues in a number of 
interesting ways. Their distribution is unique: one-third to one-half of leukocytes are 
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NK cells, making of the liver threefold more rich in these cells than blood (Racanelli 
and Rehermann, 2006). These innate leukocytes can respond to a large variety of cell 
surface ligands expressed by damaged or infected cells, making the NK cell a critical 
sentinel in the detection of viral and intracellular bacterial infections in the liver (Notas 
et al., 2009). After activation, NK cells release cytotoxic granules containing perforin 
and granzyme in a cell-directed way. In response to stimulation, these cells also release 
a large amount of cytokines, such as IFN-γ, and by doing so, shape and direct the 
immune response and also modulate MHC expression of hepatocytes and HSC (Crispe, 
2009). 
Phenotypically, nearly 50% lymphocytes express the T cell receptor (TCR) and 
also there is an enrichment of CD8
+





 T cells, but in the liver this ratio is reversed. The liver also 
contains the largest population of γδT cells in the body (Abo et al., 2000). Although 
these cells are classically described as innate T cells, the specific function of γδT cells 
in the liver is not known. The individual γδT cell is often polyreactive, able to bind to 
several different ligands, foreign and self, in both a MHC-dependent and 
MHC-independent manner (Vantourout and Hayday, 2013). These characteristics 
differentiate γδT cells from conventional T cells, which typically recognize a single 
peptide complex with MHCII. Another distinct characteristic of liver resident 
lymphocytes is that nearly all of the CD3
+
 cells in the liver (both αβ and γδ) express 
intermediate amounts of TCR (Iiai et al., 1992). This clearly distinguishes these cells 
from thymus-derived peripheral T cells that express abundant levels of TCR. This TCR 
intermediate cell subset uniformly expresses IL-2Rβ (CD122) and comprises a mix of 
NK1.1
-
T cells and NK1.1
+
 NKT cells (Watanabe et al., 1995). NKT cells are important 
and potent immunomodulatory population in the liver. These cells express a restricted 
TCR repertoire and respond to lipid antigens when presented in the context of the 
MHC-I-like molecule CD1d (Brennan et al., 2013). Like the other types of leukocytes 
discussed above, the liver is enriched with these NKT cells, when compared to other 
tissues and NKT cells perform an important role as immune modulators. NKT cells are 
able of both inflammatory and anti-inflammatory responses, producing a wide array of 
cytokines that depending on the specific nature of the activating signal can include 
IFN-γ, IL-4 and IL-17 (Matsuda et al., 2008). As a result, NKT cells have great 
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potential to shape the host immune response, but two additional characteristics of NKT 
cells demonstrate the critical importance of this population for the immune surveillance. 
NKT cells are the only liver-resident lymphocyte to actively patrol the liver vasculature 
in search of pathogens and are activated by a diverse array of signals that includes 
pathogens cytokine stimulation, self lipids and even neuromodulatory signals. In the last 
case, NKT cells of mouse liver have been shown to respond directly to a noradrenergic 
neurotransmitter released in response to brain ischemic stroke. These cells produced 
anti-inflammatory cytokines that induced a state of immune suppression in the mouse, 
reducing inflammation and therefore protecting the brain. However, this immune 
suppression state makes the host more susceptible to systemic bacterial infections 
(Wong et al., 2011).  
The delicate balance between immunity and tolerance in the liver, results 
directly from the complex interactions between the various resident immune cells and 
peripheral leukocyte populations. Under basal conditions, many liver resident cells 
(LSEC, KC and DC) have a critical role, maintaining a state of immune 
unresponsiveness, accomplished, in part, by the low expression of MHC and the 
absence of costimulatory molecules. Furthermore, the direct cell-cell contact between 
LSEC and liver DC under the continual exposition to pathogen-derived molecules from 
the gut induces the expression of anti-inflammatory molecules, reinforcing the state of 
immune tolerance. However, given an appropriate stimulation a robust immune 
response can be generated in the liver. Introduction of live bacteria, viral infection or 
the presence of elevated quantities of PAMP drives a rapid and robust inflammatory 
response involving the recruitment of large numbers of neutrophils and platelets to the 
liver. The anatomical features, blood supply, diverse network of cells and the broad 
array of receptors enable the liver to act as a crucial, frontline immune sentinel. 
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2 General objectives 
This study aims to clarify the natural mechanisms elicited by the liver of the dog, 
the main reservoir for Leishmania, to control the infection by L. infantum. Studies of 
liver immune activation and deactivating processes as well as immune pathogenic 
mechanisms may contribute to the better management of the disease and to the 
development of treatment alternatives. It is in this context that an in vitro bidimensional 
(2D) and tridimensional (3D) models of liver were established, allowing the assessment 
of the effect of L. infantum presence in the activity of hepatocytes and KC, by 
evaluating immunologic and functional cell markers. This system has also been used to 
evaluate the effect of antileishmanial drugs on liver current activity and on the immune 
response. The present study also proposes to characterize the resident memory 
lymphocyte population in the liver, eliciting its importance as an immunological 
memory organ. To do this task, it was used a murine model of visceral leishmaniasis, 
the BALB/c mice (Mus musculus). It was accessed the liver resident effector cells, 
effector memory cells and central memory cells that responded to L. infantum total 
soluble antigen or recombinant parasite proteins in healthy (non-infected), infected and 
in animals treated with a leishmanicidal drug.  
Thus, the present work proposes the characterization of the following processes: 
 Interaction of L. infantum with dog’s KC; 
 Interaction of L. infantum infected-KC with dog’s hepatocyte; 
 Interaction of L. infantum with canine hepatocytes in 2D and 3D culture 
systems; 
 Comparison of immune activation profiles of canine blood macrophages 
vs liver macrophages (KC); 
 Assess the impact of commercial anti-leishmanial compound in the 
culture systems previously described; 
 Assess the impact of new potential anti-leishmanial compound in the 
culture systems; 
 Characterize the resident memory lymphocyte population in the liver, 
eliciting its importance as an immunological memory organ. 
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3 General Methods 
3.1. Experimental design 
The present study aimed to a better understanding of the immune response 
generated by the dog liver when facing an infection by Leishmania infantum parasites. 
Therefore, this section includes the descriptions of the methods used to isolate, culture 
and analyze liver cells. The liver samples were from dogs (Canis lupus familiaris) 
belonging to the Official Kennel (Lisbon, Portugal). 
The experimental design used is represented in Figure . Briefly, livers from 
healthy stray dogs were collected and hepatocytes and the Kupffer cells were isolated. 
Bidimensional (2D) and tridimensional (3D) cultures of canine hepatocytes were 
established and cells were adapting to the new environment (culture medium) for a 72 h 
period. The cells were exposed to L. infantum amastigotes or promastigotes for another 
72 h and several parameters were evaluated at successive time points. Cells were 
collected to assess the innate immunity (i) by evaluating the gene expression of 
membrane receptors, such as NOD1, NOD2, TLR2, TLR4 and TLR9 and (ii) the 
mRNA accumulation of pro-inflammatory (TNF-α and IL-6) cytokines and of the 
immune suppressor IL-10 and, to analyze metabolic parameters through (iii) the 
quantification of urea and nitric oxide production and by evaluating the activities of 
cytochrome P450 enzymes (e.g. CYP1A1, CYP1A2, CYP1B, CYP2B11, CYP3A12 
and CYP 3A26, alkoxyresorufin O-dealkylation family). Also confocal and electron 
scanning microscopy techniques were applied to characterize hepatic cell structure and 
parasite interaction with cell membrane. The impact of an antileishmanial drug in a L. 
infantum liver infection was also analyzed. Meglumine antimoniate, the conventional 
drug used to treat canine leishmaniasis, was added to the 3D and 2D cultures of 
parasite-exposed hepatocytes for 72 h. Experimental compounds with antileishmanial 
activity, such as chalcone, ursolic acid and quercetina were also used. Innate immunity 
and metabolic parameters, as previously described were also evaluated. 
Kupffer cells were cultured for 7 days to ensure macrophage complete 
maturation and were infected by L. infantum amastigotes or promastigotes. Infection 
dynamics was followed by flow cytometry and the gene expression of innate immune 
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receptors (NOD1, NOD2, TLR2, TLR4 and TLR9) and of cytokines (TNF-α, IL-12, 
IL-4, IL-10 and TGF-β) were assessed at different time points. Meglumine antimoniate 
was added to parallel cultures for 24 h. Cells were analyzed as previously described.  
To compare the immune response on Kupffer cells, as liver resident 
macrophages and peripheral blood macrophages, monocytes were isolated blood from 
dog blood and differentiated in macrophages after 3-days in culture. Macrophages were 
then infected with L. infantum promastigotes and the gene expression of the innate 
immune receptors and of cytokines were followed for 24 h.  
 
 
Figure 12: Experimental design. 
Hepatocytes and Kupffer cells were isolated from livers of healthy stray dogs. 2D and 3D cultures of 
canine hepatocytes were established and exposed to L. infantum virulent parasites. In 2D culture system, 
hepatocytes were exposed to both L. infantum promastigotes and amastigotes. Antileishmanial 
conventional and experimental drugs were tested in parasite-exposed hepatocytes, in 2D culture system. 
After complete differentiation, Kupffer cells were infected with L. infantum promastigotes and 
amastigotes. The effect of a commercial antileishmanial drug (meglumine antimoniate) was also 
evaluated. Several metabolic and immunological parameters were analyzed at different time points. 
Peripheral blood was also collected to monocytes isolation and further differentiation into macrophages. 
Cells were infected with L. infantum promastigotes and immune response obtained was compared to liver 
resident macrophages- the Kupffer cells. 
  




This study was performed with 12 healthy dogs weighing between 8 and 28 kg 
(Table 3). These dogs belonged to the Official Kennel (an organization recognized by 
the European Convention for the Protection of Small Animals). Unless reclaimed or 
adopted after a quarantine period, these animals undergo euthanasia. Animals were 
firstly injected with heparin intravenous (5000 U/ml) 30 minutes prior surgery, to avoid 
blood coagulation in the liver during extraction. Animals were then anesthetized with 
ketamine intravenous [5 mg/Kg] (Vetnil), followed by the administration of sodium 
pentobarbital in accordance with animal weight [<10kg200 mg/kg; >10kg 300mg/Kg] 
(Eutasil). Livers were them collected. Experiments were monitored by competent 
veterinary surgeon and approved by the ethical committee of the Faculty of Veterinary 
Medicine (Lisbon, Portugal).  
 










1 Boxer 27 6 Male 
2 Mongrel 15 7 Male 
3 Mongrel 12 6 Female 
4 German Shepherd 28 9 Male 
5 Portuguese hound 8 3 Male 
6 Cross-breed German Shepherd 16 6 Female 
7 Crossed Pointer 12 7 Male 
8 Mongrel 22 8 Male 
9 Mongrel 12 7 Male 
10 Mongrel 22 8 Male 
11 Pointer 12 6 Male 
12 Portuguese hound 10 9 Male 
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3.2.1. Animal health tests 
All animals used were previously tested for parasites and biochemical and 
hematological parameters were determined to ensure that animals did not had vector 
borne infections (CVBD – canine vector borne diseases) and that blood parameters were 
normal. The parasitological and bacterial tests performed to each dog are summarized in 
Table 4. As biochemical tests quantification of urea and creatinine in circulating blood 
was performed to assess kidney function. The liver function was evaluated in circulating 
blood by total bilirubin quantification, aspartate aminotransferase and alanine 
aminotransferase presence as well as alkaline phosphatase and bile acid. Hematological 
parameters assessed were hemogram and ionogram (sodium, potassium, clorets) as well 
as inorganic phosphorus. Albumin and calcium blood concentrations were also 
measured. Animals were CVBD negative and evidenced normal values for 
hematological and biochemical parameters. 
 
Table 4: Parasitological and bacterial tests performed in the dogs included in the present study. 
 
Parasitological and bacterial tests  
Canine Leishmaniasis 
Indirect immunofluorescence (IFI), cut off 1:80 
DNA amplification by real-time PCR for L. infantum 
(Helhazar et al., 2013) 




DNA amplification by real-time PCR* 
Mycoplasma haemocanis 
Blood smear for microscopy observation  
Ricketsia spp.  
Blood smear for microscopy observation 
 
*According to the protocol implemented in Virology laboratory of 
FMV, UTL. Primers and probes were designed with Primer 3 and 
BLAST software.   




3.3.1. Leishmania infantum promastigotes 
L. infantum zymodeme MON-1 (MHOM/PT/89/IMT151) was maintained by 
successive passages in BALB/c mice. The spleens of infected mice were extracted and 
homogenized with a tissue disaggregator with 50 μm separator screen (Medicons, 
Syntec International) to isolate a suspension of single cells. This cell suspension was 
added to Schneider medium with L-glutamine (SCHN, Sigma-Aldrich) supplemented 
with 10% (v/v) of heat-inactivated fetal bovine serum (FBS, Sigma-Aldrich) and 
penicillin-streptomycin (Biochrom) at 100 U/ml and 100 μg.ml
-1
 respectively (complete 
SCHN medium). Spleen cells were incubated at 24 ºC until complete differentiation of 
promastigotes. Only virulent parasites with less than five passages were used 
(Santos-Gomes and Abranches, 1996) in the present study. The concentration (C) of 








 are consideration factors for the number of squares counted and the 
volume of the chamber. Together they stand for counting 5 squares in 0.0001 ml – 
volume of the Neubauer chamber. 
3.3.2. Leishmania infantum axenic amastigotes 
L. infantum zymodeme MON-1 (MHOM/PT/89/IMT151) was maintained by 
successive passages in complete SCHN medium (see 3.3.1) until reaching the stationary 
phase (around three passages). Promastigotes concentration was determinate in a 





Parasites were inoculated into complete SCHN medium (as described in 3.3.1) with acid 
pH at 5.5 and supplemented with 2% of filtered human urine (from a healthy male 
donor) for amastigote differentiation. Cultures were incubated at 37 ºC, in a humidified 
atmosphere with 5% CO2 during two to three weeks to allow complete amastigote 
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transformation. The amastigote differentiation was followed by inverted microscopy 
and confirmed with scanning electronic microscope (JEOL5200-LV). 
3.3.3. Leishmania infantum-GFP 
Transgenic Green Fluorescent Protein (GFP)-expressing L. infantum 
promastigotes were kindly given by Professor Ana Tomás from Instituto de Biologia 
Molecular e Celular (IBMC), Universidade do Porto (Oporto, Portugal). Briefly the 
GFP open reading frame was inserted in the trypanosomatid expression plasmid pTEX 
(Kelly et al., 1992) and the resulting construct electroporated in L. infantum 
promastigotes following standard procedures. L. infantum mutants were selected on 
agar plates using Geneticin (G418 disulfate salt solution, Sigma-Aldrich) at 25g.ml
-1
. 
Individual colonies were grown in culture medium using the same selection conditions, 
analyzed by southern blotting to confirm that the construct was structurally intact, and 
by fluorescence to ensure GFP expression. L. infantum GFP promastigotes were 
maintained in culture using SCHN medium supplemented with 25 g.ml
-1
 of Geneticin. 
GFP amastigotes were also obtained using the method described in 3.2, but maintaining 
the 25 g.ml
-1
of Geneticinin culture medium to ensure the conservation of the plasmid. 
Amastigotes differentiation was confirmed under a fluorescent microscope with GFP 
filter (Nikon eclipse 80i) and camera Nikon DS-Ri1. 
3.4. Real-time PCR technique 
3.4.1. Basic principles 
Monitoring the immune response is critical for the follow-up and treatment 
evaluation of numerous diseases. Studying the profile of cytokine production can help 
to clarify functional properties of immune cells, both in research and in clinical 
diagnosis (Stordeur, 2009). Since the first documentation of real-time PCR (Higuchi et 
al., 1993) it has been used for increasing the number of applications, including mRNA 
studies, DNA copy number measurements in genomic or viral DNA, allelic 
discrimination assays or expression analysis of specific splice variant of genes (Arya et 
al., 2005). Real-time quantitative PCR offers a powerful tool for the quantification of 
target nucleic acids, being a very high throughput technique that is faster than 
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conventional PCR and both accurate and sensitive. Real-time-PCR can virtually detect 
one copy of a specific sequence, using very small samples with low gene expression. In 
a conventional PCR, the reaction must be finish before proceeding with the post-PCR 
analysis, by gel electrophoresis. Real-time PCR overcome this problem by measuring 
the PCR products at the early stages of reaction, as they accumulate in a real time 
detection mode, thus measuring the amount of PCR product when the reaction is still in 
the exponential phase. Real-time PCR allows detection and quantitative measurement of 
products generated during each cycle of the PCR process that are directly proportional 
to the amount of the template DNA before the start of the PCR process. This requires 
the use of an appropriate methodology able to detect the product formed on each cycle 
and the software must record the results obtained on each amplification cycle in a real 
time manner (Pestana et al., 2010).  
A representative amplification plot of a real-time PCR reaction is shown in 
Figure 13. In the initial cycles of amplification, there is no significant change in the 
fluorescent signal and it stays beneath the limits of detection, constituting the baseline. 
A baseline subtracted amplification plot (∆Rn) is generated by the associated software 
using the equation ∆Rn = Rnf – Rnb, where Rnb is the fluorescent emission of the 
product at each time point and Rnb is the baseline fluorescence level. The ∆Rn values 
are plotted versus the cycle number. Then a computational algorithm searches for the 
point on the amplification plot at which the ∆Rn value crosses the threshold level. This 
point defines the threshold cycle (CT) of a sample. The exponential growth phase of 
amplification starts from this point on. The CT value consists in the value (number of 
cycles) where the reaction curve intersects the threshold line, showing the numbers of 
cycles need to detect a real signal from the samples. CT values are inverse to the amount 
of nucleic acid in the sample and correlate to the number of copies the sample. Lower 
CT values indicate high amounts of targeted nucleic acid, while higher CT values mean 
lower amounts of target nucleic acid. The standard curve method is used when absolute 
quantification is critical for the investigator (Arya et al., 2005; Pestana et al., 2010). 




Figure 13: Real-time PCR amplification plot. 
Fluorescent emission is measured continuously during the reaction if amplification and a baseline 
subtracted amplification plot (∆Rn) is generated. The CT value constitutes the point where the 
fluorescence of the sample is above the threshold (adapted from Pestana et al., 2010). 
There are a wide variety of commercial available fluorescent DNA dyes. The 
most commonly used is SYBR®Green I, an asymmetrical cyanine dye with two 
positive charges that under PCR conditions contributes to its high double strand DNA 
(dsDNA) binding affinity. When SYBR®Green dye binds to the minor groove of 
dsDNA its fluorescence is increased and can be measured in the extension phase of each 
real-time PCR cycle. Given that nonspecific products and primer dimers can be formed 
during the PCR process, a melting curve analysis is recommended to check for 
unspecific amplifications (Navarro et al., 2015). An example of IL-6 melting curve 
obtained in the current study is shown in Figure 14B. The advantages of the 
SYBR®Green dye are mainly related to its capacity to monitor the amplification of any 
dsDNA, as no probe is required, and specificity is ensured by the primer sequence. This 
reduces the assay running costs and due to the dye characteristics, the generated 
fluorescent signals are much stronger, increasing sensitivity. SYBR®Green provides a 
convenient and cost effective technique to screen a large number of samples and targets.  
In the present study, absolute quantification was performed to determine the 
levels of expression of several genes with immunological importance. As said before, 
absolute quantification determines the copy number of the target in a sample by 
associating the PCR signal to a standard curve. In order to measure a specific cytokine 
or innate immune receptor copy number in a sample, a standard curve constructed with 
known quantities of each gene target was performed. The standard curve is generated by 
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serial dilutions of known quantities of plasmid with target insert, produced as described 
in 3.4.3. 
 
Figure 14: Quantitative analysis of gene expression by real-time PCR. 
Quantitative analysis of gene expression by real-time PCR. Exemplificative real-time PCR amplification 
plot for a standard curve performed with seven duplicate dilutions of a plasmid with the IL-6 insert (A) 
and the melting curves of IL-6 amplification in different samples (B). 
The efficiency of real-time PCR amplification is defined as the rate at which a 
PCR product is generated and is expressed as a percentage value. The slope of the 
standard curve (Figure 14A) is used to estimate the PCR amplification efficiency of a 
real-time PCR reaction. A real-time PCR standard curve is graphically represented by a 
semi-log regression line plot of CT value vs log of the input nucleic acid. The calculation 
for the real-time PCR assay efficiency (E) is given by the following equation. 
 
Equation 2: 
             
Slope value of the standard curve.  
Ideally, the amount of PCR product will perfectly double during each cycle of 
exponential amplification, meaning that, there will be a 2-fold increase in the number of 
copies with each cycle. This translates to a reaction efficiency of 2, which correspond to 
100% of efficiency in a PCR reaction. In the present study all real-time PCR reactions 
were performed with 90% to 99% of efficiency, depending on the gene evaluated. 
3.4.2. Primer selection and optimization 
Primers were selected using data from published works in an extended literature 
review or were designed using Primer-BLAST software (Ye et al., 2012) (Table 5). For 
each pair of primers (Stabvida, Portugal) PCR conditions were optimized by changing 
B A 
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the annealing temperature (TAN) and duration of cycles until the desired fragment was 
the only DNA amplified in each sample. TAN of each gene fragment was calculated 
subtracting 5 ºC to the primer melting temperature specified by the manufacturer of the 
primers. To establish the PCR conditions, TAN was gradually increased by 0.5 ºC until 
the required amplification specifications were set (Figure 15). For all the pair of primers 
used in this study it was confirmed the absence of cDNA amplification in dog, mouse 
and L. infantum samples, evidencing the high specificity of the primers. 
 
Table 5: List of forward (FW) and reverse (RV) primers, base pair number (bp) of amplified 
fragment and primer annealing temperature (TAN) for each gene studied. 
 












FW-5’ AATCCCCCGTTCAAGTTGTG 3’ 
RW-5’ ATGGTTTTGCGGCTCTTCTC 3’ 




FW-5’ CCCCACATCAACCGAGAAACTGGA 3’ 
RW-5’ GCAGTTTTGGGAAGTTGGAGAAGCA 3’ 
* 86 64 
TLR9 
FW-5’ ACCACATCATCACCCTGGCACCT 3’ 
RW-5’ CGGCGACAGTTCCCACCCAC 3’ 
* 82 67 
NOD1 
FW-5’ CCTTGGCTGTCGGAGATTGGCT 3’ 
RW-5’ ACCTGCTTACTGGGTCGGTGT 3’ 
* 82 63 
NOD2 
FW-5’ TGGCGTGGGAGCAGGGTTTC 3’ 
RW-5’ CGCTGGGAGGATGTGAAGATGG 3’ 
* 76 68.5 
TNF-α 
FW-5’ AATCATCTTCTCGAACCCCAAGT 3’ 





FW-5’ CAGCAGAGAGGGTCAGAGTGG 3’ 





FW-5’ CATCCTCACAGCGAGAAACG 3’ 





FW-5’ CAAGCCCTGTCGGAGATGAT 3’ 
RW-5’ CTTGATGTCTGGGTCGTGGTT 3’ 




FW-5’ CTCTCCACAAGCGCCTTCTC 3’ 





FW-5’ CAGAATGGCTGTCCTTTGATGTC 3’ 





* indicates that the primers were designed with Primer-BLAST software. 
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PCR amplifications were done using NZTech master mix PCR (Nzytech genes 
& Enzymes), according to manufacturer’s guidance. A 20 µl of a mix containing 2 µl of 
a sample and 0.2 µl of 20 pmol.µl
-1
 forward primer solution and of the reverse primer 
solution were used. Optimized PCR conditions were 5 min at 94 ºC for complete DNA 
denaturation, 30 cycles of 30 sec. at 94 ºC, 15 sec. at primer/gene specific TAN and 30 
sec. at 72 ºC, and a final step of 3 min at 72 ºC to guarantee complete elongation of 
most PCR products initiated during the last cycle. Samples were analyzed by DNA 
electrophoresis using a gel with 3% (m/v) agarose in Tris-acetate-EDTA (TAE) buffer 
(Merck) containing 0.1µl.ml
-1
 of 10000× GelRed Nucleic Acid Stain (Biotium). 
 
Figure 15: Agarose gel showing the amplified fragments of the dog genes β-actin (β-act), NOD1, 
NOD2, TLR2, TLR4, TLR9, IL-10, IL-12p40 (IL-12), IL-4, TGF-β, TNF-α and IL-6. 
Two negative controls (Neg.) are included. 
3.4.3. Plasmid cloning 
cDNA isolated from dog macrophages or dog hepatocytes were previously 
analyzed by PCR and those samples that were positive for the gene of interest were 
amplified by PCR. The PCR product was analyzed by agarose gel electrophoresis to 
confirm that the amplification was performed correctly. The remaining PCR product 
was purified using innuPREP DOUBLE pure Kit (Analytik Jena AG) following the 
manufacturer’s instructions and again visualized by agarose gel electrophoresis to 
ensure the purity of cDNA fragment. Then the purified fragment was introduced into a 
circular plasmid using pGEM®-T Easy Vector Systems (Promega) as described in the 
manufacturer protocol. Briefly, 10 µl of ligation mix, containing the linear form of the 
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vector, was prepared using 3 µl of PCR product and DNA ligase enzyme and incubated 
overnight at 4 ºC to ensure the maximum number of transformants. Competent 
Escherichia coli strain JM109 was used for plasmid cloning.  
To induce the growth of competent E. coli JM109 able to incorporate the 
plasmid construction, bacteria was grown overnight in solid M9 medium. This medium 
is prepared with 0.6% Na2HPO4 (m/v), 0.3% KH2PO4 (m/v), 0.05% NaCl (m/v), 0.1% 
NH4Cl (m/v), 0.2% MgSO4 (m/v), 0.01% CaCl2 (m/v), 0.4% glucose (m/v) and 1.5% 
agar (m/v) in distilled water, and supplemented with 1 mM of thiamine. After 
incubation a colony was selected and grown in 5 ml of LB broth EZMIX 
(Sigma-Aldrich) overnight, at 37 ºC. About 5ml of overnight culture were inoculated 
into 500 ml of LB medium and left to grow at 37 ºC in a rotary shaker at 250 rpm until 
OD 600 nm reached 0.4 density value. The bacterial culture was then pellet by 
centrifugation at 1000 xg for 10 min at 4 ºC and resuspended in 50 ml of cold 
transformation and storage solution (TSS). This solution was constituted by Luria broth 
(LB) medium with 10% (m/v) of PEG 8000, 5% (v/v) of DMSO and 50 mM of MgCl2 
(Chung et al.,1989). Aliquots were frozen within liquid nitrogen until use.  
To proceed with the cloning process, frozen aliquots of competent E. coli were 
then thawed on ice and 50 µl of thawed competent cells transferred to 2 ml tubes 
previously chilled on ice. These two tubes were added 2µl of plasmid with the gene 
fragment insert (ligation mixture) and incubated on ice for 30 min. Tubes were then 
subjected to heat shock in a water bath at 42 ºC for 60 sec. and placed on ice again for 2 
min. To each tube 500 µl of Super Optimal broth with Catabolite repression (SOC, 
Invitrogen) was added and bacteria were incubated at 37 ºC with shaking at 250 rpm for 
3 h, to allow the cells to recover from the heat shock. Then 250 µl of the cell solution 
was plated on LB agar medium [LB with 1.5% (m/v) of agar] supplemented with 100 
µg.ml
-1
 of ampicillin (Sigma-Aldrich), 80 µg.ml
-1
 of X-Gal (Sigma-Aldrich) and 0.5 
mM of IPTG (Sigma-Aldrich) and incubated at 37 ºC for 18 h.  
The use of this specific E. coli strain and the pGEM®-T Easy vector allowed the 
differentiation of colonies containing the plasmid from the colonies with the plasmid 
and the insert fragment by blue/white color screening and resistance to ampicillin. Only 
bacteria with plasmid will be able to grow on the LB-agar plates with ampicillin. In this 
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method of screening, it is used the β-galactosidase, a bacterial enzyme encoded by the 
lacZ gene of the lac operon. In its active state, the enzyme is a homotetramer, however, 
a mutant β-galactosidase, as E. coli JM109 strain has a deletion in the N-terminal 
residues of the ω-peptide and is unable to form an active tetramer. This mutant form of 
protein however may return to its active tetrameric state in the presence of an 
N-terminal fragment of the protein, the α-peptide. The rescue of function of the mutant 
β-galactosidase by the α-peptide is called α-complementation. The blue/white screening 
method works by disrupting this α-complementation process. The plasmid carries 
within the lacZα sequence an internal multiple cloning site (MCS). This MCS, within 
the lacZα sequence, can be cut by restriction enzymes so that the foreign DNA may be 
inserted within the lacZα gene, thereby disrupting the gene and thus production of α-
peptide. Consequently, in cells containing the plasmid with an insert, no functional β-
galactosidase may be formed. Blue colonies result from bacteria with an active 
β-galactosidase enzyme, which is able to cleaved X-gal, a colorless analog of lactose to 
form 5-bromo-4-chloro-indoxyl, which then spontaneously dimerizes and oxidizes to 
form a blue insoluble pigment 5,5'-dibromo-4,4'-dichloro-indigo. Blue colonies contain 
a vector with an uninterrupted lacZα, therefore no insert, while white colonies, where 
X-gal is not hydrolyzed, indicate the presence of an insert in lacZα which disrupts the 
production of an active β-galactosidase. The white colonies were picked and incubated 
overnight in liquid LB medium supplemented with 100 µg.ml
-1
 of ampicillin at 37 ºC 
with shacking at 250 rpm. The isolation of plasmid DNA was then made using the 
innuPREP Plasmid Mini Kit (Analytik Jena AG) according to the manufacturer protocol 
In order to confirm the presence of the insert fragment in the plasmid. The plasmid 
DNA was amplified by PCR with the respective primers and the PCR product 
visualized in agarose gel. 
3.4.4. RNA extraction and cDNA synthesis 
Cellular RNA extraction was performed using NZY Total RNA Isolation kit 
(Nzytech genes & enzymes) according to manufacturer’s indications. Liver cells 
(hepatocytes and Kupffer cells) and blood macrophages were stored in NR buffer 
(supplied in the kit) supplemented with β-mercaptoethanol (Sigma-Aldrich) to lysate 
cells and preserve total RNA. Samples were conserved at -80 ºC until further 
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processing. After thawed, samples were used for RNA extracted according to 
manufacturer’s instructions followed by digestion of contaminant DNA with DNAse in 
order to maximize the purity of extracted RNA. The purity level of total RNA was 
confirmed by Nanodrop® 1000 spectrophotometer (Thermo Fisher Scientific) at the 
absorbance ratio of 260/280nm. Values ≈2 indicates pure RNA.  
Extracted RNA samples were additionally processed into cDNA synthesis using 
NZY First-strand cDNA Synthesis Kit (Nzytech genes & enzymes) according to 
manufacturer’s indications. Complementary DNA (cDNA) consists of a DNA copy 
synthesized from mRNA. Reverse transcriptases (RTs), initially isolated from virus, use 
an RNA template and a short primer complementary to the 3' end of the RNA to direct 
the synthesis of the first strand cDNA, which can be used directly as a template for a 
posterior PCR. NZY First-strand cDNA Synthesis Kit includes all the necessary 
components to synthesize first-strand cDNA, resulting in a single-stranded cDNA 
suitable for use in real-time PCR. Degradation of the cDNA:RNA hybrids formed after 
the first-stranded cDNA synthesis is ensured by the addition of RNase H. This step 
increases RT-PCR sensitivity, as primers will bind more easily to the cDNA.  
3.4.5. Real-time PCR running 
In order to generate the calibration curves, allowing the exact quantification of 
each gene copy number, serial dilutions of the plasmid with the insert fragment 
(described in 3.4.3) were also amplified.  
Plasmid DNA was quantified with a Nanodrop® 1000 spectrophotometer 
(Thermo Fisher Scientific) and for each gene 1:5 serial dilutions were prepared starting 
from 250 pg.µl
-1
 to 0.016 pg.µl
-1
 in ultra-pure water. cDNA from cells, produced from 
total extracted mRNA (as described in 3.4.4) were analyzed in duplicate for each 
sample and in duplicate for each time point for all genes in the study. For every sample 
and standard, 20 µl of the real-time PCR reaction mix was prepared with 2 µl of cDNA 
sample or with a standard dilution, 10 µl of SensiFAST SYBR Lo-ROX (Bioline), 0.15 
µl of 20 pmol.µl
-1
 forward primer solution, 0.15 µl of 20 pmol.µl
-1
 reverse primer 
solution and 7.7 µl of ultra-pure water. Amplification was performed in an Applied 
Biosystems 7500 Fast Real-Time PCR System thermal cycler (Applied Biosystems) and 
the conditions were 5 min at 95 ºC for complete DNA denaturation, 40 cycles of 30 sec. 
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at 95 ºC and 30 sec. at primer/gene specific TAN (Table 5) for annealing and extension, 
followed by 90 cycles of 10 sec. at starting temperature of 50 ºC with an increment of 
0.5 ºC for each cycle to complete a melting curve. The fluorescence levels of each 
sample were analyzed in real time by the thermal cycler and the amount of gene copies 
calculated in comparison to the calibration curves for each gene. The number of gene 




                 
                       




 is the amount of molecules presented in 1µg of DNA with 1000 
pb. The length of the plasmid used was 3.015 kp. 
The number of copies of each gene and sample was normalized to the 
housekeeping gene β-actin, in order to normalize differences in relative quantities of 
initial cDNA in the sample. Normalization was performed by dividing the obtained 
number of gene copies by 1000 copies of β-actin for each sample. The final results for 
each gene and sample were expressed in a number of copies per 1000 copies of β-actin. 
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4 Chapter 1: Interactions of canine hepatocytes with 
L. infantum 
4.1. Introduction 
4.1.1. Hepatocytes: metabolic characteristics 
The liver is a key metabolic organ which governs body energy metabolism. It 
acts as a center to metabolically connect various tissues, including skeletal muscle and 
adipose tissue. As the main detoxifying organ of the body, the liver also plays a central 
role in metabolic homeostasis and is a major site for synthesis, metabolism, storage and 
redistribution of carbohydrates proteins and lipids. Hepatocytes are highly active 
metabolic cells playing critical roles in synthesizing molecules that are utilized in 
supporting body homeostasis, regulating energy balances, detoxifying the body from 
endo or exogenous molecules and also may have immune activity. Hepatocytes 
constitute about 80% of all hepatic cells, are key cells in maintaining the glucose levels 
in the blood, which is critical for animal survival. Hepatocytes perform many different 
metabolic pathways and express dozens of enzymes that are alternately turned on or off 
depending on whether blood levels of glucose are rising or falling out of the normal 
range. Glucose resulting from digestion is taken up by the hepatocyte’s glucose 
receptors GLUT1/2 and is phosphorylated by glucokinase to generate glucose 6-
phosphate (G6P), leading to a reduction in the intracellular glucose concentration, 
which further increases glucose uptake (Agius, 2008). This excess of glucose is 
sequestered as a large polymer, glycogen, by the activity of glycogen synthase in a 
process called glycogenesis. The major hormone regulating the glucose uptake by 
hepatocytes is insulin. In the fed state, pancreatic-β cells secrete insulin in response to 
an increase in blood glucose, amino acids, and fatty acids, stimulating glycogen 
synthesis and glucose uptake. Later, when blood concentrations of glucose begin to 
decline, the liver activates other pathways which lead to deploymerization of glycogen 
(glycogenolysis) and export of glucose back into the blood for transport to all other 
tissues. During prolonged fasting, glycogen is depleted and hepatocytes synthesize 
glucose, trough gluconeogenesis, from lactate, pyruvate, glycerol, and amino acids (Rui, 
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2014). These gluconeogenic substrates are either generated in the liver or delivered to 
the liver through the circulation from extrahepatic tissues. The ability of the liver to 
perform gluconeogenesis is of immense importance to carnivores, which, at least in the 
wild, have diets virtually devoid of starch. Also the immune environment of the liver 
may influence hepatocyte metabolism. The immune cells present in the liver, as well as 
hepatocytes, secrete numerous cytokines, which regulate hepatocyte metabolism in an 
autocrine/paracrine fashion. Insulin-signaling hypothalamus stimulates IL-6 production 
in the liver, and in turn IL-6 suppresses gluconeogenesis by activating STAT3 (Inoue et 
al., 2006). IL-13 also stimulates tyrosine phosphorylation of STAT3 in hepatocytes, and 
genetic deletion of IL-13 increases hepatic gluconeogenesis. IL-13 null mice develop 
hyperglycemia and intolerance to glucose (Stanya et al., 2013). However, the metabolic 
activity of hepatocytes is not reduced to the glucose balance. The liver, in the form of 
hepatocytes, also has its role in the fatty acid metabolism. Hepatocytes are extremely 
active in oxidizing triglycerides producing energy, breaking down many more fatty 
acids that needed, and exporting large quantities of acetoacetate into the blood where it 
can be picked up and readily metabolized by other tissues. The liver is the major site for 
converting excess carbohydrates and proteins into fatty acids and triglyceride, which are 
then exported and stored in adipose tissue. This organ also synthesizes large quantities 
of cholesterol and phospholipids. Some of this is packaged with lipoproteins and made 
available to the rest of the body. The remains are excreted in bile as cholesterol or after 
conversion to bile acids. Hepatocytes are also critical cells of protein metabolic process 
that occur in the liver. At the protein metabolism, the liver has four main functions: 
generation of plasma proteins, amino acid interconversion, deamination of amino acids 
and urea synthesis (for ammonia excretion) (Charlton, 1996). Deamination and 
transamination of amino acids, followed by conversion of the non-nitrogenous part of 
those molecules to glucose or lipids are also processes performed by hepatocytes. 
Several of the enzymes used in these pathways (for example, alanine and aspartate 
aminotransferases) are commonly assayed in serum to assess liver damage. Liver 
energy metabolism is tightly controlled. Multiple nutrient, hormonal, and neuronal 
signals have been identified to regulate glucose, lipid, and amino acid metabolism in the 
liver. Dysfunction of the liver signaling and of the metabolism causes or predisposes to 
nonalcoholic fatty liver disease (NAFLD) and/or type 2 diabetes (Rui, 2014). 
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Detoxification of the body by removal of ammonia by synthesis of urea is another 
critical role played by liver hepatocytes. Ammonia is very toxic and if not rapidly and 
efficiently removed from the circulation will result in central nervous system disease.  
Hepatocytes are also responsible for synthesis of most of the plasma proteins. 
The liver manufactures a broad spectrum of proteins, including many clotting factors, 
albumin, accounting for fully 40% of hepatic protein synthesis and synthesized almost 
exclusively by hepatocytes, thyroid binding globulin, very-low density proteins 
(VLDL), apolipoprotein B100 and complement. Over 80% of the proteins synthesized 
by the liver are exported into the systemic circulation. These proteins are central to the 
maintenance of homeostasis, osmotic pressure, transportation of hormones and lipid and 
acute phase reactions. Among the many other functions of the liver, it is also 
responsible for the metabolism of many hormones that have discordant effects on 
protein metabolism, such as insulin, sex hormones and glucagon. It is thus not 
surprising that chronic and acute liver diseases are associated with dysfunction of many 
physiological processes, and can profoundly alter amino acid and protein metabolism. 
When the liver fails acutely, it is the loss of hepatic regulation of protein metabolism 
that results rapidly in death. It is widely believed that the changes in amino acid 
metabolism play a role in the pathogenesis of many of cirrhosis complications 
(Charlton, 1996). Liver is also the major organ responsible for the detoxification of 
foreign chemicals and the metabolism of drugs.  
4.1.1.1. Cytochrome P450 enzymes 
The elimination of external chemicals (xenobiotics), such as drugs and toxins, 
from the body are an essential process designed to protect against the potential toxicity 
of feeding. The hypothesis that xenobiotics consumed by animals are transformed into 
water-soluble substances and excreted through the urine was first put forth in the late 
18
th
 century. Only in 1947, R.T. Williams proposed for the first time that these non-
reactive compounds could be biotransformed in two phases: functionalization, which 
uses oxygen to form a reactive site, and conjugation, which results in the addition of a 
water-soluble group to the reactive site. These would be designated phase I and phase II 
metabolization (Liska, 1998). Cytochromes P450 (CYP450) constitutes a superfamily of 
heme enzymes found from bacteria to humans. It is reasonable to suppose that a P450 
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enzyme is present in every living species on Earth, as this enzyme has been found in 
archaebacteria, in plants, and in various animal species (Anzenbacher and 
Anzenbacherová, 2001). The liver is the main metabolic organ where these reactions 
occur. In the liver, there are two main types of metabolism that deal with xenobiotics, 
and a third that deals with their transport: 
 Phase I: The phase I detoxification system, composed mainly by the cytochrome 
P450 supergene family of enzyme, is usually the first enzymatic defense against 
foreign compounds. Most pharmaceuticals are metabolized through the phase I 
biotransformation. In a typical phase I reaction, a cytochrome P450 enzyme 
(CYP450) uses oxygen and, as a cofactor, NADH, to add a reactive group, such as 
a hydroxyl radical. These reactions result in small chemical changes that make a 
compound more hydrophilic, so it can be effectively eliminated by the kidneys. 
However, as a consequence of this detoxification step, reactive molecules, which 
may be more toxic than the parent molecule, can be produced. Most information 
available on the phase I activities has been derived from studies with drug 
metabolism, but phase I enzymes are also involved in detoxifying endogenous 
molecules, such as steroids (Anzenbacher and Anzenbacherová, 2001). 
 Phase II: Phase II enzymes also perform an important role in the biotransformation 
of endogenous compounds and xenobiotics into more easily excreted forms as well 
as in the metabolic inactivation of pharmacologically active substances. Phase II 
metabolism takes place if phase I is insufficient to clear a compound from 
circulation, or if phase I generates a reactive metabolite. The purpose of phase II 
biotransformation is to perform conjugating reactions, which usually involve the 
addition of a large polar group (conjugation reaction) to further increase the 
compound’s solubility. These include glucuronidation, sulfation, methylation, 
acetylation, glutathione, and amino acid conjugation. In general, the respective 
conjugates are more hydrophilic than the parent compounds. Phase II drug 
metabolizing enzymes are mostly transferases and include: UDP-
glucuronosyltransferases (UGTs), sulfotransferases (SULTs), N-acetyltransferases 
(NATs), glutathione S-transferases (GSTs) and various methyltransferases [mainly 
thiopurine S-methyl transferase (TPMT) and catechol O-methyl transferase 
(COMT)] (Jancova et al., 2010). 
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There is an intrinsic relation between phase I and phase II enzyme metabolism. 
Reactive molecules originated in phase I metabolism not further metabolized by phase 
II conjugation may cause damage to cell proteins, RNA, and DNA. Several studies have 
shown evidence of associations between induced phase I and/or decreased phase II 
enzyme activities and an increased risk of disease, such as cancer, systemic lupus 
erythematosus, and Parkinson's disease (Bandmann et al., 1997). Compromised phase I 
and/or phase II activity have also been implicated in adverse drug responses (Lee, 
1995). 
 Phase III: Phase III transporters, for example, P-glycoprotein (P-gp), multidrug 
resistance-associated proteins (MRPs), and organic anion transporting polypeptide 
2 (OATP2) are expressed in many tissues such as the liver, intestine, kidney, and 
brain, playing crucial roles in drug absorption, distribution, and excretion. Drug 
transporters move drugs across cellular barriers, and as such can target sites of 
accumulation. They are located in epithelial and endothelial cells of the liver, 
gastrointestinal tract, kidney, blood-brain barrier and also in other organs (Xu et al., 
2005). 
Drug metabolism via the cytochrome P450 system has emerged as an important 
determinant in the occurrence of several drug interactions that can result in drug 
toxicities or reduced pharmacological effect, and adverse drug reactions. Recognizing 
whether the drugs involved act as enzyme substrates, inducers, or inhibitors can prevent 
clinically significant interactions from occurring. Avoiding co-administration or 
anticipating potential problems and adjusting a patient's drug regimen early in the 
course of therapy can provide optimal response with minimal adverse effects. A greater 
degree of interaction predictability has been achieved through the identification of 
CYP450 isozymes and some of the drugs that share them (Ogu and Maxa, 2000). 
CYP450, the main phase I enzymes, is a superfamily of mono-oxygenases that are 
found in all kingdoms of life, and which show the extraordinary diversity. Mammalian 
CYP450 enzymes can oxidize both xenobiotics and endogenous compounds, and are 
important for the detoxification of foreign substances, as well as for controlling the 
level of endogenous compounds, such as hormone synthesis and breakdown, cholesterol 
synthesis and vitamin D metabolism. CYP450 enzymes are also involved in vascular 
auto-regulation, especially in the brain, and are vital to the formation of cholesterol, 
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steroids and arachidonic acid metabolites. They can also clear the organism of 
metabolic products such as bilirubin, which arises from the breakdown of hemoglobin. 
CYP450 enzymes are named because they are bound to membranes within a cell (cyto) 
and contain a heme pigment (chrome and P) that absorbs light at a wavelength of 450 
nm when exposed to carbon monoxide. In mammals, these enzymes are found primarily 
in the membranes of the endoplasmic reticulum (microsomes) of the cells. CYP450 
enzymes are predominantly expressed in the liver, in hepatocytes, but they also occur in 
the small intestine, reducing drug bioavailability, lungs, placenta, and kidneys 
(Slaughter and Edwards, 1995). In humans there are more than 50 CYP450 enzymes, 
but CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP3A4, and CYP3A5 enzymes are 
responsible for the metabolization of 90% of commercial available drugs (Wilkinson, 
2005). Given the importance of prediction of new drug metabolization and of the 
CYP450 involvement, hepatocytes from several animal models have been used by the 
pharmaceutical industry for drug screening. One major challenge in drug development 
is defining the optimal animal species to serve as a model of human metabolism. The 
most frequently used animal species in metabolism studies have been mouse, rat, rabbit, 
dog, and monkey. The sequence homology of CYP enzymes among these species is 
known to be rather high. However, minor differences in the amino acid sequences at the 
active sites of CYPs can result in a wide variation in substrate specificity and response 
to chemical inhibitors (Turpeinen et al., 2007). Phase II enzymes have attracted much 
less attention in clinical pharmacology than cytochromes P450 because drug 
interactions involving these enzymes are relatively rare. Nevertheless, the reduced 
metabolizing capacity of the phase II enzymes can lead to the manifestation of the toxic 
effects of clinical drugs. Although phase II reactions are generally detoxifying, the 
conjugates formed may also mediate adverse effects (for example conjugates acting as 
carriers for potentially carcinogenic compounds in the activation of benzylic alcohols, 
polycyclic aromatic hydrocarbons, aromatic hydroxylamines, hydroxamic acid and 
nitroal-kanes by sulphotransferases) (Glatt, 2000). Phase III constitute the less studied 
group of the liver xenobiotics metabolism. Along with phase I and phase II enzymes 
induction, pre-treatment with several kinds of inducers has been shown to alter the 
expression of phase III transporters, and alter the excretion of xenobiotics, which 
implies that phase III transporters may also be similarly regulated in a coordinated 
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fashion, and provides an important mean to protect the body from xenobiotics 
accumulation (Xu et al., 2005). 
Since the detoxification system function help in the management of exposure to 
exogenous compounds, the body has developed several mechanisms to regulate 
detoxification activity. Phase I and/or phase II enzymes can be induced, leading to more 
enzyme being present, increasing the rate of xenobiotic metabolization. Specific 
pathways may be induced or inhibited depending on the presence of various 
compounds, age and sex of the individual, genetic background and lifestyle habits 
(Meyer et al., 1990; Park et al., 1996). Furthermore, the disease can also influence the 
enzyme activity. In some disease states detoxification activities appear to be induced or 
up-regulated whereas in other conditions these activities may be inhibited or, the 
enzymes were not produced at higher levels (Lee, 1995), which may compromise the 
response to treatment and the disease outcome. It has also been described that immune 
environment can influence CYP450 activities (Sunman et al., 2004). Inducers are 
classified as mono-functional, if their action is on one particular CYP450 or multi-
functional, if their influence extends to several CYP450 or even to phase II enzymes. 
Inducers and inhibitors are well characterized in humans. Mono-functional inducers, 
such as polycyclic hydrocarbons from cigarette smoke and aryl amines from charbroiled 
meats, result in dramatic induction of the CYP1A1 and CYP1A2 enzymes, leading to a 
substantial increase in phase I activity, with little or no induction of phase II enzymes 
(Guengerich, 1984). Pharmacological drugs may also lead to the same result: induction 
of phase I enzyme as seen in glucocorticoids and anti-convulsants inducing CYP3A4 
activity, and ethanol, acetone and isoniazid induce CYP2E1 (Denison et al., 1995). 
Induction of these enzyme activities without co-induction of phase II metabolism may 
lead to an uncoupling of the phase I and phase II balance of activity and, therefore, a 
higher level of reactive intermediates, which can cause damage to DNA, RNA, and 
proteins (Park et al., 1996). The multi-functional inducers include many of the 
flavonoid molecules found in fruits and vegetables. For example, ellagic acid found in 
red grape skin has been shown to induce several phase II enzymes while decreasing 
phase I activity (Barch et al., 1995; Manson et al., 1997). Many other compounds 
regularly found in food, as garlic oil, rosemary, soy, cabbage, and brussel sprouts all 
contain compounds that can induce several phase II enzyme activities (Liska, 1998). 
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Commonly, the glutathione S-transferase and glucuronyltransferases are induced by 
multi-functional inducers. In general, phase II increase supports better detoxification 
and helps to promote and maintain a healthy balance between phase I and phase II 
activities. The enhancement of phase II activity has been proposed to explain, at least in 
part, the ability of fruits and vegetables to protect against many cancers (Elangovan et 
al., 1994; Manson et al., 1997). The functionality of phase I and phase II enzymes can 
also be inhibited. Inhibition can occur by competition between two or more compounds 
for the same detoxifying enzyme. Increased toxic load may lead to inhibition of 
detoxification of a number of compounds by simply overwhelming the system and 
competing for detoxification enzyme activities. Moreover, some compounds selectively 
inhibit only one detoxifying activity. Quinidine, which inhibits CYP2D6 activity and 
cimetidine are examples of compounds that can inhibit phase I enzymes. The first by 
competition and the second by binding directly to the iron of cytochrome P450 reactive 
site, abolishing phase I enzyme activity (Liska, 1998). For phase II enzymes, a common 
mechanism of inhibition is the depletion of cofactors necessary for enzymatic activity. 
In humans, sulfation is a classical example, particularly susceptible to inhibition due to 
compromised cofactor status.  
Genetic differences in the ability of an individual to metabolize xenobiotics are 
related to the presence of genetic polymorphisms: different versions of the gene 
encoding CYP450 or phase II enzymes. Polymorphisms in CYP450 are described in 
several species, as humans, mouse and dog. In humans, CYP2D6 is the classic example 
of the influence of genetic polymorphism on phenotype. The polymorphism of the 
enzyme results in poor, intermediate, efficient or ultrarapid metabolizers of CYP2D6 
drugs. The enzyme is largely non-inducible and metabolizes approximately 25% of 
current drugs. Typical substrates of CYP2D6 are largely lipophilic bases and include 
some antidepressants, antipsychotics, antiarrhythmics, antiemetics, beta-adrenoceptor 
antagonists (beta-blockers) and opioids. Adverse side-effects occurring from these 
drugs may be reduced by decreasing dosages in those individuals who are CYP2D6 
slow metabolizers (Ingelman-Sundberg, 2005; Zhou, 2009). Polymorphisms in 
CYP2D6 have also been associated with a high risk of early onset Parkinson's disease 
(Lu et al., 2013). Polymorphisms in the phase II activity of N-acetyltransferase can also 
lead to slow metabolizers. Associations have been found between slow metabolism 
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through the N-acetyltransferase pathway and high risk of some types of cancer and 
Parkinson's disease (Daly et al., 1993). As dogs are widely used by the pharmaceutical 
companies to test new drugs, some studies were performed to evaluate canine drug 
metabolism and CYP450 activities. The most comprehensively studied on canine CYP 
genetic polymorphism is the premature stop codon mutation located in the coding 
region of the CYP1A2 gene that results in complete loss of hepatic CYP1A2 protein 
associated with enzyme activity failure. It was also found that some dogs had a partial 
or complete gene deletion of CYP2C41 and amino acid variants in the coding sequence 
of CYP2D15, CYP2E1 and CYP3A12 are also described, evidencing great variability in 
drug metabolism by CYP (Court, 2013). 
4.1.2. Hepatocyte innate immune role 
The structural organization of the liver has profound implications for its immune 
function. Blood enters the hepatic parenchyma mainly via terminal portal vessels, and 
then passes through a network of liver sinusoids, leaving the parenchyma via the central 
hepatic veins. Due to the small diameter of the sinusoids, minimal increases in systemic 
venous pressure and perturbations of sinusoidal flow result in stasis, which lengthens 
the contact between lymphocytes and antigen-presenting cells and promotes lymphocyte 
extravasation. Extravasation is further facilitated by fenestrations in the monolayer of 
sinusoidal endothelial cells (LSEC) that allow lymphocytes to access the space of Disse 
via cytoplasmic extensions and to close contact the underlying extracellular matrix, 
stellate cells and hepatocytes. Hepatocytes play a key role in controlling systemic innate 
immunity via production of secreted pattern recognition receptors (PRRs) and 
complement components found in plasma. Expression of genes encoding these proteins 
is controlled by liver-specific transcription factors, such as hepatocyte nuclear factors, 
nuclear factor-1, and CCAAT-enhancer-binding protein, which account for their liver-
specific expression. During an acute phase or systemic inflammatory response, a variety 
of pro-inflammatory cytokines, such as interleukin-6 (IL-6), IL-1, tumor necrosis factor 
α (TNF-α), and interferon (IFN)-γ, can stimulate hepatocytes to produce high levels of 
complement and secreted PRRs (Gao et al., 2008). The complement system consists of 
more than 35 plasma or membrane proteins that interact with one another in a cascading 
fashion to protect against infections. Three different pathways have been identified that 
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activate the complement system. These include the classical pathway (target-bound 
antibody), the lectin pathway (microbial repetitive polysaccharide structures), and the 
alternative pathway (recognition of other foreign surface structures). After activation, 
the complement system generates a wide range of biologic activities such as opsonic, 
inflammatory, and cytotoxic functions. Hepatocytes are a major site that biosynthesizes 
complement components found in plasma. These include C1r/s, C2, C4, and Cbp of the 
classical pathway, C3 and factor B of the alternative pathway, mannan-binding lectin, 
mannan-binding lectin-associated serine proteases 1-3, and mannan-binding lectin-
associated protein 19 of the lectin pathway, and terminal components C5, C6, C8, and 
C9 of the complement system (Qin and Gao, 2006). Although immune cells and 
endothelial cells also produce these components their contributions are minor compared 
to those of hepatocytes. Additionally, hepatocytes are also primarily responsible for the 
biosynthesis of several complement regulator proteins found in plasma, such as factor I, 
factor H, and the C1 inhibitor (Morgan and Gasque, 1997). In addition to being an 
important part of innate defenses against infection, the complement system also 
contributes to the pathogenesis of a variety of liver disorders, including liver fibrosis, 
alcoholic liver disease and liver ischemia (Pritchard et al., 2007). However, the 
molecular mechanisms underlying the involvement of complements in liver injury and 
repair remain obscure. Hepatocytes are also the major source for production of secreted 
PRRs, which have two main functions: complement activation and microbial cell 
opsonization for phagocytosis. Four major classes of soluble PRRs have been identified 
according to their domain composition: collectins, pentraxins, lipid transferases, and 
peptidoglycan-recognition proteins. Many of these proteins are synthesized by 
hepatocytes and released into the bloodstream, thereby playing an important role in 
innate immunity against local and systemic microbial infection. In addition, the liver is 
also a major source of many other acute phase proteins, which play key roles in innate 
defenses against infection and in reducing tissue damage through inactivation of 
proteinases released by pathogens and death or dying cells (Gao et al., 2008). The liver 
not only is the major source of secreted PRRs but also expresses membrane-bound 
PRRs, such as Toll-like receptors (TLRs). TLRs are a family of proteins that recognize 
pathogen associated molecular patterns (PAMPs). TLRs are expressed on all major 
subsets of liver cells. Both exogenous ligands derived from pathogens, and endogenous 
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ligands that are products of cellular injury, can engage these receptors and activate 
innate immunity. TLRs play a vital role in viral and parasitic infections of the liver, in 
ischemia-reperfusion injury, and in toxic liver damage, promoting antipathogen 
immunity but also hepatocellular injury and fibrogenesis. There are 13 different TLRs 
identified so far. Each of them recognizes specific PAMPS and activates specific 
signaling pathways and antimicrobial responses (Akira and Takeda, 2004). However, 
hepatocytes express messenger RNAs for all known TLRs their role on hepatocyte 
defenses against invading pathogens is less clear. Hepatocytes TLR2 and TLR4 are 
responsive to LPS. TLR4 has been detected on all types of liver cells and is likely 
involved in the uptake and clearance of endotoxins, production of pro- and anti-
inflammatory cytokines, and generation of reactive oxidative stress (Szabo et al., 2006; 
Schwabe et al., 2006). Recently, several other cytoplasmic PRRs have been identified in 
hepatocytes, including NOD-like receptors and the RIG-like helicases. Among them, 
RIG-1 serves as a pathogen receptor to regulate cellular permissiveness to hepatitis C 
virus (HCV) replication (Sumpter et al., 2005). In addition, activation of several TLRs 
has been shown to inhibit hepatitis B virus (HBV) and HCV infection, providing novel 
strategies to treat hepatitis viral infection. NOD-like receptor’s role is not yet well 
defined in liver immunology (Isogawa et al., 2005; Thomas et al., 2007). 
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4.2. Chapter objectives 
In the present chapter it is proposed to investigate how liver hepatocytes sense 
and react to L. infantum presence. Hepatocytes are major metabolic cells of the liver, a 
target organ for L. infantum infection. To understand the roles played by these cells 
during infection outcome in the dog’s liver, several specific goals were established: 
 Characterize L. infantum interaction with canine hepatocytes using two different 
culture systems: bi-dimensional (2D) and three-dimensional (3D). 
 Analyze the immunological status of hepatocytes exposed to L. infantum by 
assessing innate immune receptors and cytokine gene expression, as well as 
metabolic parameters. 
 Investigate the relation between the immune status of hepatocytes and the activity 
of cytochrome P450 enzymes. 
 Evaluate the impact of a leishmanicidal drug in hepatocytes exposed to the parasite 
by assessing innate immune receptors and cytokine gene expression, and metabolic 
parameters. 
 Characterization of the potential leishmanicidal activity of new compounds: ursolic 
acid, chalcone and quercetin. Impact of these compounds in the canine hepatocytes. 
 
Some of the techniques used in the present work, mainly confocal microscopy 
and scan electron microscopy (SEM) were the fruit of a generous collaboration with 
Professor Graça Alexandre-Pires of the Faculdade de Medicina Veterinária - 
Universidade de Lisboa and, additional processing of the images for artificial coloration 
was performed by Tiago Pereira (MSc) under my tutorial guidance. 
 




4.3.1. Hepatocyte isolation 
Isolation of dog hepatocytes was achieved by two step perfusion protocol 
followed by collagenase digestion and a Percoll® gradient centrifugation, as described 
in Miranda et al., (2009 and 2010) with some adaptations. A hepatic lobule was cleaned 
externally with a NaCl solution supplemented with 0.9% of penicillin/streptomycin. To 
get rid of the internal blood a first perfusion was performed with 500 ml of perfusion I 
solution [2.4 M ethylene glycol tetra acetic acid (EGTA), 142 mM NaCl, 6.7 mM KCl 
and 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH 7.4] 
heated at 38 ºC (Figure 16A). The second perfusion was implemented in order to digest 
the collagen of the tissue to allow the isolation of single hepatocytes. The Perfusion II 
solution (67 mM NaCl, 6.7 mM KCl, 100 mM HEPES, 4.8 mM CaCl2, pH 7.6) was 
supplemented with 250 mg of collagenase H (Roche) and 0.5% albumin (Prolabo®) 
and, heated at 38 ºC. Following digestion, a cell suspension was obtained by gently 
scratch the lobule surface with a scalpel. Cellular suspension was filtered through a 
funnel with sterile gauze and centrifuged at 50 xg for 10 min at 4 ºC. Pellets were 
resuspended in Williams’E medium (Sigma-Aldrich) and concentration of viable cells 
was estimated in trypan blue under optical microscope through Equation 4.  
Equation 4: 
[ ](        )  
               
 
        
[C]= Concentration of cell suspension 
DF= dilution factor 
4= number of counting squares in a Neubauer chamber 
104=Volume of Neubauer chamber correspond to 0.1 mm3=0.0001 ml. For determination of the cell 





, in a maximum of 6 ml) were overlaid into 20 ml of a 
solution of 25% Percoll® (GE Healthcare) in PBS 1x and centrifuged at 1300 xg at 4 ºC 
for 20 min (Figure 16B). After centrifuged, viable hepatocytes obtained in the pellet 
were then resuspended in cold PBS and washed two times. Final pellet was resuspended 
in supplement Williams’E medium [Penicillin (100 U/ml)/streptomycin (100 µg.ml
-1
) 
(Sigma-Aldrich), 1.4 µM hydrocortisone (Sigma-Aldrich), 15 mM HEPES (Sigma-
Aldrich), 1 mM sodium pyruvate (Sigma-Aldrich), 1 mM non-essential amino acids 
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(NEAA) (Biochrom), 40 µg.ml
-1
 gentamycin (Sigma-Aldrich) and 10% (v/v) FBS9] and 
concentration of viable cells estimated under optical microscope using the exclusion dye 
trypan blue. This procedure allowed the isolation of a solution of pure hepatocytes with 
≈80% of viability. 
 
Figure 16: Isolation of canine hepatocytes by a two-step methodology. 
Perfusion of an excised liver lobule to clean the peripheral blood (A) and cellular suspension overlaid into 
a Percoll® gradient in order to purify hepatocytes (B). 
4.3.1.1. 3D-hepatocyte culture 
3D-hepatocyte culture was established in a 250 ml Spinner vessel (Wheaton) 
(Figure 17). Prior to cell culture, the spinner vessel was washed with 2 ml of tuloene 
(Sigma-Aldrich) and siliconized with 2 ml of dichlorodimethylsilane (Sigma-Aldrich). 
Dichlorodimethylsilane is a tetrahedral, organosilicon compound [Si(CH₃)₂Cl₂] that 
reacts to form both linear and cyclic Si-O chains on the glass inner superficies, which 
become hydrophobic, avoiding cellular deposition on the vessel walls. The spinner 




) were inoculated in 
supplemented Williams’E medium, extra supplemented with 15% of FBS (v/v), to 
promote cell aggregation. At 24 h post-inoculation, half of the medium was replaced 
with fresh medium and, at 72 h the total medium of the vessel was replaced with fresh 
medium. The cell suspension was collected to 50 ml tubes and centrifuged at 50 xg for 
10 min at room temperature. Pelleted cells were resuspended in fresh culture medium 
and inoculated again in the spinner vessel to ensure no loss of cells. The spinner was 
maintained at 50 rpm rotation in a cell incubator (Sanyo MCO-18AIC) at 37 ºC in a 
humidified atmosphere with 5% CO2. Cells were followed by optical microscopy 
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observation under an inverted microscope (Olympus, CKX41) and digital images were 
acquired with an Olympus CS30 camera. 
 
Figure 17: Dog 3D hepatocyte culture system. 
Hepatocyte aggregates were established in a spinner vessel with controlled atmosphere and in a constant 
low rotation. 
4.3.1.2. 2D-hepatocyte culture 




) were plated in the supplemented Williams’E medium. Medium was replaced 
at 24 h, 48 h and 72 h. At 72 h, L. infantum parasites were added and the plates were 
kept for about 10 days in an incubator (Sanyo MCO-18AIC) at 37 ºC, in a humidified 
atmosphere with 5% CO2. Cells were followed by optical microscopy observation under 
an inverted microscope (Olympus, CKX41) and digital images were acquired using an 
Olympus CS30 camera. 
4.3.2. Hepatocyte exposure to L. infantum virulent promastigotes 
or axenic amastigotes 
After 72 h in 2D- or 3D-culture systems, hepatocytes were exposed to L. 
infantum parasites. L. infantum virulent promastigotes and axenic amastigotes were 
obtained as described in the General Methods chapter, under sub-headings 3.3.1 and 
3.3.2, respectively. Parasites were added to hepatocyte culture in a proportion of three 
promastigotes or amastigotes per one hepatocyte. The 3D-system was maintained at 50 
rpm, 37 ºC in a humidified atmosphere with 5% CO2 and the parasite as let to interact 
with hepatocyte aggregates for 72 h. In the 2D-system the parasites were left to interact 
with hepatocytes for 72 h at 37 ºC, in a humidified atmosphere with 5% CO2. Samples 
of medium and cells were collected at 1.5 h, 3 h, 5 h, 24 h, 48 h and 72 h incubation 
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from both culture systems and used for determination of several parameters. Cells were 
followed by optical microscopy observation under an inverted microscope (Olympus, 
CKX41) and digital images were acquired using an Olympus CS30 camera. 
4.3.2.1. Positive controls 
Escherichia coli lipopolysaccharide (LPS, Sigma-Aldrich) was used as a 
positive control of inflammation. LPS was added to hepatocyte cultures at 1 µg.ml
-1
. 
After 72 h of 2D-heptocyte culture, the medium was carefully replaced by 
supplement William’s E fresh medium with LPS and cells were left to incubate for 
more 72 h at 37 ºC in a humidified atmosphere with 5% CO2. Samples of medium and 
cells were collected at 1.5 h, 3 h, 5 h, 24 h, 48 h and 72 h of incubation and used as 
positive controls for further immune tests.  
4.3.3. Treatment 
Since the liver is a central organ in drug metabolism, the effect of leishmanicidal 
compounds was tested in hepatocytes exposed to L. infantum. The goal of this specific 
study was to evaluate the effect of drugs in the metabolism and in the immune response 
of hepatocytes. The following drugs were assessed: meglumine antimoniate, a 
commercially available and well known antileishmanial drug used for leishmaniasis 
treatment (see 4.3.3.1) and, three new compounds with leishmanial activity (see 
4.3.3.2). The drugs were added to 3D- and 2D-culture systems. After 72 h of hepatocyte 
incubation with L. infantum, drugs were added and cells and parasites were left to 
incubate for more 72 h. Samples of medium and cells were collected at 1.5 h, 3 h, 5 h, 
24 h, 48 h and 72 h of incubation and used for the evaluation of several parameters. 
4.3.3.1. Meglumine antimoniate 
Meglumine antimoniate is a drug commercially available as Glucantime® 
(Merial), presented in a formulation constituted by 81 mg of the compound.ml
-1
. This 
drug belongs to a class of compounds known collectively as pentavalent antimonials 
used in both human and veterinarian medicine. After 72 h in contact with L. infantum 
virulent promastigotes or axenic amastigotes, the medium of 2D-hepatocyte culture was 
carefully removed, avoiding disturb the bottom of the well, and supplement William’s E 
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fresh medium with 100 µM of meglumine antimoniate was gently added. Medium of 
3D-hepatocyte culture was also removed and the cell aggregates were resuspended in 
supplemented William’s E fresh medium with 100 µM of meglumine antimoniate. Cells 
of both culture systems were left to incubate for more 72 h at 37 ºC in a humidified 
atmosphere with 5% CO2. Samples of medium and cells were collected at 1.5 h, 3 h, 
5 h, 24 h, 48 h and 72 h incubation for the evaluation of several parameter analyses.  
4.3.3.2. New leishmanicidal compounds 
In the present work were used three new compounds with previous proven 
leishmanicidal activity. Ursolic acid (URS) gently offered by Prof. Doutor Luiz Felipe 
Passero (LPMI-FMUSP, S. Paulo, Brazil) and Prof. Doutor João Lago (ICAQF-UFSP, 
S. Paulo, Brazil), and quercetin (QC) and chalcone (CH8) cordially given by Prof. 
Doutora Bartira Rossi Bergmann (IBCCF-UFRJ, Rio de Janeiro, Brazil). These 
compounds were dissolved in dimethyl sulfoxide (DMSO) (Sigma-Aldrich) assuring 
that the DMSO concentration in the final suspension was inferior to 1% (v/v). The 
concentration of drugs used in hepatocyte cultures follows the amounts previously used 
in a MØ-like murine cell line (Rafael-Fernandes, 2015). In the present study, 
hepatocytes were exposed to the IC90 determinate for murine MØ cell line, ensuring the 
survival of 90% of cells. Therefore the concentrations used in hepatocyte cultures were 
0.091 µg.ml
-1
of URS, 1.52 µg.ml
-1
 QC and 65.8 µg.ml
-1
 of CH8.  
4.3.4. Hepatocytes viability 
To ensure that hepatocytes were viable during the treatment, the mitochondria's 
reducing ability was evaluated, using resazurin. The fluorescent compound resazurin (7-
hydroxy-3H-phenoxazin-3-one-10-oxide) (Sigma-Aldrich) is a redox indicator of 





) were plated for 72 h in a sterile 96 well back plate (Nunc), using a final 
volume of 200 µl of supplemented William’E medium that was replaced daily with 
fresh medium. Then William’E medium plus the drug (described in 4.3.3.1 and 4.3.3.2) 
was added to hepatocyte and cells were left to incubate for 1.5 h, 3 h, 5 h, 24 h, 48 h and 
72 h at 37 ºC in a humidified atmosphere with 5% CO2. At each time point, 25 µl of a 
1.25 mM resazurin solution in PBS 1x was added to each well and incubated for 24 h. 
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Plates were read in a fluorometer (TRIADTM 1065, DYNEX Technologies) with 
excitation and emission wavelengths of 535 NM and 595 NM, respectively. 
Hepatocytes in the absence of drugs (viable cells) and non-viable hepatocytes were used 
as controls. Non-viable hepatocytes were obtained by the addition of 2% (m/v) 
paraformaldehyde (Sigma-Aldrich) in PBS.  
4.3.5. Parasite viability 
To estimate the viability of parasites that were in contact with hepatocytes in the 
presence of drugs, an approximation to the limit dilution assay (LDA) was performed 
with some adaptations. For each of the treatment time points (described in 4.3.3.), 1 ml 
of cell suspension of the 3D-culture system or one well in the 2D-culture system were 
collected and centrifuged. For each time point, samples were collected in quadruplicate. 
Sediments were resuspended in 1 ml of complete SCH medium and 200µl of cell 
suspension was added to the first column wells of a sterile 96 transparent well plate and 
used for 1:4 serial dilutions. Plates were sealed and incubated at 24 ºC for 15 days. After 
this period, each well was observed under optical microscope and the presence of motile 
promastigotes was registered as positive titers. Parasite viability was estimated by the 
rate between the reciprocal of the obtained titers and the reciprocal of the highest 
positive titers obtained for amastigote differentiation without previous contact with 
hepatocytes or drugs and plated in the same concentration as used in 4.3.2. 
4.3.6. Microscopy techniques 
4.3.6.1. Confocal microscopy 




) were also cultured in a 
8-well chamber slide with cover (Lab-Tek II, Nunc) and incubated at 37 ºC in a 
humidified atmosphere with 5% CO2 for 72 h. L. infantum GFP-amastigotes or 
GFP-promastigotes were added to cultured cells in a proportion of 3 parasites per cell. 
Cells were incubated with the parasite for 1.5 h, 3 h, 5 h, 24 h, 48 h and 72 h. Adherent 
cells were washed with PBS 1x and fixed with 2% (m/v) paraformaldehyde in PBS for 
20 min on ice. Slides were maintained in sterile PBS 1x at 4 ºC until further processing. 
For immunostaining, cells were permeabilized overnight at 4 ºC with a solution of PBS 
1% Tween-20 (v/v) (Sigma-Aldrich) and 0.2% fish gelatin (m/v) (Sigma-Aldrich). For 
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antibodies incubation buffer, it was used a solution of PBS 0.125% fish gelatin (m/v) 
and 1% Tween-20 (v/v). The incubation with primary antibodies was performed during 
90 min at room temperature, kept in the dark. For observation of cell morphology, actin, 
the cytoskeleton protein of the cell, was stained with an actin goat polyclonal antibody 
FITC conjugated (sc-1616, Santa Cruz), raised against a peptide at the C-terminus of 
actin of human origin and diluted 1:500 according to manufacturer’s recommendation. 
Therefore, no secondary antibody was necessary and cells were washed three times with 
PBS 0.08% tween-20 (v/v) and finishing with three more washes with PBS 1x. Ferritin 
is a protein of iron storage and transport present in functional hepatocytes. Goat 
polyclonal antibody (sc-14416, Santa Cruz) raised against a peptide near the N-terminus 
of the ferritin heavy chain of human origin was used in a 1:100 dilution accordingly to 
manufacturer’s instructions. Polyclonal antibodies (anti-actin and anti-ferritin) were 
described as having cross reactivity with several species, including dogs. For the anti-
ferritin staining, a secondary rabbit polyclonal anti-goat IgG Alexa Fluor® 647 
(ab150143, Abcam) antibody was used at a dilution of 1:500. Between primary and 
secondary antibodies, cells were washed three times with buffer PBS 0.08% tween-20 
(v/v) and finishing with three more washes in PBS 1x. Control slides were prepared 
with only one antibody staining. Slides were prepared for fluorescence microscopy 
using TO-PRO®-3 or Vectashield® antifade mounting medium with a red-fluorescent 
compound and DAPI to localize nucleus and chromosomes, respectively. Slides were 
observed under a Leica TCS SP2 Laser Scanning Confocal Microscope and digital 
images were acquired. 
4.3.6.2. Electron scanning microscopy 
Cultured hepatocytes were washed with cold PBS 1x and fixed with 2% 
paraformaldehyde (m/v) in PBS for 20 min on ice. Cells were then washed again with 
cold PBS 1x by centrifugation at 350 xg for 10 min. Cells were filtrated through a 
Millipore mesh and subsequently dehydrated in a graded ethanol series [30, 50, 70, 80, 
90 and 100% (v/v)]. Samples were dried using the critical point drying method, coated 
with gold palladium and mounted on stubs. Cells were then observed in a scanning 
electronic microscope (JEOL5200-LV) and digital images were acquired. 
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4.3.7. Liver enzymes 
The elimination of foreign compounds from the body (xenobiotics) such as 
drugs and toxins is an essential process designed to protect against potential toxicity 
from the food and the environment. In the liver, there are two main types of metabolism 
that deal with xenobiotics – phase I and phase II – and a third that are associated with 
the transport of xenobiotics metabolites. 
4.3.7.1. Phase I enzymes 
The activity of Phase I enzymes causes small chemical changes, generating more 
hydrophilic compounds able to be effectively eliminated by the kidneys. These 
chemical reactions usually involve either adding or removing a hydroxyl group or other 
hydrophilic groups such as amine or sulphydryl groups, directing hydrolysis and 
oxidation or reduction. Cytochrome P450 enzymes are responsible for most reactions of 
phase I. In the present work the activity of alkoxyresorufin O-dealkylation (AROD) of 
CYP450 family was analyzed with the appropriate substrates, 7-ethoxyresorufin 
(EROD), 7-methoxyresorufin (MROD), 7-pentoxyresorufin (PROD), or 
7-benzyloxyresorufin (BROD) (see Table 6).  
EROD, MROD, PROD and BROD reactions were performed throughout all the 
sampling time points of this study of the diverse conditions (2D- and 3D-culture 
systems; non-exposed hepatocytes; L. infantum exposed hepatocytes; drug treated cells 
and inflammation controls). All substrates were purchased at Sigma-Adrich dissolved in 
DMSO at a final concentration of 10 µM in William’s E culture medium. In the 
3D-culture system, 1 ml of cell suspension was taken and 10 µl of the correct substrate 
was added. The cell suspension was then incubated during 1 h at 37 ºC in a humidified 
atmosphere with 5% CO2, allowing substrate metabolization by hepatocytes. After 
incubation, cells were centrifuged at 500 xg for 10 min at 4 ºC and supernatants were 
collected and stored at -20 ºC until further analysis. In 2D-culture system, after carefully 
removing the medium of a well, new culture medium containing 10 µl of substrate was 
added and cells were left to incubate as described above. After incubation, the 
supernatant was collected, centrifuged to eliminate any cell or debris, and stored at 
-20 ºC until further processing. Samples were analyzed by fluorescence on a 
fluorometer with excitation and emission wavelengths of 535 nm and 595 nm, 
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respectively. After thawed, samples were vigorously vortex and 200 µl of each sample 
were plated in duplicate in a sterile 96 well black plate (Nunc). A standard curve with 
resorufin (Sigma-Aldrich), the product of the O-dealkylase reaction performed by the 
hepatocytes, was established. The starting dilution was 0.16 µM of resorufin and serial 
1:2 dilutions were performed in William’s E medium. A blank prepared with William’s 
E medium and an assay control prepared with the substrate added to fresh culture 
medium (free of hepatocytes) and incubated for 1 h (as described above) were also 
included in the assay. 
Table 6: List of phase I enzymes and the respective substrate. 
Evaluated enzymes are collectively designated as alkoxyresorufin O-dealkylases (AROD) since all 
produce the same product – resorufin – from different substrates. Identification of the principal CYP450 
responsible for the metabolization of each substrate in dog, mouse and man (Cai et al., 1996; Dayal et al., 










































4.3.7.2. Phase II enzymes 
The metabolites resultant of xenobiotics chemically altered by conjugation with 
charged species, such as glutathione (GSH), sulfate, glycine, or glucuronic acid, are 
generated due to the intervention of phase II enzymes. The addition of large anionic 
groups (such as GSH) detoxifies reactive electrophiles and produces more polar 
metabolites that cannot diffuse across membranes, and may, therefore, be actively 
transported (phase III). 
4.3.7.2.1. UGT 
Uridine 5'-diphospho-glucuronosyltransferase (UDP-glucuronosyltransferase, 
UGT) is a cytosolic glycosyltransferase that catalyzes the transfer of the glucuronic acid 
component of UDP-glucuronic acid into a small hydrophobic molecule. It is considered 
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one of the most important phase II enzymes. In the present work UGT activity was 
evaluated by adding a final concentration of 10 mM of 4- methylumbelliferone (4-MU) 
(Sigma-Aldrich) to the culture medium. The base for this assay is the difference in 
fluorescence of 4- methylumbelliferone (4-MU), which exhibits high levels of 
fluorescence, to its conjugated 4-methylumbelliferone-β-d-glucuronide (4MUG), with 
little fluorescence levels. In the 3D-culture system, 1 ml of cell suspension was taken 
and 4-MU was added. Cell suspensions were incubated during 1 h at 37 ºC in a 
humidified atmosphere with 5% CO2. The assay was performed in duplicate. After 
incubation, cells were centrifuged at 500 xg, 10 min at 4 ºC, and supernatants were 
collected and stored at -20 ºC until further analysis. In the 2D-system, after removing 
the medium from a well, fresh culture medium containing the substrate was added and 
cells were left to incubate in the same conditions. The assay was also performed in 
duplicate. After incubation, the supernatant was collected and centrifuged to clean it 
from any cell or debris, and stored at -20 ºC until further processing. Samples were 
analyzed by fluorescence emission on a fluorometer (BIOTEK® FLx800) with 
excitation at 360/40 nm and emission at 460/40 nm. The blank was considered as 
William’s E culture medium and a control assay of substrate and culture medium 
incubate without cells, was also included. After thawed, samples were vigorously vortex 
and, 250 µl of each sample were plated in duplicate in sterile 96 black well plates 
(Nunc). A standard curve with 4-MU, was performed, starting at 10 mM and followed 
by 1:2 serial dilutions. 4-MU mobilization was calculated by subtracting the amount 
detected in samples to the initial amount of 4-MU. 
4.3.8. Urea production 
Production of urea is a metabolic characteristic of fully differentiated active 
hepatocytes. In this study, urea was analyzed in the supernatant of cell samples by a 
commercial kit QuantiChrom™ Urea Assay Kit -DIUR-500 (BioAssay System) for 
colorimetric determination of urea. In the 3D-hepatic culture system, 1 ml of cell 
suspension was taken and in the 2D-hepatic culture system, the medium of each well 
was collected in duplicate. Cell suspensions were centrifuged at 500 xg, for 10 min at 
4 ºC, and supernatants were collected and stored at -20 ºC until further analysis.  
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The urea assay kit is designed to measure urea directly in biological samples 
without any pre-treatment. The improved Jung method uses a chromogenic reagent that 
forms a colored complex specifically with urea. The intensity of the color measured at 
450 nm is directly proportional to the urea concentration in the sample. After thawed, 
samples were vigorously vortex and 50 µl of each sample were plated in duplicate in a 
sterile 96 well transparent plate (Nunc). Standard urea concentration [5 mg.dl
-1
] and the 
blank (water) were included and urea was estimated accordingly manufacturer’s 
instructions (equation 5). For posterior analysis sterile William’s E culture medium 
reading was subtracted to each sample reading. 
 
Equation 5: 
[ ](     -1)  
                   
                     
                          (     ) 
 
Where OD indicates optical density and n the dilution factor (in the present 
study n=1) 
4.3.9. Nitric oxide production 
In biological systems, nitric oxide (NO) is synthesized by the enzyme nitric 
oxide synthase (NOS). NOS acts on molecular oxygen, arginine and NADPH, 
producing NO, citrulline and NADP.  
In the present study, a commercial kit Nitrate/Nitrite Colorimetric Assay kit 
(Abnova) was used accordingly to the manufacture’s recommendation to quantify the 
nitrate/nitrite production in cell supernatants. This kit provides an accurate and 
convenient method to measure total nitrate/nitrite production in a two-step protocol. In 
the first step there is the conversion of nitrate to nitrite by the enzyme nitrate reductase. 
In the second step occurs the addition of Griess reagent which converts the nitrite into a 
deep purple azo compound that can be measured by absorbance at 550 nm 
(BioRad-680, microplate reader), determining the NO2
-
 concentration. Samples of cell 
suspension (1 ml) were taken from the 3D-culture system and centrifuged at 500 xg, for 
10 min at 4 ºC. Supernatants were collected and stored at -20 ºC until further analysis. 
In the 2D-culture system, medium was removed from each well and centrifuged as 
indicated above. After thawed, samples were vigorously vortex and plated (80 µl) in 
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sterile 96 well transparent plate (provide by the manufactures). Samples were performed 
in duplicate. A standard curve was constituted by 1:5 nitrate serial dilutions. The blank 
performed with sterile William’s E culture medium was also included in the plate and 
the production of NO was estimated through the following equation (equation 6), in 




[               ](  )  (                            )        
 
Where OD indicates optical density, SV is sample volume (µl) and DF, the 
dilution factor. 
4.3.10. Real-time PCR analysis 
Collection of samples for RNA extraction, followed by cDNA synthesis and 
real-time PCR analysis were described in the chapter General Methods (section 3.4). 
β-actin was used for normalization of gene expression of innate immune receptors 
NOD1, NOD2, TLR2, TLR4 and TLR9 and of cytokines IL-6, IL-10 and TNF-α, 
correcting sample to sample variations in RNA extraction and minimal changes of real 
time PCR run-to-run. Samples from 3D- and 2D-culture system exposed to L. infantum 
promastigotes and amastigotes (only 2D cultures) and hepatocytes exposed to the 
parasite and leishmanicidal drugs, were collected and analyzed. In parallel, positive 
controls of inflammation and cells not exposed to the parasite were also evaluated. 
4.3.11. Statistical analysis 
The Wilcoxon test for paired samples was used to perform the statistical analysis 
as is the non-parametric equivalent of the paired samples t-test. It should be used when 
the sample data are not normally distributed, as is the case of the present study.  
To explore the differences between time points and experimental conditions, the 
non-parametric Wilcoxon test for two related samples was used. All the data analysis 
was performed using the software IBM SPSS Statistics version 16.0 (IBM, USA). A 
significance level of 5% (p<0.05) was used to evaluate statistical significance of the 
data analyzed. 




4.4.1. Establishment of 2D and 3D in vitro cultures of dog 
hepatocytes 
Dog hepatocytes were successfully isolated and purified from liver lobules. The 
isolated cells were cultured in two different culture systems: in the traditional 
bidimensional (2D) 24 well plates and in a tridimensional (3D) form, exploiting the 
natural tendency of hepatocytes to aggregate and form cellular spheroids. 
4.4.1.1. 2D-culture system preserves normal morphology of dog 
hepatocytes 
The plated hepatocytes presented the typical hepatocyte morphology. The cells 
exhibited a round shape with a nucleus and an abundance of intracellular organelles 
associated with metabolic and secretory functions easily observed in the refrangibility 
of the light under an optical microscope (OM, Figure 18A, B and C). Scanning electron 
microscopy (SEM, Figure 18D, E and F) allowed to observe the hepatocyte cellular 
membrane with a smooth aspect pointing to the absence of major perturbation after 
isolation. As expected, hepatocytes also exhibited the characteristic tendency to 
establish cellular aggregates. 




Figure 18: Morphology of dog hepatocytes in 2D-culture system. 
Samples of cultured cells with 24 h (A), 48 h (B) and 72 h (C) of incubation were observed under an 
optical inverted microscope (A-C, scale bar 20 µm, 400x magnification) and a scanning electron 
microscope (D-F), from where images were acquired. Individualized cells with round shape, nucleus and 
abundance of intracellular organelles (A, B, C) with tendency to aggregate (C and F) were identified. 
Hepatocytes with a smooth cell membrane were observed 24 h after isolation (D-F). Artificial color (G-I) 
was applied on cells (red), to evidence the cell morphology. 
Isolated cells were stained for actin and ferritin. Actin is a component of the cell 
cytoskeleton microfilaments and ferritin is an intracellular protein that stores and 
releases iron in a controlled way. Culture hepatocytes exhibited distinctly rounded 
nuclei and majority of the cells presented a single nucleus. Cells also exhibited spots 
positively staining for ferritin, and it is known that hepatocytes have high levels of this 
protein (Figure 19). Several spots of actin deposition (green spots) were observed, 
probably indicating secretory vesicles, and some of those were co-localized with 
ferritin. Hepatocytes are cell rich in organelles, including the endoplasmic reticulum 
(smooth and rough) and Golgi apparatus that assure secretory functions. 




Figure 19: Actin and ferritin in cultured hepatocytes. 
Dog hepatocytes incubated for 72 h were stained for actin (green), a component of cell cytoskeleton, and 
for ferritin (red), usually prevailing in secretory vesicles. Cells were observed under fluorescent confocal 
microscope and images were acquired. The characteristic rounded shape of individualized hepatocytes, 
nuclei (black round spots) and cell aggregates is also observed. 
4.4.1.2. In vitro generation of hepatic spheroids 
Culturing hepatocytes as three-dimensional (3D) structures provide cells with an 
in vivo-like environment, enabling the retention of important hepatic functions without 
the need of extracellular matrix components. The spinner vessel in conjugation with the 
aggregation properties naturally evidenced by hepatocytes generated cellular spheroids 
(OM, Figure 20A-C). The cellular spheroids constituted for several cells were cultured 
in suspension. Spheroid sizes range between 30 µm – 50 µm and their number increased 
during the first 72 h in culture after hepatocyte isolation, reflecting good cell viability. 
In SEM images (Figure 20D-I) it was possible to observe that hepatocyte membrane 
maintained the smooth appearance and cells were united with extracellular matrix 
produced by the hepatocytes forming cellular aggregates. The production of 
extracellular matrix enables cells to recreated cell-to-cell communications structures and 
mimetize the in vivo tissue environment. 




Figure 20: Morphology of hepatic spheroids. 
Samples of cells cultured in a 3D-system for 72 h were observed under an inverted microscope (A-C, 
scale bar 20 µm, 400x magnification), a scanning electron microscope (D-F) and images were acquired. 
Artificial color (G-I) was applied on cells (red), to better evidence cells morphology. Hepatic spheroids 
with diverse levels of complexity and the nearly complete cell fusion as a consequence of extracellular 
matrix production were observed. 
Hepatic aggregates were also stained for actin and ferritin (Figure 21), revealing 
a three-dimensional cell arrangement (with cell superposition). Actin presented the 
expected cytoplasmic network feature with some intense spots, probably due to 
secretory vesicles. Ferritin spots are also identified in the spheroids, indicating possible 
storing vesicles. 




Figure 21: Actin and ferritin in hepatic spheroids. 
Hepatic spheroids generated in 3D-culture system were stained for actin (green) and ferritin (red). 
Spheroids were observed under fluorescent confocal microscope and images were acquired. 
Tree-dimensional cell superposition, nuclei (black spots), actin network, actin spots of high fluorescence, 
and spots of ferritin can be observed. 
4.4.1.3. 2D- and 3D-culture systems preserves viability and metabolic 
functions of canine hepatocytes 
Characteristics of viable and differentiated hepatocytes were assessed in both 
culture systems. Urea production and CYP450 enzyme activity were assessed. CYP450 
activity was evaluated through EROD, BROD, MROD and PROD assays. (Figure 22) 
EROD (CYP1A1 and CYP1A2 enzymes) and PROD (CYP2B11) assays revealed the 
metabolizing activity of hepatocytes in both culture systems, being the higher activity 
registered in the 3D-system. The 3D-culture system allowed hepatocytes to recover 
more rapidly from isolation trauma and recover their natural CYP450 enzyme activity, 
since after 24 h of incubation exhibited EROD and PROD activity. 2D-cultured 
hepatocytes needed more time to recover (48 h in culture) but achieved similar EROD 
activity levels compared to the 3D-culture system. Although BROD (CYP2B11, 
CYP3A12 and CYP3A26) and MROD (CYP1A2 and CYP1B) assays revealed a similar 
pattern a significant difference (PBROD=0.0469, PMROD=0.0313) in the enzyme activity 
level was detected when comparing hepatocytes from 2D- and 3D-culture system with 
24 h of incubation. Phase II enzymes assessed by the UGT reaction evidenced stable 
and similar metabolization levels throughout the 72 h of incubation in both culture 
systems. Altogether, these findings evidenced that in vitro conditions established in the 
present study hepatocytes isolated from dog liver preserve the enzymatic activity of 
CYP450 and therefore the key metabolic function is assured. 




Figure 22: Phase I and phase II enzyme activity of dog hepatocytes. 
Samples of 2D- and 3D-culture systems were used to evaluate EROD(A), BROD(B), MROD(C) 
PROD(D) and UGT(E) enzyme activity at 24 h, 48 h and 72 h of hepatocyte in culture. Samples were 
performed in triplicate and represented by box plots and whiskers (minimum to maximum). The 
non-parametric Wilcoxon test was used for statistical comparisons. * represents values of statistical 
significance (P<0.05) between 2D- and 3D-culture systems. 
In order to confirm that hepatocytes were active, beyond CYP450 activities urea 
production was also assessed. Urea constitutes a characteristic metabolite of active and 
viable hepatocytes. At the initial 24 h, 2D- and 3D-culture systems showed similar urea 
production rate indicating that in both culture systems hepatocytes are active (Figure 
23). In the 2D-culture system the medium was replaced by fresh medium every 24 h, 
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reason why the de novo urea production rate remains similar at 24 h, 48 h and 72 h in 
culture. However, the medium of 3D-cultures was only replaced after the first 72 h, 
allowing urea accumulation and relatively decrease of de novo production rate. There 
were significant differences in the de novo urea production rate of between the two 
culture systems at 48 h (P=0.0039) and 72 h (P=0.0039) when compared with the level 
of urea at 24 h. 
 
Figure 23: Urea de novo production rate in cultured dog hepatocyte, the 2D- and 3D-culture 
systems. 
Samples of 2D- and 3D-culture systems were used to evaluate urea production at 24 h, 48 h and 72 h of 
hepatocyte incubation. Values are represented as mean plus standard error of samples performed in 
triplicate. The non-parametric Wilcoxon test was used for statistical comparisons. * represent values of 
statistical significance (P<0.05) between 2D and 3D culture systems. 
Therefore, these findings indicate that dog hepatocytes were viable and 
metabolic active in both culture systems, allowing the continuation of the study by the 
evaluation of the immune parameters. 
4.4.2. Activation of dog hepatocytes and development of immune 
response direct to L. infantum parasites 
4.4.2.1. L. infantum parasites interact closely with canine hepatocytes 
To investigate how hepatocytes sensed and respond to the presence of L. 
infantum parasite, plated hepatocytes were exposed to axenic amastigotes and to 
virulent promastigotes. At first, the L. infantum morphological forms differentiated in 
cultured were confirmed by SEM. In fact, parasites cultured at 24 ºC exhibited an 
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elongated shape and a long free flagellum that emerges from the anterior part of the cell 
(Figure 24A and C) corresponding to the promastigote morphological form. Parasites 
cultured at 37 ºC presented around shape with no visible flagellum, characteristics of 
amastigote morphological form (Figure 24B and D). 
 
Figure 24: L. infantum morphological forms differentiated in different culture conditions. 
Parasites were grown at 24 ºC or a 37 ºC and at neutral or acidic pH in axenic culture medium, observed 
under scanning electron microscope and images were acquired. Promastigote (A) and amastigote (B) 
morphological forms of L. infantum were observed. Artificial color (C and D) was applied on cells 
(yellow) to better evidence cells morphology. 
The addition of virulent L. infantum promastigotes to 2D-cultured hepatocytes 
evidenced a strong promastigote tropism to hepatocytes, as parasites seem to be highly 
attracted by dog hepatocytes, directly interacting with the cell membrane (Figure 25). 
After 5 h of promastigote exposure, parasites appeared to be strongly attached to 
hepatocyte membrane, remaining linked to dog cells over the 72 h of incubation. With 
time, promastigotes seem to reduce motility and the elongated form, becoming more 
similar to amastigotes. However, under optical microscopy, no evidences of 
promastigotes or amastigotes-like parasites entering the canine hepatocytes were found. 





Figure 25: Canine hepatocytes exposed to L. infantum virulent promastigotes. 
Culture samples obtained at 1.5 h (A), 5 h (B), 24 h (C) and at 72 h (D) of parasite exposure were 
observed under inverted microscope (scale bar 20 µm, 400x magnification) and images were acquired. 
The interaction of the parasite with cell membrane (B, white arrow) and parasites exhibiting 
morphological characteristics of amastigote (C and D) are observed. 
Interaction of L. infantum promastigotes with the canine hepatocyte was also 
observed with SEM (Figure 26). An intense promastigote tropism to canine hepatocyte 
was also observed and, in a few cases, parasite flagellum deeply linked to the 
hepatocyte membrane (Figure 27). 
  




Figure 26: Dog hepatocytes exposed to L. infantum virulent promastigotes. 
Culture samples obtained at 1.5 h (A), 5 h (B) and 24 h (C) of parasite exposure were observed under 
SEM and images were acquired. At early parasite exposure, promastigotes are near the hepatocyte (A) 
but, with time, promastigotes surround the hepatocyte and parasite interaction with the cell membrane of 
hepatocyte become evident (B, C). Images with artificial color (D-F) evidenced the close interaction of 
the promastigote form (yellow) and the hepatocyte membrane (red). 




Figure 27: Detail of L. infantum virulent promastigotes interaction with canine hepatocytes. 
Culture samples obtained after 24 h (A) of parasite exposure were observed under SEM and images were 
acquired. Promastigotes interact closely with the membrane of the hepatocyte (A) evidencing to be 
attached to cell. Artificial colored image (B) highlighting the close interaction of the promastigote form 
(yellow) and the hepatocyte membrane (red). 
2D-cultured hepatocytes were also exposed to GFP-L. infantum promastigotes 
and stained for actin and ferritin. Observation under fluorescence confocal microscope 
(Figure 28) also revealed the high promastigote tropism to dog hepatocytes. 
Promastigotes were apparently attached to the hepatocyte and in some cases, even seem 
to be able to enter the hepatocyte, but in a non-conclusive way. In addition, 
promastigote seems to induce hepatocyte to generate more vesicles. These vesicles 
presented actin filaments, probably related to increased secretion levels by hepatocytes 
as a consequence of parasite contact. Curiously, promastigotes appear to progressively 
lose motility and, later on, parasite elongated body also suffer some changes, acquiring 
a more round shape (48 h). Ferritin, an iron storage protein, increased its content in 
hepatocytes at 5 h of exposure and then, ferritin appears to be sequestrated by 
promastigotes. After 48 h, hepatocyte evidenced a decrease in ferritin and promastigotes 
presented ferritin localized into a small intracellular vesicle. 
  












Figure 28: Actin and ferritin in cultured hepatocyte exposed to L. infantum virulent promastigotes. 
Dog hepatocytes incubated for 48 h in the presence of L. infantum promastigotes (with arrows) were 
stained for actin (green), a component of cell cytoskeleton, and for ferritin (red), frequently present in 
secretory vesicles. Cells were observed under fluorescent confocal microscope and images were acquired. 
Promastigotes exhibited a high tropism to hepatocytes, and in some cases appear to enter the cells (24 h – 
48 h), but in non-conclusive way. Hepatocytes presented a large round nucleus (stained red by TO-
PRO®). The presence of the parasite seemed to induce hepatocyte to generate more vesicles and 
sequester ferritin inside the cell (5 h). 
2D plated canine hepatocytes were also exposed to L. infantum axenic 
amastigotes in order to investigate the possible differences in sensing the parasite, since 
the amastigote is the parasite morphological form that reaches the dog liver in a natural 
infection. Hepatocytes were exposed to amastigotes for 72 h (similar to promastigote 
exposure) and amastigotes also evidenced hepatocyte tropism (Figure 29). After 5 h of 
exposure, amastigotes were attached to hepatocyte, interacting with the cell membrane 
throughout.  
 
Figure 29: Canine hepatocytes exposed to L. infantum axenic amastigotes. 
Culture samples obtained at 5 h (A), 24 h (B) and 72 h (C) of parasite exposure were observed under 
inverted microscope (scale bar 20 µm, 400x magnification) and images were acquired. Amastigotes, 
motionless ovoid body shapes, surround hepatocytes and appear to be attached to the cell membrane. 
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Observation of 2D-cultured hepatocytes under SEM also demonstrated 
amastigotes attached to dog hepatocytes, closely interacting with the cell membrane of 
hepatocyte (Figure 30) throughout the incubation time. 
 
Figure 30: Dog hepatocytes exposed to L. infantum axenic amastigotes. 
Culture samples obtained at 72 h of parasite exposure were observed under SEM. Image directly acquired 
(A) and after being artificial painted (B) are shown. Amastigote (yellow) interacting with the cell 
membrane of dog hepatocyte (red) is observed. 
4.4.2.2. L. infantum parasites disturb dog hepatocytes 
In order to investigate how hepatocyte senses and reacts to L. infantum presence 
some metabolic parameters were assessed. Urea is produced by hepatocytes as 
detoxification product and is highly influenced by the presence of inflammatory stimuli. 
Hepatocytes non-exposed to L. infantum presented a steady urea production,  
but when exposed to amastigotes (P=0.0313), promastigotes (P=0.0156) or 
lipopolysaccharide (LPS) (P=0.0313) which may cause stress, hepatocytes reacted with 
the production of a burst of urea in first 1.5 h of contact (Figure 31A). After 24 h, 
hepatocytes significantly reduced the urea production (Pamastigotes=0.0313, 
Ppromastigotes=0.0156) and at 72 h urea production was almost completed inhibited 
(Pamastigotes,promastigotes=0.0313), even at LPS-stimulated hepatocytes (P=0.0313). 
Compared with non-exposed hepatocytes that exhibit a gradual accumulation 
over incubation time, hepatocytes exposed to amastigotes (P1.5 h, 5 h, 24 h, 72 h=0.0313), 
promastigotes (P1.5 h, 24 h =0.0156; P5 h=0.0313) or LPS (P1.5 h, 5 h, 24 h, 72 h=0.0313) showed 
an intense urea accumulation (Figure 31B) early after contact with the inflammatory 
stimuli or with the parasite, regardless the morphological form. 





Figure 31: Production and accumulation of urea by hepatocytes exposed to L. infantum. 
Samples of 2D-cultured hepatocytes were used to evaluate urea de novo production (A) and urea 
accumulation (B) after 72 h of exposure to amastigotes or promastigotes. In parallel, non-exposed 
hepatocytes and LPS-stimulated hepatocytes were also evaluated. Results of samples performed in 
triplicate are represented as mean and standard error. The non-parametric Wilcoxon test was used for 
statistical comparisons. * represents values of statistical significance (P<0.05) when comparing non-
exposed hepatocytes vs the other conditions. 
CYP450 enzymes, also designated as phase I enzymes, were assessed in order to 
investigate how inflammatory stimuli might influence hepatocyte metabolism. EROD, 
BROD, MROD and PROD assays were performed (Figure 32). The metabolization 
values of EROD (CYP1A1 and CYP1A2 enzymes) and PROD (CYP2B11) assays were 
similar between non-exposed hepatocytes, LPS-stimulated hepatocytes and hepatocytes 
exposed to L. infantum amastigotes or promastigotes. BROD assay (CYP2B11, 
CYP3A12 and CYP3A26) revealed a similar tendency for maintaining metabolization 
values. However, after 72 h of exposure to L. infantum amastigotes, BROD 
metabolization was significant lower in comparison with non-exposed hepatocytes 
(P=0.0469). MROD (CYP1A2 and CYP1B) activity also showed similar results 
throughout the evaluation period, except for 72 h of LPS-stimulated hepatocytes that 
revealed a significant metabolic increase (P=0.0313). Phase II enzymes were assessed 
through the UGT reaction. In this particular case, when compared with the activity 
evidenced by hepatocytes non-exposed to parasites, phase II enzyme abruptly decreased 
their metabolization levels in hepatocytes early after exposure to L. infantum 
promastigotes (P=0.0234) or amastigotes (P=0.0156).  
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Altogether, these results indicate that L. infantum, despite the parasite 
morphological form used are able to negatively disturb the normal activity of phase II 
enzymes and also interferes with phase I CYP2B11, CYP3A12 and CYP3A26 normal 
metabolization.  
 
Figure 32: Phase I and phase II enzyme activity of dog hepatocytes exposed to L. infantum. 
Samples of 2D-cultured hepatocyte were used to evaluate EROD (A), BROD (B), MROD (C) PROD (D) 
and UGT (E) enzyme activity at 1.5 h, 5 h, 24 h, and 72 h of exposure to amastigotes or promastigotes. 
Non-exposed hepatocytes and LPS-stimulated hepatocytes were also evaluated. Results of samples 
performed in triplicate are represented by box plots and whiskers (minimum to maximum). The non-
parametric Wilcoxon test was used for statistical comparisons. * represents values of statistical 
significance (P<0.05) between non-exposed hepatocytes vs the other conditions. 
The synthesis of nitric oxide (NO) by hepatocytes was also assessed. 
Hepatocytes non-exposed to L. infantum evidenced a residual NO production and the 
exposure to inflammatory stimuli increased the NO production by hepatocytes (Figure 
33). When comparing the different stimuli some statistical differences were found 
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(Pamastigote 24 h vs LPS 24 h=0.0156, PLPS 1.5 h vs LPS 24 h=0.0313, P1.5 h amastigotes vs 72 h 
amastigote=0.0234). 
 
Figure 33: Nitric oxide production by canine hepatocytes exposed to L. infantum. 
Samples of 2D-cultured hepatocytes were used to evaluate NO production at 1.5 h, 5 h, 24 h, and 72 h of 
exposure to amastigotes (A) or promastigotes (B). Non-exposed hepatocytes and LPS-stimulated 
hepatocytes were also evaluated. Results of samples performed in triplicate are represented by box plots 
and whiskers (minimum to maximum). The non-parametric Wilcoxon test was used for statistical 
comparisons (P<0.05). * represents values of statistical significance when comparing hepatocytes 
exposed to different stimuli, and # indicates significant differences when comparing hepatocytes exposed 
to the same stimuli. 
Early immune response developed by canine hepatocyte when exposed to 
L. infantum amastigotes or promastigotes was assessed by evaluating the gene 
expression of the innate immune receptors TLR2, TLR4, TLR9, NOD1 and NOD2 and 
of the cytokines IL-10, TNF-α and IL-6 by real-time PCR. Gene expression of NOD1 
increased with exposure to amastigotes and with the incubation time (Figure 34A). 
From 1.5 h to 5 h of amastigote exposure, NOD1 mRNA levels increased (P=0.0313) 
and at 24 h the high accumulation of NOD1 mRNA was different from hepatocytes not 
exposed to parasites (P=0.0371). NOD2 gene expression in not-exposed hepatocytes 
was low and exposition to inflammatory stimuli transiently increases NOD2 activation 
(Figure 34B). Amastigote exposition for 1.5 h leads to a transient increase of NOD2 
mRNA (P=0.0195). Hepatocytes exposed to promastigotes exhibited a progressive 
increase of NOD2 mRNA that reaches significant values at 5 h (P=0.0020) and at 24 h 
(P=0.0353) when compared with not-exposed cells. After 24 h of LPS stimulation 
hepatocytes revealed a significant increase in NOD2 gene expression (P= 0.0049) when 
compared with hepatocytes non-exposed to parasite. The increase in NOD2 expression 
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on LPS-stimulated cells was statistically significant compared to the presence of 
amastigotes (P= 0.0020) or promastigotes (P= 0.0342). 
Taken together, these findings suggest that although the parasite disturbs the 
immune status of dog hepatocytes, enhancing the gene expression of NOD1 and NOD2, 
the parasite also seems to exert a negative regulation of these innate immune receptors, 
with exposition time, pointing for a balance between hepatocyte activation and 
tolerance. 
 
Figure 34: NOD1 and NOD2 gene expression in canine hepatocytes exposed to L. infantum. 
Samples of 2D-cultured hepatocyte were used to evaluate NOD1 and NOD2 mRNA accumulation at 
1.5 h, 5 h and 24 h of exposure to amastigotes or promastigotes. Hhepatocytes not exposed to parasites 
and LPS-stimulated hepatocytes were also evaluated. Results of samples performed in triplicate are 
represented by Tukey graphs. Black dots are indicative of outlier values. The non-parametric Wilcoxon 
test was used for statistical comparisons (P<0.05). * represents values of statistical significance when 
comparing not-exposed hepatocyte vs the other conditions and # indicates significant differences when 
comparing hepatocytes exposed to the same stimuli. 
The contact of L. infantum virulent promastigotes or axenic amastigotes with 
dog hepatocytes did not cause important changes in TLR2 (Figure 35A), TLR4  
(Figure 35B) and TLR9 (Figure 35C) gene expression. 
TLR2 expression exhibits a tendency to increase with the exposition to 
inflammatory stimuli. Amastigotes exposition lead to a significant increase in TLR2 
expression after 5 h incubation (P= 0.0195) compared to initial expression levels. TLR4 
expression in stimulated hepatocytes remains similar to hepatocytes not-exposed to 
parasites. Amastigotes registered a significant decrease in TLR4 expression after 24 h 
exposition (P= 0.0469).  
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TLR9 expression revealed a tendency to decrease by the presence of 
L. infantum. Amastigote exposition lead to a decrease in TLR9 expression after 5 h  
(P= 0.0273) and in promastigote exposition after 24 h (P= 0.0244). LPS lead to an 
initial increase in TLR9 expression, achieving the higher expression level. 
Although accumulation fluctuations of TLR mRNA were observed these results 
seems to reflect a probable hepatic tolerance to this parasite as no major expression 
increase was observed. 
 
Figure 35: TLR2, TLR4 and TLR9 gene expression in canine hepatocytes exposed to L. infantum. 
Samples of 2D-cultured hepatocytes were used to evaluate TLR2 (A), TLR4 (B) and TLR9 mRNA 
accumulation at 1.5 h, 5 h and 24 h of exposure to amastigotes or promastigotes. Hepatocytes not exposed 
to parasites and LPS-stimulated hepatocytes were also evaluated. Results of samples performed in 
triplicate are represented by Tukey graphs. Black dots are indicative of outlier values.* represents values 
of statistical significance when comparing not-exposed hepatocyte vs the other conditions and # indicates 
significant differences when comparing hepatocytes exposed to the same stimuli. 
Gene expression of pro- and anti-inflammatory cytokines by dog hepatocytes 
exposed to L. infantum parasites were also assessed by real-time PCR. The gene 
expression of the anti-inflammatory interleukin 10 (IL-10) was significantly increased 
in LPS-stimulated hepatocytes at 1.5 h (P=0.0024) and at 5 h (P=0.0049) when 
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compared with hepatocytes not-exposed to parasite (Figure 36). The amastigote 
exposition lead to an initial and transitory burst of IL-10 mRNA (P=0.0269). 
Promastigote exposition only generated a notorious augment of IL-10after 24 h 
(P=0.0186). Gene expression of pro-inflammatory interleukin 6 (IL-6) by hepatocytes 
was low throughout the study. The only break trough was observed after 5 h of 
hepatocyte contact with promastigotes (P= 0.0342). When compared with hepatocytes 
not-exposed to parasites, gene expression of pro-inflammatory tumor necrosis factor α 
(TNF-α) by LPS-stimulated hepatocytes (P1.5 h= 0.0186, P5h=0.0210) and by hepatocytes 
exposed to promastigotes (P1.5 h=0.0391, P5h= 0.0389) were significantly increased from 
1.5 h to 5 h. Hepatocytes exposed to amastigotes for 24 h exhibited significant 
accumulation of TNF-α mRNA (P=0.0245). 
 
Figure 36: Gene expression of IL-10, IL-6 and TNF-α by canine hepatocytes exposed to L. infantum. 
Samples of 2D-cultured hepatocytes were used to evaluate IL-10 (A), IL-6 (B) and TNF- (C) mRNA 
accumulation at 1.5 h, 5 h and 24 h of exposure to amastigotes or promastigotes. Not-exposed 
hepatocytes and LPS-stimulated hepatocytes were also evaluated. Results of samples performed in 
triplicate are represented by Tukey graphs. Black dots are indicative of outlier values. * represents values 
of statistical significance when comparing not-exposed hepatocyte vs the other conditions and # indicates 
significant differences when comparing hepatocytes exposed to the same stimuli. 
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These findings indicate that the contact with the parasite induce dog’s 
hepatocyte to generate pro- and anti-inflammatory cytokines. 
4.4.2.3. L. infantum parasites seem to have more difficulty in 
activating metabolic and immune pathways dog hepatic spheroids 
After the establishment of a 3D-culture system constituted by hepatocyte 
spheroids that better mimic the in vivo three-dimensional environment of the cells, the 
spheroids were exposed to L. infantum promastigotes and the direct physical interaction 
with dog hepatocytes were assessed and the effect on the biochemical and immune 
parameters were evaluated. 
L. infantum promastigotes close interacted with hepatocyte membrane and 
remain strongly attached to the cell membrane (Figure 37). 
 
Figure 37: 3D Canine hepatic spheroids exposed to L. infantum promastigotes. 
3D-culture samples obtained at 5 h (A) and 24 h (B) of parasite exposure were observed under inverted 
optical microscope (400x magnification). Parasites were found in suspension in the medium and in closed 
contact with the hepatic spheroids (white arrows). 
Cellular spheroids exposed to L. infantum promastigotes were stained for actin 
and ferritin (Figure 38). Actin staining revealed the cytoskeleton of the spheroids with 
cell superposition and fused hepatocytes. In conjugation with the exposition time, it was 
observed an increase in hepatocyte vesiculation (green dots), particularly visible at 24 h 
of exposition to promastigotes, indicating that the close interaction of the promastigotes 
leads spheroids to produce more vesicles, similar to 2D-culture system. Ferritin spots 
were observed in spheroids exposed to promastigotes during 5 h. After 24 h, a protein 
reduction within the spheroids was visible. In addition, ferritin appeared to be stored in 
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vesicles at hepatocyte border (Figure 38, 24 h), probably as a result of promastigote 
interaction with the cell membrane of hepatocytes, as it was observed in 2D-cultured 
hepatocytes. 
 
Figure 38: Hepatocyte aggregates exposed to L. infantum promastigotes and stained for actin 
(green) and ferritin (red). 
3D-culture samples obtained at 1.5 h, 5 h and 24 h of parasite exposure were observed under confocal 
fluorescent microscope and images were acquired. Hepatocytes actin (green) increased the number of 
vesicles after 24 h exposition to the parasite and ferritin (red) appear to increase inside hepatocytes after 5 
h parasite exposition and decreases its expression and concentrate in small points after 24 h exposition to 
L. infantum promastigotes. Back spots correspond to the hepatocyte nucleus. 
Metabolic characteristics of hepatocytes, such as urea production and CYP450 
enzymes were investigated in order to evaluate the impact of the promastigote presence 
in the 3D hepatocyte aggregate. The interaction of L. infantum promastigotes with the 
hepatic spheroids led to an early transitory burst of urea production (P=0.0156). At 24 h 
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of parasite exposure, the de novo urea production was apparently abolished when 
compared with non-exposed spheroids (P= 0.0156) that were still able to produce urea 
(Figure 39). During the entire observation period urea accumulation was highly 
increased (P1.5 h=0.0156; P5 h=0.0156; P24 h=0.0156; P72 h=0.0156) (Figure 39B) as a 
probable consequence of the parasite interaction with the hepatic spheroids. 
Urea production and accumulation follow a pattern similar in both 2D- and 
3D-cultures hepatocytes when faced with L. infantum virulent promastigotes, 
confirming that hepatocytes as an individualized cell or as cell aggregates becomes 
disturbed when interact with the parasite, reacting in an identical way. 
 
Figure 39: Urea production and accumulation by hepatic spheroids exposed to L. infantum 
promastigotes. 
Samples of 3D-cultured hepatocyte were used to evaluate de novo production of urea (A) and urea 
accumulation (B) after 1.5 h, 5 h, 24 h and 72 h of promastigote exposure and compared to non-exposed 
spheroids. Results of samples performed in triplicate are represented by the mean and standard error. The 
non-parametric Wilcoxon test was used for statistical comparisons. * represents statistical significance 
values (P<0.05) when comparing spheroids non-exposed to parasite vs spheroids exposed to 
promastigotes. 
Hepatic spheroid showed reduced enzymatic activity when in the presence of L. 
infantum promastigotes, similar to what was previously observed in the 2D-culture 
system with L. infantum parasites or LPS. EROD (CYP1A1 and CYP1A2) revealed a 
progressive decrease in enzyme activity (P= 0.0319) (Figure 40A). PROD (CYP2B11) 
assay did not exhibit important changes (Figure 40D). BROD assay (CYP2B11, 
CYP3A12 and CYP3A26) revealed no induction in the presence of promastigotes. 
Compared with spheroids non-exposed to L. infantum, the early interaction with the 
parasite caused significant suppression of enzymatic activity (P= 0.0156). Identical 
significant suppression was also observed at 72 h (P=0.0391) (Figure 40B). MROD 
(CYP1A2 and CYP1B) activity registered a significant decrease after 5 h of 
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promastigote exposure (P=0.0469) followed by another significant decrease at 24 h 
(P=0.0469) (Figure 40C). 
Phase II enzyme, UGT, of promastigote-exposed spheroids registered 
stabilization in metabolization rate compared to non-exposed spheroids (Figure 40E).  
 
Figure 40: Phase I and phase II enzyme activity of hepatic spheroids exposed to L. infantum 
virulent promastigotes. 
Samples of 3D-cultured hepatocytes were used to evaluate EROD (A), BROD (B), MROD (C) PROD 
(D) and UGT (E) enzyme activity at 1.5 h, 5 h, 24 h and 72 h of exposure to promastigotes and compared 
to spheroids non-exposed to parasites. Results of samples performed in triplicate are represented by box 
plots and whiskers (minimum to maximum). The non-parametric Wilcoxon test was used for statistical 
comparisons. * represents statistical significance values (P<0.05) when comparing non-exposed spheroids 
vs promastigote-exposed spheroids. 
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Hepatic spheroids non-exposed to inflammatory stimuli produced residual NO. 
However, when exposed to promastigotes for 5 h (P= 0.0313) and 24 h (P= 0.0313) 
significant higher levels of NO were detected (Figure 41).  
These findings indicate that the close cell-to-cell contact of spheroids may have 
implications in the oxidative stress. 
 
Figure 41: Nitric oxide production by canine hepatic spheroids exposed to L. infantum virulent 
promastigotes. 
Samples of 3D-cultured hepatocytes were used to evaluate NO production at 1.5 h, 5 h, 24 h and 72 h of 
parasite exposure and compared to hepatic spheroids non-exposed to L. infantum. Results of samples 
performed in triplicate are represented by box plots and whiskers (minimum to maximum). The non-
parametric Wilcoxon test was used for statistical comparisons (P<0.05). * represents statistical 
significance values when comparing non-exposed spheroids vs promastigote-exposed spheroids. 
Immune activation of hepatic spheroids by contact with L. infantum 
promastigotes was assessed by real-time PCR. NOD1 (Figure 42A) and NOD2 (Figure 
42B) gene expression did not differ from spheroids not-exposed to promastigotes 
throughout the incubation time. These findings indicate that L. infantum virulent 
promastigotes do not induce changes in the gene expression of these innate receptors in 
hepatic spheroids. 




Figure 42: NOD1 and NOD2 gene expression by canine hepatic spheroids exposed to L. infantum 
virulent promastigotes. 
Samples of 3D-cultured hepatocytes were used to evaluate NOD1 and NOD2 mRNA accumulation at 1.5 
h, 5 h and 24 h of exposure to promastigotes and compared to L. infantum non-exposed spheroids. Results 
of samples performed in triplicate are represented by Tukey graphs. Black dots are indicative of outlier 
values. 
When compared to hepatic spheroids not-exposed to virulent promastigotes, 
TLR2 gene expression registered a significant increase in promastigote-exposed 
spheroids for 5 h (P= 0.0105) and 24 h (P= 0.0353), indicating that exposition to the 
parasite trigger TLR2 receptor (Figure 43A). On the contrary, the amounts of TLR4 and 
TLR9 mRNA did not reveled major changes in spheroids exposed to parasites, during 
the entire observation period (Figure 43B and C). Taken together, these results indicate 
that it is probable that hepatocyte’s TLR2 recognize L. infantum promastigotes where 
the others TLRs and NODs evaluated in the present study do not seem to be signalized 
by parasite PAMPs. 




Figure 43: TLR2, TLR4 and TLR9 gene expression in hepatic spheroids exposed to L. infantum 
virulent promastigotes. 
Samples of 3D-cultured hepatocytes were used to evaluate TLR2 (A), TLR4 (B) and TLR9 (C) mRNA 
accumulation at 1.5 h, 5 h and 24 h of exposure to promastigotes and compared with Non-exposed 
spheroids. Results of samples performed in triplicate are represented by Tukey graphs. Black dots are 
indicative of outlier values. The non-parametric Wilcoxon test was used for statistical comparisons. 
* represents statistical significance values (P<0.05) when comparing non-exposed spheroids vs parasite-
exposed spheroids. 
In comparison with spheroids not-exposed to promastigotes, gene expression of 
the anti-inflammatory cytokines IL-10 (Figure 44A) and IL-6 (Figure 44B) and of 
pro-inflammatory TNF-α (Figure 44C) by promastigotes spheroids incubated with L. 
infantum promastigotes did not reveal important changes during the entire observation 
period. Only an increase in IL-10 expression (P= 0.0161) after 24 h exposition to 
promastigotes was observed. As a consequence of cells superimposition and 
aggregation in spheroids, the parasite direct contact of with hepatocytes is limited, 
therefore promoting a tolerant immune environment. 




Figure 44: Gene expression of IL-10, IL-6 and TNF-α by canine hepatic spheroids exposed to L. 
infantum virulent promastigotes. 
Samples of 3D-cultured hepatocytes were used to evaluate the accumulation of IL-10 (A), IL-6 (B) and 
TNF- (C) mRNA at 1.5 h, 5 h and 24 h of exposure to promastigotes and compared to not-exposed cell. 
Results of samples performed in triplicate are represented by Tukey graphs. Black dots are indicative of 
outlier values. The non-parametric Wilcoxon test was used for statistical comparisons. # represents 
statistical significance values (P<0.05). 
4.4.3. Leishmanicidal drugs stimulate metabolism and immunity 
of dog hepatocytes when in the presence of L. infantum 
parasites 
4.4.3.1. MgA and other drugs increase CYP450 activity in canine 
hepatocytes 
To assess the impact of leishmanicidal drugs on canine hepatocytes exposed to 
L. infantum axenic amastigotes (during 72 h), four different compounds were tested. 
Meglumine antimoniate (MgA), a commercial antileishmanial drug (Glucantime®) and 
other three experimental compounds with anti-leishmanial potential: ursolic acid 
(URA), chalcone-8 (CH-8) and quercetin (QC). In order to verify the survival of 
hepatocytes in the presence of these compounds, a resazurin assay was performed 
(Figure 45). Resazurin is a blue dye that is reduced by mitochondria of active cells to a 
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pink color and highly red fluorescent compound – resorufin. The assay demonstrated 
that the addition of leishmanicidal compounds to cultured hepatocytes did not disturb 
the viability of hepatocytes throughout the 72 h of observation. 
 
Figure 45: Viability of dog hepatocytes exposed to L. infantum treated with antileishmanial 
compounds. 
The viability of 2D-cultured hepatocytes 72 h exposed to axenic hepatocytes and incubated with MgA, 
URA, CH-8 and QC were periodically evaluated by a resazurin assay. Non-exposed and non-treated 
hepatocytes (100% live cells) and hepatocytes fixated with paraformaldehyde (100% dead cells) were 
evaluated in parallel. Results of samples performed in triplicate are represented by XY graph with 
connected lines. Results are represented be mean values and standard deviation. 
Urea production by hepatocyte exposed to amastigotes and tested with 
antileishmania compounds was influenced by the addition of leishmanicidal compounds 
producing an initial burst of urea (PMgA =0.0156; PURA =0.0078; PCH-8 =0.0078 and  
PQC =0.0078) when compared with the urea production values of treated hepatocytes. 
However, no statistical difference was found between the urea production induced by 
the parasite (amastigote) and the addition of leishmanicidal compounds to 
parasite-exposed hepatocytes (Table 7). URA was the compound that induced higher 
production of urea by amastigote-exposed hepatocytes, presenting a significant 
difference when compared with CH-8 (P=0.0416). After 5 h, urea values produced by 
amastigote-exposed hepatocytes were minimal. However, only amastigote-exposed 
hepatocytes treated with URA differ significantly from non-exposed hepatocytes 
(P=0.0313). After 24 h, amastigote-exposed treated hepatocytes presented a significant 
decrease in urea production when compared to non-exposed hepatocytes (PMgA =0.0313; 
PURA =0.0078; PCH-8 =0.0078; PQC =0.0078). At 72 h of incubation, the reduction 
observed in urea production by amastigote-exposed hepatocytes in contact with the 
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drugs still was statistically important (PMgA=0.0313; PURA=0.0078; PCH-8=0.0078; 
PQC=0.0078). The difference in urea production between amastigote-exposed 
hepatocytes treated with CH-8 and QC for 72 h was statistically significant (P=0.0140). 
Table 7: De novo urea production by hepatocytes exposed to L. infantum amastigotes for 72 h and 
treated with the leishmanicidal compounds MgA, ursolic acid (URA), chalcone-8 (CH-8) and 
quercetin (QC). 
Urea produced by non-exposed hepatocytes and amastigote-exposed hepatocytes were also compared. 
Mean urea values and standard error are indicated. The non-parametric Wilcoxon test was used for 
statistical comparisons (P<0.05). * represents statistically significant values when comparing 
non-exposed hepatocytes vs parasite exposed treated hepatocytes and # represents statically significant 








Amastigote-exposed hepatocytes and treated with 
MgA URA CH-8 QC 
1.5 0.17±0.0008 26.91±4.45 28.27±2.17* 29.10±1.08* 26.53±0.96*# 26.47±2.97* 
5 0.56±0.003 1.78±0.77 1.40±0.67 2.49±0.92* 0.77±0.45 0.38±0.033 
24 2.69±0.13 0.11±0.04 0.05±0.03* 0.22±0.09* 0.22±0.17* 0.13±0.05* 
72 2.07±0.19 0.07±0.04 0.1±0.04* 0.05±0.05* 0.05±0.05* 0.28±0.03*# 
 
To verify if the addition of leishmanicidal compounds affects the activity of 
metabolizing enzymes in amastigote-exposed hepatocytes, Phase I enzymes (CYPs450) 
were assessed by EROD, BROD, MROD and PROD assays and phase II enzyme trough 
UGT assay. All of the evaluated enzymes showed an increase activity rate in the 
presence of the drugs (Figure 46) 
The addition of MgA to amastigote-exposed hepatocytes induced the significant 
augment of EROD (P1.5 h, 24 h, 72 h = 0.0156; P5 h= 0.0313) (Figure 46A), BROD  
(P1.5 h, 5 h, 24 h, 72 h = 0.0156) (Figure 46B) and MROD (P1.5 h, 5 h, 24 h, 72 h = 0.0313)  
(Figure 46C) activities throughout the times points evaluated when compared with 
untreated amastigote-exposed hepatocytes.  
These results reflect an important increase in CYP450 activities, indicating that 
the addition of MgA decreases inflammation levels on hepatocytes helping CYPs to 
restore their metabolization rate and also that MgA probable to be metabolized by 
CYP1A1, CYP1A2, CYP2B11, CYP3A12, CYP3A26 and CYP1B enzymes. 
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After MgA treatment, PROD assay also revealed significant high enzymatic 
activity by MgA treated amastigotes-exposed hepatocytes (P5 h, 24 h, 72 h=0.0313) in 
comparison with untreated amastigote-exposed hepatocytes (Figure 46D). In this 
particular case, although the increment of enzymatic activity only was detected after 5 h 
of incubation with the drug these findings confirm that MgA influence on CYP2B11 
metabolization rate.  
After 24 h incubation, a transient increase in EROD metabolization by 
amastigote-exposed hepatocytes treated by URA was statistically different from 
non-treated amastigote-exposed hepatocytes (P=0.0313). URA addition to amastigote-
exposed hepatocytes increased CYPs activity in all the assays performed. CH-8 
treatment also induced an increase in all performed assays, with more evident results 
with EROD. In EROD (CYP1A1 and CYP1A2 enzymes) and PROD (CYP2B11) assay 
of hepatocytes exposed to amastigotes and treated with CH-8, the enzymes activity were 
increased with incubation time (P24 h EROD = 0.0345; P24 h PROD = 0.0345). QC treatment 
similarity to other treatments induced increasing in the assessed CYPs, but to lesser 
extent.  
These results reveal the used drugs were able to increase in CYP450 activities, 
especially MgA and URA, demonstrating that the addition of leishmanicidal drugs 
decreases inflammation levels on hepatocytes aiding CYPs to restore their 
metabolization rate and also that probably the used drugs are metabolized by the 
assessed phase I enzymes.  
Phase II UGT revealed differential tendencies with the drugs used. MgA and 
URA treated hepatocytes maintained a similar metabolization profile to non-treated and 
amastigote-exposed hepatocytes, revealing no induction (Figure 46E). CH-8 and QC 
treated hepatocytes presented a tendency to increase phase II activity, especially in the 
first 5 h incubation with the drugs (PCH-8 = 0.0345). 
The present results reveal some tendency to impairment of phase I and phase II 
enzymes by the application of drugs, particularly MgA and URA. These induce phase I 
and not phase II enzymes, which lead to the accumulation of toxic metabolites on cells. 




Figure 46: Phase I and phase II enzyme activity after treatment of hepatocytes exposed to L. 
infantum axenic amastigotes. 
Samples of 2D-cultured hepatocytes were used to evaluate EROD (A), BROD (B), MROD (C) PROD 
(D) and UGT (E) enzyme activity at 1.5 h, 5 h, 24 h and 72 h of treatment with MgA, URA, CH-8 or QC 
and compared to non treated amastigote-exposed hepatocytes (LiAexp). Results of samples performed in 
triplicate are represented by box plots and whiskers (minimum to maximum). The non-parametric 
Wilcoxon test was used for statistical comparisons. * represents statistical significance values (P<0.05) 
when comparing non-treated amastigote-exposed hepatocytes vs treated amastigote-exposed hepatocytes. 
# represents statistical significance values (P<0.05) when comparing treated amastigote-exposed 
hepatocytes with different drugs. 
The leishmanicidal potential of the drugs was evaluated trough an adapted 
limiting dilution assay. The viability of amastigotes that were in culture with dog 
hepatocytes and then treated for 72 h were evaluated by the parasite’s ability to fully 
revert to promastigotes in complete Schneider medium at 24 ºC. The reciprocal of the 
last positive dilution was considered a measure of parasite viability (Figure 47). Axenic 
amastigotes used as control are indicative of maximum viability (100%). As expected, 
all the compounds exhibited leishmanicidal activity that increased with the time of 
contact. At 1.5 h incubation with the leishmanicidal drugs (Figure 47A), a significant 
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inhibition of parasite viability was obtained with URA (P= 0.0355) and CH-8  
(P= 0.0355) treatments. After 5 h incubation (Figure 47B) all the drugs presented a 
significant reduction in parasite viability (PMgA= 0.0271; PURA= 0.0335; PCH-8=0.0272; 
PQC= 0.0257) and after 24 h treatment the inhibition of parasite growth reached the 
100% and no viable parasites were observed. 
Altogether, these results confirm the effect of the evaluated drugs in parasite 
viability. However, in the conditions of this study, the drug classical used to treat 
leishmaniasis (MgA), including canine leishmaniasis, seems to be the less efficient in 
comparison with the experimental compounds used in the present study.  
 
Figure 47: Viability of L. infantum axenic amastigotes exposed to dog hepatocytes and 
leishmanicidal drugs. 
Samples of amastigote-exposed hepatocytes treated with MgA, URA, CH-8 and QC for 1.5 h (A) and 5 h 
(B) were plated in SCH medium and incubated at 24 ºC. In parallel, platted axenic amastigotes were also 
allowed to differentiate in promastigotes in the same conditions. The reciprocal of last promastigote 
positive dilution was considered as indicative of viability. The reciprocal of the dilution obtained for each 
condition is represented by the mean and standard error. The non-parametric Wilcoxon test was used for 
statistical comparisons. * indicates statistically important differences (P<0.05). Inscribed values indicate 
the reduction obtained when compared to the amastigote reciprocal dilution (100% viability). 
The immune response, eventually potentiated by the addition of leishmanicidal 
drugs was evaluated by analyzing the gene expression of innate immune receptors and 
of cytokines.  
Curiously, after treatment NOD1 gene expression of amastigotes-exposed 
hepatocytes stay similar to non-treated amastigotes-exposed hepatocytes or evidenced a 
significant reduction (PQC1.5 h=0.0273, PURA, 5h; CH-8, 24 h=0.0078, Figure 48A). On the 
contrary, the addition of MgA to amastigotes-exposed hepatocytes for 5 h led to the 
increase of NOD2 mRNA (P=0.0162, Figure 48B). 




Figure 48: NOD1 and NOD2 gene expression by amastigote-exposed hepatocytes after treatment. 
Samples of amastigote-exposed hepatocytes treated with MgA, URA, CH-8or QC were used to evaluate 
NOD1 (A) and NOD2 (B) mRNA accumulation at 1.5 h, 5 h and 24 h of treatment and values compared 
to amastigote-exposed hepatocytes (LiAexp). Results of samples performed in triplicate are represented 
by Tukey graphs. Black dots are indicative of outlier values. The non-parametric Wilcoxon test was used 
for statistical comparisons. * indicates statistically important differences (P<0.05) when comparing 
treated and non-treated hepatocytes. 
After treatment with different leishmanicidal drugs, gene expression of TLRs stay 
similar to non treated amastigote-exposed hepatocytes or significantly decreased  
(Figure 49). TLR2 expression revealed a accentuated decrease during treatment with 
URA (PURA,1.5 h = 0.0391, P URA,5 h = 0.0137, P URA,24h=0.0049) (Figure 49A). Quercetin 
treatment also demonstrated a significant decrease during early treatment time  
(PQC,1.5 h= 0.0371). TLR4 expression exhibited the unique exception, presenting a 
transient increase of TLR4 mRNA 5 h after MgA treatment (P= 0.0049), as a possible 
consequence of high availability of parasite antigens (Figure 49B). TLR9 expression 
levels were kept similar between amastigote-exposed hepatocytes and not treated and 
treated cells, revealing that parasite antigen’s apparently do not activate this innate 
immune receptor. 




Figure 49: TLR2, TLR4 and TLR9 gene expression after treatment of canine hepatocytes exposed 
to L. infantum axenic amastigotes. 
Samples of amastigote-exposed hepatocytes treated with MgA, URA, CH-8or QC were used to evaluate 
TLR2 (A), TLR4 (B) and TLR9 (C)mRNA accumulation at 1.5 h, 5 h and 24 h after treatment and 
compared to not treated amastigote-exposed hepatocytes (LiAexp). Results of samples performed in 
triplicate are represented as Tukey graphs. Black dots are indicative of outlier values. The non-parametric 
Wilcoxon test was used for statistical comparisons. * represents statistical significance values (P<0.05) 
when comparing not treated vs treated hepatocytes. 
The addition of leishmanicidal drugs led to transient changes cytokine 
environment in treated hepatocytes (Figure 50). In the IL-10 profile exhibit by 
amastigote-exposed hepatocytes after 1.5 h of URA treatment was observed an increase 
of IL-10 mRNA accumulation (P=0.0020) and 24 h incubation with the drug  
(P= 0.0098). The treatment with QC also increase IL-10 gene expression at the 
beginning (P1.5 h=0.0078) and again after 24 h treatment (P24 h=0.0371). After 24 h of 
treatment, MgA significantly increased IL-10 gene expression (P= 0.0098) when 
compared with non-treated hepatocytes (Figure 50A). However, after application of the 
leishmanicidal drugs gene expression of IL-6 and TNF-α did not show important 
differences when compared with non-treated hepatocytes, although IL-6 expression 
evidenced an increasing tendency (Figure 50B and C). Altogether, these findings 
indicate that some of the drugs are able to induce dog hepatocytes to generate transient 
peaks of the anti-inflammatory cytokine IL-10, probably in an attempt to preserve 
immune homeostasis. 




Figure 50: Gene expression of IL-10, IL-6 and TNF-α after treatment of hepatocytes exposed to L. 
infantum axenic amastigotes. 
Samples of amastigote-exposed hepatocytes treated with MgA, URA, CH-8 or QC were used to evaluate 
IL-10, (A), IL-6 (B) and TNF-α (C) mRNA accumulation at 1.5 h, 5 h and 24 h after treatment and 
compared to not treated amastigote-exposed hepatocytes(LiAexp). Results of samples performed in 
triplicate are represented by Tukey graphs. Black dots are indicative of outlier values. The non-parametric 
Wilcoxon test was used for statistical comparisons. * represents statistical significance values (P<0.05) 
when comparing not treated vs treated hepatocytes. 
4.4.3.2. Dog hepatic spheroid become activated by parasite antigens 
and nucleic acids released during MgA treatment 
Hepatic spheroids cultured in a 3D-system were previously exposed to 
L. infantum promastigotes for 72 h and then MgA was added to the system in order to 
evaluate the impact of the leishmanicidal drug into hepatocyte aggregates. Although not 
observed under optical microscopy, SEM revealed that the morphology of the cell 
membrane was altered (Figure 51C and E). Hepatocytes remain attached to each other 
by the extracellular matrix but the exposition to promastigotes and MgA seem to 
increased membrane roughness probably associated with high secretion levels and 
disrupted some of the cellular initial cohesion. Furthermore, was also apparent that the 
initially added promastigotes differentiated into amastigotes (ovoid body form without a 
free flagellum) and remain strongly attached to the spheroid membrane (Figure 51D-F). 




Figure 51: Morphology of promastigote-exposed spheroids after treatment. 
Samples of 72 h promastigote-exposed hepatic spheroids and 72 h treated with MgA (C and E) were 
observed under SEM. Images were acquired and artificial colored to evidence the transformation of 
promastigotes into amastigotes (yellow) while attached to the hepatic spheroid membrane (red). 
Compared to the initial spheroids (A and B) the exposition to L. infantum promastigotes and MgA 
increased the membrane roughness of hepatic spheroids (C-F). 
Nitric oxide (NO) production in the 3D-culture system was not altered by the 
addition of MgA, presenting identical high production levels during the 72 h of 
treatment. In addition, similar NO production levels were observed in no  
treated promastigote-exposed spheroids (Figure 52A). Urea production by 
promastigote-exposed spheroids follows the anterior described pattern, producing an 
initial burst when facing a stress situation. The addition of MgA does not cause 
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important changes, inducing a peak (1.5 h) of de novo synthesis urea followed by a 
major decrease. Then, high levels of urea accumulation remained constant (Figure 52B). 
 
Figure 52: Nitric oxide and urea production by promastigote-exposed spheroids after MgA 
treatment. 
Supernatant samples of hepatic spheroids exposed to L. infantum promastigotes for 72 h and treated with 
MgA for more 72 h were used to evaluate NO and urea production, supernatants of untreated 
promastigote-exposed spheroids (LiPexp) were used for comparison. NO results are represented by box 
plots and whiskers (minimum to maximum) (A) and urea production by mean and standard deviation (B). 
Phase I enzyme of promastigote-exposed spheroids treated with MgA exhibited 
activity levels similar to untreated promastigote-exposed spheroids. With the exception 
of EROD metabolization that exhibited a significant decrease (P=0.0391) at the 
beginning of treatment (1.5 h) in comparison with untreated hepatocytes (Figure 53). 
Phase II enzymes exhibited a decreasing tendency with statistical significance after 24 h 
incubation with MgA (P=0.0234). 
Taken together, these results indicated that treatment with MgA has minimal 
effect on the CYP450 metabolization and of urea and NO production of dog hepatic 
spheroids that have established contact with L. infantum promastigote parasites. 
 




Figure 53: Phase I and phase II enzyme activity after MgA treatment of hepatic spheroids exposed 
to L. infantum axenic promastigotes. 
Samples of 3D-cultures supernatants were used to evaluate EROD (A), BROD (B), MROD (C) PROD 
(D) and UGT (E) enzyme activity at 1.5 h, 5 h, 24 h and 72 h of MgA treatment. Untreated and 72 h 
amastigote-exposed hepatocytes (LiAexp) were used for comparison. Results of samples performed in 
triplicate are represented by box plots and whiskers (minimum to maximum). The non-parametric 
Wilcoxon test was used for statistical comparisons. * represents statistical significance values (P<0.05) 
when comparing untreated vs treated amastigote-exposed spheroids. 
Gene expression of the innate immune receptors NOD1 and NOD2 (Figure 54) 
were assessed after addition of MgA to spheroids previously exposed for 72 h to 
L. infantum promastigotes. When compared with exposed and untreated spheroids, the 
addition of MgA induces a significant increase of NOD1 expression (P=0.0342) after 
24 h incubation with the drug. NOD2 exhibited a similar tendency with an increased 
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mRNA accumulation 24 h of MgA treatment (P=0.0166) and compared to spheroids 
exposed to L. infantum and not-treated (P= 0.0049). These results together with results 
obtained from treated 2D cultures, indicates that NOD2 receptors may play a role in 
recognize parasite antigens. 
 
Figure 54: NOD1 and NOD2 gene expression after MgA treatment of promastigote-exposed 
spheroids. 
Samples of 3D-hepatocytes cultures treated with MgA, were collected and NOD1 (A) and NOD2 (B) 
mRNA accumulation at 1.5 h, 5 h and 24 h of treatment assessed and compared with samples of untreated 
72 h promastigote-exposed hepatocytes (LiAexp). Results of samples performed in triplicate are 
represented by Tukey graphs. Black dots are indicative of outlier values. The non-parametric Wilcoxon 
test was used for statistical comparisons. * indicates statistically important differences (P<0.05) when 
comparing treated and non-treated hepatocytes. # * indicates statistically important differences (P<0.05) 
when comparing treated spheroids throughout incubation time. 
The application of a leishmanicidal drug lead to an increase in TLR2 expression 
in treated promastigote-exposed spheroids after 24 h incubation with MgA (P=0.0353) 
(Figure 55A). TLR4 expression levels did not revealed differences caused by the 
addition of MgA and TLR9 gene expression registered an increase after 24 h incubation 
with MgA, when compared with untreated spheroids (P=0.0353) (Figure 55C). 




Figure 55: TLR2, TLR4 and TLR9 gene expression after treatment of hepatic spheroids exposed to 
L. infantum promastigotes. 
Supernatant of 3D-cultures treated with MgA were used to evaluate TLR2 (A), TLR4 (B) and TLR9 
(C)mRNA accumulation at 1.5 h, 5 h and 24 h after treatment and compared to untreated promastigote-
exposed spheroids (LiAexp). Results of samples performed in triplicate are represented by Tukey graphs. 
Black dots are indicative of outlier values. The non-parametric Wilcoxon test was used for statistical 
comparisons. * represents statistical significance values (P<0.05) when comparing not treated vs treated 
spheroids. 
After MgA treatment of promastigote-exposed spheroids, gene expression of the 
anti-inflammatory IL-10 and IL-6 (Figure 56A, B) were kept similar to the untreated 
promastigote-exposed spheroids, although IL-6 presented a transient increase at 5 h 
incubation with MgA. However, the pro-inflammatory TNF-α registered a significant 
increased gene expression (P=0.0031) after 24 h of treatment (Figure 56C). 
Altogether, these findings demonstrated that only a prolonged treatment (24 h) 
with MgA induced changes in the gene expression of a few innate receptors (internal 
and external) and of a pro-inflammatory cytokine of spheroids previously exposed to 
L. infantum parasites suggesting the spheroid activation by recognition of parasite 
antigens and nucleic acids, released as a consequence of treatment, and the 
establishment of a pro-inflammatory environment. 




Figure 56: Gene expression of IL-10, IL-6 and TNF-α after treatment of hepatic spheroids exposed 
to L. infantum virulent promastigotes. 
Samples of promastigote-exposed spheroids treated with MgA were used to evaluate IL-10, (A), IL-6 (B) 
and TNF-α (C) mRNA accumulation at 1.5 h, 5 h and 24 h after treatment and compared to untreated 
promastigote-exposed spheroids (LiAexp). Results of samples performed in triplicate are represented by 
Tukey graphs. Black dots are indicative of outlier values. The non-parametric Wilcoxon test was used for 
statistical comparisons. * represents statistical significant values (P<0.05) when comparing untreated vs 
treated spheroids. 




Hepatocytes are cells of the main parenchymal tissue of the liver. These cells, 
which constitute 70-85% of the liver's mass, display vital roles in protein synthesis and 
storage, carbohydrate metabolism, cholesterol synthesis, detoxification and in the 
modification and excretion of exogenous and endogenous substances. The typical 
hepatocyte presents cubical shape with lateral sides of 20-30 µm. Exhibits eosinophilic 
cytoplasm, reflecting the numerous mitochondria present, and basophilic stippling due 
to the large amounts of rough endoplasmic reticulum and free ribosomes that support 
the immense protein synthesis. Hepatocyte nuclei are round with a dispersed chromatin 
and prominent nucleoli. Variation in the size of the nuclei is common and often reflects 
tetraploidy and other degrees of polyploidy, a normal feature of 30-40% of hepatocytes 
in the adult human liver. Binucleate cells are also common (Celton-Morizur et al., 
2010). Cells isolated from dog liver correspond to this description with a cytoplasm full 
of organelles positively staining for ferritin, the major intracellular protein. Constituted 
by 24 protein subunits of two types, the heavy (H) and light (L) subunits, this protein is 
involved in the storage and release of intracellular iron. Ferritin corresponds to ion Fe
2+
 
that when oxidized originates the ion Fe
3+
, which in turn can be complexed with ferritin 
in the cytosol of cells, transferrin in serum or with lactoferrin in mucosal secretions 
(Theil, 2003). Ferritin, a non-toxic form of iron storing is deposited within hepatocyte 
which has a large capacity for iron storage and transport. Free iron is toxic to cells as it 
acts as a catalyst in the formation of free radicals from reactive oxygen species. 
However, iron is essential for diverse cellular functions such as oxygen transport, 
electron transfer, nitrogen fixation, DNA synthesis, and the production of hemoproteins 
like hemoglobin and myoglobin. Therefore, vertebrates evolve an elaborate set of 
protective mechanisms to bind iron in various tissue compartments. When hepatocytes 
become iron overload, an insoluble hemosiderin is derived from iron-rich ferritin 
(Koorts and Viljoen, 2007). Ferritin is widely distributed in cells and is found in the 
cytosol, nucleus, mitochondria and lysosomes and appears in plasma as a result of 
cellular secretion. This specific distribution enables ferritin to supply, in particular 
enzymes and other proteins with appropriate amounts of iron, and, equally important, 
places ferritin in close proximity to sites where large amounts of iron are metabolized 
(Koorts and Viljoen, 2007). Ferritin synthesis is stimulated during cell differentiation by 
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pro-inflammatory cytokines as well as by some hormones (Festa et al., 2000). An 
important role for ferritin during the acute phase response is to restrict the availability of 
iron by sequestration into the cavity of the ferritin protein shell. Furthermore, ferritin 
can modulate many immune functions, play a role in pro-apoptotic and anti-apoptotic 
pathways, and is implicated in the pathology of cancer (Koorts and Viljoen, 2011). 
During infection, the pathogen usurps host iron for its survival and pathogenicity, thus 
maintenance of the plasma ferritin level during infection is a crucial host defense 
mechanism. Endotoxin is an inducer of the gene encoding for ferritin, thus causing the 
rise of ferritin concentration. The concentration of ferritin has been shown to increase in 
response to stress, such as anoxia, suggesting that can be considered as an acute phase 
protein (Tsuji et al., 2000). Vertebrate ferritin has been indirectly linked to innate 
immune response since its synthesis is regulated by pro-inflammatory cytokines at both 
the transcriptional and translational levels. In the present work ferritin seem to be 
augmented in canine hepatocytes early after exposure to L. infantum promastigotes, in 
both 2D- and 3D-culture systems, although more evident in the 2D-culture, as a 
consequence of an initial inflammatory response. Curiously, this increase in ferritin 
content of protein, correspond to the generation of IL-6 and TNF-α, both potent 
inflammatory cytokines. IL-6 is a pleiotropic cytokine with beneficial effects in the 
liver. This cytokine promotes liver regeneration and protects against a multitude of 
liver-damaging influences such as alcohol and CCl4 (carbon tetrachloride) intoxication 
(Mizuhara et al., 1994). IL-6 also prevents apoptosis and exhibits positive effects in 
both ischemia models and fatty liver (Kovalovich et al., 2000). However, the IL-6–
triggered molecular mechanisms leading to liver protection are not completely 
understood. Panesar et al. (1999) related that murine hepatocytes release significant 
amounts of IL-6 when exposed to endotoxin or pro-inflammatory cytokines. In the 
present work, canine hepatocytes reacted to the presence of LPS with the generation of 
TNF-α similar to the response given by hepatocytes exposed to L. infantum amastigotes 
or promastigotes, and in this case together with the expression of IL-6, indicating that 
hepatocytes sense and react to the presence of L. infantum parasites, launching a 
classical inflammatory response, not specific for the parasite. In addition, IL-6, together 
with TNF-α and IL-1, is required for induction of the acute phase response which 
comprises fever, corticosteroid release, and hepatic production of acute phase proteins. 
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However, IL-6 is the major mediator for the hepatocytic secretion of most of the acute 
phase proteins. Overall, induction of the acute phase response by IL-6 has been 
regarded as part of an attempt to maintain homeostasis (Streetz et al., 2000) and also 
seem to be associated with some of LV characteristic symptoms, such as fever. 
Inflammation in the liver has other consequences for the host. In laboratory animal 
species, IL-1, IL-6, and TNF-α have been found to modulate intermediary metabolism 
of carbohydrate, fat, and protein substrates, regulate hypothalamic-pituitary outflow, 
and act in the brain to reduce food intake (Johnson et al., 1993, Johnson, 1997). 
Furthermore, TNF-α causes muscle catabolism that is also mediated by glucocorticoids, 
as well as glucagon-induced hyperglycemia and amino acid uptake by the liver, 
influencing the metabolic state of the host. The acute phase response changes blood 
plasma composition is thought to be beneficial to the organism by preventing microbial 
growth and helping to restore homeostasis. Some acute phase proteins can promote 
microorganism opsonization and activate complement, others scavenge cellular 
remnants and free radicals, or neutralize proteolytic enzymes (Gruys et al., 2005). After 
stimulation by the pro-inflammatory cytokines, KCs release IL-6 that are recognized by 
hepatocytes. In this phase, IL-6 depresses mononuclear production of IL-1 and TNF-α 
(Schindler et al., 1990) thus mitigating the whole cascade reaction and controlling 
inflammation. Downregulation of the hepatocytic acute phase receptors is achieved by 
rapid hepatic removal of circulating cytokines (Heinrich et al., 1998) and release of 
IL-10 by KCs, inducing tolerance and suppressing the local IL-6 production. Acute 
phase protein production can be regulated by cytokines. Although cytokine production 
is also influenced by the presence of some acute phase proteins, IL-1 and IL-4 suppress 
acute protein synthesis (Loyer et al. 1993). A recent work by Silvestrini et al. (2013) 
addressed the relation between iron levels and C-reactive protein levels in canine 
leishmaniasis, concluding that inflammation contributes for the alteration of iron 
molecular status, but other mechanisms are likely involved. Low total iron-binding 
capacity and increased C-reactive protein are risk factors for the outcome of canine 
leishmaniasis. In summary, the exposure of canine hepatocytes to L. infantum parasites 
promote the increase in ferritin protein simultaneously with the generation of 
pro-inflammatory IL-6 and TNF-α cytokines, corroborating what was described in 
literature about inflammation increased ferritin levels. This enhancing ferritin levels 
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may be an attempt to transiently reduce iron availability for invading pathogens at the 
same time that hepatocytes react to the presence of L. infantum parasites by 
orchestrating an inflammatory response. Also, it has been described that in order to 
suppress pathogen growth the host responds by sequestering iron as evidenced by 
increased ferritin deposits in the trypanosomiasis chronic phase (Stijlemans et al., 
2008). 
Since iron is an essential element for survival, dimorphic protozoan Leishmania 
spp. parasites had to evolve different strategies to acquire iron. Leishmania spp. are 
defective in the heme biosynthetic pathway and require exogenous heme for growth 
(Chang et al., 1985). Iron is critically required as a cofactor of various important 
enzymes and can also influence the differentiation of Leishmania promastigotes into 
virulent amastigote forms (Mittra and Andrews, 2013). In Leishmania amastigotes 
which replicates inside phagolysosomes of MØ, iron superoxide dismutases are 
important for protection against the oxidative damage resulting from activation of the 
NADPH oxidase (Paramchuk et al. 1997). In vitro, promastigotes or amastigotes are 
supplemented with serum, which has high levels of ferritransferrin or with blood (lysed 
erythrocytes) rich in hemoglobin. Wilson et al. (1994) demonstrated that L. chagasi 
promastigotes are able to use iron bound to transferrin, lactoferrin or hemin, showing 
plasticity in the iron uptake. However, according with the same study, ferritin, the 
principal intracellular form of eukaryotic iron storage was unable to support 
promastigote growth. Although Leishmania appears able of acquiring Fe
3+
 complexed 
with lactoferrin or transferrin, the existence of a specific receptor-based uptake 
mechanism in these parasites has not been confirmed (Huynh et al., 2006). Experiments 
with L. chagasi revealed the presence of NADPH-dependent ferric reductase activity 
associated with the cell surface of live parasites (Wilson et al., 2002), indicating the 
existence of a potential pathway for direct membrane translocation of Fe
2+
. The LFR1 
(L. amazonensis plasma membrane-associated ferric reductase) was identified by 
Flannery et al., 2011. LFR1 revealed to be essential to the intracellular growth of 
parasites and development of cutaneous lesions in mice (Huynh et al., 2006). Together, 
LFR1 and LIT1 provide Leishmania with an inorganic iron acquisition pathway that has 
several similarities with the system found in plants. However, the ability of Leishmania 
to store iron in the cytosol is still debated (Flannery et al., 2013). In fact, Leishmania 
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may not have a system to store cytosolic iron. This possibility may explain the 
observation that moderate amounts of Fe-NTA (ferric nitriloacetate) are toxic to 
Leishmania (Mittra et al., 2013). Another possibility is that alternatively to ferritin, 
Leishmania utilize frataxin to store iron in the mitochondria (Adamec et al., 2000). In 
the present study L. infantum promastigote appear to be also positive to ferritin. 
However, this result might be caused by a cross reaction from the polyclonal antibody 
anti-ferritin with the bovine ferritin found in bovine serum added to the parasite cultures 
as medium supplementation. This can cause a positive reaction due to the polyclonal 
antibody and species cross reactivity. Consequently, positive ferritin in L. infantum 
promastigotes in the present study should be carefully interpreted, even though, canine 
hepatocytes appear to increase their levels in ferritin early after exposure to the parasite. 
Therefore, it is possible that hepatocytes initially react to parasite presence with an 
inflammatory response accompanied by lowering extracellular iron levels in order to 
difficult pathogen survival, similar to what occurs with MØ. To avoid iron acquisition 
by invading organisms, MØ sequester iron using different strategies, including 
expression reduction of principal iron uptake protein transferrin receptor-1 (Mulero and 
Brock, 1999), increase synthesis of iron storage protein ferritin (Drakesmith et al., 
2005) or decrease expression of iron release gene ferroportin (Nairaz et al., 2007). 
However, hepatocytes decreased ferritin content after 48 h of exposure to L. infantum. 
Direct release of cellular ferritin from damaged cell membranes has also been proposed 
(Tran et al., 1997). During infection, it is speculated that plasma ferritin scavenges and 
helps to detoxify Fe
2+
 leaking from damaged cells. Evidence of ferritin secretion has 
been shown in rat hepatoma cells where it is regulated by inflammatory cytokines and 
iron (Tue et al., 1997). In the present study it was evident a close contact between the 
parasite and the hepatocyte membrane, stressing hepatocytes. It is hypothesized that 
hepatocytes may release ferritin as a consequence of membrane damage caused by a 
longer interaction with L. infantum parasites. 
Close parasites interaction with hepatocyte membrane lead to the hypothesis that 
L. infantum can be internalized by dog hepatocytes. It is known that hepatocytes can 
perform phagocytosis under special circumstances. The phagocytic action of KCs is 
well known in the liver, but such a phenomenon has not been well documented for 
hepatocytes. Soji et al. (1992) referred that hepatocytes can perform phagocytosis 
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although not in a uniform manner. There are evidences of the presence of L. donovani 
amastigotes in the liver biopsies from human patients with VL (Duarte et al., 1989). 
Amastigotes were found within hepatocytes, using electron microscopy, and after 
patients gone through successful therapy. Gangneux et al. (2005) demonstrated in vitro 
that murine, rat and human primary hepatocytes were permissive to L. donovani 
promastigote infection, but parasites do not massively proliferate. This slight infection 
resulted in limited damage to hepatocytes. However, these results bring into question a 
possible role for hepatocytes as a parasite reservoir during latent infection. The present 
work is not conclusive regarding the question of L. infantum promastigotes or 
amastigotes entering the hepatocytes. L. infantum exhibited a clear tropism to 
hepatocytes and the interaction that parasite establish with the cell membrane seem to 
be very strong, as parasite remain attached to the hepatocytes throughout all the 
experimental period of time. Leishmania species are known to trigger MØ phagocytosis 
by establishing ligation with the surface receptors. Receptors reported to facilitate 
Leishmania internalization include the third complement receptor (CR3), first 
complement receptor (CR1) mannose receptor (MR), Fc gamma receptors (FcγRs, in 
particular FcγRII-B2) and fibronectin receptors (FnRs) (Ueno and Wilson, 2012). It is 
described the presence of mannose receptor (Ohnishi et al., 2012) and fibronectin 
receptors (Johansson and Lundgren, 1987) in hepatocytes. A number of pathogenic 
microorganisms, including C. albicans (Maródi et al., 1991), Pneumocystis carinii 
(Ezekowitz et al., 1991) and L. donovani (Chakraborty et al., 2001) display glycans on 
their surfaces with terminal mannose residues that are recognized by the C-type CRDs 
of the mannose receptor, thereby acting as a non-self marker. In phagocytic cells, upon 
recognition, the receptor internalizes the bound pathogen and transports it to lysosomes 
for degradation via the phagocytic pathway. In this way, the mannose receptor acts as a 
pattern recognition receptor (PRR). However, the ability of the mannose receptor to 
assist pathogen internalization is also thought to facilitate infection of intracellular 
pathogens as M. tuberculosis or Leishmania spp.. M. tuberculosis also reside and 
multiply inside MØ, preventing formation of the phagolysosome to avoid degradation. 
Hence, by mediating their entrance into the MØ, the mannose receptor helps these 
pathogens to infect and growth in their target cell (Gazi and Martinez-Pomares, 2009). 
In MØ, fibronectin receptors act synergistically with complement receptor to phagocyte 
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pathogens. Fibronectin receptors alone may retain the pathogen, possibly being the 
major responsible for the close interaction of L. infantum parasites with the hepatocyte 
membrane that was observed in the present work. 
Urea production is a characteristic of functional hepatocytes. The liver is 
quantitatively the major organ involved in urea synthesis and it is doubtful whether 
other cell types, such as enterocytes, can produce significant amounts of urea (Wu, 
1995). However, at least some urea cycle enzymes are found in extra-hepatic tissues, 
where they are involved in providing arginine for nitric oxide (NO) synthesis (Husson et 
al., 2003). There are two major pathways for ammonia detoxication in the liver: urea 
and glutamine synthesis. The liver is the most important site of ammonia metabolism; it 
removes much of the toxic ammonia presented to it by urea and glutamine synthesis. To 
prevent hyperammonemia and its dangerous effects, liver detoxifies ammonia by 
ureagenesis in periportal hepatocytes and by glutamine synthesis in perivenous 
hepatocytes. However, hyperammonemia was observed in experimental rodent models 
of sepsis suggesting defective hepatic ammonia detoxification (Luiking et al., 2008). 
According with a recent work from Soria et al., (2014) hepatocyte ureagenesis in 
LPS-treated rats seemed to be functional but dependent on the specific source of 
precursors. In the case, ureagenesis from ammonia was decreased but ureagenesis from 
glutamine was significantly increased. In the present work LPS addition to 2D cultured 
hepatocytes resulted in an initial burst of urea, probable due to a similar mechanism by 
which glutamine, present in the medium is being taken up into mitochondria, and 
metabolized to ammonia and glutamate via glutaminase. However, as the culture 
medium was not changed over the 72 h incubation, turning glutamine into a limiting 
substrate together with the establishment of an inflammatory response (elevating levels 
of TNF-α) lead to a decrease in urea production in LPS exposed hepatocytes. Balancing 
enzymes from the urea cycle is a key feature in Leishmania survival. When infecting 
macrophages Leishmania has to balance two inducible enzymes present in the cell that 
might kill or allow its survival: nitric oxide synthase (iNOS) and arginase. These two 
enzymes use a common substrate, L-arginine, and are competitively regulated by 
cytokines secreted by Th1 and Th2 cells. Arginase is classically considered to be an 
enzyme of the urea cycle in the liver and Leishmania through the modulation of a Th2 
polarized response is able to induce arginase activity and urea synthesis, ensuring 
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parasite survival (Kropf et al., 2005). The initially exposition of hepatocytes to L. 
infantum amastigotes or promastigotes also induced an increase in IL-10 expression 
concomitant with an increase in urea synthesis, probably induced by the parasite 
presence in order to control NO synthesis by hepatocytes, which was not different from 
non-exposed hepatocytes. After that initial burst of urea, exposed hepatocytes produced 
very little urea throughout the 72 h exposition in both 2D and 3D culture system. It is 
also described that inflammation can likewise lead to inhibition of urea synthesis in 
hepatocytes. Cytokines secreted locally by hepatic non-parenchymal cells, including 
TNF-α, IL-1β and IL-6 have been implicated in the inhibition of a wide range of hepatic 
functions after systemic injury or local hepatic injury (Luster et al., 1994). Kang et al., 
(2002) proved that hepatocytes chronically exposed to inflammatory cytokines IL-1 and 
IL-6 exhibited altered function as suppressed albumin production and reduced urea 
synthesis. The decreased observed in urea production in hepatocytes exposed to L. 
infantum amastigotes or promastigotes may also reflect the mix immune environment 
with IL-6 and TNF-α inflammatory cytokines and also IL-10 regulatory and permissive 
effect. 
It is well known that cytotoxic factors, such as lipopolysaccharides, disrupt 
nitrogen metabolism in hepatocytes and NO is involved among other factors in 
regulating this metabolic pathway (Tabuchi et al., 2000). NO is a free radical that is 
involved in many cellular events. Its biosynthesis are mainly performed by converting 
L-arginine to L-citrulline. Nitric oxide synthase (NOS) is either a constitutive or 
inducible enzyme. NOS has three distinguishable isoforms: NOS-1 (ncNOS), a 
constitutive isoform originally isolated from neuronal sources; NOS-2 (iNOS), an 
inducible isoform that may generate large quantities of NO and may be induced in a 
variety of cell types by inflammatory stimuli, such as TNF-α, IL-1 and IL-6; and NOS-3 
(ecNOS), a constitutive isoform originally located in endothelial cells (Alexander, 
1998). Unlike the constitutive form, iNOS is not regulated by the intracellular calcium 
concentration or by the Ca
2+
-calmodulin complex. It is also known that iNOS is 
expressed by many cell types including MØ, smooth muscle cells and hepatocytes (Sesti 
et al., 2005). Hepatocytes have been shown to express increased levels of NO following 
exposure to endotoxins, such as bacterial lipopolysaccharide or cytokines, such as 
TNFα, IL-6 and IL-1 (Saad et al., 1995). NO may possess both cytoprotective and 
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cytotoxic properties, depending on the amount and on the NOS isoform by which it is 
produced. In the liver, NO release in small quantities may be beneficial since it has been 
shown to decrease tumor cell growth and prostaglandin levels (pro-inflammatory 
products) and to increase protein synthesis and DNA-repair enzymes (Alexander, 1998). 
2D- and 3D-cultured hepatocytes exposed to L. infantum amastigote or promastigote 
register small NO increase, more evident in the 3D system. L. infantum is known to 
exhibit the ability to control NO production since it is a potent leishmanicidal molecule. 
L. infantum parasites stimulate the urea production and do not disturb NO pathway, 
subverting the host immune system to promote a Th2 response. NO production on 
hepatocytes was accompanied by the increased expression of inflammatory cytokines 
TNFα, IL-6 and also anti-inflammatory IL-10 probably to control the inflammatory 
response and avoid cellular damage. 
In the present work two culture models of hepatocytes were used to better 
characterize the interaction between the parasite forms and the hepatocytes. The 2D-
culture system consisted in the addition of hepatocytes to flat plates, allowing cells to 
adhere to a surface in a monolayer. This might be considered an inadequate 
representation of the cell’s original environment and 3D-spheroids culture system were 
developed in order to overcome this issue. The generation of 3D-multicellular spheroids 
is an attempt to mimic the in vivo liver architecture. 3D-culture model improved cell-to-
cell and cell-to-matrix interactions, recapitulating many in vivo tissue structures and 
functions. A 3D-culture system was developed to solve one of the main problems in the 
pharmaceutical industry: the need for viable and metabolic active hepatocytes to drug 
screening (Bachmann et al., 2015). In the present work it was observed that hepatocytes 
recover faster from isolation trauma if cultured in the 3D-spheroid system. The recovery 
was indicated by the higher CYPs activity after early after hepatocyte isolation (24 h). 
However, 2D-cultured hepatocytes also recovered, but take longer time (48 h). Similar 
urea production rate indicates that hepatocytes of both culture systems were at similar 
conditions. However, in the present work there were differences in the immune 
response magnitude to L. infantum promastigotes between hepatocytes cultured in 2D- 
and 3D-system. In 2D-culture system the interaction between the parasites (in both 
forms) was more intense and persistent than in the 3D-culture system. In the 3D-system 
due to the nature of the spinner vessel, hepatocytes had a less intense, more indirect 
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interaction with the parasites. Although the results indicate that hepatocytes were able to 
recognize the presence of the pathogen and react by orchestration an inflammatory 
response. Generation of IL-6 and TNF-α in the 3D-culture system were kept stable 
compared with non-exposed hepatocytes and did not register the increase of TNF-α 
genes expression recorded in the 2D-culture system. It seems that, hepatic spheroids 
induced tolerance to the inflammatory stimulus (presence of promastigote), probably by 
increased cell-to-cell contact and decreased direct contact between the promastigotes 
and individual hepatocyte membrane. 
By controlling systemic innate immunity via production of secreted PRRs and of 
the complement components found in plasma, hepatocytes play and essential role in 
innate immunity. During the acute phase response, a variety of pro-inflammatory 
cytokines, such as IL-6, IL-1, TNF-α, and IFN-γ, can stimulate hepatocytes to produce 
high levels of complement and secreted PRRs (Gao et al., 2008). Hepatocytes also 
express membrane-bound PRRs, such as TLRs and NODs. TLRs are a family of 
proteins that recognize pathogen associated molecular patterns (PAMPs) and are 
expressed on all major subsets of liver cells. TLRs can be triggered by exogenous 
ligands derived from pathogens or by endogenous ligands resulting from cellular injury, 
activating innate immunity. TLR recognition is often associated with the production of 
pro-inflammatory cytokines and generation of effector molecules, which promote 
differentiation of Th1 cells, leading to an inflammatory response. The specific response 
initiated by individual TLRs depends on the recruitment of a single or a specific 
combination of TIR-domain-containing adaptor protein (e.g., MyD88, TIRAP, TRIF, or 
TRAM) (Kawai and Akira, 2010). MyD88, utilized by all TLRs (with the exception of 
TLR3) and members of the IL-1 receptor family, transmits signals culminating in 
NF-κB and MAP kinase activation and downstream induction of inflammatory 
cytokines such as IL-1β, IL-12, TNF-α, and IL-6. TLR3 and TLR4 use TRIF to activate 
an alternative pathway leading to the activation of NF-κB and IRF3 and the production 
of type I IFN and of other inflammatory cytokine. TLR2 and TLR4 use TIRAP as an 
additional adaptor to recruit MyD88. Hepatocytes express mRNAs for all known TLRs, 
but their role in hepatocyte defense against invading pathogens is less clear. Hepatocyte 
expresses TLR2 and TLR4 and is responsive to LPS (Szabo et al., 2006; Schwabe et al., 
2006). In the present study a tendency to increased TLR2 and TLR4 expression was 
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observed in LPS stimulated hepatocytes, in accordance to what was previously 
described. However, the obtained values were not statistically significant, may be due to 
low LPS concentration or low exposition time. NOD-like receptors (NLRs) comprise a 
family of intracellular pattern recognition receptors that are important for recognition of 
the cell damage and of microbial-associated molecular patterns. NOD1 and NOD2 are 
specialized NLRs that participate in the recognition of a subset of pathogenic 
microorganisms that are able to invade and multiply intracellularly. Once activated, 
these molecules trigger intracellular signaling pathways that lead to the activation of 
transcriptional responses culminating in the expression of a subset of inflammatory 
genes. The role NOD receptors are not yet well defined in liver immunology (Isogawa 
et al., 2005; Thomas et al., 2007). In the present work it was assessed, for the first time, 
the expression pattern of NOD1 and NOD2, as well as TLR2, TLR4 and TLR9 
exhibited after hepatocytes were exposed to L. infantum promastigotes or amastigotes. 
The liver is another main target organ in VL. In contrast to the spleen that stays 
chronically infected, infection in the liver is normally self-containing. Resolution of 
disease in the liver is associated with granuloma formation which is one of the key 
features of hepatic resistance (Murray, 2001). However, the role of hepatocytes to 
control the infection by Leishmania is poorly studied. The resolution of the infection in 
the liver is attributed to the development of a Th-dominated granulomatous response, 
characterized by high IFN-γ, IL-12 and TNF-α production through CD4
+
 T cells. IL-12 
is an essential cytokine in the development of protective immunity against L. donovani, 
since IL-12 blocking reduce both IFN-γ production and granuloma formation in the 
liver of infected mice (Murray, 1997). Hepatic resistance in VL is also attributed to the 
generation of reactive nitrogen and oxygen intermediates, both of which have been 
shown to play a role in containing parasite growth during the early stages of infection 
(Murray and Nathan, 1999). In the present study, amastigote and promastigote 
exposition seem to trigger similar responses from the canine hepatocytes. Although both 
receptors react to the parasite presence seem to have a specificity for the morphological 
form of the parasite, amastigote and promastigote parasites induced NOD2 and 
amastigotes induce NOD1 gene expression. To the best of our knowledge, this is the 
first time that NOD1 and NOD2 gene expression are assessed in L. infantum exposed 
hepatocytes. Structurally, NLRs are multi-domain proteins containing an N-terminal 
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Caspase Recruitment Domain (CARD) that associates with downstream signaling 
molecules, a centrally located nucleotide-binding oligomerization domain (NBD or 
NACHT), and a C-terminal leucine-rich repeat domain (LRR) or sensor domain. The 
NLR members NOD1 and NOD2 belong to the NLRC subgroup as they contain an 
amino-terminal CARD domain and share the two common domains (NBD and LRR). 
NOD1 contains a single CARD domain, whereas NOD2 has two (Ogura et al., 2001). 
NOD1 and NOD2 function as intracellular receptors for bacterial peptidoglycan 
fragments, d-glutamyl-meso-diaminopimelic acid (DAP), which is found in 
Gram-negative and in a few Gram-positive bacteria, including Listeria and Bacillus 
(Chamaillard et al., 2003). In contrast, NOD2 activation was triggered by muramyl 
dipeptide (MDP), a peptidoglycan motif widely distributed among both Gram-positive 
and Gram-negative bacteria (Girardin et al., 2003). It also has been shown that NOD2 
can act synergistically with TLRs. The addition of MDP in combination with TLR 
agonists, such as lipoteicoic acid, LPS, and peptidoglycan, triggers a robust 
inflammatory response, including the release of pro-inflammatory cytokines such as 
IL-1β and IL-6 (Wolfert et al., 2002). It is possible that TLR stimulation facilitates the 
internalization of MDP, a process that is required for NOD2 activation under 
physiological conditions. In the present study, it is possible that the increase expression 
observed for NOD1 and NOD2 receptors are a result of a synergy with TLRs in order to 
activate an inflammatory and protective immune response against L. infantum parasites. 
TLR2 also registered, in the present study, a tendency to increase in hepatocytes 
exposed to L. infantum amastigotes or promastigotes. Curiously, in the 3D hepatic 
spheroids, only TLR2 expression was increased, probably due to the nature of the 
spinner vessel. In this case hepatic spheroids were exposed to parasites with less 
intensity and a more indirect interaction was established. Comparing the two cultures 
system, TLR2 receptor emerges as a possible first innate immune receptor (of the 
assessed ones) to be triggered by L. infantum virulent promastigotes, leading to the 
hypothesis that this innate immune receptor may play an important role in L. infantum 
detection and orchestrate the immune response against it. TLR2 and TLR4 are 
extracellular PRRs and TLR9 is an intracellular PRR. The microbial molecules 
recognized by TLRs are conserved polymers, such as bacterial LPS, peptidoglycans, 
unmethylated bacterial DNA, and double-strand viral RNA, among others. Since 
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protozoan lack most of these structures, TLRs also recognize other groups of molecules 
in order to sense these pathogens. The recognition of Trypanosoma cruzi tGPI 
(glicosylphosphatidylinositol anchor) by TLR2 (Campos et al., 2001) and of 
glycoinositolphospholipids by TLR4 (Oliveira et al., 2004), of Plasmodium hemozoin 
by TLR9 (Coban et al., 2005), and of the profilin-like molecule of Toxoplasma gondii 
by TLR11 (Yarovinsky et al., 2005) are such well described examples. A few 
Leishmania-derived molecules have been reported to activate TLRs, and the majority of 
the studies focused on the activation of TLR2, TLR4, and TLR9 in MØ of several 
mammal host species (Faria et al., 2012). Purified L. major lipophosphoglycan (LPG) 
induced the upregulation and stimulation of TLR2 in human NK cells, with additional 
enhancement of TNF-α and IFN-γ production (Becker et al., 2003). LPGs of L. major, 
L. mexicana, L. aethiopica, and L. tropica were defined as TLR2 ligands in studies 
using murine MØ, although the stimulation degree was variable. Intriguingly, LPG also 
induced the expression of suppressors of pro-inflammatory cytokines, the signaling 
family proteins SOCS-1 and SOCS-3. The finding that negative modulators of cytokine 
synthesis were also induced by LPG indicated that TLR2 stimulation by L. major can 
lead to both positive and negative inflammatory signals (de Veer et al., 2003). The fact 
that SOCS1 itself directly downmodulates TLR4 signaling pathways illustrates how the 
initial stimulation of TLR2 by L. major can ultimately lead to the attenuation of further 
TLR responses (Nakagawa et al., 2002). The potential role played by the innate immune 
receptors TLR2, TLR4 and TR9 of canine hepatocytes in surveillance and activation 
against L. infantum parasites is not yet described. There are evidences that TLR4 might 
have a protective role in L. major infection. Kropf et al. (2004) observed diminished 
parasite load at the skin lesions of infected mice at the initial stages of infection and 
found increased parasite survival in host cells from TLR4-deficient mice, which 
correlates with a higher activity of arginase. However, TLR4 does not seem important 
to define the range of cytokines produced in the skin or in the draining lymph nodes of 
mice infected with L. major (Antoniazi et al., 2004). It was described in L. pifanoi 
amastigotes a potential ligand for TLR4, the proteoglycolipid complex (P8) composed 
of a cysteine and serine metalloprotease, host-derived ApoE, and four glycolipids. 
Stimulation of MØ with complex P8 or its isolated glycolipids provoked the synthesis 
of pro-inflammatory cytokines, including IL-1β and TNF-α (Whitaker et al., 2008). 
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However, the exact molecular entity serving as the TLR4 ligand in P8 complex still 
remains to be determined and the role for TLR4 in Leishmania infection is still not fully 
understood. TLR9 stimulation with CpG motifs was described to induce 
pro-inflammatory cytokines synthesis, in particular of IL-12, indicating that TLR9 
stimulation could lead to protective immunity against the parasite. Liese et al. (2007) 
showed that TLR9 was required to induce IL-12 in bone marrow derived DCs by either 
L. major or its DNA. Furthermore, it was also observed that TLR9
−/− 
mice exhibited 
more severe skin lesions and higher parasite burdens compared to controls, coupled 
with a transient increase in IL-4, IL-13, and arginase. In another study, it was reported 
that plasmacytoid DCs responded to L. infantum by secreting IFN-α and β and IL-12 in 
a TLR9 dependent manner and that NK induced cytotoxicity was abolished in TLR9
−/− 
mice (Schleicher et al., 2007). Those results were the first to link TLR9, IL-12, and DCs 
to the activation of NK cells during VL. The protective role of NK cells in murine 
leishmaniasis is now proven to be strictly dependent on IL-12 secreted by myeloid DCs 
in response to Leishmania via TLR9, proven that TLR9 is important in protection 
against Leishmania. The present work constitutes the first report of the innate immune 
response exhibited by canine hepatocytes in the presence of L. infantum. Taking 
together, the majority of the above described studies were performed in MØ of several 
host species that makes difficult a comparison with hepatocytes. MØ constitute the final 
host cell for Leishmania, but the parasite or parts of it may yet contact with other non-
immune cells, as hepatocytes. Recently in a canine study, increased frequency and 
expression of TLR9 was associated with a lower parasite load in the jejunum of L. 
infantum infected dogs, whereas the colon showed a higher parasite load along with an 
increased frequency and expression of TLR2 (Figueiredo et al., 2014). Hosein et al. 
(2015) addressed the role of TLRs in the canine model of VL caused by L. infantum. 
The authors analyzed several tissues, including the liver, where they describe increased 
TLR2 transcription and TLR9 downregulation. However, the study is not conclusive 
and the analysis was performed with whole liver tissue and not isolated cells. In the 
present study, increase gene expression of TLR2 seems to confirm previous findings 
that in fact TLR2 a have a non negligible role in Leishmania infection, and in particular 
in L. infantum infection of the canine liver. TLR9 exhibited an increasing tendency in 
2D cultured hepatocytes exposed to L. infantum. Nevertheless, the increase TLR2 and 
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the tendency to increase TLR9 gene expression was concomitant with pro-inflammatory 
IL-6 and TNF-α increased expression suggesting a synergistic model in hepatocyte 
activation. Curiously in the 3D culture system only occurred the increase in TLR2 and 
no major alterations in cytokine profile were observed. From the close interaction of 
parasites with hepatocyte membrane in the 2D culture system it is possible that a 
synergistic effect of both NOD1 and NOD2 with TLR2, in conjugation with a possible 
TLR9 stimulation lead to the activation of hepatocytes to produce inflammatory 
cytokines IL-6 and TNF-α, breaking the immune tolerance that characterizes the liver 
tissue and initiating a protective immune response. The results indicate that hepatocytes 
are active cells in innate immune surveillance and that are able to initiate an immune 
response. Throughout the present study, several outliers were registered as a reflex of 
the dog’s natural population. The dogs included in the present study were collected 
from a natural population with no restrictions of breed and sex, in order to reflect the 
natural diversity of the population. It is interesting to notice, that it is described that 
some dogs are more resistant to L. infantum infection than others and the outliers 
identified support that hypothesis. However, genetic associations are not yet fully 
defined. 
The liver is also a major metabolic organ and CYP450s constitute the major drug 
metabolizing enzymes in the liver. These enzymes are responsible for the 
metabolization of endogenous molecules such as hormones and exogenous and 
potentially harmful compounds. CYPs are particularly important in the pharmacological 
industry as induction/inhibition of CYPs is one of the factors that can affect the 
pharmacokinetics of a drug molecule upon multiple dosing, and it can result in 
pharmacokinetic drug-drug interactions with co-administered drugs causing potential 
therapeutic failures. Canine hepatocytes, and thus canine CYP450, have been used by 
the pharmaceutical industry to study the pharmacokinetics of new drugs in order to 
predict drug interaction based on enzymes homology between dogs and human. By 
doing so, canine CYPs are well documented and, as in humans, the canine enzymes 
typically display high interindividual variability in expression and function, as a 
consequence of the balance between enzyme induction/inhibition and of genetic 
polymorphism, thereby predisposing patients to adverse drug reactions or therapeutic 
failure (Court, 2013). As CYP450 are functionally important for organism survival it is 
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interesting to investigate their presence in invading pathogens. Curiously, L. donovani 
genome database annotates 3 CYP450s in Leishmania, nevertheless the functional role 
of cytochrome P450 enzymes in Leishmania spp. remains elusive. Verma et al. (2011) 
reported the involvement of one effective CYP450s, the CYP5122A1 in the survival 
and synthesis of ergosterol in L. donovani parasite. The importance of CYP5122A1 for 
parasite survival indicates this enzyme for further evaluation as a possible drug target.  
 The present work addresses the question whether L. infantum amastigotes or 
promastigotes influence the activity of canine hepatocytes’ CYPs (CYP1A1, CYP1A2, 
CYP2B11, CYP3A12, CYP3A26 and CYP1B) by altering the immune environment. 
Both culture systems showed a pattern of preserve or reduction of CYPs activity when 
in the presence of L. infantum amastigotes or promastigotes. 2D-cultured hepatocytes 
incubated with LPS, as a positive control for inflammation, also evidence a similar 
tendency. It has been described that the immune environment can influence CYPs 
activity. The present work constitutes the first report on inflammation caused by L. 
infantum presence and influence on canine hepatic CYPs activity. As dogs constitute the 
peridomestic reservoir of the parasite, understanding how the major metabolic enzymes 
of the liver react in the presence of the parasite, might be useful to predict drug 
metabolization during treatment. The first indications of an interaction between the host 
immune system and hepatic drug metabolizing enzymes arise from studies using 
modulators of the reticuloendothelial system (RES), which includes KCs. In 1953, 
Samaras and Dietz reported that rats injected with the RES depressant trypan blue had 
prolonged pentobarbital sleeping times (Samaras and Dietz, 1953). Due to the clinical 
importance of understanding the CYP450 mechanisms of inhibition or induction, 
several studies were performed since then. In humans and animals, infections or 
inflammatory stimuli cause changes in the expression and activity of various forms of 
liver CYP450, as well as in extrahepatic tissues such as kidney and brain. However the 
effects are not uniform for all CYPs. In most cases, CYP450s activities are suppressed, 
but some are unaffected and others are induced under inflammatory conditions. 
CYP450 suppression can result in increased clinical toxicity of drugs with a low 
therapeutic index (Morgan, 1997). Likewise, some drugs must be converted to their 
pharmacological or toxicological active metabolites by CYP450 enzymes, and 
suppression of their metabolism during an inflammatory response can lead to a reduced 
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therapeutic or toxic effect (Morgan, 1997). On the other hand, the CYP4A and CYP2E1 
families in Wistar rats are described to be induced by inflammatory stimuli such as LPS 
(Morgan, 1997). The results of the present study revealed that the presence of L. 
infantum increased the gene expression of the inflammatory cytokine IL-6 and TNF-α 
by canine hepatocytes, directing hepatic CYPs to a pro-inflammatory immune 
environment, and as a consequence, decreasing their activity. However, the 
inflammation is also balance by the expression of IL-10, that promotes tolerance to the 
parasite and may avoid that CYPs activity decrease, remaining similar to the control 
(non-exposed hepatocytes). Inhibition of CYPs by inflammation was particularly 
evident in the case of BROD (CYP2B11, CYP3A12 and CYP3A26) and phase II UGT 
for hepatocytes cultured in the 2D system and EROD (CYP1A1 and CYP1A2) and 
MROD (CYP1A2 and CYP1B) for the hepatocytes cultured as spheroids. Interestingly, 
exposition to L. infantum, especially to amastigotes reduced the levels of BROD 
metabolization, as well as the phase II UGT, deeper than LPS in 2D-cultured 
hepatocytes. These observations are in concordance with what is described in literature. 
In a given infection, the innate immune system is activated via TLRs and NODs 
receptors and, as previously discussed L. infantum presence activates NOD1 and TLR2 
of individual hepatocytes associated with the generation of IL-10 and TNF-α and TLR2 
in aggregated hepatocytes. The liver responds to infection by increasing acute phase 
proteins and concomitantly downregulating liver specific proteins involved in drug 
metabolism (Morgan, 1997; Aitken et al., 2006). CYPs are downregulated by infection 
and inflammatory stimuli and the rapid reduction of CYP mRNAs has led to consider 
transcription as the primary mechanism (Morgan, 1997). This hypothesis is supported 
by the magnitude and speed of transcriptional downregulation as demonstrated in rats in 
vivo (Cheng et al., 2003). In humans, this downregulation is associated with decreased 
drug clearance and can result in increased incidence of drug toxicity (Aitken and 
Morgan, 2007). It is also important to investigate this possibility in veterinary medicine 
as dogs are more often treated for canine leishmaniasis. Understand that canine 
hepatocytes are also influenced by the inflammatory response may help to better direct 
the treatment. According to Aitken and Morgan (2007), three lines of evidence support 
a major role of inflammatory cytokines as the mediators of CYP regulation in the liver 
during inflammation. First, cytokines can deregulate CYP expression in cultures of 
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rodent and human hepatocytes; secondly, mice with null mutations in cytokine or 
cytokine receptor genes display less CYP downregulation in response to some 
inflammatory stimuli and finally CYP dependent drug clearance has been correlated 
inversely with plasma levels of IL-6 in tumor human patients. However, the reason for 
the inflammatory process to be able to downregulate CYPs remains in discussion. 
Despite the possibility that downregulation of P450 constitutes a pathophysiological 
consequence of inflammatory processes, there are three major properties of CYP450 
that offer a possible explanation for the organism find advantageous to suppress hepatic 
CYP450 enzymes during inflammation. The first came from models of inflammation 
(such as injection of LPS or a model of bacterial sepsis) that induce iNOS and, by doing 
so causing reduction of cellular glutathione available in the hepatocyte (Harbrecht et al., 
1997). Reaction of NO with superoxide (from CYP450s) generates the highly reactive 
peroxynitrite, which can result in protein oxidation and nitration reactions, and 
depletion of reduced glutathione would render the cell more susceptible to oxidative 
stress. Thus, CYP450 downregulation could be a mechanism to protect the cell from the 
deleterious effects of oxidizing species (Aitken and Morgan, 2007). Also, the CYPs 
suppression would allow cells to allocate all the energy resources in the protein 
producing machinery to the inflammatory response in order to rapidly control the 
invading pathogen. Another reason for downregulation of CYP450 enzymes in the liver 
during inflammation could be related to the ability of hepatocytes regulate NO, by 
producing an extra burst of NO or reducing its production, attenuating the immune 
response (Aitken and Morgan, 2007). In the present study, the parasite did not stimulate 
NO production by dog hepatocytes. So, the most probable cause for the observed 
CYP450 decrease in activity is related to the generated cytokines. Milosevic et al. 
(1999) evaluated the responses of hepatocytes co-cultured with KCs in comparison with 
hepatocytes cultured alone, showing that suppression of phenobarbital-induced 
CYP2B1 mRNA by LPS was mediated by TNF-α release from KCs. Therefore, is 
possible to hypothesize that the response of isolated hepatocytes is limited when 
compared with the total potential of a complete coordinated organ response. Even so, 
isolated hepatocytes exhibited a similar response to what would happen in the whole 
organ. Samant et al. (2003) assessed the metabolism of the hamster liver infected with 
L. donovani. A significant decrease in the level of CYP450 was observed concomitantly 
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with the maximum parasite load in the liver. The decrease in CYP450 level was 
accompanied by a significant increase of liver enzymes and tissue degeneration. The 
impairment in CYP450 metabolism was isoezyme-specific and associated with the 
induction of iNOS. Interestingly, treatment of the infected animals with a combined 
therapy showed reduction in parasite load and reverted CYP450 impairment closed to 
normal values. Regarding phase II liver enzymes the assessed UDP-glucuronosyl 
transferases are the key enzymes in the formation of glucuronide conjugates, 
constituting the most important detoxification pathway of the Phase II drug metabolism 
in all vertebrates. In humans, approximately 40–70% of all clinical drugs are subjected 
to glucuronidation reactions metabolized by UGTs (Wells et al., 2004). UGT enzymes 
are responsible for the metabolism of many xenobiotics and endobiotics (e.g.: bilirubin, 
steroid hormones and fat-soluble vitamins) (Jancova et al., 2010). These enzymes can 
also be induced by several drugs as analgesics, antivirals and anticonvulsants, which 
may act as putative UDP-glucuronosyltransferase inducers in humans. However, their 
role in inflammation is not yet completed described and is poorly exploited. In the 
present work UGT activity was found to be reduced in hepatocytes exposed to 
inflammatory stimuli such as L. infantum amastigotes, promastigotes or LPS. The most 
probable cause of inflammatory environment reduction is the presence of IL-6 and 
TNF-α. In order to keep the balance, phase I and phase II enzyme metabolization rate 
should be coordinated, as imbalance may lead to the accumulation of potentially 
harmful products. In the present situation, the decrease of CYP450 was accompanied by 
the metabolization reduction or stabilization by phase II UGT in order to keep the 
balance in the hepatocytes.  
Beyond inflammation, another factor such as age, sex and polymorphisms can 
also influence CYPs metabolizing rate. The canine population included in this study did 
not have restriction on sex and age (preference was made for young adults) and 
polymorphism were not assessed although there are two important CYP polymorphism 
described in dogs. Sex influences a number of pharmacokinetically important 
parameters, including body weight, fat distribution, liver blood flow, as well as 
expression of drug metabolizing enzymes and transporters (Beierle et al., 1999). 
Sex-specific expression of CYP450 are common in laboratory animals including rats 
and mice and was shown to be controlled by the different secretion profiles of growth 
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hormone in female versus male animals (Dhir and Shapiro, 2003). Most clinical studies 
indicate that women metabolize drugs more quickly than men. This is particularly the 
case of substrates as erythromycin, midazolam or verapamil for the major drug 
metabolizing CYP450, the CYP3A4 (Cotreau et al., 2005). Age is also a 
well-established influential factor for drug metabolism capacity, particularly at the 
extremes of life, where drug metabolism capacity appears to be substantially lower 
(Zanger and Schwab, 2013). Polymorphisms have also been identified as to be able to 
impact in CYPs metabolization. The most comprehensively studied of canine CYP 
genetic polymorphism is the premature stop codon mutation (c.1117C>T; R373X) 
located in the coding region of the CYP1A2 gene that results in complete loss of hepatic 
CYP1A2 protein and associated enzyme activity (Tenmizu et al., 2004). However, 
animals that had at least one normal CYP1A2 copy (heterozygotes) did not have 
substantially different drug metabolization from the wild-type dogs. Other canine CYPs 
with known genetic polymorphisms include CYP2C41 (gene deletion), as well as 
CYP2D15, CYP2E1, and CYP3A12 (coding SNPs). However, the impact of these 
variants on drug metabolism in vitro or on drug pharmacokinetics is unknown (Court, 
2013). Other factors that can influence the CYP450 activities are related to food intake 
and also to disease state. As discussed above, during infection, inflammation and 
cancer, circulating pro-inflammatory cytokines such as IL-1β, TNF-α and IL-6, which 
act as signaling molecules to elicit marked changes in liver gene expression profiles, 
lead to severe downregulation of many drugs metabolizing enzymes (Aitken et al., 
2006). 
In the present work were tested three potential new leishmanicidal compounds 
isolated from natural sources: ursolic acid, chalcone-8 and quercetin. The ursolic acid 
(URA) used in the present study was extracted from Petiveria alliaceae 
(Phytolaccaceae). URA is a triterpenoid compound that widely occurs in nature in the 
free acid form or as an aglycone precursor for triterpenoid saponins (Liu, 1995). URA 
diversity is highly associated with the broad range of pharmacological effects, and 
different studies already showed that these compounds were effective against L. major, 
L. donovani, L. infantum, L. amazonensis, L. mexicana, L. braziliensis and L. 
panamensis, suggesting that these classes of compounds present strong leishmanicidal 
activity (da Silva Filho et al., 2009; Inocêncio da Luz et al., 2011; Passero et al., 2011). 
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However, the mechanism of action of this compound is not yet described, but appears to 
be directed to amastigote forms of the parasite (Passero et al., 2011). Chalcone is an 
aromatic ketone and an enone that forms the central core for a variety of important 
biological compounds, which are known collectively as chalcones or chalconoids. 
Several chalcones have been described as potential leishmanicidal compounds against 
promastigotes of L. braziliensis, L. amazonensis, L. donovani, L. infantum, L. major and 
L. enrietti (Borges-Argáez et al., 2007; Andrighetti-Fröhner et al., 2009; de Mello et al., 
2014). In some cases, the estimate leishmanicidal activity is even superior to the 
standard drug (Boeck et al., 2006). However, the toxicity is variable between the 
chalcone analogous. In the present study, a synthetic analogue of a natural occurring 
chalcone, the chalcone-8, isolated from Piper aduncum (Silva, 2014) was used against 
L. infantum amastigotes in culture with hepatocytes. The third compound was quercetin, 
a flavonoid. This compound is naturally present in several plants and was isolated from 
Kalanchoe pinnata (Muzitano et al., 2006). In nature, quercetin is found in its 
glycosidated form, quercitrine, and is during digestion that is transformed in quercetin. 
This flavonoid has been associated with the inhibition of MRP1 transporter in cancer 
cells (Leslie et al., 2001), efflux pumps in fungus (Roohparvar et al. 2007) and recently 
inhibition of arginase in L. amazonenis (Manjolin et al., 2013). Leishmanicidal activity 
on promastigotes of L. donovani (Mittra et al., 2000) and L. amazonensis (Montrieux et 
al., 2014) have recently proved, and its administration in conjugation with other drugs 
also have been investigated (Sen et al., 2005). Torres-Santos et al., (2003) presented a 
clinical case where the cutaneous lesion was reverted with the application of quercetin. 
However, due to some problems with delivery and potential complexation with other 
compounds, the incorporation of these compounds in nanoparticle formulations has also 
been investigated (Das et al., 2013). Meglumine antimoniate (MgA) is a classical 
leishmanicidal drug belonging to the pentavalent antimonial class. In this study, it was 
used a commercial version, Glucantime®. MgA mechanism of action is still not fully 
understood. Initial studies suggested that antimonials inhibit the biosynthesis of 
macromolecules in the amastigotes, possibly by perturbing the energy metabolism 
caused by the inhibition of glycolysis and fatty acid beta-oxidation. Sodium 
stibogluconate, another antimonial formulation, specifically inhibits type I DNA 
topoisomerase, thus reducing unwinding and cleavage. A similar mechanism is also 
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described for MgA (Lucumi et al., 1998). In the present study these four leishmanicidal 
compounds were added to hepatocytes exposed to L. infantum amastigotes for a long 
period (72 h). The results corroborate what has been described in literature for the new 
leishmanicidal compounds. All new drugs (URA, CH-8 and QC) quickly (in 5 h after 
drug contact) decrease amastigote viability to to non-detectable levels, constituting 
promising leishmanicidal drugs, probably more effective than MgA. Hepatocyte 
viability was not affected even after a long period of contact with the drugs, making the 
new compounds real hopeful drugs. The addition of leishmanicidal drugs impacts the 
immune response exhibited by hepatocytes at cytokine generation and at innate immune 
receptor gene expression. Curiously, MgA treatment increases NOD2, TLR2 and TLR4 
gene expression and generates IL-10. This coincides with MgA accentuated 
leishmanicidal activity. These findings may suggest that amastigote killing ensure the 
exposition of hepatocytes to new antigens, affecting the immune response. In the 
3D-culture system also treated with MgA, augments of NOD1, NOD2, TLR2 and TLR9 
found, highlighting the importance of innate immune receptors in controlling the 
immune response. In this case, IL-10 registered increased gene expression. URA, Ch-8 
and QC also increase NOD1 and TLR2 gene expression during the treatment, but TLR2 
and TLR9 was kept at similar levels as before treatment. The addition of these 
compounds also changed the cytokine profile, IL-10 gene expression was increased, but 
IL-6 and TNF-α was kept at similar levels as before treatment. These findings highlight 
the importance of NOD1 and TLR2 in sensing L. infantum in the liver. The role of 
TLR4 and TLR9, however, seem more difficult to define.  
As TNF-α, the major inflammatory cytokine exhibited a tendency to decreased 
expression over incubation time with leishmanicidal drugs and the generation of IL-10 
to control immune homeostasis, produced an immunological environment propitiate to 
CYPs regain their activity. CYPs appear also to be involved in the metabolization of the 
added drugs, as enzymes presented an induced activity. Understanding what are the 
CYPs that metabolize the used drugs are important in order to avoid future drug-to-drug 
interaction. CYP1A1 and CYP1A2 (measured in EROD assay) and CYP2B11 
(measured in PROD) were increased in all the testes drugs in the first 24 h, specially by 
MgA and URA. CYP1A2 and CYP1B (measured in MROD assay) were highly induced 
by the administration of MgA, indicating that this compound (or a metabolite derivated 
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from it) probably is metabolized by these two CYP450. CYP2B11, CYP3A12 and 
CYP3A26 (measured in BROD assay) were highly induced by MgA. Using the 
described homology between species, it is possible to infer that the some drugs, 
including MgA and URA, will be probable metabolized by human CYP3A4. This 
information is particularly valuable because human CYP3A4 is the CYP450 responsible 
for the metabolization of the majority of clinically used drugs and by that some drug-
to-drug interaction may be observed or impairment of treatment if administered in 
simultaneous with other drugs (Zanger and Schwab, 2013). However, the products of 
phase I metabolism are potentially more toxic than the original molecules, which does 
not present a problem if the phase II enzymes are functioning at a rate to rapidly 
neutralize the phase I products as they are formed. This was observed as all the added 
drugs induced phase II UGT enzyme. However, CH-8 and QC induced the higher 
increase in UGT activity, indicating that these compounds probably during 
metabolization probable generate some toxic intermediates that induced phase II 
functioning at a rate to rapidly neutralize them. Factors which increase the ratio of phase 
I to phase II activity can upset this delicate balance, producing harmful metabolites 
faster than they can be detoxified, and increasing the risk of cellular damage (Jancova et 
al., 2010). In the 3D-system the exposition to promastigotes followed by the addition of 
MgA induced some morphological alteration on hepatocytes, as evidenced by SEM. 
Hepatocyte membrane became rough and full of vesicles. However, the initially added 
L. infantum promastigotes were found to be transformed into amastigotes and remain 
permanently attached to the hepatocyte membrane in low concentrations, compared to 
the 2D-culture system. Barak et al. (2005) reported the development of host-free 
differentiation systems for L. donovani. Previous studies indicated that concomitant 
exposure to elevated temperatures and acidic pH signals promastigotes to differentiate 
into amastigotes (Saar et al., 1998; Debrabant et al., 2004). In this study, the authors 
determined the time course of L. donovani differentiation and assessed the role of 
several parameters. The major observations were: (1) morphological transformation to 
amastigote-shaped cells initiates 5 h after the signal, (2) differentiation occurs 
synchronously, while cells arrest at G1, (3) heat induces the cell cycle arrest in 
promastigotes, (4) subsequently, acidic pH resumed growth and route promastigotes to 
differentiate into amastigotes and (5) modulators of heat shock can replace heat in the 
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differentiation signal. In the present study, promastigotes added to the hepatocytes were 
observed to lose their mobility and gain an oval shape characteristic of amastigotes. 
Taking this together, it is possible that L. infantum parasites promastigotes, incubated at 
37 ºC in contact with cells and were transformed into amastigotes or amastigote-like 
forms.  
Since the liver constitutes a major metabolic organ, impairment of liver 
functions may have great impact on individual health. Hepatocyte culture, although not 
represents the full complexity of the liver or of the organism constitutes effective tools 
contributing to understanding how hepatocytes can activate and orchestrate an immune 
response and react to L. infantum parasites, testing of new leishmanicidal drugs, 








In summary, the main conclusions raised in this chapter are the following:  
– To the best of our knowledge, this constitutes the first study that investigates 
in vitro the immune response exhibited against L. infantum parasites by 
canine hepatocytes; 
– Although this study presented some evidences that L. infantum parasite can 
be internalized by canine hepatocytes, they were not enough to be conclusive; 
– Dog hepatocyte 2D- and 3D-culture systems evidence similar metabolic and 
immune parameters when challenged with L. infantum parasites, being good 
in vitro models for the evaluation of drug efficacy and toxicity; 
– Dog hepatocytes react to L. infantum by increasing ferritin accumulation, 
making difficult the acquisition of iron by the parasite; 
– Dog hepatocytes recognize L. infantum parasites by activation of NOD1 and 
NOD2 receptors and by a possible synergistic effect with TLR2. Amastigotes 
seem to induce higher NOD1 expression than promastigotes.  
– L. infantum direct hepatocytes to generate pro- and anti-inflammatory 
cytokines ensuring the immune tolerance that characterizes the liver tissue; 
– Inflammation caused by the presence of the parasite induces the decrease of 
phase I CYP450s and phase II enzymes, in accordance with the literature.  
– The new leishmanicidal drugs, ursolic acid, chalcone-8 and quercetin, 
revealed good hepatic tolerance and good leishmanicidal activity, comparable 
to the commercial meglumine antimoniate;  
– The tested drugs induced an increase in phase I CYP450, indicating a 
possibility of some the drugs being metabolized by the assessed enzymes, as 
meglumine antimoniate and ursolic acid; 
– When in the presence of parasites, all leishmanicidal drugs used in this study 
stimulates hepatocytes to generate IL-10, preserving immune homeostasis 
and ensuring parasite tolerance. 




Adamec J, Rusnak F, Owen WG, Naylor S, Benson LM, Gacy AM, Isaya G. 2000. 
Iron-dependent self-assembly of recombinant yeast frataxin: implications for Friedreich ataxia. 
Am J Hum Genet. 67(3):549-62.  
Adamec J, Rusnak F, Owen WG, Naylor S, Benson LM, Gacy AM, Isaya G, Agius L. 
2008. Glucokinase and molecular aspects of liver glycogen metabolism. Biochem J. 414(1):1-
18. 
Agius L. 2008. Glucokinase and molecular aspects of liver glycogen metabolism. 
Biochem J. 414(1):1-18. doi: 10.1042/BJ20080595. 
Aitken AE, Richardson TA, Morgan ET. 2006. Regulation of drug-metabolizing 
enzymes and transporters in inflammation. Annu Rev Pharmacol Toxicol. 46:123-49. 
Aitken AE, Morgan ET. 2007. Gene-specific effects of inflammatory cytokines on 
cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes. Drug Metab 
Dispos.35(9):1687-93.  
Akira S, Takeda K. 2004. Toll-like receptor signalling. Nat Rev Immunol. 4:499-511. 
Alexander B. 1998. The role of nitric oxide in hepatic metabolism. Nutrition. 14(4):376-
90. 
Andrighetti-Fröhner CR, Oliveira KN, Gaspar-Silva D, Pacheco LK, Joussef AC, 
Steindel M, Simões CMO, Souza AMT, Magalhães UO, Afonso IF, Rodrigues CR, Nunes RJ, 
Castro HC. 2009. Synthesis, Biological Evaluation and SAR of Sulfonamide 4-
Methoxychalcone Derivatives with Potential Antileishmanial Activity. European Journal of 
Medicinal Chemistry 44: 755–763.  
Antoniazi S, Price HP, Kropf P, Freudenberg MA, Galanos C, Smith DF, Müller I. 
2004. Chemokine gene expression in toll-like receptor-competent and -deficient mice infected 
with Leishmania major. Infect Immun. 72(9):5168-74. 
Anzenbacher P, Anzenbacherová E. 2001. Cytochromes P450 and metabolism of 
xenobiotics. Cell Mol Life Sci. 58(5-6):737-47. 
Bandmann O, Vaughan J, Holmans P, Marsden CD, Wood NW.1997. Association of 
slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease. Lancet. 
350(9085):1136-9. 
4 | Chapter 1 
 
230 
Barak E, Amin-Spector S, Gerliak E, Goyard S, Holland N, Zilberstein D. 2005. 
Differentiation of Leishmania donovani in host-free system: analysis of signal perception and 
response. Mol Biochem Parasitol. 141(1):99-108. 
Barch DH, Rundhaugen LM, Pillay NS. 1995. Ellagic acid induces transcription of the 
rat glutathione S-transferase-Ya gene. Carcinogenesis. 16:665-668. 
Becker I, Salaiza N, Aguirre M, Delgado J, Carrillo-Carrasco N, Kobeh LG, Ruiz A, 
Cervantes R, Torres AP, Cabrera N, González A, Maldonado C, Isibasi A. 2003. Leishmania 
lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2. Mol Biochem 
Parasitol. 130(2):65-74. 
Beierle I, Meibohm B, Derendorf H. 1999. Gender differences in pharmacokinetics and 
pharmacodynamics. Int J Clin Pharmacol Ther 37, 529–547. 
Ben-Othman R, Flannery AR1, Miguel DC1, Ward DM2, Kaplan J2, Andrews NW1. 
2014. Leishmania-mediated inhibition of iron export promotes parasite replication in 
macrophages. PLoS Pathog. 10(1):e1003901. doi: 10.1371/journal.ppat.1003901. 
Boeck P, Falcão CAB, Leal PC, Yunes RA, Filho VC, Torres-Santos EC, Rossi-
Bergmann AC. 2006. Synthesis of Chalcone Analogues with Increased Antileishmanial 
Activity. Bioorganic & Medicinal Chemistry 14: 1538–1545.  
Borges-Argáez R, Balnbury L, Flowers A, Giménez-Turba A, Ruiz G, Waterman PG, 
Peña-Rodríguez LM. 2007. Cytotoxic and antiprotozoal activity of flavonoids from 
Lonchocarpus spp. Phytomedicine. 14(7-8):530-3.  
Burchmore RJ, Barrett MP. 2001. Life in vacuoles--nutrient acquisition by Leishmania 
amastigotes. Int J Parasitol. 31(12):1311-20. 
Cai Y, Baer-Dubowska W, Ashwood-Smith MJ, Ceska O, Tachibana S, DiGiovanni 
J.1996. Mechanism-based inactivation of hepatic ethoxyresorufin O-dealkylation activity by 
naturally occurring coumarins. Chem Res Toxicol. 9(4):729-36. 
Campos MA1, Almeida IC, Takeuchi O, Akira S, Valente EP, Procópio DO, Travassos 
LR, Smith JA, Golenbock DT, Gazzinelli RT. 2001. Activation of Toll-like receptor-2 by 
glycosylphosphatidylinositol anchors from a protozoan parasite. J Immunol. 167(1):416-23. 
Celton-Morizur S, Desdouets C. 2010. Polyploidization of liver cells. Adv Exp Med 
Biol. 676:123-35. 
4 | Chapter 1 
 
231 
Chakraborty P, Ghosh D, Basu MK. 2001. Modulation of macrophage mannose 
receptor affects the uptake of virulent and avirulent Leishmania donovani promastigotes. J. 
Parasitol. 87(5): 1023–7. 
Charlton MR. 1996. Protein metabolism and liver disease. Baillieres Clin Endocrinol 
Metab.10(4):617-35.  
Chamaillard M, Hashimoto M, Horie Y, Masumoto J, Qiu S, Saab L, Ogura Y, 
Kawasaki A, Fukase K, Kusumoto S, Valvano MA, Foster SJ, Mak TW, Nuñez G, Inohara N. 
2003. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing 
diaminopimelic acid. Nat Immunol. 4(7):702-7. 
Chang CS, Chang KP.1985. Heme requirement and acquisition by extracellular and 
intracellular stages of Leishmania mexicana amazonensis. Mol Biochem Parasitol. 16(3):267-
76. 
Cheng PY, Wang M, Morgan ET. 2003. Rapid transcriptional suppression of rat 
cytochrome P450 genes by endotoxin treatment and its inhibition by curcumin. J Pharmacol 
Exp Ther. 307:1205–1212. 
Coban C, Ishii KJ, Kawai T, Hemmi H, Sato S, Uematsu S, Yamamoto M, Takeuchi O, 
Itagaki S, Kumar N, Horii T, Akira S. 2005. Toll-like receptor 9 mediates innate immune 
activation by the malaria pigment hemozoin. J Exp Med. 201(1):19-25. 
Cotreau M M, Von Moltke L L, Greenblatt D J. 2005. The influence of age and sex on 
the clearance of cytochrome P450 3A substrates. Clin Pharmacokinet 44, 33–60. 
Court H. 2013. Canine cytochrome P450 (CYP) pharmacogenetics. Vet Clin North Am 
Small Anim Pract. 43(5): 1027–1038. doi: 10.1016/j.cvsm.2013.05.001. 
Da Silva Filho AA, Resende DO, Fukui MJ, Santos FF, Pauletti PM, Cunha WR, Silva 
ML, Gregório LE, Bastos JK, Nanayakkara NP. 2009. In vitro antileishmanial, antiplasmodial 
and cytotoxic activities of phenolics and triterpenoids from Baccharis dracunculifolia D. C. 
(Asteraceae). Fitoterapia. 80(8):478-82. 
Daly AK, Cholerton S, Gregory W, Idle JR. 1993. Metabolic polymorphisms. 
Pharmacol Ther. 57(2-3):129-60. 
Das S, Das J, Samadder A, Bhattacharyya SS, Das D, Khuda-Bukhsh AR. 2013. 
Biosynthesized silver nanoparticles by ethanolic extracts of Phytolacca decandra, Gelsemium 
sempervirens, Hydrastis canadensis and Thuja occidentalis induce differential cytotoxicity 
4 | Chapter 1 
 
232 
through G2/M arrest in A375 cells. Colloids Surf B Biointerfaces. 101:325-36. doi: 
10.1016/j.colsurfb.2012.07.008.  
Dayal M, Parmar D, Dhawan A, Dwivedi UN, Doehmer J, Seth PK. 1999. Induction of 
rat brain and liver cytochrome P450 1A1/1A2 and 2B1/2B2 isoenzymes by deltamethrin. 
Environ Toxicol Pharmacol. 7(3):169-78. 
De Mello TFP, Bitencourt HR, Pedroso RB, Aristides SMA, Lonardoni MVC, Silveira 
TGV. 2014. Leishmanicidal Activity of Synthetic Chalcones in Leishmania (Viannia) 
braziliensis. Experimental Parasitology 136: 27–34.  
De Veer MJ, Curtis JM, Baldwin TM, DiDonato JA, Sexton A, McConville MJ, 
Handman E, Schofield L. 2003. MyD88 is essential for clearance of Leishmania major: possible 
role for lipophosphoglycan and Toll-like receptor 2 signaling. Eur J Immunol. 33(10):2822-31. 
Debrabant A, Joshi MB, Pimenta PF, Dwyer DM. Generation of Leishmania donovani 
axenic amastigotes: their growth and biological characteristics. Int J Parasitol 2004;34:205–17. 
Denison MS, Whitlock JP Jr. 1995. Xenobiotic-inducible transcription of cytochrome 
P450 genes. J Biol Chem. 270:18175-18178. 
Dhir RN, Shapiro BH. 2003. Interpulse growth hormone secretion in the episodic 
plasma profile causes the sex reversal of cytochrome P450s in senescent male rats. Proc Natl 
Acad Sci U S A 100, 15224–15228. 
Drakesmith H, Schimanski LM, Ormerod E, Merryweather-Clarke AT, Viprakasit V, 
Edwards JP, Sweetland E, Bastin JM, Cowley D, Chinthammitr Y, Robson KJ, Townsend AR. 
2005. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of 
ferroportin. Blood. 106(3):1092-7. 
Duarte MI, Mariano ON, Corbett CE. 1989. Liver parenchymal cell parasitism in 
human visceral leishmaniasis. Virchows Arch A Pathol Anat Histopathol. 415(1):1-6. 
Elangovan V, Sekar N, Govindasamy S. 1994. Chemopreventive potential of dietary 
Ezekowitz RA, Williams DJ, Koziel H, Armstrong MY, Warner A, Richards FF, Rose 
RM. 1991. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. 
Nature. 351 (6322): 155–8. doi:10.1038/351155a0. 
Faria MS, Reis FC, Lima AP. 2012. Toll-like receptors in Leishmania infections: 
guardians or promoters? J Parasitol Res. 2012:930257. doi: 10.1155/2012/930257.  
4 | Chapter 1 
 
233 
Festa M, Ricciardelli G, Mele G, Pietropaolo C, Ruffo A, Colonna A. 2000. 
Overexpression of H ferritin and up-regulation of iron regulatory protein genes during 
differentiation of 3T3-L1 pre-adipocytes. J Biol Chem 275(47):36708 – 12. 
Figueiredo MM, Deoti B, Amorim IF, Pinto AJ, Moraes A, Carvalho CS, da Silva SM, 
de Assis AC, de Faria AM, Tafuri WL. 2014. Expression of regulatory T cells in jejunum, 
colon, and cervical and mesenteric lymph nodes of dogs naturally infected with Leishmania 
infantum. Infect Immun. 82(9):3704-12. doi: 10.1128/IAI.01862-14.  
Flannery AR, Huynh C, Mittra B, Mortara RA, Andrews NW. 2011. LFR1 ferric iron 
reductase of Leishmania amazonensis is essential for the generation of infective parasite forms. 
J Biol Chem. 286(26):23266-79. 
Galbraith RA, McElrath MJ. 1988. Heme binding to Leishmania mexicanaamazonensis. 
Mol Biochem Parasitol. 29(1):47-53. 
Gangneux JP, Lemenand O, Reinhard Y, Guiguen C, Guguen-Guillouzo C, Gripon P. 
2005. In vitro and ex vivo permissivity of hepatocytes for Leishmania donovani. J Eukaryot 
Microbiol.52(6):489-91. 
Gao B, Jeong WI, Tian Z. 2008. Liver: An organ with predominant innate immunity. 
Hepatology. 47(2):729-36. doi: 10.1002/hep.22034. 
Gazi U, Martinez-Pomares L. 2009. Influence of the mannose receptor in host immune 
responses. Immunobiology. 214 (7): 554–61. doi:10.1016/j.imbio.2008.11.004. 
Gentric G, Celton-Morizur S, Desdouets C. 2012. Polyploidy and liver proliferation. 
Clin Res Hepatol Gastroenterol. 36(1):29-34. doi: 10.1016/j.clinre.2011.05.011.  
Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, Philpott DJ, 
Sansonetti PJ. 2003. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide 
(MDP) detection. J Biol Chem. 278(11):8869-72.  
Glatt H.2000. Sulfotransferases in the bioactivation of xenobiotics. Chem Biol Interact. 
129(1-2):141-70. 
Gruys E, Toussaint MJM, Niewold TA, Koopmans SJ. 2005. Acute phase reaction and 
acute phase proteins. J Zhejiang Univ Sci B. 6(11): 1045–1056.doi: 10.1631/jzus.2005.B1045. 
Guengerich FP. 1984. Effects of nutritive factors on metabolic processes involving 
bioactivation and detoxification of chemicals. Ann Rev Nutr. 4:207-231 
4 | Chapter 1 
 
234 
Hagemeyer CE, Bürck C, Schwab R, Knoth R, Meyer RP.2010. 7-Benzyloxyresorufin-
O-dealkylase activity as a marker for measuring cytochrome P450 CYP3A induction in mouse 
liver. Anal Biochem. 398(1):104-11. doi: 10.1016/j.ab.2009.11.004.  
Harbrecht BG, Taylor BS, Xu Z, Ramalakshmi S, Ganster RW, Geller DA.2001. cAMP 
inhibits inducible nitric oxide synthase expression and NF-kappaB-binding activity in cultured 
rat hepatocytes. J Surg Res. 99(2):258-64. 
Haüssinger D. 1990. Nitrogen metabolism in liver: structural and functional 
organization and physiological relevance. Biochem J. 267(2):281-90. 
Heinrich PC, Behrmann I, Müller-Newen G, Schaper F, Graeve L. 1998. Interleukin-6-
type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J. 334 ( Pt 2):297-314. 
Hosein S, Rodríguez-Cortés A, Blake DP, Allenspach K, Alberola J, Solano-Gallego L. 
2015. Transcription of Toll-Like Receptors 2, 3, 4 and 9, FoxP3 and Th17 Cytokines in a 
Susceptible Experimental Model of Canine Leishmania infantum Infection. PLoS One. 
10(10):e0140325. doi: 10.1371/journal.pone.0140325.  
Husson A1, Brasse-Lagnel C, Fairand A, Renouf S, Lavoinne A. 2003. 
Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle. Eur J Biochem. 
270(9):1887-99. 
Huynh C, Sacks DL, Andrews NW. 2006. A Leishmania amazonensis ZIP family iron 
transporter is essential for parasite replication within macrophage phagolysosomes. J Exp Med. 
203(10):2363-75.  
Inocêncio da Luz RA, Vermeersch M, Deschacht M, Hendrickx S, Van Assche T, Cos 
P, Maes L. 2011. In vitro and in vivo prophylactic and curative activity of the triterpene saponin 
PX-6518 against cutaneous Leishmania species. J Antimicrob Chemother. 66(2):350-3. 
Inoue H, Ogawa W, Asakawa A, Okamoto Y, Nishizawa A, Matsumoto M, 
Teshigawara K, Matsuki Y, Watanabe E, Hiramatsu R, Notohara K, Katayose K, Okamura H, 
Kahn CR, Noda T, Takeda K, Akira S, Inui A, Kasuga M. 2006. Role of hepatic STAT3 in 
brain-insulin action on hepatic glucose production. Cell Metab. 3(4):267-75. 
Isogawa M, Robek MD, Furuichi Y, Chisari FV. 2005. Toll-like receptor signaling 
inhibits hepatitis B virus replication in vivo. J Virol. 79:7269-7272. 
Jacques I, Andrews NW, Huynh C. 2010. Functional characterization of LIT1, the 
Leishmania amazonensis ferrous iron transporter. Mol Biochem Parasitol. 170(1):28-36. 
4 | Chapter 1 
 
235 
Jancova P, Anzenbacher P, Anzenbacherova E. 2010. Phase II drug metabolizing 
enzymes. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 154(2):103-16. 
Johansson S, Forsberg E, Lundgren B.1987. Comparison of fibronectin receptors from 
rat hepatocytes and fibroblasts. J Biol Chem. 262(16):7819-24. 
Johnson RW. 1997. Inhibition of growth by pro-inflammatory cytokines: an integrated 
view. J Anim Sci. 75(5):1244-55. 
Kang YH, Berthiaume F, Yarmush ML. 2002. Long-term stable cultures of rat 
hepatocytes: an in vitro model to study acute and chronic hepatic inflammation. Tissue Eng. 
8(4):681-93. 
Koorts AM, Viljoen M. 2007. Ferritin and ferritin isoforms I: Structure-function 
relationships, synthesis, degradation and secretion. Arch Physiol Biochem. 113(1):30-54. 
Kovalovich K, DeAngelis RA, Li W, Furth EE, Ciliberto G, Taub R. 2000. Increased 
toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology. 31(1):149-
59. 
Kropf P, Freudenberg MA, Modolell M, Price HP, Herath S, Antoniazi S, Galanos C, 
Smith DF, Müller I. 2004. Toll-like receptor 4 contributes to efficient control of infection with 
the protozoan parasite Leishmania major. Infect Immun. 72(4):1920-8. 
Lee WM. 1995. Drug-induced hepatotoxicity. N Engl J Med. 333(17):1118-27. 
Leslie EM, Mao Q, Oleschuk CJ, Deeley RG, Cole SPC. 2001. Modulation of 
Multidrug Resistance Protein 1 (MRP1/ABCC1) Transport and ATPase Activities by 
Interaction with Dietary Flavonoids. Molecular Pharmacology 59:1171–1180. 
Liese J, Schleicher U, Bogdan C. 2007. TLR9 signaling is essential for the innate NK 
cell response in murine cutaneous leishmaniasis. Eur J Immunol. 37(12):3424-34. 
Liska DJ. 1998. The detoxification enzyme systems. Altern Med Rev. 3(3):187-98. 
Liu J. 1995. Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol. 
49(2):57-68. 
Loyer P, Ilyin G, Abdel Razzak Z, Banchereau J, Dezier JF, Campion JP, Guguen-
Guillouzo C, Guillouzo A. 1993. Interleukin 4 inhibits the production of some acute-phase 
proteins by human hepatocytes in primary culture. FEBS Lett. 336(2):215-20. 
4 | Chapter 1 
 
236 
Lu Y, Mo C, Zeng Z, Chen S, Xie Y, Peng Q, He Y, Deng Y, Wang J, Xie L, Zeng J, Li 
S, Qin X. 2013. CYP2D6*4 allele polymorphism increases the risk of Parkinson's disease: 
evidence from meta-analysis. PLoS One. 8(12):e84413. doi: 10.1371/journal.pone.0084413.  
Lucumi A, Robledo S, Gama V, Saravia NG. 1998. Sensitivity of Leishmania 
vianniapanamensis to pentavalent antimony is correlated with the formation of cleavable DNA-
protein complexes. Antimicrob Agents Chemother.42(8):1990-5. 
Luiking YC, Hallemeesch MM, van de Poll MC, Dejong CH, de Jonge WJ, Lamers 
WH, Deutz NE. 2008. Reduced citrulline availability by OTC deficiency in mice is related to 
reduced nitric oxide production. Am J Physiol Endocrinol Metab. 295(6):E1315-22. doi: 
10.1152/ajpendo.00055.2008.  
Luster MI, Germolec DR, Yoshida T, Kayama F, Thompson M. 1994. Endotoxin-
induced cytokine gene expression and excretion in the liver. Hepatology. 19(2):480-8. 
Ingelman-SundbergM . 2005. Genetic polymorphisms of cytochrome P450 2D6 
(CYP2D6): clinical consequences, evolutionary aspects and functional diversity. The 
Pharmacogenomics Journal. 5, 6–13. doi:10.1038/sj.tpj.6500285 
 
Manjolin LC, Reis MBG, Maquiaveli CC, Santos-Filho OA, Silva ER. 2013. Dietary 
Flavonoids Fisetin, Luteolin and Their Derived Compounds Inhibit Arginase, a Central Enzyme 
in Leishmania (Leishmania) amazonensis Infection. Food Chemistry 141: 2253–2262.  
Manson MM, Ball HW, Barrett MC, Clark HL, Judah DJ, Williamson G, Neal GE. 
1997. Mechanism of action of dietary chemoprotective agents in rat liver: induction of phase I 
and II drug metabolizing enzymes and aflatoxin B1 metabolism. Carcinogenesis. 18(9):1729-38. 
Maródi L, Korchak HM, Johnston RB.1991.Mechanisms of host defense against 
Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages. J. 
Immunol. 146 (8): 2783–9. 
Martignoni M, Groothuis GM, de Kanter R. 2006. Species differences between mouse, 
rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert 
Opin Drug Metab Toxicol. 2(6):875-94. 
Meyer UA, Zanger UM, Skoda RC, Grant D, Blum M. 1990. Genetic polymorphisms of 
drug metabolism. Prog Liver Dis. 9:307-23. 
Milosevic N, Schawalder H, Maier P. 1999. Kupffer cell-mediated differential down-
regulation of cytochrome P450 metabolism in rat hepatocytes. Eur J Pharmacol. 26;368(1):75-
87. 
4 | Chapter 1 
 
237 
Miranda JP, Leite SB, Muller-Vieira U, Rodrigues A, Carrondo MJ, Alves PM. 2009. 
Towards an extended functional hepatocyte in vitro culture. Tissue Eng Part C Methods. 
15(2):157-67. doi: 10.1089/ten.tec.2008.0352. 
Miranda JP, Rodrigues A, Tostões RM, Leite S, Zimmerman H, Carrondo MJ, Alves 
PM. 2010. Extending hepatocyte functionality for drug-testing applications using high-viscosity 
alginate-encapsulated three-dimensional cultures in bioreactors. Tissue Eng Part C 
Methods.16(6):1223-32. doi: 10.1089/ten.TEC.2009.0784.  
Mise M, Hashizume T, Komuro S. 2008. Characterization of substrate specificity of dog 
CYP1A2 using CYP1A2-deficient and wild-type dog liver microsomes. Drug Metab Dispos. 
36(9):1903-8.  
Mittra B, Andrews NW. 2013. IRONy OF FATE: role of iron-mediated ROS in 
Leishmania differentiation. Trends Parasitol. 29(10):489-96. doi: 10.1016/j.pt.2013.07.007.  
Mittra B, Cortez M, Haydock A, Ramasamy G, Myler PJ, Andrews NW. 2013. Iron 
uptake controls the generation of Leishmania infective forms through regulation of ROS levels. 
J Exp Med. 210(2):401-16. doi: 10.1084/jem.20121368.  
Mittra B, Saha A, Chowdhury AR, Pal C, Mandal S, Mukhopadhyay S, Bandyopadhyay 
S, Majumder HK. 2000. Luteolin , an Abundant Dietary Component Is a Potent Anti-
Leishmanial Agent That Acts by Inducing Topoisomerase II-Mediated Kinetoplast DNA 
Cleavage Leading to Apoptosis. Molecular Medicine 6: 527–541. 
Mizuhara H, O'Neill E, Seki N, Ogawa T, Kusunoki C, Otsuka K, Satoh S, Niwa M, 
Senoh H, Fujiwara H. 1994. T cell activation-associated hepatic injury: mediation by tumor 
necrosis factors and protection by interleukin 6. J Exp Med. 179(5):1529-37. 
Montrieux E, Perera WH, García M, Maes L, Cos P, Monzote L. 2014. In vitro and in 
vivo Activity of Major Constituents from Pluchea carolinensis against Leishmania 
amazonensis. Parasitology Research 113: 2925–2932.  
Morgan BP, Gasque P. 1997. Extrahepatic complement biosynthesis: where, when and 
why? Clin Exp Immunol. 107(1):1-7. 
Morgan ET. 1997. Regulation of cytochromes P450 during inflammation and infection. 
Drug Metab Rev. 29(4):1129-88. 
Morgan ET. 2001. Regulation of cytochrome p450 by inflammatory mediators: why and 
how? Drug Metab Dispos. 29(3):207-12. 
4 | Chapter 1 
 
238 
Mulero V, Brock JH. 1999. Regulation of iron metabolism in murine J774 
macrophages: role of nitric oxide-dependent and -independent pathways following activation 
with gamma interferon and lipopolysaccharide. Blood. 94(7):2383-9. 
Murray HW, Nathan CF. 1999. Macrophage microbicidal mechanisms in vivo: reactive 
nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania 
donovani. J Exp Med. 189(4):741-6. 
Murray HW. 1997. Endogenous interleukin-12 regulates acquired resistance in 
experimental visceral leishmaniasis. J Infect Dis. 175(6):1477-9. 
Murray HW. 2001. Tissue granuloma structure-function in experimental visceral 
leishmaniasis. Int J Exp Pathol. 82(5):249-67. 
Muzitano MF, Tinoco LW, Guette C, Kaiser CR, Rossi-Bergmann B, Costa SS. 2006. 
The Antileishmanial Activity Assessment of Unusual Flavonoids from Kalanchoe pinnata. 
Phytochemistry 67: 2071–2077.  
Nakagawa R, Naka T, Tsutsui H, Fujimoto M, Kimura A, Abe T, Seki E, Sato S, 
Takeuchi O, Takeda K, Akira S, Yamanishi K, Kawase I, Nakanishi K, Kishimoto. 2002. 
SOCS-1 participates in negative regulation of LPS responses. Immunity. 17(5):677-87. 
Nairaz M, Theurl I, Ludwiczek S, Theurl M, Mair SM, Fritsche G, Weiss G. 2007. The 
co-ordinated regulation of iron homeostasis in murine macrophages limits the availability of 
iron for intracellularSalmonella typhimurium. Cell Microbiol. 9:2126–2140. 
Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, Nebert DW. 2004. 
Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including 
nomenclature recommendations for genes, pseudogenes and alternative-splice variants. 
Pharmacogenetics. 14(1):1-18. 
Ogu CC, Maxa JL.2000. Drug interactions due to cytochrome P450.Proc (Bayl Univ 
Med Cent). 13(4):421-3. 
Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G. 2001. nod2, a 
Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol 
Chem. 276(7):4812-8. 
Ohnishi H, Oka K, Mizuno S, Nakamura T. 2012. Identification of mannose receptor as 
receptor for hepatocyte growth factor β-chain: novel ligand-receptor pathway for enhancing 
macrophage phagocytosis. J Biol Chem. 287(16):13371-81. doi: 10.1074/jbc.M111.318568.  
4 | Chapter 1 
 
239 
Oliveira AC, Peixoto JR, de Arruda LB, Campos MA, Gazzinelli RT, Golenbock DT, 
Akira S, Previato JO, Mendonça-Previato L, Nobrega A, Bellio M. 2004. Expression of 
functional TLR4 confers proinflammatory responsiveness to Trypanosoma cruzi 
glycoinositolphospholipids and higher resistance to infection with T. cruzi. J Immunol. 
173(9):5688-96. 
Panesar N, Tolman K, Mazuski JE. 1999. Endotoxin stimulates hepatocyte interleukin-6 
production. J Surg Res. 85(2):251-8. 
Paramchuk WJ, Ismail SO, Bhatia A, Gedamu L. 1997. Cloning, characterization and 
overexpression of two iron superoxide dismutase cDNAs from Leishmania chagasi: role in 
pathogenesis. Mol Biochem Parasitol. 90(1):203-21. 
Park BK, Kitteringham NR, Pirmohamed M, Tucker GT. 1996. Relevance of induction 
of human drug-metabolizing enzymes: pharmacological and toxicological implications. Br J 
Clin Pharmacol. 41(6):477-91. 
Passero LF, Bonfim-Melo A, Corbett CE, Laurenti MD, Toyama MH, de Toyama DO, 
Romoff P, Fávero OA, dos Grecco SS, Zalewsky CA, Lago JH. 2011. Anti-leishmanial effects 
of purified compounds from aerial parts of Baccharis uncinella C. DC. (Asteraceae). Parasitol 
Res. 108(3):529-36. 
Pritchard MT, McMullen MR, Stavitsky AB, Cohen JI, Lin F, Medof ME, Nagy LE. 
2007. Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced 
fatty liver in mice. Gastroenterology. 132(3):1117-26.  
Qin XB, Gao B. 2006. The complement system in liver diseases. Cell Mol Immunol. 
3(5):333-40. 
Rafael-Fernandes M. 2015. Caracterização da Internalização de fármacos antileishmania 
e novos compostos por macrófagos parasitados por Leishmania spp.. Master Thesis from 
Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa. 128pp 
Roohparvar R, Huser H, Zwiers LH, Waard MA. 2007. Control of Mycosphaerella 
graminicola on Wheat Seedlings by Medical Drugs Known to Modulate the Activity of ATP-
Binding Cassette Transporters. Applied and Environmental Microbiology 73: 5011–5019.  
Rui L. 2014. Energy Metabolism in the Liver. Compr Physiol. 4(1): 177–197. doi: 
10.1002/cphy.c130024 
4 | Chapter 1 
 
240 
Saad B, Frei K, Scholl FA, Fontana A, Maier P. 1995. Hepatocyte-derived interleukin-6 
and tumor-necrosis factor alpha mediate the lipopolysaccharide-induced acute-phase response 
and nitric oxide release by cultured rat hepatocytes. Eur J Biochem. 229(2):349-55. 
Saar Y, Ransford A, Waldman E, Mazareb S, Amin-Spector S, Plumblee J, Turco SJ, 
Zilberstein D. 1998. Characterization of developmentally-regulated activities in axenic 
amastigotes of Leishmania donovani. Mol Biochem Parasitol. 95(1):9-20. 
Saar Y, Ransford A, Waldman E, Mazareb S, Amin-Spector S, Plumblee J, Turco SJ, 
Zilberstein D. 1998. Mol Biochem Parasitol. 95(1):9-20. 
Samanta TB, Das N, Das M, Marik R. 2003. Mechanism of impairment of cytochrome 
P450-dependent metabolism in hamster liver during leishmaniasis. Biochem Biophys Res 
Commun. 312(1):75-9. 
Samaras SC, Dietz N. 1953. Jr., Fed. Proc., 12, 122. Cited by Morgan ET. 1997. 
Regulation of cytochromes P450 during inflammation and infection. Drug Metab Rev. 
29(4):1129-88. 
Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA. 1990. 
Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis 
factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood. 
75(1):40-7. 
Schleicher U, Liese J, Knippertz I, Kurzmann C, Hesse A, Heit A, Fischer JA, Weiss S, 
Kalinke U, Kunz S, Bogdan C. 2007. NK cell activation in visceral leishmaniasis requires 
TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. J Exp Med. 
204(4):893-906.  
Schwabe RF, Seki E, Brenner DA. 2006. Toll-like receptor signaling in the liver. 
Gastroenterology. 130:1886-1900 
Sen G, Mandal S, Roy SS, Mukhopadhyay S, Biswas T. 2005. Therapeutic Use of 
Quercetin in the Control of Infection and Anemia Associated with Visceral Leishmaniasis. Free 
Radical Biology & Medicine 38: 1257–1264.  
Sesti S, Martino G, Mazzulla S, Chimenti R. 2005. Effect of bradykinin on nitric oxide 
production, urea synthesis and viability of rat hepatocyte cultures. BMC Physiol. 5(1):2. 
Silva CIM. 2014. Eficácia Da Quercetina Na Leishmaniose Visceral Murina: 
Associação Com a Chalcona CH8, Formulações Nanoestruturadas E Imunomodulação. Thesis 
4 | Chapter 1 
 
241 
Universidade Federal do Rio de Janeiro, Centro de Ciências da Saúde Instituto de Biofísica 
Carlos Chagas Filho, Rio de Janeiro: 1-148. 
Silvestrini P, Zoia A, Planellas M, Roura X, Pastor J, Cerón JJ, Caldin M. 2014. Iron 
status and C-reactive protein in canine leishmaniasis. J Small Anim Pract. 55(2):95-101. doi: 
10.1111/jsap.12172.  
Slaughter RL, Edwards DJ. 1995. Recent advances: the cytochrome P450 enzymes. Ann 
Pharmacother. 29(6):619-24. 
Soji T, Murata Y, Ohira A, Nishizono H, Tanaka M, Herbert DC. 1992. Evidence that 
hepatocytes can phagocytize exogenous substances. Anat Rec. 233(4):543-6. 
Soria LR, Marrone J, Molinas SM, Lehmann GL, Calamita G, Marinelli RA. 2014. 
Lipopolysaccharide impairs hepatocyte ureagenesis from ammonia: involvement of 
mitochondrial aquaporin-8. FEBS Lett. 588(9):1686-91. doi: 10.1016/j.febslet.2014.03.012.  
Stanya KJ, Jacobi D, Liu S, Bhargava P, Dai L, Gangl MR, Inouye K, Barlow JL, Ji Y, 
Mizgerd JP, Qi L, Shi H, McKenzie AN, Lee CH. 2013. Direct control of hepatic glucose 
production by interleukin-13 in mice. J Clin Invest. 123(1):261-71. 
Streetz KL, Luedde T, Manns MP, Trautwein C. 2000. Interleukin 6 and liver 
regeneration. Gut.47(2):309-12. 
Stijlemans B, Vankrunkelsven A, Brys L, Magez S, De P. 2008. Role of iron 
homeostasis in trypanosomiasis-associated anemia. Immunobiology. 213:823–835. 
Sumpter R Jr, Loo YM, Foy E, Li K, Yoneyama M, Fujita T, Lemon SM, Gale M Jr. 
2005. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA 
replication through a cellular RNA helicase, RIG-I. J Virol. 79(5):2689-99. 
Sunman J, Hawke R, LeCluyse E, Kashuba A. 2004. Kupffer cell-mediated IL-2 
suppression of CYP3A activity in human hepatocytes. Drug Metabolism and Disposition. 32 
(3). Pag. 359-363 
Szabo G, Dolganiuc A, Mandrekar P. 2006. Pattern recognition receptors: a 
contemporary view on liver diseases. HEPATOLOGY. 44:287-298 
Tabuchi S, Gotoh T, Miyanaka K, Tomita K, Mori M. 2000. Regulation of genes for 
inducible nitric oxide synthase and urea cycle enzymes in rat liver in endotoxin shock. Biochem 
Biophys Res Commun. 268: 221-224. 10.1006/bbrc.2000.2105. 
4 | Chapter 1 
 
242 
Tenmizu D, Endo Y, Noguchi K, Kamimura H. 2004. Identification of the novel canine 
CYP1A2 1117 C &gt; T SNP causing protein deletion. Xenobiotica. 34(9):835-46. 
Theil EC. 2003. Ferritin: at the crossroads of iron and oxygen metabolism. J Nutr. 133(5 
Suppl 1):1549S-53S. 
Thomas A, Laxton C, Rodman J, Myangar N, Horscroft N, Parkinson T. 2007. 
Investigating toll-like receptor agonists for potential to treat hepatitis C virus infection. 
Antimicrob Agents Chemother. 51:2969-2978. 
Torres-Santos EC, Da Silva SA, Costa SS, Santos AP, Almeida AP, Rossi-Bergmann B. 
2003. Toxicological Analysis and Effectiveness of Oral Kalanchoe pinnata on a Human Case of 
Cutaneous Leishmaniasis. Phytotherapy Research 17: 801–803. 
Tran TN, Eubanks SK, Schaffer KJ, Zhou CY, Linder MC. 1997. Secretion of ferritin 
by rat hepatoma cells and its regulation by inflammatory cytokines and iron. Blood. 
90(12):4979-86. 
Tsuji Y, Ayaki H, Whitman SP, Morrow CS, Torti SV, Torti FM.2000. Coordinate 
transcriptional and translational regulation of ferritin in response to oxidative stress. Mol Cell 
Biol. 20(16):5818-27. 
Turpeinen M, Ghiciuc C, Opritoui M, Tursas L, Pelkonen O, Pasanen M. 2007. 
Predictive value of animal models for human cytochrome P450 (CYP)-mediated metabolism: a 
comparative study in vitro. Xenobiotica 37, 1367-77. 
Ueno N, Wilson ME. 2012. Receptor-mediated phagocytosis of Leishmania: 
implications for intracellular survival. Trends Parasitol. 28(8):335-44. doi: 
10.1016/j.pt.2012.05.002.  
Verma S, Mehta A, Shaha C. 2011. CYP5122A1, a novel cytochrome P450 is essential 
for survival of Leishmania donovani. PLoS One. 6(9):e25273. doi: 
10.1371/journal.pone.0025273.  
Wells PG, Mackenzie PI, Chowdhury JR, Guillemette C, Gregory PA, Ishii Y, Hansen 
AJ, Kessler FK, Kim PM, Chowdhury NR, Ritter JK. 2004. Glucuronidation and the UDP-
glucuronosyltransferases in health and disease. Drug Metab Dispos. 32(3):281-90. 
Whitaker SM, Colmenares M, Pestana KG, McMahon-Pratt D. 2008. Leishmania 
pifanoi proteoglycolipid complex P8 induces macrophage cytokine production through Toll-like 
receptor 4. Infect Immun. 76(5):2149-56. doi: 10.1128/IAI.01528-07.  
4 | Chapter 1 
 
243 
Wilkinson GR. 2005. Drug metabolismand variability among patients in drug response. 
N Engl J Med. 352:2211–21. 
Wilson ME, Lewis TS, Miller MA, McCormick ML, Britigan BE. 2002. Leishmania 
chagasi: uptake of iron bound to lactoferrin or transferrin requires an iron reductase. Exp 
Parasitol.100(3):196-207. 
Wilson ME, Vorhies RW, Andersen KA, Britigan BE. 1994. Acquisition of iron from 
transferrin and lactoferrin by the protozoan Leishmania chagasi. Infect Immun. 62(8):3262-9. 
Wolfert MA, Murray TF, Boons GJ, Moore JN. 2002. The origin of the synergistic 
effect of muramyl dipeptide with endotoxin and peptidoglycan. J Biol Chem. 77(42):39179-86. 
Wu G. 1995. Urea synthesis in enterocytes of developing pigs. Biochem J. 312, 717–
723. 
Xu C, Li CY, Kong AN. 2005. Induction of phase I, II and III drug 
metabolism/transport by xenobiotics. Arch Pharm Res. 28(3):249-68. 
Yarovinsky F, Zhang D, Andersen JF, Bannenberg GL, Serhan CN, Hayden MS, Hieny 
S, Sutterwala FS, Flavell RA, Ghosh S, Sher A. 2005. TLR11 activation of dendritic cells by a 
protozoan profilin-like protein. Science. 308(5728):1626-9.  
Zanger UM, Schwab M. 2013. Cytochrome P450 enzymes in drug metabolism: 
regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol 
Ther. 138(1):103-41. doi: 10.1016/j.pharmthera.2012.12.007.  
Zhou SF. 2009. Polymorphism of human cytochrome P450 2D6 and its clinical 
significance: Part I. Clin Pharmacokinet. 48(11):689-723. doi: 10.2165/11318030-000000000-
00000. 
  













CHAPTER  2 
Interaction of canine liver Kupffer cells and 
 L. infantum  
 
4 C
5 | Chapter 2 
 
247 
5 Chapter 2: Interaction of canine liver Kupffer cells 
and L. infantum 
5.1. Introduction 
5.1.1. Mononuclear phagocytic system: monocytes and 
macrophages 
5.1.1.1. Circulating monocytes  
Monocytes are members of the mononuclear phagocytic system, which 
constitute a crucial defense system for host nonspecific antimicrobial defense and tumor 
surveillance. These cells are also a critical effector component of the innate immune 
system, equipped with chemokine receptors and adhesion molecules are easily recruited 
to sites of infection. Monocytes secrete inflammatory cytokines, take up cells and toxic 
molecules, thus contributing to the immune defense against bacterial, protozoa, and 
fungal pathogens. Monocytes can kill bacteria by producing reactive nitrogen 
intermediates (RNIs), reactive oxygen intermediates (ROIs) and through the action of 
phagolysosomal enzymes. However, these cells also constitute the host cells for 
Leishmania infection, replication and permanent establishment inside the host. 
Leishmania parasites are well adapted to the aggressive conditions inside 
phagolysosome, being able to influence and control the immune activation of 
macrophages (MØs) (Mauël, 1990). 
Monocytes are established circulating precursors for tissue macrophages and 
dendritic cells (DCs) and originate from a common myeloid progenitor cell in the bone 
marrow that is shared with neutrophils. Monocytes are released into the bloodstream as 
non-differentiated cells and circulate in the blood for 1 or 3 days in the case of mice and 
humans, respectively (Tacke and Randolph, 2006). Following tissue recruitment, 
monocytes can differentiate into tissue MØs or myeloid DCs, replenishing the existing 
populations and contributing to homeostasis maintenance, host defense and to tissue 
remodeling and repair (Gordon and Taylor, 2005). Macrophages have been recognized 
to play a central role in the immune response. They are mononuclear phagocytic cells, 
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which are involved in pathogen recognition, clearance, antigen processing and 
presentation, inflammation and tissue repair as well as pro-and anti-tumoral responses. 
Tissue MØs perform a range of important homeostatic functions and exist in many 
different tissue-specific forms: microglia in the brain, alveolar MØs in the lung, KCs in 
the liver, osteoclast in the bone as well as sub-capsular sinusoidal/modular MØs 
associated with spleen, intestine, bone marrow and lymph node tissues. Thus, MØs are 
central to innate immune inflammatory mechanisms and in priming the adaptive 
immune responses to both intracellular and extracellular pathogens as well as participate 
in the immune regulation and tumor surveillance (Foey, 2014). Circulating monocytes 
constitute approximately 5–10% of peripheral blood leukocytes and exhibit 
morphological heterogeneity. The heterogeneity among human monocytes is known 
since 1989 (Passlick et al., 1989). The differential expression of CD14 (part of the 
receptor for bacterial lipopolysaccharide -LPS) and CD16 (also known as FcγRIII) was 
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monocytes lack CCR2 but have higher levels of MHCII and 
FCγRII (CD32) (Tacke and Randolph, 2006). It is important to refer that considerable 
heterogeneity is known to exist in the minor CD16
+ 
monocyte fraction. An 
“intermediate” population of monocytes that is CD14
+










(Grage-Griebenow et al., 2001). The interest in this CD16
+
 monocytes has been driven 
in part by observations showing that this monocyte subset was elevated in blood during 
inflammatory conditions, carcinoma, atherosclerosis (Schlitt et al., 2004), rheumatoid 
arthritis (Baeten et al., 2000) and cancer (Saleh et al., 1995), linking this CD16
+
 
monocytes to the context of chronic inflammation. For mouse blood monocytes, a 
subdivision into three subsets, classical, intermediate and non-classical, similar to 
humans is also proposed.  
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5.1.1.2. Kupffer cell – the liver resident macrophages 
Kupffer cells (KCs), the resident MØs of the liver, comprise the largest 
population of resident tissue MØs in the body. First described by Karl Wilhelm von 
Kupffer in 1876 as “sternzellen” (star cells or stellate cells), KC were first thought to be 
a part of the endothelium of the liver blood vessels. Only in 1898, Tadeusz Browiecz 
correctly identified these cells as MØs (Naito et al., 1997). KCs are now defined as 
MØs of the hepatic sinusoid evidencing defined MØs characteristics such as active 
phagocytosis, reactivity to anti-macrophage monoclonal antibodies and proliferative 
capacity. As resident MØ, KCs play an essential role in the innate immune response. 
The preferential localization of KCs in the hepatic sinusoid allows them to efficiently 
phagocyte pathogens entering from the portal or arterial circulation, functioning as the 
first line of defense against particulates and immunoreactive material coming from the 
gastrointestinal tract via the portal circulation. Their location within the hepatic 
sinusoids enable an intimate contact with circulating blood, including with 
blood-derived leukocytes, facilitating their role in the clearance of bacterial products 
and interaction. KCs have been implicated in both immunogenic and tolerogenic 
immune reactions. These cells eliminate pathogens, including bacteria and parasites and 
may directly kill tumor cells by receptor-mediated phagocytosis or release tumor 
necrosis factor-α (TNF-α), oxygen metabolites, and proteinases. As professional 
antigen-presenting cells (APCs), can also promote adaptive immune responses by 
processing and presenting antigen via class I and class II of major histocompatibility 
complex (MHC). In case of pathogenic infection or tissue damage, the release of 
cytokines from activated MØ recruits other cells of the immune system to control 
inflammation, infection and to participate in tissue repair (Seki et al., 2000). KCs thus 
comprise the major phagocytic activity of what was classically termed the 
reticular-endothelial system and now more properly called the mononuclear phagocytic 
system (Dixon et al., 2013).  
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5.1.1.2.1. KC origin 
The origin of KCs and how homeostasis of the cell population is maintained 
over time still are controversy. Classically, tissue MØs are not self-renewing and are 
replenished from bone marrow–derived monocytes (Dulk et al., 1979). However, it has 
been suggested that KCs are a self-renewing population that replicate as mature cells or 
originate from local intrahepatic progenitors (Yamamoto et al., 1996). This issue 
assumes practical importance in clinical situations such as myeloid diseases treated with 
bone marrow allografts and also during liver transplantation. In both situations, large 
self-renewing APC populations that are not readily replaced from bone marrow sources 
are likely to affect the specificity of immune responses. In adult mammals, monocytes 
of the peripheral blood originated from precursor cells in the bone marrow and are 
considered to be immature precursors for tissue MØs. Peripheral blood monocytes can 
enter the liver and then mature into a phenotype characteristic of tissue MØs. MØs 
differentiation is regulated by various growth factors, but the role of macrophage colony 
stimulating factor (M-CSF) appears to be crucial for the development of mature KCs 
(Naito et al., 1997). Klein et al., (2007) found evidence of the presence of two distinct 
KC populations within the liver, depending on the method of evaluation. 
Multiparameter flow cytometry of isolated hepatic leukocytes, a method frequently used 
to analyze the frequency of both intrahepatic and extrahepatic leukocyte populations, 
indicated a clear predominance of bone marrow–derived KCs that were rapidly replaced 
after irradiation reconstitution. However, in situ analysis by immunohistologic staining 
revealed a large population of residual non–bone marrow–derived KCs – the sessile 
KCs. While both the bone marrow–derived and the sessile KCs shared the same 
morphology and phagocytic capabilities, only the bone marrow–derived KCs engaged 
in inflammatory responses. Thus, the term “sessile” alludes both to their lack of rapid 
turnover and to their lack of capacity for local recruitment, inducing tolerance. 
However, the local precursor for these sessile KCs was not found and the model of a 
single lineage is still debated. Although it is known that the amount of KCs in the liver 
is tightly maintained, the mechanisms responsible for this control are not well 
understood. It is clear that the rate of influx of peripheral monocytes into the liver is 
higher than in other tissues, such as the lung. But, the KC life span in the liver still is 
debated. Studies performed in KC depleted animals, either in response to clodronate or 
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in bone marrow transplants revealed that KC replacement occurs over 14 to 21 days 
(Naito et al., 1997). However, under physiological circumstances the KC fate is not 
understood. It was hypothesized that the KC turnover may occur due to programmed 
cell death (apoptosis) and/or migration to other sites, such as lymph nodes. Recent data 
suggest that in response to Th2 inflammatory signals, such as IL-4, resident MØ, 
including KCs can proliferate after stimulation (Jenkins et al., 2011). 
5.1.1.2.2. KC localization within the liver architecture  
The liver is a complex organ constituted by several different cell types distribute 
within the sinusoidal structure of the liver. Hepatocytes, which encompass the majority 
of the liver are considered the key cells of the liver and carry out a vast array of 
metabolic, regulatory and toxicological functions. The hepatic sinusoid is lined with a 
specialized liver sinusoidal endothelial cell characterized by the presence of fenestrae. 
KCs, as well as other cells of the innate immune system, including NK cells, NKT cells, 
and dendritic cells reside within the sinusoid (Figure 7). KCs exhibit an amoeboid shape 
and adhere to the surface of fenestrated sinusoidal endothelial cells. The surface of KCs 
bears microvilli and lamellipodia, extending their projections in all directions. 
Cytoplasm is enriched with dense bodies and vacuoles of various sizes. Some of 
vacuoles are lysosomes staining positive for acid phosphatase. Golgi apparatus, coated 
vesicles, pinocytic vesicles, ribosomes, centrioles, microfilaments, and microtubules are 
also present in the cytoplasm. KCs nuclei are ovoid and occasionally lobulated. 
Peroxidase activity is observed in the rough endoplasmic reticulum (RER), nuclear 
envelope, and lamellae. Wormlike structures, fuzzy coat, microvilli, and peudopodia are 
KCs structural components involved in endocytic mechanisms. KCs incorporate large 
particles, such as erythrocytes and bacteria, by phagocytosis and take up small particles 
and molecules via pinocytic vesicles (Naito et al., 2004). 
  




Figure 57: Hepatic localization of KC. 
A) Histological preparation of liver tissue from mice which was injected intravenously with a suspension 
of carbon particles. These particles are actively phagocytized by Kupffer cells (macrophages), whose 
cytoplasm becomes packed with black carbon particles (1000x magnification). B) Schematic structure of 
the liver. Hepatic sinusoids are constituted by sinusoidal endothelial cells and KCs. Blood circulates 
within the sinusoids in the liver. Stellate cells have implications on hepatic development, regeneration, 
xenobiotic responses, intermediary metabolism, and immunoregulation. Lym: lymphocytes, including NK 
cells, NKT cells, and other lymphocytes. [Adapted from http://www.siumed.edu/~dking2/erg/GI166b.htm 
and Tsutsui and Nishiguchi, 2014]. 
The close proximity of KCs to parenchymal and non-parenchymal cells within 
the liver supports the ability of these cells to regulate hepatic function, both in health 
and disease. In a healthy liver, KCs exhibit a tolerogenic phenotype, preventing 
excessive and undesired immune responses when faced with incoming immunoreactive 
materials, including gut-derived materials and antigens of dead or dying cells as they 
are cleared from bloodstream by the liver (Thomson and Knolle, 2010). However, under 
certain conditions as is the case of chronic inflammatory diseases, KCs shift from 
tolerance to pathologically activation. As these cells are in close proximity with 
hepatocytes and several non-parenchymal cells, loss of the tolerogenic state can render 
cellular injury and liver damage. Thus, like many other components of the innate 
immune system, maintenance of the appropriate balance between activation and 
tolerance is critical to preserve a healthy organism. Absence or lowered functional 
activity of KCs can contribute to pathogen invasion and/or systemic inflammation. On 
the other hand, activation may result in uncontrolled inflammatory state in the liver.  
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5.1.2. MØ immune activation  
MØ and neutrophils are cells of the innate immune system, which provide a first 
line of defense against many common microorganisms, being essential for the control of 
common infections. The cells of the innate immune system are equipped with 
pathogen-recognition receptors (PRRs) are able to recognize both pathogens-associated 
molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs), which 
are involved in the activation and control of the innate immune response. PAMPs 
represent exogenous stimuli arriving from infectious agents, while DAMPs are 
endogenous indicators of stress. Toll-like receptors (TLRs) and nucleotide-binding 
oligomerization domain (NOD)-like receptors (NLRs) are the two major classes of 
PRRs that recognize both PAMPs and DAMPs. However, there are some pathogens 
able to negatively modulate crucial pathways, rending cells unable to control infection. 
Lymphocytes of the adaptive immune system have evolved to provide a more versatile 
means of defense which, in addition, provides increased protection against subsequent 
re-infection with the same pathogen, through the existence of memory cells. Cells of the 
innate immune system, however, play a crucial role in the initiation and subsequent 
direction of adaptive immune responses, as well as participating in the removal of 
pathogens that have been targeted by an adaptive immune response. Moreover, since 
there is a delay of 4–7 days before the adaptive immune response to be initiated, the 
innate immune response has a key role in controlling infections (Janeway et al., 2001). 
There is a growing appreciation that the mature phenotype of resident tissue 
MØs is very plastic, with the MØs functional activity based on inputs from both the 
local metabolic and immune environment, superimposed on the MØ intrinsic program. 
In the liver, plasticity can rend changes in KC activation state and/or a recruitment of 
new monocytes/ MØs. Much of our understanding of MØ plasticity comes from adipose 
tissue resident MØs and from non-tissue MØs (Fukushima et al., 2009). However, the 
regulation of functional phenotype of hepatic MØs is associated with the progression of 
various liver diseases, including non-alcoholic steatohepatitis (NASH), alcoholic liver 
disease (ALD), fibrosis, and hepatocellular carcinoma (Dixon et al., 2013). In an 
attempt to classify these activation states, two extremes of MØ macrophage polarization 
have been designated as M1 and M2. M1 or classically MØs are characterized by the 
increased expression of pro-inflammatory cytokines, such as TNF-α, IL-6, IL-12, and of 
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inducible NO synthase (iNOS). By other hand, M2 or alternatively activated MØs 
exhibit low expression of pro-inflammatory cytokines, but increased expression of 
anti-inflammatory mediators, such as IL-10 and IL-1 decoy receptor expression 
(Gordon and Taylor, 2005). The M1/M2 classification is a simplified view, with data 
demonstrating that even within each of these groupings there is significant 
heterogeneity. For example, the M2 grouping has been further subdivided into M2a, 
M2b, and M2c. These subclasses exhibit distinct marker proteins on their cell surface 
and are induced by different regulators, presenting distinct functional activity (Mosser 
and Edwards, 2008). Although the understanding of the precise mechanism involved in 
the regulation of MØ polarization is still very rudimentary, recent studies have begun to 
elucidate the specific transcription factors that regulate the switch, including signal 
transducers and activator of transcriptions (STATs), peroxisome proliferator-activated 
receptor (PPAR) family members, hypoxia-inducible factor 2α and Kruppel-like factor 
4 (Lawrence and Natoli 2011; Liao et al., 2011). Strong M1 polarizing factors include 
STAT1 and interferon-regulatory factor 5 (IRF), while STAT6, IRF-4, and PPARγ are 
important transcription factors regulating M2 polarization (Lawrence and Natoli, 2011). 
MicroRNAs also contribute to the regulation of MØ polarization in cultured MØ cell 
lines (Graff et al., 2012). However, data for an in vivo role of nicroRNA in regulating 
KC phenotype is still lacking. Proliferation of M2 MØs in response to IL-4 has also 
been reported (Jenkins et al., 2011). There is also growing evidence that the MØ 
metabolic state, in particular whether it utilizes glucose or fatty acids as a primary 
energy source, influences its phenotypic activity (Chawla et al., 2011). Indeed, 
regulators of lipid metabolism, such as the PPAR family members and adiponectin are 
important mediators of macrophage polarization. This dual regulation of lipid 
metabolism and polarization is particularly interesting in the light of the contribution of 
KC and other hepatic MØs for the progression of metabolic liver diseases, such as ALD 
and NASH, which are initially characterized by deregulation in hepatic lipid 
metabolism (Dixon et al., 2013). 
KCs are active phagocytes, which uptake intravascular debris, dead bacterial 
cells, and other blood-borne particles, and are able to secrete various inflammatory 
cytokines, including IL-1, IL-6, tumor necrosis factor (TNF), granulocyte-MØ 
colony-stimulating factor (GM-CSF), and chemokines such as MØ inflammatory 
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protein 1 alpha (MIP-1α). However, overproduction of such inflammatory mediators by 
KCs can rend liver injury (Morita et al., 2003). KCs, as MØ, express several 
cell-surface receptor complexes involved in immune stimulation. Lining in the 
sinusoids, KCs express a wide range of phagocytics and innate recognition receptors, 
including CD32, complement receptors, Fc receptors, receptors for lectin-containing 
opsonins such as plasma mannose-binding lectin, adhesion receptors and those that bind 
to ICAM-1 and to TLRs (notably TLR 2, 3, 4 and 9) and, receptors for polysaccharides 
of microbial and host origin. Their avid phagocytic activity has been associated with the 
clearance of blood borne pathogens and the maintenance of immune homeostasis (Naito 
et al., 2004). The expression of high-affinity Fc receptors facilitates phagocytosis of 
IgG-coated particles, as well as scavenger receptors and receptors for IgA, galactose, 
mannose are able of directly binding microbial surface components (Ross and Vetvicka, 
1993).  
 After the exposition to various stimuli, KC activation is characterized by a rapid 
phenotype change. Phagocytosable particles and several soluble substances are able to 
activate MØs by binding to specific receptors on the plasma membrane. The most 
important KC activators are the complement factors C3a and C5a, β-glucans from 
bacteria and fungi or lipopolysaccharide (LPS) and, the endotoxins of Gram-negative 
intestinal bacteria (Thornton et al., 1996; Schieferdecker et al., 2001). The role of LPS, 
a component of the cell wall of gram-negative bacteria and a ligand of TLR4, in 
triggering TLR4-downstream pathway has been well described.  
In addition, high LPS concentrations can indirectly activated KCs by triggering 
complement activation either in the portal or in the systemic circulation. After activation 
of complement cascade, cleavage of C3 and C5 leads to the generation of the potent 
anaphylatoxins C3a and C5a, and the subsequent stimulation of their specific receptors, 
RC3a and RC5a (Ember and Hugli, 1997). Thus, KC activation can be best described as 
a wide spectrum of gradually different alterations of the KC phenotype resulting from a 
complex interplay of various activators and signaling pathways. However, much less is 
known about the role of other PRRs in the progression of liver injury. Both TLR2 and 
TLR9 have also been identified as specific contributors to non-alcoholic fatty liver 
disease and Non-alcoholic Steatohepatitis (NAFLD/NASH) in mouse models (Miura et 
al., 2010; Rivera et al., 2010). Based on these few reports, there is a clear need to 
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expand our knowledge of the role of PRRs in the progression of liver injury and 
incorporate the likely complex interactions between KCs and multiple PAMPs and 
DAMPs in the progression of chronic liver injury. In spite of the importance of KCs in 
the uptake of pathogens, data on their role in the presentation of pathogen-derived 
antigens are scarce, with most studies focusing on the role of sinusoidal endothelial 
cells and hepatocytes in the induction of CD8
+
 T cell tolerance, or the ability of hepatic 




 and NKT cells. 
KCs can also recognize DAMPs. Initially, damaged cells release cytoplasmic 
and nuclear components, constituting alarm signals that are able to activate tissue 
resident macrophages. CLEC4E is a transmembrane C type lectin, which has been 
reported to be involved in initiating the early inflammatory response after necrotic cell 
death. The subsequent production of pro-inflammatory cytokines and chemokines, 
including TNF, IL-6, CXCL1, CXCL2, CXCL3, CXCL8, CCL2, CCL3, and CCL4 can 
stimulate the recruitment of neutrophils and monocytes. Granule proteins discharged 
from activated neutrophils anchor on endothelial proteoglycans and are recognized by 
monocytes promoting their firm adhesion. Moreover, azurocidin, IL-37 and cathepsin G 
proteases release from activated recruited neutrophils. Neutrophil granule proteins can 
promote de novo synthesis of monocyte-attracting chemokines by endothelial cells and 
MØs. During inflammation resolution, neutrophil apoptosis holds a central position as it 
stops the recruitment of neutrophils, while the phagocytic clearance of apoptotic 
neutrophils reprograms MØs throw an anti-inflammatory phenotype (Liaskou et al., 
2012). 
5.1.2.1. MØs in visceral leishmaniasis 
Leishmania parasites are obligatory intracellular pathogens and MØ are 
indispensable for parasite survival, replication, and differentiation. Both neutrophils and 
MØs are recruited to the infection site and their interaction with parasites significantly 
influences the outcome of infection (Ribeiro-Gomes et al., 2004). However, recent 
studies suggest that neutrophils recruited to the site of infection are very efficient in 
parasite uptake. Since neutrophils are short-lived phagocytes, they are believed to serve 
as intermediate host cells and have been proposed to act as “Trojan horses” used by 
parasites to get a lift in order to silently enter MØs, thereby avoiding cell activation 
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(Laufs et al., 2002). In fact, L. major infection of polymorphonuclear neutrophils 
(PMNs) leads to significant delay in cell programmed death and secretion of high levels 
of MIP-1β, which is known to attract MØs to the site of infection (van Zandbergen et 
al., 2004). Recruited MØs phagocytosis free parasites and infected PMNs, becoming the 
definitive host cells for parasite replication as well as effector cells responsible for 
parasite destruction. The uptake of Leishmania promastigotes by host cells is a classical 
receptor-mediated process that initiates phagocytosis. The complement receptors (CR)1, 
CR3 (Mac-1), fibronectin receptor, and the mannose-fucose receptor (MR) on the MØs 
surface play import roles in promastigote binding (Kane and Mosser, 2000). 
Interestingly, an earlier study found that the individual ligation of parasites to these 
receptors does not trigger MØs activation, suggesting that multiple receptor parasite 
ligands are needed to initiate the appropriate protective response (Aderem and 
Underhill, 1999). However, some studies report differences between MØ receptors used 
by metacyclic promastigotes and avirulent ones. L. infantum (chagasi) metacyclic 
promastigotes of were described to use CR3 but not MR to be uptake by MØ, in 
contrast to avirulent promastigotes, which use both receptors to enter the cells. It is 
already known that CR3 ligation by itself does not trigger NADPH oxidase activation 
and subsequently the respiratory burst (Sehgal et al., 1993), while MR ligation has been 
shown to promote inflammatory responses (Linehan et al., 2000). Thus metacyclic 
promastigotes avoid using MR receptor during the MØ invasion in order to enhance 
their intracellular survival. 
MØs are also the major effector cells responsible for parasite destruction. MØs 
can be activated by different signals leading to their development into functionally 
distinct subsets with different outcomes. Thus, MØs appropriate activation is crucial for 
the elimination of this intracellular pathogen. MØ activation is generally divided into 
two functionally distinct spectra: classical and alternative activation. Classical 
activation is mediated by Th1 and NK cell immune mediators, in particular IFN-γ, 
which stimulates MØs to produce inducible nitric oxide synthase (iNOS), an enzyme 
which catalyzes L-arginine to generate nitric oxide (NO) (Liew et al., 1990). NO is a 
toxic molecule that plays a major role in killing intracellular parasites, including 
Leishmania. In the absence of IFN-γ or microbial products such as LPS, iNOS mRNA 
and the respective protein are undetectable in MØs. In contrast to classical activation, 
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alternative MØ activation is induced by the Th2 cytokines interleukin 4 (IL-4) and 
interleukin 13 (IL-13) (Gordon, 2003). It has been demonstrated that IL-4-induces 
polyamine biosynthesis (via upregulation of arginase), favoring L. major parasite 
survival inside MØs (Kropf et al., 2005). Another cytokine that negatively affects 
classical MØ activation is interleukin 10 (IL-10). Inhibits the respiratory burst and the 
release pro-inflammatory cytokines, particularly TNF (Gordon, 2003), affecting 
leishmanicidal activity of infected cells and promoting parasite survival. To avoid being 
killed by activating MØs, parasites must manipulate the activation of MØ pathways at 
his favor, ensuring their survival replication and dissemination in the host. Interleukin 
12 (IL-12) is a critical cytokine required for CD4
+
 Th1 development and for IFN-γ 
production (Mosmann and Coffman, 1989). IL-12 is mainly produced by 
antigen-presenting cells (APCs) and MØs were initially proposed as the major source of 
IL-12 in L. major-infected mice. Although MØs efficient phagocytosis Leishmania 
parasites, there is evidence that their ability to release IL-12 is selectively impaired by 
the parasites (Desjardins and Descoteaux, 1998). In addition, infected MØ also directs 
the production of immune-regulatory cytokines such as IL-10 and TGF-β, cytokines that 
are known for their inhibitory effect on MØ functions. Certain parasite-derived 
molecules have been shown to regulate the outcome of L. major infection in mice. It 
was demonstrated that in the absence of phosphoglycan (PG) Leishmania parasites are 
unable to induce early production of IL-4 in BALB/c mice (Liu et al., 2009), suggesting 
that parasite-derived molecules can modulate host adaptive immune response, favoring 
parasite survival. Similarly, parasites can also induce the expression of 
immunomodulatory molecules, such as CD200, to inhibit MØ activation (Cortez et al., 
2011). Taking these evidences together, the balance between the host and parasite 
factors that control the activation vs deactivation of MØ s determines the parasite fate 
within infected MØ. 
In addition to providing a first line of defense against pathogens, KCs are also 
believed to be involved in downstream events associated with chronic disease. 
However, concerning the role played by KC in VL, little is described, apart from their 
notably role in granulomatous inflammation. Granulomas are well-defined mononuclear 
cell-rich aggregates that ideally serve to contain and control pathogen spread, but when 
unregulated may also contribute to disease pathology. Experimental infection with 
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visceralizing species of Leishmania provided along with experimental mycobacterial 
infection, some of the best characterized models for evaluating granuloma form and 
function, particularly within the hepatic microenvironment (Murray, 2001; Russell et 
al., 2009). In experimental VL, current models of hepatic granuloma formation, 
suggests that effector cells within the granuloma are largely tissue MØs and influxing 
blood monocytes fused together and ultimately attracting lymphocytes and monocytes 
through chemokine secretion. Activation, primarily by IFN-γ and after by other 
inflammatory stimuli such as TNF is the final common pathway to the functional 
antimicrobial state (Murray, 2001). BCG studies have provided some additional 
information on MØ dynamics and T cell motility within hepatic granulomas (Egen et 
al., 2008) but fail to directly address KC function. In spite of the fact that granuloma 
MØs harbor much of the hepatic pathogen load during experimental VL, presenting 
their function as antigen presenting cells (APCs) affected, the role of KCs as APC has 
yet to be directly addressed (Meier et al., 2003). Beattie et al. (2010) proven for the first 
time that within the granuloma microenvironment amastigotes loaded-KCs are the 
principal target for antigen recognition by effector CD8
+
 T cells. This evidence suggests 
that if the recognition by CD8
+
 T cell is vital to generate an immune response. 
Understand how infected KCs present antigens to CD8
+
 T cells, as well as others APCs, 
responsible for induction of CD8
+
 T cell response would be useful to generate effective 
prophylactic or therapeutic vaccination. 
 
. 
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5.2. Chapter objectives 
In the present chapter it is proposed to investigate how liver resident 
macrophages or Kupffer cells (KC) sense and react to L. infantum presence. Since KC 
constitute the target cell of L. infantum, in order to better understand the role played by 
these cells to control the infection in the canine liver several specific objectives were 
addressed: 
 Phenotype characterization of isolated cells regarding the expression of 
macrophage key characteristics; 
 Infection of isolated KC with L. infantum amastigotes or promastigotes in order 
to investigate the parasite/cell adaptation; 
 Assess the impact of a commercial leishmanicidal drug to infected KC; 
 Explore the impact of canine hepatocytes in infected KC activity; 
 Compare the immune profile generated by two different macrophage lineages, 
blood macrophage vs KC, in the presence of L. infantum. 
 
Some techniques used in the present work, mainly confocal microscopy, scan 
electron microscopy (SEM) and flow cytometry, were the result of a generous 
collaboration with Professor Graça Alexandre-Pires from Faculdade de Medicina 
Veterinária, Universidade de Lisboa. Additional processing of the images for artificial 
coloration was performed by Tiago Pereira (MSc) under my tutorial guidance. 
. 




5.3.1. Kupffer cell isolation 
Dog KCs were isolated from a liver lobule using a double Percoll® gradient. 
The protocol used was adapted from Planagumà et al. (2002), Froh et al. (2003) and 
Alabrada et al. (2007).  
A liver lobule was excised and externally cleaned with a 0.9% NaCl solution 
supplement with penicillin/streptomycin. Then, the lobule was sliced into small pieces 
with a scalpel and added to 500 ml of Gey’s balanced salt solution (GBSS) 
(Sigma-Aldrich) supplemented with 0.2% (m/v) pronase (Sigma-Aldrich) and 0.8 
µg.ml
-1
 DNAse (Roche). The tissue small pieces were then left to incubate in agitation 
(800 rpm) for 1 h at 37 ºC, in a humidified atmosphere with 5% CO2 (Figure 588A-B). 
GBSS buffer was used to ensure red blood cell lysis and DNAse was added to avoid cell 
aggregation as a consequence of cell death. Finally, the enzyme pronase was used to 
digest the extracellular matrix and the tissue collagen, releasing KCs from the interstitial 
spaces. Following digestion, cellular suspension was filtered with a falcon cell strainer 
with 40 μm pore (BD, Bioscience) and centrifuged at 600 xg for 5 min.  
 
Figure 58: Steps from the KC isolation of dog liver. 
A liver lobule was sliced into small pieces (A) and the small pieces were incubated in Gey’s balanced salt 
solution (GBSS) with pronase and DNAse in agitation (B). The cell suspension overlaid on the top of a 
double gradient of Percoll was centrifuged and the intermediate fraction (indicated by a curly bracket) 
was collected (C). Schematic representation of the different fractions found in the tube after 
centrifugation (D). NPCs - non-parenchymal cells; PCs-parenchymal cell [adapted from Froh et al. 
(2003)]. 
Pellets were resuspended in PBS 1x with 0.8 µg.ml
-1
 of DNAse and 10 ml of the 
cell suspension were overlaid into a double Percoll® (GE Healthcare) gradient 
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constituted by two consecutive 20 ml layers of 25% and 50% Percol. Then, cells were 
centrifuged at 800 xg for 25 min (Figure 588C and D). 
After centrifugation, the tube intermediate fraction (see Figure 588D) was 
collected to new tubes and cells were washed three times with PBS 1x. The pellet was 
resuspended in RPMI (Roswell Park Memorial Institute) medium (BioWhittaker Lonza) 
supplemented with 10% (v/v) of FBS, L-Glutamine 0.2 mM (Merck) and  
100 U.m
-1 
of penicillin and 100 µg.ml
-1
 of streptomycin (Sigma-Aldrich). Cell 
concentration and viability was determinate in a Neubauer’s chamber under optical 
microscopy by using trypan blue exclusion dye. Viable cell concentration was estimated 
as described in Equation 4 (see Chapter 1 - 4.3.1). This procedure allowed the isolation 
of cells with approximately 95% of viability.  
5.3.1.1. Kupffer cell culture 
To ensure maximum differentiation, KCs were cultured for 7 days in 6 well plate 
(VWR) with supplemented RPMI as described in section 5.3.1.. An additional 
supplementation with M-CSF (macrophage colony stimulating factor) produced by 
L929 cell line (see subsection 5.3.1.1.1) was added. The supplementation was 
performed adding 10% (v/v) of the L929 centrifuged supernatant to the RPMI medium 
added to the cells. Cells were incubated at 37 ºC, in a humidified atmosphere with 5% 
CO2. After 24 h and 48 h of incubation the existing medium was discharged, removing 
non-attached cells and fresh medium was added to cells. Cells were followed by optical 
microscopy observation under an inverted microscope (Olympus, CKX41) and 
photographs were taken with an Olympus CS30 camera. 
5.3.1.1.1. M-CSF production  
L929 cell line, which presents characteristics of murine fibroblast, secretes a 
factor that promotes the differentiation of peripheral blood mononuclear cells into MØ 
and monocytes. This factor is identical to murine M-CSF. The conditioned medium of 
L929 cells is frequently used as a crude source of murine M-CSF (Fisher et al., 1988). 
L929 cells also secrete a chemotactic factor specific for monocytes and an 
uncharacterized factor that promotes the growth of a large variety of cell lines. M-CSF 
used in the present study was produced using the L929 cell line.  
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 was maintained for 3 days in 
supplemented RPMI at 37 ºC, in a humidified atmosphere with 5% CO2 and regularly 
observed under OM. Then, supernatants were collected, centrifuged at 500 xg for 10 
min and stored at -20 ºC until use. After trypsinization, cells were detached, counted in 
a Neubauer’s chamber using trypan blue dye and inoculated in new t-flasks, at the same 
cell concentration, repeating the production cycle.  
5.3.2. Leishmania infantum infected Kupffer cells 
After 7 days in culture, the KC concentration was estimated and cells were 
infected with L. infantum virulent promastigotes and axenic amastigotes at the 
proportion of parasite to cell of 3:1. To avoid/minimize cell stress and cell damage, cells 
were not detached from the plate well sand concentration was estimated by the number 
of cells observed in three random microscope fields, under an inverted microscope 
(Olympus, CKX41) at 400x magnification. A direct proportion between the average of 
counting cell number and the area observed under the microscope was established, 
taking into account the total area of each well of the plate (see the following equation, 




[  ]  
                    (             )         (                    )
     (                   )
 
 
EC= estimated number of cells (total cells per well) 
OM = Optical microscopy 
L. infantum virulent promastigotes and axenic amastigotes obtained as 
previously described in General Methods (section 3.3.1 and 3.3.2) were used to infect 
the cells. Parasite concentration was determinate and the correct volume of culture was 
centrifuged at 1800 xg for 10 min at room temperature. Pelleted parasites were then 
resuspended in supplemented RPMI medium and added to KC culture. Cells were 
incubated in a cell incubator at 37 ºC, in a humidified atmosphere with 5% CO2. 
Samples of cells and supernatants were collected at 1.5 h, 3 h, 5 h and 24 h 
post-infection. Cells were followed by optical microscopy observation under an inverted 
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microscope (Olympus, CKX41) and photographs were taken with an Olympus CS30 
camera. 
5.3.2.1. Positive control  
To assure that cells were in functional conditions a positive control of 
inflammation was included. Lipopolysaccharide (LPS, 1µg.ml
-1
) from E. coli 
(Sigma-Aldrich) was added to RPMI medium and left in contact with cells for 1.5 h, 
3 h, 5 h and 24 h. Samples of cells and supernatants were periodically collected. Cells 
were maintained in a cell incubator at 37 ºC, in a humidified atmosphere with 5% CO2. 
5.3.3. Leishmanicidal drug 
To test the effect of a leishmanicidal drug in the immune activation of KC, 
antimoniate meglumine at a final concentration of 100 µM was added to KC with 24 h 
of infection. The leishmanicidal drug was in contact with cells for 1.5 h, 3 h, 5 h and 
24 h. Samples of cells and supernatants were collected at described time points. 
Incubation took place in a cell incubator at 37 ºC, in a humidified atmosphere with 5% 
CO2.  
5.3.4. Kupffer cells and hepatocyte co-cultures 
After 24 h in culture infected KC were detached from the well plate and added to 
hepatocytes, generating a co-culture. RPMI medium was removed and PBS 1x was 
added to clean non-internalized parasites. Cells were detached by a thermal shock of 30 
min on ice followed by a gently scrape will a cell scraper (VWR). Collected cells were 
centrifuged at 500 xg, for 10 min at 4 ºC and pellets resuspended in complete Wiliam’s 
E medium. Cell viability and concentration was determinate by counting in trypan blue 
dye in a Neubauer’s chamber. Co-cultures were maintained in a cell incubator for 24 h 
at 37 ºC in a humidified atmosphere with 5% CO2. Samples of cells and supernatants 
were collected at 1.5 h, 3 h, 5 h and 24 h of incubation. Cells were followed by optical 
microscopy observation under an inverted microscope (Olympus, CKX41) and 
photographs were taken with an Olympus CS30 camera. 
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5.3.5. Isolation of peripheral blood monocytes 
Peripheral blood (20 to 30 ml) of the selected dogs was collected, under 
veterinary supervision, to a tube with anticoagulant CPDA (Citrate Phosphate Dextrose 
Adenine Solution) and used for the isolation of blood monocytes. The procedure was 
done as described by Strasser et al. (1998) with some alterations. A double gradient of 
Hystopaque® density 1119 (Sigma-Aldrich) and Hystopaque® density 1077 
(Sigma-Aldrich) was prepared and 2 ml of the peripheral blood carefully overlaid on the 
top. Gradients were centrifuged at 340 xg during 30 min at room temperature and a rich 
monocyte cell ring was formed at the interface of the two gradients. The ring was 
carefully collected and washed with NaCl 0.9% (m/v) at 300 xg, for 10 min at room 
temperature. To lyse the contaminant red blood cells, a swift passage through deionized 
sterile water for 1 min was followed by the addition of a solution of NaCl 1.8% (m/v). 
Cells were again centrifuged at 300 xg for 10 min at room temperature. This procedure 
allowed the isolation of monocytes with approximately 95% viability. To induce the 
monocyte differentiation into MØs, cells were resuspended in complete RPMI medium 
supplemented with 10% (v/v) of M-CSF. Cell viability and concentration was 
determinate in trypan blue exclusion dye in a Neubauer’s chamber.  
5.3.5.1. Macrophage infection with L. infantum 
Monocytes were fully differentiated into MØs after 3 days in culture in RPMI 
medium supplemented with 10% (v/v) M-CSF. Medium was changed 24 h after 
inoculation to remove all non-attached cells and again at 72 h. L. infantum virulent 
promastigotes were obtained as described in General Methods (section 3.3.1 and 3.3.2). 
For MØ infection, a proportion of five parasites per cell were used. Adherent MØs were 
counted as described in section 5.3.2.. Parasite concentration was determined and 
adjusted to the 5:1 proportion in supplemented RPMI medium and added to the MØ cell 
culture. Cells were incubated in a cell incubator at 37 ºC, in a humidified atmosphere 
with 5% CO2. Samples of cells and supernatants were collected at 1.5 h, 3 h, 5 h and 24 
h post-infection.  
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5.3.6. Confocal microscopy  
Dog KC cultured in eight well chamber slide with cover (Lab-Tek II, Nunc) 
were incubated at 37 ºC in a humidified atmosphere with 5% CO2. L. infantum GFP-
amastigotes or GFP-promastigotes were added to cultured cells in proportion of 3:1. 
Cell suspensions were incubated for 1.5 h min, 3 h, 5 h, and 24 h. Adherent cells were 
washed with PBS 1x and fixed with 2% paraformaldeyde in PBS for 20 min in ice. 
Slides were maintained in sterile PBS 1x at 4 ºC until further processing. For 
immunostaining, cells were permeabilized overnight at 4 ºC in a solution of PBS 1% 
(v/v) Tween-20 (Sigma) and 0.2% (v/v) FBS. Antibodies were incubated in PBS 
0.125% (v/v), FBS and 1% (v/v) Tween-20 buffer for 1.5 h at room temperature and 
kept in the dark.  
Antibodies anti-CD68 and anti-lysozyme were used. CD68 is found in the 
cytoplasmic granules of a range of different blood cells and myocytes. It is particularly 
useful as a marker for the various cells of the MØ lineage, including monocytes, 
histiocytes, giant cells, Kupffer cells, and osteoclasts. Lysozymes, also known as 
muramidase or N-acetylmuramide glycanhydrolase are glycoside hydrolases. These 
enzymes can damage the bacteria walls by catalyzing and attacking peptidoglycans. 
Lysozyme is abundant in a number of secretions and it is also present in the cytoplasmic 
granules of MØ. To mark CD68 on monocyte differentiate MØs, a polyclonal FICT 
conjugated antibody was used (sc-7083, Santa-Cruz) at a dilution of 1:250. For 
lysozyme staining, a primary rabbit polyclonal antibody (ab74666, Abcam) at a dilution 
of 1:10 and a secondary goat anti-rabbit polyclonal Alexa fluor 647 (ab150091, Abcam) 
antibody at 1:1000 dilution was used. Between primary and secondary antibodies, cells 
were washed three times with the buffer PBS 0.08% tween-20 (v/v) followed by three 
more washes in PBS 1x. Control slides were also prepared with only one antibody 
staining. For fluorescent microscopy, slides were covered with TO-PRO®-3 or 
Vectashield® antifade mounting medium with a red-fluorescent compound and DAPI to 
localize nucleus and chromosomes, respectively. Slides were observed under a Leica 
TCS SP2 Laser Scanning Confocal Microscope and digital images were acquired 
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5.3.7. Scan microscopy 
After 7 days in culture, KCs were detached from the wells by thermal shock (30 
minutes on ice), and incubated with L. infantum parasites during 1.5 h min, 3 h, 5 h, and 
24 h. Cells were washed with cold PBS 1x and fixed with 2% paraformaldeyde (m/v) in 
PBS for 20 min on ice. Cells were then washed again with cold PBS 1x by 
centrifugation at 500 xg for 10 min, filtrated through a Millipore mesh and subsequently 
dehydrated in a graded ethanol series [30, 50, 70, 80, 90 and 100% (v/v)]. Samples were 
dried using the critical point drying method and coated with gold palladium and 
mounted on stubs. Observations were made under a scanning electron microscope 
(JEOL5200-LV). Digital images were acquired at high, medium and low magnification.  
5.3.8. Flow cytometry 
5.3.8.1. Determination of KC differentiation 
To determine the time most suitable for KCs complete differentiation and 
proliferation, a flow cytometry analysis of cells was performed throughout 12 days of 
culture. Cells were cultured with supplemented RPMI as described in section 1 and an 
additional supplementation with M-CSF produced by L929 cell line (see 5.3.1.1.1) was 
added. Cells were incubated in a cell incubator at 37 ºC, in a humidified atmosphere 
with 5% CO2. For flow cytometry analysis cells were detached by a thermal shock of 30 
min on ice followed by a gently scrape will a cell scraper (VWR) and centrifuged. Next 
cells were fixed with a 2% (v/v) paraformaldehyde in PBS 1x. After fixation cells were 
washed in PBS and stored at 4 ºC in PBS until flow cytometer analysis. Cell acquisition 
was performed on a FACSCalibur cell analyzer (BD Biosciences). The analysis of 
forward scatter (FSC) vs side scatter (SSC) allowed the distinction between several cell 
types presented in the culture based on their size (FSC) and granular content (SSC). 
5.3.8.2. KC dynamic of infection with GFP-L. infantum 
After 7 days in culture, KCs were detached from the plate wells as described 
above (see subsection 5.3.1.1), washed with PBS 2% FBS and the concentration 
determined under optical microscopy (see Chapter 1 - 4.3.1). Cells were resuspended in 
RPMI with 10% (v/v) FBS and infected with L. infantum GFP-promastigotes or L. 
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infantum GFP-axenic amastigotes at parasite to cell proportion of 3:1. Cells were kept 
in suspension and were incubated in a cell incubator at 37 ºC in a humidified 
atmosphere with 5% CO2 for 1.5 h, 3 h, 5 h and 24 h. At the same time, non-infected 
KCs were incubated for 30 min at 4 ºC with a polyclonal mouse anti-human 
monocyte/macrophages FITC antibody (AbD Serotec clone MAC387) that recognizes 
the L1 or Calprotectin molecule, an intracytoplasmic antigen expressed by granulocytes, 
monocytes and by tissue macrophages. The antibody presented a cross reactivity with 
dog and allowed the identification of KC population. Non-infected and non-stained cells 
and parasites were also used as assay controls. After incubation with the parasites, cells 
were centrifuged and fixed with a 2% (v/v) paraformaldehyde in PBS 1x. After fixation 
cells were washed in PBS and stored at 4 ºC in PBS until flow cytometer analysis. Cell 
acquisition was performed on a FACSCalibur cell analyzer (BD Biosciences).  
5.3.9. Urea quantification  
In this study urea production was assessed in the supernatant of KC cultures 
throughout the experimental period. Samples were analyzed by a commercial kit 
QuantiChrom™ Urea Assay Kit-DIUR-500 (BioAssay System) for quantitative 
colorimetric urea determination accordingly with the manufacture’s recommendations. 
The urea assay kit is designed to measure urea directly in biological samples without 
any pretreatment. The intensity of the color, measured at 450 nm (TRIADTM 1065, 
DYNEX Technologies), is directly proportional to the urea concentration in the sample. 
Supernatants of KC cultures were collected from duplicated wells and centrifuged at 
500 xg, 10 min and 4 ºC. Samples were stored at -20 ºC until further analysis. After 
thawed, samples were vigorously vortex and, 50 µl of each sample were plated in 
duplicate in a sterile 96 transparent well plate (Nunc). Standard urea concentration and 
blank (water) was included and calculations were performed accordingly to 
manufacturer’s instructions as indicate in Equation 8. For posterior result analysis 
RPMI medium values were subtracted to the samples. 
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OD= optical density  
n= dilution (in the present study n=1) 
5.3.10. Nitric oxide quantification  
Nitric oxide production is related to the immune activation state of KCs. In the 
present study it was used a commercial kit Nitrate/Nitrite Colorimetric Assay kit 
(Abnova) accordingly with the manufacture’s recommendation to quantify the 
nitrate/nitrite production in cell supernatants. This kit provides a precise and convenient 
method to measure total nitrate/nitrite production in a two-step protocol. In the first step 
there is the conversion of nitrate to nitrite by the nitrate reductase enzyme. In the second 
step, the addition of Griess reagent converts the nitrite into a deep purple azo compound 
that can be measured at 550 nm (BioRad-680, microplate reader) and accurately 
determines the NO2
-
 concentration. Supernatants of KC cultures were collected from 
duplicated wells and centrifuged at 500 xg, 10 min and 4 ºC. Samples were stored at -20 
ºC until further analysis. After thawing samples, were vigorously vortex and, 80 µl of 
each sample were plated in duplicate in a sterile, transparent 96 well plate (provide by 
the manufactures). A standard curve was performed with nitrate 1:5 serial dilutions and 
blank (RPMI medium) was included. Calculations were performed accordingly to 
manufacturer’s instructions (Equation 9). For posterior result analysis RPMI medium 
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OD= optical density 
SV= sample volume (µl) 
DF= dilution factor 
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5.3.11. Real-time PCR analysis 
Samples of non-infected KCs (negative controls), KCs infected by L. infantum 
promastigotes or axenic amastigotes, infected KCs exposed to leishmanicidal drug and 
KCs stimulated by inflammatory mediators (positive controls) were collected at 
previously established time points and processed for RNA extraction, cDNA synthesis 
and real-time PCR analysis (as described in the chapter General Methods, section 3.4). 
β-actin was used as normalizing gene and the gene expression of the innate immune 
receptors NOD1, NOD2, TLR2, TLR4 and TLR9 were quantified. Gene expression of 
the cytokines IL-12, IL-10, IL-4, TGF-β and TNF-α were also analyzed. 
5.3.12. Statistical analysis  
The non-parametric Wilcoxon test for two related samples was used to compare 
differences between time points and different experimental conditions. This statistical 
test is the equivalent of parametric paired samples T-test and should be used when the 
sample data do not exhibit a normally distribution, as in the present study. All the data 
analysis was performed using the software IBM SPSS Statistics version 16.0 (IBM, 
USA). A significance level of 5% (p≤0.05) was used as indicative of statistical 
significance. 
 




5.4.1. Kupffer cell's identity was confirmed 
In order to ensure that hepatic recovered cells were in fact liver resident MØs 
(KCs), the morphology of isolated cells was regularly observed under optical 
microscopy, evidencing characteristics of macrophages. KCs as MØs, are cells with 
phagocytic properties, containing abundant lysosomes required for the breakdown of 
phagocytic materials. Active MØs, have numerous phagocytic vesicles (or phagosomes) 
for the transient storage of ingested materials. Nucleus evidence an irregular outline and 
the cytoplasm may vary in shape (Figure 60A).  
To determine the time most suitable for KCs complete differentiation and 
proliferation, a flow cytometry analysis of cells was performed throughout 12 days of 
culture (Figure 5959). The analysis of forward scatter (FSC) vs side scatter (SSC) 
allowed the distinction between several cell types presented in the culture based on their 
size (FSC) and granular content (SSC). These two parameters together were able to 
identify three distinct cell populations at the initial culture: one population with small 
size and low granular content identified as lymphocytes, other population with bigger 
size and higher granular content related to granulocytes, and a third cell population with 
the highest size and low granular content, associated with MØs. FSC and SCC analysis 
also allowed distinguishing between cellular debris and living cells. After 6 days in 
culture, MØs were the dominant cell type presented in the culture and after 9 days the 
unique cell type existent.  
  
Figure 59: Liver MØ differentiation and proliferation in culture medium. 
Identification of cell subsets by flow cytometry analysis of forward scatter (FSC) vs side scatter (SSC) 
during 12 days of culture After 6 days in culture, macrophages were the dominant cell type present in the 
culture and after 9 days the unique cell type present. Results expressed by mean and standard deviation. 




Taking these evidences, isolated cells were maintained in culture for 7 days to 
ensure differentiation and proliferation. After that period adherent cells were prepared 
and staining for CD68 and lysozyme detection. Isolated and cultured cells that presented 
the typical MØ morphology were also CD68
+
 (green) and lysozyme
+
 (red) cells  
(Figure 600). CD68 is particularly useful as a marker for the various cells of the MØ 
lineage, being predominantly localized in lysosomes and endosomes with a smaller 
fraction circulating to the cell surface. Lysozyme is mainly present in the granules of the 
MØs and the polymorphonuclear neutrophils. Taking into account that cells were  





 positive cells, it is possible to assure that the isolated cultured cells are 
in fact canine KCs (liver resident MØs).  
 
Figure 60: Identification of dog KCs. 
Cells cultured for 7 days were observed under inverted optical microscope (A) and stained for CD68 and 
lysozyme (B, C, D, E). Cells evidencing MØ morphological characteristics, such as numerous phagocytic 
vesicles, and irregular outline. (Scale bar 20 µm, 400x magnification) (A).Image overlay of the double 
positive staining for CD68 (green) and lysozyme (red). CD68 and lysozyme co-localization is visible in 
yellow. Nucleus stained with To-pro®-3 (red) are of oval shape and located in periphery of the cell (400x 
magnification) (B). Single cell showing CD68 (green) localization in endocytic compartments (lysosomes 
and endosomes) (C) and lysozyme (red) in cytoplasmic granules (D). Merging of images C and D images 
show the co-localization of CD68 and lysozyme in cytoplasmic vesicles (E). 
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5.4.2. Kupffer cells recognize and internalize Leishmania 
parasites 
Infection dynamics of KCs when exposed to Leishmania morphological forms, 
amastigotes and promastigotes, was investigated. Axenic amastigotes in vitro 
differentiated and virulent promastigotes with less than five passages in the culture 
medium were added to KCs in a proportion of 3 parasites: 1 cell. Infections were 
followed for 24 h.  
After 1.5 h of incubation, KCs were surrounded by promastigotes (Figure 611) 
showing parasite tropism for these cells. After 5 h of incubation, promastigotes were 
fully adherent to the cell membrane and at 24 h of incubation KCs exhibit the cytoplasm 
with numerous vacuoles, probable with parasite internalized, and KCs were increased in 
size. External parasites were motionless and adherent to the KCs membrane. 
 
Figure 61: Dynamics of KC infection by L. infantum virulent promastigotes. 
KCs after 7 days in culture (A) and KCs incubated with promastigotes for 1.5 h (B), 5 h (C) and 24 h (D) 
were observed under inverted optical microscope (Scale bar 20 µm, 400x magnification) and images were 
acquired. KCs incubated with promastigotes for 5 h stained for nucleic acids (blue)with DAPI were 
observed under fluorescence microscope and images were acquired (scale bar 10 µm, 1000x 
magnification) (E). Promastigotes interacting with KC membrane are indicated by arrows (B, C). Parasite 
accumulation on KCs membrane are indicated by arrows (D). KC nucleus (N), parasite nucleus (n) and 
kinetoplast (k) (E). 
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KCs surface was also analyzed by scanning electron microscopy (Figure 622). 
The cells exhibited irregular membrane, characteristic of MØs, and some cytoplasmic 
extensions, constituting bridges and agglomerates (Figure 622A).  
 
 
Figure 62: KCs exposed to L. infantum virulent promastigotes. 
KCs after 7 days in culture (A) and KCs incubated with promastigotes for 3 h (B) and 5 h (C, D) were 
observed under SEM. Images directly acquired and artificially colored (Blue – KCs; Yellow- L. infantum 
promastigotes) are shown. Non infected KCs evidence irregular cell membrane and some membrane 
extensions, originating bridges and cell agglomerates (A). Promastigotes on KC membrane (B). KCs 
phagocyting one (C) or more promastigotes (D) after 5 h of infection. 
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L. infantum exhibited an evident tropism to KCs (Figure 622B). Infection of 
KCs by L. infantum virulent promastigotes were demonstrated through the phagocytosis 
of several parasites by a single cell (Figure 622C and D). 
To confirm parasite internalization, KCs was incubated with GFP-transformed  
L. infantum promastigotes (Figure 633A) and axenic amastigotes (Figure 633B), in the 
same proportion and incubation time referred above and cells were observed under 
fluorescent microscopy. This technique allowed for a better characterization of the 
parasite behavior and cell performance.  
 
Figure 63: GFP-L. infantum. 
GFP-promastigotes (A) cultured at 24 ºC and GFP-axenic amastigotes (B) differentiated at 37 ºC were 
fixed and observed under fluorescent microscope (1000x magnification) and images were acquired. 
Promastigote (A) form exhibits an elongated shape and a flagellum and the axenic amastigotes (B) 
present the characteristic round body shape without free flagellum. 
After 1.5 h of incubation, KCs were rapidly surrounded by parasites, evidencing 
once again the promastigote preference for these cells (Figure 644). After 5 h of 
incubation, promastigotes were uptake by KCs, indicating that parasites were 
5 | Chapter 2 
 
278 
recognized by cell receptors and easily phagocytized. After 24 h of incubation, all the 
promastigotes were internalized and it was possible to observe the loss of the flagellum 
and a change into an ovoid body characteristic of the amastigote form. In some cases 
there was observed morphological alteration on KC morphology with evidences of cell 
lysis. Nevertheless, the presence of the parasite did not influence the expression of 







KCs incubated with L. infantum. 
Cells incubated with GFP-promastigotes (green) for 1.5 h (A), 5 h (B) and 24 h (C) were stained with 
anti-CD68 antibody conjugated with FICT (green) and anti-lysozyme antibody (red) conjugated with 
Alexa fluor 647. Cells were then observed under confocal fluorescent microscope and images were 
acquired. After 1.5 h KCs were surrounded by parasites (A) and after 5 h of incubation (B) promastigotes 
were internalized by KCs. At 24 h (C) the promastigotes appear to be located inside the KC cytoplasm 
and exhibit an ovoid body form characteristic of amastigotes. Arrows identify L. infantum parasites 
located extracellular (A) and intracellular (B-C). 
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As for infection with amastigote form of the parasite, earlier, after amastigote 
exposure (1.5 h) it was possible to identify some parasites attached to the KC membrane 
(Figure 655A) showing the clear parasite tropism to the cells. After 5 h, (Figure 655B) 
the parasite appears to be phagocyted by the cells. After 24 h of incubation, almost no 
amastigotes were visible in culture medium, indicating that parasites were easily 
phagocytized, and some cellular debris appeared, suggesting that cell lysis may occur in 
some cells.  
 
Figure 65: Interaction of dog’s KC with L. infantum axenic amastigotes. 
Cells incubated with axenic amastigotes for 1.5 h (A) and 5 h (B) were observed under inverted optical 
microscope (Scale bar 20 µm, 400x magnification) and images were acquired. Arrows indicate 
amastigotes close to the surface of KCs (A) and 5 h incubation parasites are being internalized KCs (B). 
Arrow indicates points the cell membrane appear to be phagocyting amastigotes. 
The observation of GFP-amastigote infection under fluorescence microscopy 
revealed an aggressive infection (Figure 666). At 3 h post-incubation, L. infantum 
axenic amastigotes were completed phagocytized and internalized by KCs and at 5 h 
incubation are perfectly observed in the KCs cytoplasm. At 24 h of incubation, KCs lost 
the membrane integrity and cellular lysis occurred. Compared with non-infected KCs, 
the amastigote infection seems to diminish the expression of CD68 and lysozyme, 
possible compromising the immune activation of these cells.  




Figure 66: Interrelation of dog’s KCs with L. infantum amastigotes. 
Non infected cells (A) and cells incubated with GFP-axenic amastigotes (green) for 3 h (B), 5 h (C) and 
24 h (D) were stained with anti-CD68 antibody conjugated with FICT (green) and anti-lysozyme antibody 
conjugated with Alexafluor® 647(red). Cells were then observed under confocal fluorescent microscope 
and images were acquired. Nucleus stained with To-pro®-3 (red) appears as a large regular red bodies. A) 
Non-infected cells exhibiting high content of CD68 protein and co-localization with lysozyme. B)3 h of 
incubation amastigotes appear in the to be phagocytized and at 5 h incubation (C) amastigotes were 
perfectly internalized, as indicate by arrows (D) Later on, KCs loss membrane integrity and cell lysis are 
observed. 
To better characterize the apparent difference of amastigotes and promastigotes 
infectious potential, the analysis of infected cells was performed by flow cytometry. 
KCs incubated with GFP-promastigotes or with GFP-amastigotes and KCs not exposed 
to parasites were positively marked with anti-MØ antibody (Figure 677A). KC gating 
was defined on uninfected cells. 
L. infantum axenic amastigotes were more infectious than promastigotes, 
achieving near 100% of infection at 1.5 h of incubation (Figure 677G) and cellular lysis 
after 24 h. Promastigotes required 24 h to achieve maximum values of infected KCs. 
These results indicate that the fully differentiated intracellular form of the parasite, the 
amastigote, is able to induce a faster phagocytic response from KCs than the 
promastigote form. The tested dogs appear to have a similar degree of susceptibility to 
amastigote infection. But regarding promastigote, some dogs exhibit low infection rate, 
suggesting some kind of resistance, at least in the first incubation hours. Due to the 
cellular lysis observed in KCs amastigote infection, the following comparison on KCs 
infection by amastigotes and promastigotes was analyzed during the first 5 h incubation.  




Figure 67: Dynamics of KCs infection with L. infantum promastigotes and amastigotes evaluated by 
flow cytometry. 
Dog KCs were incubated with GFP parasites for 1.5 h, 3 h, 5 h and 24 h and marked with anti-MØ 
antibody. KCs gate was determined using marked cells unexposed to the parasite (A) and the frequency of 
KCs infected after incubation with axenic GFP-amastigotes (B-C) or promastigotes (D-F) were estimated. 
The frequency of infected cells is shown by whisker box-plot (minimum to maximum) (G). 
5.4.2.1. L. infantum parasites mainly direct dog’s KCs to produce urea  
Nitric oxide (NO) is produced by immune activated MØs and is a potent 
leishmanicidal agent. Urea can also be produced by MØs, but is not leishmanicidal and 
promotes parasite survival. To investigate the activation status of infected KCs, the 
production levels of urea and NO was assessed. 
Early in amastigote infection (1.5 h), KCs produced high levels of NO 
(P=0.0313). (Figure 688A). However, L. infantum amastigote hastily diminish the NO 
production to undetectable levels within 3 h post-infection (P=0.0156), probably to 
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assure the establishment of infection. Decrease of NO production was also verified in 
promastigote infected-KCs, but in slower way. This faster immune modulation, leading 
to NO decrease performed by the parasite intracellular form, demonstrates how well 
Leishmania is adapted to intra-KC life. Urea production was higher in amastigote 
infected KCs when compared to non-infected cells that present very low levels of urea 
(P=0.0313) (Figure 688B). This production was kept elevated throughout the infection 
period. Promastigote parasites also caused a burst of urea production by KCs 
(P=0.0313), but at statistically smaller level than amastigote infection (P=0.0469). Also 
the addition of lipopolysaccharide (LPS) to KCs, as an inflammation positive control, 
induced an initial burst of urea (P=0.0313), rapidly decreased and at 3 h incubation LPS 
induced the higher NO production pick. Some values distant from the majority of 
measurements found at different time points identified as outliers probably reflect 
different genetic backgrounds and different degrees of susceptibility to L. infantum 
infection of a natural dog population.  
 
Figure 68: Nitric oxide (NO) and urea production by canine KC exposed to L. infantum parasites 
and LPS. 
A) Nitric oxide production. B) Urea production. The black dots represent outlier values. Results 
performed in triplicate are expressed by whisker box-plot (minimum to maximum). Outlier values are 
indicated by black dots. The non-parametric Wilcoxon test was used for statistical comparisons.  
* and # (p<0.05) indicate significant differences. 
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5.4.3. Kupffer cell immune response to L. infantum infection 
5.4.3.1. L. infantum does not seem to be recognized by KC’s innate 
receptors  
To characterize the role played by L. infantum in activating or silencing KC 
immune response, the gene expression of several innate immune receptors were 
accessed by real-time PCR. Since previous results indicated that at 24 h post-infection 
the membrane integrity of KCs was compromised and cell lysis occurred, real-time PCR 
analysis was performed only until 5 h post-infection.  
NOD1 and NOD2 expression levels important gene expression differences were 
not found between infections by amastigote or promastigote (Figure 6969). Amastigote 
infection led to a transient decline of NOD1 mRNA accumulation after 3 h of 
incubation (P=0.0094). However, comparing the initial copy number and the gene 
expression observed at 5 h of incubation, there was a significant increase (P=0.0079). 
This indicates that the amastigote infection did not promote important changes in the 
gene expression of NOD1 probably avoiding tackling the activation NOD1 downstream 
pathways in order to fully establish an intracellular infection. L. infantum promastigote 
did not affect the gene expression of NOD1 until 5 h post-infection (Figure 6969A). At 
this time point, a significant decrease in the copy number was observed when compared 
with non-infected KCs (P=0.0391). The incubation of KCs with LPS exhibited some 
increase in NOD1 expression after 5 h incubation, although not statistically significant. 
KC exposition to L. infantum parasites did not exert significant changes in NOD2 gene 
expression (Figure 6969B). Taking this together it seem that L. infantum does not 
trigger NOD1 or NOD2 expression during the first hours of infection on KCs. However, 
the presence of LPS increases NOD2 expression significantly more compared to 
amastigotes (P= 0.0013). 




Figure 69: Gene expression of innate immune receptor by L. infantum-infected. 
KCs exposed to amastigotes or promastigotes for 1.5 h, 3 h and 5 h were used to extract RNA. Uninfected 
KCs and LPS stimulated-KCs were also used. NOD1 (A) and NOD2 (B) gene expression was quantified 
by real time PCR Results performed in triplicate are represented by whisker box-plot (Tukey). Outlier 
values are indicated by black dots. The non-parametric Wilcoxon test was used for statistical 
comparisons. * and # (p<0.05) indicate significant differences. 
Gene expression of TLR2, TLR4 and TLR9 were also accessed in KCs exposed 
to promastigotes and amastigotes parasite forms (Figure 700). After 5 h of incubation 
TLR2 gene expression was increased in both promastigote (P=0.0097) and amastigote 
(P=0.0075) infected KCs when compared with earlier infection time point (1.5 h) 
However this increase is not statistically different from uninfected KCs (Figure 700A). 
Taken together, these results indicate that both morphological forms of the parasite 
seem to be recognized by TLR2, possible inducing a slight KC activation. LPS 
incubation with KCs revealed an increase in TLR2 levels similar to what was observed 
with L. infantum forms. However, gene expression of TLR4 (Figure 700B) and TLR9 
(Figure 700C) was constant during the entire period of infection regardless the 
morphological form of the parasite used in the infection, suggesting that these KC 
innate immune receptors do not sense L. infantum parasites, at least during an initial 
infection. LPS did not shown great induction of TLR4 or TLR9 expression.  
Several outliers representing higher values were identified when evaluating the 
gene expression of internal and external KC sensors, probably reflecting the diverse 
genetic background of the tested dogs.  
 




Figure 70: Gene expression of TLR2, TLR4 and TLR9 by L. infantum-infected KCs. 
KCs exposed to amastigote and promastigote for 1.5 h, 3 h and 5 h were used to extract RNA. Uninfected 
KCs and LPS stimulated-KCs were also used as negative control. TLR2 (A), TLR4 (B) and TLR9 (C) 
gene expression was quantified by real time PCR. Results performed in triplicate are represented by 
whisker box-plot (Tukey). Outlier values are indicated by black dots. The non-parametric Wilcoxon test 
was used for statistical comparisons. * and # (p<0.05) indicate significant differences. 
5.4.3.2. L. infantum parasites do not induce the generation of pro- and 
anti-inflammatory cytokines by dog KCs 
In order to better characterize the immune response generated by KCs facing the 
infection by L. infantum, gene expression of pro- (IL-12 and TNF-α) and 
anti-inflammatory (IL-10, IL-4 and TGF-β), cytokines were evaluated by real-time 
PCR. Promastigote infected-KCs revealed slight variations of IL-12 gene expression 
over incubation time (Figure 711A). After 3 h of incubation, KC expressed more IL-12 
(P=0.0012) and at 5 h post-infection the amount of mRNA accumulation was more 
evident (P=0.0382). However, these increases were not enough to present significant 
differences when compared with non-infected KCs. On the other hand, amastigotes did 
not seem to induce IL-12 expression, which remained at low levels during the 
observation period. LPS exposed KCs exhibited an earlier increase in IL-12 expression 
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(1.5 h incubation) that was maintained through the incubation time, being indicative of 
activation of a pro-inflammatory response. After 3 h of incubation, amastigote infected-
KCs evidenced a transient increase of TNF-α gene expression (P=0.0263) although not 
significantly different of uninfected KCs (Figure 711B). LPS incubated KCs react early 
and strongly with increased TNF-α expression, compared to non-infected KCs  
(P= 0.0059) or amastigote infection (P<0.0001). This increase was sustained through 
the incubation time. At 3 h incubation the observed TNF-α increase was statistically 
different from amastigote (P=0.0329) and promastigote infection (P=0.0178), which in 
their turn were not different from non-exposed KCs. Taken together, these results 
indicate that during an initial period of infection the amastigote parasite form, which is 
quickly internalized by KCs, is able to direct these cells into a non-inflammatory state 
of activation. 
 
Figure 71: Gene expression of pro-inflammatory cytokines by dog KCs exposed to L. infantum 
virulent promastigotes, axenic amastigotes or LPS. 
A) IL- 12. B) TNF-α. Uninfected KCs were also used as negative control. Gene expression was quantified 
by real time PCR at 1.5 h, 3 h and 5 h of cells incubation. Results performed in triplicate are represented 
by whisker box-plot (Tukey). Outlier values are indicated by black dots. The non-parametric Wilcoxon 
test was used for statistical comparisons. * and # (p<0.05) indicate significant differences. 
In promastigote infected-KCs, a transient slight increase of IL-10 gene 
expression was observed early during infection (1.5 h) followed by a rapid decreased to 
levels similar of non-infected KC. After 3 h of incubation, amastigote infected-KCs 
exhibited a significant transient increase of IL-10 gene expression (P=0.0214), then 
returning to normal values (Figure 722A). LPS exposed KCs induce more IL-10 
expression than L. infantum presence, probably to balance the immune environment, as 
LPS actives inflammatory cytokine expression. Promastigote promoted KCs to 
increased IL-4 gene expression, this enhance was significant at 5 h of incubation 
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(P=0.0022). This increase was statistically different from LPS incubated KCs 
(P=0.0160). Although amastigote infection maintained IL-4 levels similar to 
non-infected KCs statistical differences were observed between incubation time points 
showing an increasing tendency (Figure 722B). After 3 h of incubation, IL-4 gene 
expression was slightly increased in amastigotes infected KCs (P=0.0014). The IL-4 
increased accumulation was maintained until 5 h of incubation (P=0.0353). In 
amastigote infected-KCs TGF-β gene was kept at low levels (Figure 722C). At 3 h post-
infection, there was a significant increase of TGF-β gene expression (P=0.0102). 
However the values were not different from non-infected KCs.  
Several outliers were evident as possible reflection of a diverse genetic 
background of the tested dogs. 
 
Figure 72: Gene expression of anti-inflammatory cytokines by KC exposed to L. infantum virulent 
promastigotes or axenic amastigotes. 
A) IL- 10. B) IL- 4. C) TGF-β. Uninfected KC were also used as negative control. Results performed in 
triplicate are represented by whisker box-plot (Tukey). Outlier values are indicated by black dots. The 
non-parametric Wilcoxon was used for statistical comparisons. * and # (p<0.05) indicate significant 
differences. 
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Taken together, these results indicate that although the presence of the parasite 
induces some changes in gene expression of anti-inflammatory cytokines by KCs, the 
effective anti-inflammatory activation of these cells is not much evident regardless the 
parasite morphological form used for infection.  
5.4.3.3. Treatment with Meglumine antimoniate trigger the expression 
of innate KC sensors and generate pro- and anti-inflammatory 
cytokines  
In order to investigate the effect of treatment in restoring KC activation, 
breaking the anergic effect imposed by the parasite, meglumine antimoniate (MgA) was 
added to KC after 24 h of promastigote infection. After this period of time, 
promastigote had already transformed into amastigote inside KC, as demonstrated in the 
fluorescence microscope images (Figure 64). NO and urea production were assessed 
after the addition of MgA.  
MgA treatment of infected KC did not lead to increase of NO production  
(Figure 733A). However, an early transient burst of urea, (Figure 733B) significantly 
different from non-treated infected-KCs (P=0.0391) was detected. Afterwards, the 
addition of MgA led to a significant decrease of urea (P3h= 0.0078; P24h = 0.0416) 
production when compared with the production estimated at 1.5 h.  
 
Figure 73: Production of NO and urea by L. infantum infected-KC treated with MgA. 
KC infected with virulent promastigotes for 24 hand treated with MgA were used to evaluate NO (A) and 
urea (B) production at 1.5 h, 3 h and 5 h and 24 h after treatment. Untreated infected-KCs (KCinf) were 
also evaluated. Results evaluated in triplicate are represented by whisker box-plot (minimum to 
maximum). Outlier values are indicated by black dots. The non-parametric Wilcoxon test was used for 
statistical comparisons. * and # (p<0.05) indicate significant differences. 
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Gene expression of innate immune receptors NOD1, NOD2, TLR2, TLR4 and 
TLR9 by L. infantum infected-KC that were under MgA treatment were measured by 
real-time PCR. Gene expression of pro- and anti-inflammatory key cytokines were also 
accessed.  
Treatment with MgA induced an initial increase of NOD1 and NOD2 gene 
expression by KC after 1.5 h, however, not statistical significant (Figure 744A). NOD2 
mRNA in MgA treated KC decreased with the time of exposition to treatment, 
compared to infected KC and LPS exposed cells (P= 0.0039) (Figure 744B). 
 
Figure 74: Gene expression of innate sensors by L. infantum infected-KC treated with MgA. 
KC infected with virulent promastigotes for 24 hand treated with MgA were used to evaluate the number 
of copies of NOD1 (A) and NOD2 (B) by real time PCR at 1.5 h, 3 h, 5 h and 24 h after treatment. NOD1 
and NOD2 of untreated infected KCs and LPS-stimulated KCs were also evaluated. Results evaluated in 
triplicate are represented by whisker box-plot (Tukey). The non-parametric Wilcoxon test was used for 
statistical comparisons. Outlier values are indicated by black dots. * and # (p<0.05) indicate significant 
differences. 
After MgA addition, it was verified an increase in gene expression of TLR2 and 
TLR4 indicating a possible involvement of these receptors in the immune activation 
against L. infantum amastigotes (Figure 75). Early after MgA addition (1.5 h 
incubation) TLR2 expression registered a significant increase compared with not treated 
infected-KC (P= 0.0070). Significant increases were also observed at 3 h (P=0.0080) 
and 5 h (P=0.0105) after treatment. TLR4 registered significant increases at 1.5 h 
(P=0.0067) and 3 h (P= 0.0151) of treatment. TLR9 registered an increase in expression 
levels after 5 h incubation, however, not statistically significant.  




Figure 75: Gene expression of TLRs in KCs infected by L. infantum and treated with MgA. 
KC infected with virulent promastigotes for 24 hand treated with MgA were used to evaluate the e 
number of copies of TLR2(A), TLR4 (B) and TLR9 (C) by real time PCR at 1.5 h, 3 h, 5 h and 24 h after 
treatment. TLR2, TLR4 and TLR9 of untreated infected KCs and LPS-stimulated KCs were also 
evaluated. Results evaluated in triplicate are represented by whisker box-plot (Tukey). Outlier values are 
indicated by black dots. * and # (p<0.05) indicate significant differences. 
After MgA treatment, increased accumulation of TNF-mRNA by infected 
KCs was observed, indicating that treatment overcome the silencing effect imposed by 
the parasite (Figure 766). IL-12 registered an evident increase in expression after 1.5 h 
incubation with meglumine antimoniate, which decreased with incubation time. Even 
so, these increases did not present statistical relevance, However, TNF-α presented a 
significant augment after 1.5 h of treatment (P=0.0033) that was maitainded until 5 h 
(P3h = 0.0053, P5h = 0.0302) treatment time. At this point some dogs evidence an 
activation and increased expression and others exibited an decreased in TNF-α 
expression.  




Figure 76: Gene expression pro-inflammatory cytokines by L. infantum-infected KC treated with 
MgA. 
KC infected with virulent promastigotes for 24 h and treated with MgA was used to evaluate the number 
of IL-12 copies (A) and TNF-α (B) by real time PCR at 1.5 h, 3 h, 5 h and 24 h of treatment. IL-12 and 
TNF-of untreated infected KCs and of LPS stimulated KCs were also evaluated. Results evaluated in 
triplicate are represented by whisker box-plot (Tukey). Outlier values are indicated by black dots. The 
non-parametric Wilcoxon test was used for statistical comparisons * and # (p<0.05) indicate significant 
differences.  
Th2 cytokines analyzed also revealed some differences when infected KC were 
exposed to a leishmanicidal drug (Figure 777). When compared with untreated infected 
KCs, IL-10 gene expression was significantly increased after 1.5 h exposition to MgA 
(P=0.0413) and decreased with treatment time, indicating that exposition to MgA may 
influence IL-10 expression of infected KC. On the other hand, IL-4 gene expression 
revealed a decrease after 3 h treatment with MgA, when compared to infected-KC 
(P=0.0465). Non treated infected-KC exhibited the higher accumulation of IL-4 mRNA. 
LPS-stimulated KC also showed a significant IL-4 decrease when compared with 
untreated infected KC (P= 0.0043) and with treated cells (P1.5h=0.0215 and P3h=0.0342). 
As for TGF-β expression, an increase was observed after 1.5 h of incubation with MgA, 
although not statistically significant. TGF-β expression showed a decreasing tendency 
with MgA treatment. All together, these results indicate that the addition of MgA to 
infected KCs influences the immune response exhibited by KCs. 




Figure 77: Expression anti-inflammatory cytokines in L. infantum-infected KC treated with MgA. 
KC infected with virulent promastigotes for 24 hand treated with MgA were used to evaluate the number 
of copies of IL-10 (A), IL-4 (B) and TGF-β (C) by real time PCR at 1.5 h, 3 h, 5 h and 24 h of treatment. 
IL-10, IL-4 and TGF-β of untreated infected KCs and LPS stimulated KCs were also evaluated. Results 
evaluated in triplicate are represented by whisker box-plot (Tukey). Outlier values are indicated by black 
dots. The non-parametric Wilcoxon test was used for statistical comparisons * and # (p<0.05) indicate 
significant differences. 
5.4.4. Hepatocytes induce TLR2 gene expression in co-culture 
with L. infantum-infected Kupffer cells and generate a mix 
profile of cytokines 
To investigate if the presence of hepatocytes could increase immune activation 
signals, co-cultures of KC-infected by L. infantum and canine hepatocytes were 
performed. KC were infected with L. infantum virulent promastigotes for 24 h. During 
this period of time, parasites were internalized and differentiated into amastigotes. Gene 
expression of innate immune sensors NOD1, NOD2, TLR2, TLR4 and TLR9 of KCs 
were accessed after 1.5 h, 3 h, and 5 h of culture with hepatocytes and compared with 
just infected KCs.  
NOD1 gene expression registered an increased after 1.5 h, although not 
statistically important (Figure 788A). At 3 h of incubation cells registered a decrease in 
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NOD1 mRNA accumulation (P=0.0066). However, it is still considered an increase in 
NOD1 expression when compared to amastigote-infected KC (P=0.451). Curiously, 
NOD2 expression levels (Figure 788B) in co-culture did not differ from NOD2 
expression levels in KC infected with amastigote. 
 
Figure 78: Gene expression of NOD1 and NOD2by infected-KC in co-culture with hepatocytes. 
KCs infected with amastigotes for 24 h co-cultured with hepatocytes were used to evaluate the number of 
copies of NOD1(A) and NOD2 (B). In parallel NOD1 and NOD2 of just infected KCs were also 
evaluated. The number of copies was determined by real time PCR at 1.5 h, 3 h, and 5 h. Results 
evaluated in triplicate are represented by whisker box-plot (Tukey). Outlier values are indicated by black 
dots. The non-parametric Wilcoxon test was used for statistical comparisons. * and # (p<0.05) indicate 
significant differences. 
As for TLR2 gene expression, the presence of hepatocyte was able to induce a 
transient increse in this receptor after 1.5 h incubation in co-culture (P=0.0020) when 
compared with just infected KCs (Figure 7979). In KC infected with amastigotes there 
was a significant increse in TLR2 gene expression from 1.5 h to 5 h (P=0.0131). TLR4 
gene expression in co-cultures exhibited a significant decrease after 3 h in culture 
(P=0.0156) and were kept lower than in infected KCs. TLR9 gene expression appeared 
to increase in infected KCs after 3 h in co-culture, but transiently and without 
statistically significance.  




Figure 79: Gene expression of TLR2, TLR4 and TLR9 by infected KC in co-culture with 
hepatocytes. 
KCs infected with amastigotes for 24 h co-cultured with hepatocytes were used to evaluate the number of 
copies of TLR2 (A). TLR4(B) and TLR9(C). In parallel TLR2, TLR-4 and TLR9of just infected KCs 
were also evaluated parallel. The number of copies of was determined by real time PCR at 1.5 h, 3 h, and 
5 h. Results evaluated in triplicate are represented by whisker box-plot (Tukey). The non-parametric 
Wilcoxon test was used for statistical comparisons. Outlier values are indicated by black dots. * and # 
(p<0.05) indicate significant differences. 
Cytokine gene expression of infected KCs experienced slight changes when in 
the presence of hepatocytes. IL-12 registered an increase in gene expression after 1.5 h 
in co-culture, although not statistically significant (Figure 800A). The levels of TNF-α 
mRNA accumulation in infected-KC co-cultured with hepatocytes for 1.5 h registered a 
significant increase when compared with amastigote-infected KC (P=0.0098). KC 
infected with amastigotes significantly decreased TNF-α expression after 3 h post-
infection (P=0.0263) and also when in co-culture (P= 0.0137) (Figure 800B). These 
indicate that hepatocytes were able to induce infected KCs to generate TNF-α, evading 
parasite imposed silencing. 




Figure 80: Gene expression of pro-inflammatory cytokines by infected KC co-cultured with 
hepatocytes. 
KCs infected with amastigotes for 24 h co-cultured with hepatocytes were used to evaluate the number of 
copies of IL-12 (A) TNF-α (B). In parallel IL-12 and TNF- α of just infected KCs were also evaluated. 
The number of copies was determined by real time PCR at 1.5 h, 3 h, and 5 h. Results evaluated in 
triplicate are represented by whisker box-plot (Tukey). Outlier values are indicated by black dots. The 
non-parametric Wilcoxon test was used for statistical comparisons. * and # (p<0.05) indicate significant 
differences. 
Anti-inflammatory cytokines IL-4 and TGF-β exhibit major increases in their 
gene expression in infected-KCs co-cultured with hepatocytes (Figure 811). IL-10 
expression levels were increased after 1.5 h in co-culture and remain raised. The 
increase verified at 5 h in co-culture was statistically important (P=0.0078) and 
corresponded to the higher expression value observed. KCs infected with amastigote 
revealed a increase in IL-10 gene expression after 3 h post-infection (P=0.0214). IL-4 
gene expression were increased in infected KCs co-cultured with hepatocytes during the 
entire experimental period when compared with infected-KC (P1.5h=0.039, P3h=0.0195, 
P5h =0.0156). TGF-β gene expression were also greatly impacted by the presence of 
hepatocyte in a KC-infected co-culture. This cytokine also revealed a major increase 
after 1.5 h in co-culture (P=0.0039) when compared with just infected KCs. A light 
increase in TGF-β in KC amastigote infection was observed after 3 h post-infection 
(P=0.0102).  




Figure 81: Gene expression of anti-inflammatory cytokines by infected KC co-cultured with 
hepatocytes. 
KCs infected with amastigotes for 24 h  
co-cultured with hepatocytes were used to evaluate the number of copies of IL-10 (A), IL-4 (B) and TGF-
β (C).In parallel IL-10, IL-4 and TGF-β of just infected KCs were also evaluated. The number of copies 
was determined by real time PCR at 1.5 h, 3 h, and 5 h. Results evaluated in triplicate are represented by 
whisker box-plot (Tukey). Outlier values are indicated by black dots. The non-parametric Wilcoxon test 
was used for statistical comparisons. * and # (p<0.05) indicate significant differences. 
5.4.5. Kupffer cells are immune tolerant cells in comparison with 
blood macrophages when facing a L. infantum infection 
The immune profile evidenced by circulating blood MØs when exposed to L. 
infantum promastigotes and by KCs when exposed to L. infantum amastigotes was 
compared. In this particular case, MØs and KCs were infected with different parasite 
forms, mimicking the natural progression of the parasite infection. Promastigotes are 
inoculated by the sand fly in the dog and they are the most likely form able to induce 
blood monocyte differentiation into MØ in association with parasite phagocytosis.  
When arriving to the liver, the parasite was already up taking by the host cell, acquiring 
the intracellular amastigote form. Although, it is possible that blood-MØs transport 
amastigotes the presence of promastigote forms in internal compartments, such as the 
liver, is not usually described. Lipopolysaccharide (LPS) was used in KCs as a positive 
control of inflammation, since it is a classical inducer of MØ inflammation.  
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5.4.5.1. Gene expression of cell sensors 
Gene expression of the innate immune receptors NOD1 and NOD2 revealed a 
similar tendency in promastigote infected-blood MØs and in amastigote infected-KCs. 
During the first 3 h of infection, blood-MØs evidenced significant higher levels of 
expression that were reduced at 5 h of infection (Figure 822). After 1.5 h and 3 h of 
exposition to promastigotes, there was a significant accumulation of NOD1  
(P1.5h<0.0001, P3h=0.0145) and NOD2 (P1.5h<0.0001, P3h =0.0156) mRNA when 
compared with KCs. At early infection (1.5 h), the NOD1 gene expression observed in 
KCs was significantly lower than by LPS stimulated-KCs (Figure 822A). After 5 h of 
infection, MØs decreased the gene expression of both sensors (P<0.0001) in comparison 
to the previous time point (3 h). When compared with blood-MØs, KCs exhibited a 
significant increase of NOD1 copy number (P=0.0303) at 5 h of infection, reaching 
levels similar to LPS stimulated-KCs However, the accumulation of NOD2 mRNA in 
blood-MØ (Figure 822B) still is more elevated that in KCs (P=0.0129). LPS-stimulated 
KCs exhibited higher NOD1 gene expression at 1.5 h of incubation (P=0.0095) and, 
NOD2 at 1.5 h (P=0.0015) and 3 h (P=0.0067) of incubation. 
 Taken together, these results indicate that MØs from two different lineages 
seem to differ in L. infantum recognition through NOD1 and NOD2 sensors. Also, the 
stimulation induced by LPS had different effects in the two sensors investigated. 
 
Figure 82: Gene expression of NOD1and NOD2 sensors by L. infantum infected KCs and blood-
MØs. 
KCs were exposed to amastigotes and blood-MØs to promastigotes for 5 h. The number of copies of 
NOD1(A) and NOD2 (B) was determined by real time PCR at 1.5 h, 3 h and 5 h. In parallel, NOD1 and 
NOD2 gene expression of LPS-stimulated-KCs was also evaluated. Results expressed by whisker box-
plot (Tukey). Outlier values are indicated by black dots. The non-parametric Wilcoxon test was used for 
statistical comparisons. * and # (p<0.05) indicate significant differences. 
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Other accessed innate immune receptors included TLR2, TLR4 and TLR9. For 
these receptors also major differences were registered between blood-MØ sand KCs 
(Figure 833). After 1.5 h of infection, it was verified a significant increase of TLR2 
(Figure 833A) and TLR4 mRNA (P<0.0001) (Figure 833B) in comparison with KCs. 
These higher values persisted until 3 h post-infection, being still statistically significant 
for TLR4 (P=0.0020). After 5 h of infection, the number of copies of both sensors 
decreased to lower levels (PTLR2<0.0001, PTLR4=0.0010) when compared with the 
previous time point. In a similar way, the TLR9 expression levels significantly increase 
in infected blood MØs when compared with infected KCs at both 1.5 h (P<0.0001) and 
3 h (P=0.0195) time points (Figure 833C). After 5 h of infection, the levels of TLR9 
mRNA significantly decrease when compared with 3 h time point (P<0.0001) and with 
KCs (P=0.0228).  
Taken together, these results indicate that MØs from two different lineages seem 
to differ in L. infantum recognition through cell innate sensors. The reduction of 
sensor’s gene expression observed 5 h post-infection could be a consequence of a 
possible silencing effect exerted by the parasite. Also, the stimulation induced by LPS 
had different effects in the sensors investigated. It is also apparent the presence of 
several outliers as a probable evidence of the different genetic background of the canine 
population. 




Figure 83: Gene expression of TLR2, TLR4 and TLR9 sensors by L. infantum infected blood MØs 
and KCs. 
Blood MØs were exposed to promastigotes and KCs to amastigotes for 5 h. The number of copies of 
TLR2 (A), TLR4 (B) and TLR9 (C) was determined by real time PCR at 1.5 h, 3 h and 5 h. In parallel 
TLR2 and TLR4 gene expression of LPS-stimulated KCs was also evaluated. Results expressed by a 
whiskers box-plot (Tukey). Outlier values are indicated by black dots. The non-parametric Wilcoxon test 
was used for statistical comparisons.* and # (p<0.05) indicate significant differences. 
5.4.5.2. Pro- and anti-inflammatory cytokine gene expression  
Until 3 h of infection, blood-MØs exhibited significant increase of IL-12  
(P1.5h<0.0001, P3h=0.0010) and TNF-α (P1.5h<0.0001) gene expression when compared 
with KCs (Figure 844). Nevertheless, after 5 h post-infection the expression 
significantly decays when compared with the previous time point (3 h) as a result of a 
possible silencing effect exerted by the parasite. Expression levels of IL-12 (P1.5h= 
0.0066,  
P3h= 0.0052, P5h= 0.0425) and TNF-α (P1.5h< 0.0001, P3h = 0.0329) by infected-KCs is 
lower than by LPS stimulated-KCs. 




Figure 84: Gene expression of pro-inflammatory cytokines IL-12 and TNF- by L. infantum 
infected KCs and blood-MØs. 
Blood-MØs were exposed to promastigotes and KCs to amastigotes for 5 h. The number of copies 
ofIL-12 (A) and TNF- (B) was determined by real time PCR at 1.5 h, 3 h and 5 h. In parallel IL-12 and 
TNF-gene expression of LPS-stimulated KCs was also evaluated. Results expressed by a whiskers 
box-plot (Tukey). Outlier values are indicated by black dots. The non-parametric Wilcoxon test was used 
for statistical comparisons. * and # (p<0.05) indicate significant differences. 
Infected blood-MØs presented significant increased IL-10 (Figure 855A) and IL-
4 (Figure 855B) gene expression from 1.5 h (P<0.0001) until 3 h (PIL-10=0.0411,  
PIL-4=0.0313) post-infection when compared with infected KCs. After 5 h in contact 
with the parasite it was observed a considerable reduction in the copy number of IL-10 
(PIL-10<0.0001) and IL-4 when compared with the previous time point (3 h)  
(PIL-4=0.0003). At 1.5 h of parasite exposure, KCs evidenced low accumulation of IL-10 
(P=0.0280) and IL-4 mRNA (P=0.0318) in comparison to LPS stimulated-KCs.  
TGF-β gene expression followed a similar pattern (Figure 855C). Significant 
high expression was observed in blood-MØs at 1.5 h (P<0.0001), 3 h (P=0.0039) and 5 
h (P=0.0240) of incubation with promastigotes when compared with infected KCs. 
However, at 5 h of incubation was verified a significant decrease in the accumulation of 
TGF-β mRNA by blood-MØs when compared with the previous time point (3 h) 
(P<0.0001). At 1.5 h, TGF-β copy number of infected KCs was significant reduced in 
comparison to LPS stimulated-KCs (P=0.0294).  




Figure 85: Gene expression of anti-inflammatory cytokines IL-10, IL-4 and TGF- by L. infantum 
infected KCs and blood-MØs. 
Blood MØs were exposed to promastigotes and KCs to amastigotes for 5 h. The number of copies of 
IL-10 (A), IL-4 (B) and TGF- (C) was determined by real time PCR at 1.5 h, 3 h and 5 h. In parallel 
IL-10, IL-4 and TGF-gene expression of LPS-stimulated KCs was also evaluated. Results expressed by 
whisker box-plot (Tukey). The non-parametric Wilcoxon test was used for statistical comparisons. Outlier 
values are indicated by black dots. * and # (p<0.05) indicate significant differences. 
Taken together, these results put in evidence that the initial contact (≈3 h) of 
blood-MØs with promastigotes induce host cell activation, leading the simultaneous 
generation of pro- and anti-inflammatory cytokines. However, a prolonged time of 
contact with the parasite (5 h) has an opposite effect in the host cell, reducing cell 
activity and the cytokine gene expression. At this time, is probable that phagocytosis 
has occurred, at least in same extension and a few parasites have differentiated into 
amastigotes. On the other hand, KCs harboring internalized amastigotes were unable to 
trigger immune activation, at least during the period of time considered in this study. 
 
. 




Kupffer cells (KCs) constitute the liver resident MØs localized within the lumen 
of the liver sinusoids, adherent to the endothelial cells that compose the blood vessel 
walls. KCs are of particular importance as they constitute the first MØ population of the 
body to come in contact with bacteria, bacterial endotoxins and microbial debris derived 
from the gastrointestinal tract and transported to the liver via the portal vein. Together 
with natural killer cells (NKs), dendritic cells (DCs) and soluble compounds, such as 
complement factors and acute phase proteins, KCs represent an important component of 
innate immunity, the initial rapid response to a potentially dangerous or, by the contrary 
have a key role in directing immune tolerance. In the present study, KCs were isolated 
from livers of apparent healthy dogs and their immune response displayed against 
L. infantum was accessed for the first time. Since dog constitutes the peridomestic 
reservoir of this parasite, it is of major importance to understand how reacts to parasite 
and why allows parasite establishment. Understanding how KCs, the host cells of 
L. infantum in the liver, sense and react to the parasite presence, may result in a better 
understanding of the mechanisms elicited by the parasite to control the host immune 
response. 
Isolated cells revealed to be positive for CD68 receptor and for lysozyme 
presence, two characteristics of macrophages (MØ). CD68 is glycoprotein highly 
expressed by monocytes and tissue macrophages, including KC, microglia, histiocytes 
and osteoclasts. Being classified as a member of the scavenger receptor family, typical 
functions of CD68 include clearance of cellular debris, promotion of phagocytosis, and 
the mediation, recruitment and activation of MØs. CD68 is also a member of the 
lysosome associated membrane protein (LAMP) family, where CD68 predominantly 
localizes to lysosomes and endosomes with a smaller fraction circulating to the cell 
surface (Saito et al., 1991). Isolated cells were CD68 positive, with receptor localization 
in several intracellular vesicles throughout the cells, coinciding with what was 
described. MØs are also an important source of physiologically active secretory 
products such as cytokines, growth factors, complement and clotting proteins, proteases 
and other enzymes. Lysozyme, also known as muramidase or N-acetylmuramide 
glycanhydrolase are glycoside hydrolases, present in several body secretions, and 
5 | Chapter 2 
 
304 
exhibit an enzymatic activity that damage bacterial cell walls. Lysozyme is found in the 
cytoplasm of MØs and is generally regarded as a constitutive marker of MØs 
biosynthetic activity (Keshav et al., 1991). KCs contain lysozyme in their cytoplasmic 
granules, vacuoles and phagosomes and some cells show a positive reaction in the 
rough endoplasmic reticulum, perinuclear cisternae and the Golgi zone (Miyauchi et al., 
1985).Isolated cells from the canine livers were also positive lysozyme, which together 
with the presence of CD68, confirm their identity as liver resident MØ or KCs. As for 
intracellular localization, lysozyme was detected in abundance in several cytoplasmic 
granules. In human MØs, it was reported co-localization of CD68 with lysozyme (Saito 
et al., 1991). A similar situation was observed with canine KCs, with co-localization of 
CD68 with lysozyme in several cytoplasmic granules and vacuoles. 
Different KC infection patterns were found between amastigotes and 
promastigotes of L. infantum. Amastigotes constitute the natural form of parasite 
infecting KCs, as it comprises the form of the parasite that arrives to the liver. 
Promastigotes are the form of the parasite that infects circulating MØs recruited to the 
site of infection. It is widely known that there are major differences between 
promastigotes and amastigotes membrane proteins, which confer higher adaptability to 
its specific environment. Leishmania experiences extreme environmental changes as it 
alternates between the insect gut as a free motile form (promastigote) and the 
fagolisossome of mammalian host cell as the intracellular non-flagellate form 
(amastigote). In addition to morphological characteristics, the two life stages also have 
differences in the surface molecular constitution. While infectious metacyclic 
promastigotes have a thick glycocalyx over the entire body this cover is almost absent 
in amastigotes (Pimenta et al., 1991). The glycocalyx is mainly constituted by 
glycoproteins and glycosylated molecules anchored to the surface membrane by a 
glycosylphosphatidylinositol (GPI) linkage (Ferguson et al., 1997). The promastigote 
surface is predominantly covered by lipophosphoglycan (LPG), a GPI-anchored 
molecule made of repeating units of a disaccharide and a phosphate. Promastigotes have 
another important GPI-anchored molecule, the surface protease gp63. By the contrary, 
amastigotes have been shown to produce very little LPG (McConville and Blackwell, 
1991) and have less gp63 at the surface (Souza et al., 1992). These differences in the 
5 | Chapter 2 
 
305 
membrane constitution as a consequence of the adaptation to different 
micro-environments are important in the immune regulation of the host. 
However, the signaling events controlling amastigote differentiation remain 
poorly understood. In some Leishmania species, differentiation of promastigotes into 
amastigotes is induced by elevated temperature and low pH, conditions found within 
MØ parasitophorous vacuoles. It is described that the link of L. mexicana to the human 
C-reactive protein present in the serum greatly stimulates the transformation of 
promastigotes into amastigotes (Bee et al., 2001). Recently, Mittra et al. (2013) 
revealed a novel role for iron uptake in orchestrating the differentiation of amastigotes, 
through a mechanism that involves production of reactive oxygen species (ROS). 
Function as signaling molecules, ROS regulate Leishmania differentiation in a process 
that is tightly controlled by iron availability and is independent of pH and temperature 
changes. Thus, the signaling process that triggers parasite differentiation is complex and 
multifactorial, culminating in the relative promastigote susceptibility and amastigote 
resistance to MØ-mediated killing and in the apparent inability of susceptible hosts to 
orchestrate the necessary immune response to activate MØs and destroy intracellular 
amastigotes (Sadick and Raff, 1985). In the present work, amastigotes were found to be 
more efficient and apt to infect KCs. This result might be expected as amastigotes 
constitute the liver infective form. However, promastigotes can also be taken in by KCs, 
pointing out the susceptibility of this cell lineage to this parasite form, with which the 
natural contact is unusual, but in this case the immunological “takeover” of host cell 
takes longer time. 
Amastigotes and promastigotes of L. infantum exhibit an evident tropism to 
KCs, with more than one parasite being phagocytized by a single cell. But the rate and 
efficiency of the infection were different between amastigote and promastigote. 
Amastigotes quickly achieve 100% infection while promastigotes required prolonged 
incubation to achieve identical infection levels. Therefore, amastigotes seem to be more 
fit to infect KCs than promastigotes. Amastigotes uses different phagocytosis receptors 
than promastigotes to be recognized by MØs, enabling a fast phagocytosis and a rapid 
control of innate immune activation of host cells. Given that, promastigotes have to 
avoid MØ microbicidal activity to establish themselves in the host and amastigotes have 
to suppress MØ killing abilities when try to invade new MØs in the course of a 
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persistent Leishmania infection, it is not surprising that both forms of the parasite might 
modulate key MØ signaling pathways (Olivier et al., 2005). Several studies have 
previously demonstrated that promastigotes and amastigotes or derived molecules are 
able to block nitric oxide (NO) production by host MØs in response to activating 
stimuli, such as gamma interferon (IFN-γ) or bacterial lipopolysaccharide (LPS). As 
indicated above, promastigote surface contains several glycoconjugates favoring the 
interaction with MØs and internalization via several types of receptors, such as 
complement receptors 1, 3, and 4, the mannose fucose receptor, the C-reactive protein 
receptor and the fibronectin receptor (Guy and Belosevic, 1993; Abu-Dayyeh et al., 
2010). On the other hand, amastigotes lack many of those glycoconjugates and seem to 
interact with MØs mainly through glycosylinositol phospholipids (GIPLs) and to be 
phagocytized via the Fc receptors following opsonization by antibodies or via 
complement receptors (Guy and Belosevic, 1993). Although redundancies might exist 
in the way promastigotes and amastigotes interact with MØs and with KCs, both 
modulate signaling to block MØs killing functions. The differences between both forms, 
whether at the gene expression, metabolic or at a surface molecule level suggests that 
some differences ought to exist, so that both forms can modulate MØ signaling to their 
own favor. Promastigote need to block immune activation to successfully infect MØ for 
the first time, and the amastigote form in order to be able to continue the ongoing 
infection without activating MØs. So, both parasitic forms can modulate the immune 
activation of the host cells, but amastigotes are more efficient in doing so. This form of 
L. infantum is perfectly adapted to keep infection ongoing, by infecting new MØs (or 
KCs), using different phagocytic receptors and strategies, as the antigen release through 
the parasitophorus vacuole, downregulating MØ activation and avoiding parasite 
destruction. 
MØs constitute a decisive effector cell in Leishmania infection. Depending on 
the balance between the inducible enzymes nitric oxide synthase (iNOS) and arginase, 
these cells may kill the parasite or host it, allowing parasite replication and dispersion. 
Both enzymes use L-arginine as a substrate and are competitively regulated by 
cytokines secreted by Th1 and Th2 cells. Th1 cytokines induce MØ classical activation, 
leading iNOS activation that oxidizes L-arginine in a two-step process and release nitric 
oxide (NO), a metabolite responsible for the parasite killing. Th2 cytokines result in the 
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MØ alternative activation with the induction of arginase, which hydrolyzes L-arginine 
into ornithine, an amino acid that is the main intracellular source for the synthesis of 
polyamines that are important for the parasite survival. Arginase is also classically 
considered to be an enzyme of the urea cycle in the liver (Hofmann et al., 1978). In 
mammals, have been identified two distinct arginase isoforms encoded by different 
genes that also differ in the cellular localization and in the mode of regulation. Type 1 
arginase is a cytosolic enzyme expressed at high levels in the liver as a component of 
the urea cycle, and type 2 arginase is a mitochondrial enzyme found in a variety of 
tissues. It is also known that MØs up-regulate arginase 1 upon activation by Th2 
cytokines, expressing at the same time low levels of arginase 2 (Munder et al., 1998). 
Kropf et al. (2005) demonstrated a direct correlation between the unrestricted 
replication of L. major parasites in susceptible hosts and the increasing levels of 
arginase at the site of lesion. In contrast, parasite load is detectable but controlled in 
genetically resistant hosts, which also resolve the cutaneous lesions and acquire 
immunity to reinfection accompanied by arginase down-regulation. It is generally 
accepted that IFN-γ produced by polarized Th1 cells of healer strains of mice, direct the 
induction of iNOS by MØs and the subsequent synthesis of NO, promoting parasite 
killing (Bogdan, 2001). In the present study, the initial contact of KCs with L. infantum, 
regardless the parasite form used, lead to NO production and to a burst of urea, 
indicating the activation of both enzymes iNOS and arginase. However, with the 
increase to parasite exposure becomes apparent the immune modulator effect exerted by 
the parasite in KCs activation through the accentuated reduction of available NO, as a 
probable consequence of iNOS downregulation. This immune modulator effect was 
much more evident in amastigote infected-KCs, where it was noted a faster decrease of 
NO and urea, pointing for the silencing of both arginine pathways associated with a 
possible induction of a KC tolerant stage. 
The importance of careful regulation of urea synthesis may also be addressed 
observing the effect of polyamines production on the host. Polyamines are not only 
beneficial for the growth of Leishmania they also have wider effects by modulating 
immune functions and affecting signaling transduction pathways. For example, 
spermine and spermidine have been shown to inhibit the secretion of pro-inflammatory 
cytokines and spermine counter-regulates innate immune response induced by the TLR4 
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ligand lipopolysaccharide (LPS) (Perez-Cano et al., 2003). Therefore, increased 
polyamine levels in Leishmania infections could contribute to the inefficient host 
defense, at least in BALB/c mice. 
To exert control over NO production, Leishmania exploits the host immune 
response. Interestingly, Trypanosoma cruzi, another member of the Trypanosomatidae 
family do not express their own arginase, inducing host MØ arginase via the parasite 
derived molecule cruzipain (Stempin et al., 2002). By capturing host arginase, this 
parasite reduces the availability of L-arginine for NO synthesis, avoiding parasite 
killing (Gobert et al., 2000). In contrast, Leishmania parasites express their own 
originals and do not directly induce arginase expression in host cells. Instead, exploit 
the Th2 immune response of susceptible hosts to induce arginase activity and the 
consequent production of ornithine/polyamines for parasite multiplication, resulting in a 
devastating circle of uncontrolled parasite growth and pathology. This particular 
strategy contributes for a successful infection, since the inactivation of both arginase 
alleles results in non-viable parasites (Roberts et al., 2004). 
Although this study present indirect evidence of the rapid action of L. infantum 
amastigotes over iNOS and arginase of KCs this modulation is not associated with an 
imbalance in the generation of pro- and anti-inflammatory cytokines. In fact, the contact 
with amastigotes or promastigotes is not related to cytokine generation by KCs, pointing 
for an unresponsiveness state characteristic of immune tolerance as consequence of 
parasite manipulation. 
The majority of the studies is focused in MØ signaling and activation by 
promastigotes and fewer reports investigated signaling alterations mediated by 
amastigotes, having a lack of comparative studies. The cytokine profile obtained for 
KCs in this study indicates an incomplete activation and gives evidence of a rapid 
suppressive effect of amastigotes and promastigotes over KCs that can outline the 
infection outcome. For instance, the pro-inflammatory cytokine TNF-α is the key to 
initiate granuloma formation, which is associated with host resistance to L. infantum 
infection in the mouse model of VL as well as in canine and human host (Pearson and 
Sousa, 1996; Murray, 2001; Sanchez et al., 2004). TNF-α gene expression was kept 
low, similar to non-infected cells, as well as pro-inflammatory IL-12, demonstrating the 
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immune modulating activity of L. infantum. Curiously, TNF-α gene expression is 
rescued if a leishmanicidal drug is added or in a co-culture with hepatocytes. 
There are plenty of studies on the innate immune response in animal 
leishmaniasis models, only a few studies are completed in human leishmaniasis and, to 
the best of our knowledge the present work constitutes the first study of innate immune 
receptors in dog KCs in the context of a L. infantum infection. Toll-like receptors 
(TLRs) are a well-characterized class of PRRs dependent on the recruitment of a single 
or a specific combination of TIR-domain-containing adaptor protein (e.g., MyD88, 
TIRAP, TRIF, or TRAM) (Kawai and Akira, 2010). Myeloid differentiation factor 88 
(MyD88) is used by the majority of the TLRs, constituting a protein that interacts with 
several other molecules in signaling a downstream cascade that leads production of 
pro-inflammatory cytokines. The activation of MØ functions is first mediate by TLRs 
that play important roles in the control of infection (Gazzinelli and Denkers, 2006). 
TLRs are essential in connecting the innate and adaptive immune systems, in enhancing 
phagocytosis and promoting parasite killing. Signaling TLR downstream pathways is 
often associated with the production of effector molecules, such as pro-inflammatory 
cytokines that promote the differentiation of Th1 cells, leading to a resistant response of 
the host. There are limited studies on the characterization of TLR2 and TLR4 possible 
role in Leishmania infections, even in animal models. One of these studies performed in 
L. infantum infected BALB/c mice demonstrated an induction of TLR2 and TLR4 
mRNA throughout the course of infection and a higher expression of TLR4 and TLR2 
recorded at the peak of parasitic load. Further evidences suggest that the interaction of 
parasite with TLR2/TLR4 promotes cytokine modulation during the acute and chronic 
phases of the disease (Cezario et al., 2011). Studies using TLR4
−/−
 mutant mice indicate 
a protective role in L. major infection, clearly showing a less efficient parasite control at 
the site of infection when compared with wild-type mice (Kropf et al., 2004). More 
recently, it was reported that TLR2
−/−
 mutant mice were less susceptible to the infection 
with L. amazonensis than the wild-type C57BL6 mice, presenting a lower parasite 
burden and showing less inflammatory cells in the first weeks of infection (Guerra et 
al., 2010). Together, these observations indicate that depending upon Leishmania 
species TLR2 might play a role in disease establishment or resistance. In humans, it was 
demonstrated the relation of TLR2 and TLR4 with Leishmania protection and with the 
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differentiation of a Th1 immune response, in particular under the administration of a 
leishmanicidal drug (Tolouei et al., 2013). However, in dogs little is known about the 
role of TLRs during Leishmania infection. 
De Veer et al. (2003) demonstrated that TLR2 is essential for the protective 
immune response against intracellular pathogens including L. major and Toxoplasma 
gondii. TLR2 seems to be able to recognize lipophosphoglycan (LPG), a major surface 
promastigote phosphoglycan, and be up-regulated by LPG purified from L. major 
metacyclic promastigotes at least in human NKs (Becker et al., 2003). Bazzocchi et al. 
(2005) demonstrated TLR2 expression in canine granulocytes, monocytes and less 
markedly in lymphocytes from peripheral blood. Flandin et al. (2006) demonstrated in 
mouse MØ that TLR2 can act synergistically with TLR3 in recognizing L. donovani 
promastigotes. These authors also verified that when TLR2 or TLR3 were silenced 
using RNA interference, internalization of L. donovani promastigotes and NO and 
TNF-α secretion were reduced. Kavoosi et al. (2010) demonstrated that NO production 
in response to L. major lipophosphoglycan was significantly decreased in macrophage 
cell line cultures pretreated with anti-TLR2, highlighting the importance of TLRs in 
Leishmania infection by inducing NO production via the TLR2 signaling pathway. 
Therefore, TLR2 recognizes a numerous of unrelated molecules, and their role in 
infection by Leishmania has been evaluated but is still controversial. In the present 
work it was observed a slight increase in KC sensor gene expression after 5 h 
post-infection with both amastigotes and promastigotes. TLR2 constitute a 
transmembrane receptor expressed on the cell surface of immune cells, as MØ and KCs 
in particular. The interaction of LPG with TLR2 leads to the production of 
inflammatory mediators as IL-12 and in a lesser extent of TNF-α, suggesting that 
signalization through TLR2 can have a potential anti-parasite effector role. However, 
according to Chandra and Naik (2008), TLR2 could be down-regulated by LPG from 
parasites of the L. donovani complex with an increasing IL-10 production by 
monocytes-MØs. In dog KCs infected by L. infantum parasites, cells seem to be unable 
of generating TLR2. It is also interesting to note that even the virulent promastigote 
form, which expresses high levels of LPG were not able to increase TLR2 
accumulation. TLR4 polymorphisms have been linked to increased susceptibility and 
severity of L. major infection in human patients (Ajdary et al., 2011). In the present 
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work, KCs infection by amastigote or promastigote did not lead to an increase in the 
expression of this innate immune receptor, suggesting that L. infantum does not activate 
TLR4. However, TLR2 and TLR4 levels were in fact increased in blood derived MØ, 
pointing out the differences between tissue MØs (KCs) and circulating MØs. 
TLR9 has been associated with host protective anti-leishmanial immune 
response, as activation of TLR9 associated pathway by its ligand 
cytosine-phosphate-guanosine (CpG) elicits an anti-Leishmania immune response (Rhee 
et al., 2002). TLR9
-/-
 C57BL/6 mutant mice were transiently susceptible to L. major. 
The CpG motif containing L. major DNA was suggested signalize TLR9 pathway, 
inducing a host-protective effect (Fakher et al., 2009). In a more recent work, Srivastava 
et al. (2013) investigated the interaction of L. major LPG with TLR2 and TLR9 of 
mouse MØs. Curiously, LPG seems to activate TLR2, reducing host anti-leishmanial 
response via cytokine-mediated decrease of TLR-9 expression. In the present study, no 
significant alterations were observed in the levels of TLR9 expression in KCs infected 
with L. infantum amastigotes or promastigotes. This indicates that L. infantum does not 
activate TLR9 in canine KCs. Regarding the role of canine TLR2, TLR4 and TLR9 in 
KCs anti-Leishmania response more studies are needed in order to better understand the 
role of these receptors and clarify possible interactions between them. 
NOD1 and NOD2 gene expression in KCs are well described, but its role in 
Leishmania infection has been poorly explored. Turchetti et al. (2015) first investigated 
NOD1 and NOD2 in L. infantum infection in canine blood derived MØ. In the present 
work, KCs infected by L. infantum amastigotes or promastigotes did not evidence 
increased levels NOD1 or NOD2 mRNA, suggesting that L. infantum is not recognized 
by these immune receptors. According Turchetti’s work, NOD1 and NOD2 were found 
to have lower expression. The present results are in some accordance, as expression 
levels of both receptors did not increase with parasite presence. However, the levels of 
gene expression of both sensors were different in blood derived MØ. 
In the current study it was found that canine KCs infected by L. infantum 
amastigotes and exposed to an leishmanicidal drug – meglumine antimoniate (MgA) –
result in the activation of the cells with increasing expression of specific innate immune 
receptors and pro-inflammatory cytokines IL-12 and TNF-α. However, to balance the 
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pro-inflammatory response and avoid possible damage to the host an increase in IL-10 
and TGF-β was also verified. MgA is a pentavalent antimonial, which mechanism of 
action is still not fully understood. It is considered a pro-dug, that need cellular 
metabolization to achieve its active form and initial studies suggested that antimonials 
inhibited macromolecular biosynthesis in amastigotes, possibly via perturbation of 
energy metabolism due to inhibition of glycolysis and fatty acid beta-oxidation. It is 
also attributed to MgA an immunomodulator role. MgA decreases parasite load in 
human patients with CL caused by L. tropica, with considerable effect on up-regulation 
of T cells, demonstrating the parasitocidal and immunomodulator effects of MgA 
(Meymandi et al., 2011). As MgA is a leishmanicidal drug the killing of amastigotes 
may lead to the exposition of parasite antigens otherwise hidden and lead to the 
activation of the KCs. Amastigotes regulates very carefully the antigens released from 
the parasitophorous vacuole to avoid MØ activation. In addition to repressing the 
microbicidal activities, such as NØ and pro-inflammatory cytokine production by host 
MØ, Leishmania also inhibits the ability of the host cell to display parasite antigens to 
other components of the immune system. The regulation of pro-inflammatory cytokine 
production is particularly evident in the case of IL-12 and TNF-α inhibition, which 
prevent MØ from be activate. Some studies have shown that L. donovani inhibits 
antigen presentation by repressing major histocompatibility complex (MHC) class II 
gene expression (Reiner et al., 1987). Antigen presentation may be inhibited by 
interfering with the loading of antigens onto MHC class II molecules (Fruth et al., 
1993) or by sequestration of the MHC class II molecule and/or antigens within the 
phagolysosome (Kima et al., 1996). A third mechanism of inhibition was described, at 
least in L. amazonensis, where it was observed direct endocytosis of MHC class II 
molecules by amastigotes themselves, followed by cysteine peptidase-dependent 
degradation (De Souza Leao et al., 1995). The present results support the idea of an 
immunoregulator role associated with the administration of MgA. KCs infected with L. 
infantum amastigotes exhibit signals of silencing imposed by the parasite on MØ, with 
low NO production and anergic cytokine production. The addition of a leishmanicidal 
drug allows KC to break this imposed silence and activating IL-12 and TNF-α 
expression orchestrating an inflammatory immune response. Th2 cytokines were also 
increased in treated KCs, probably due to a balanced immune response, as an 
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uncontrolled inflammatory immune response may lead to serious consequences in the 
host, especially in the liver. Urea production was decreasing with treatment time to 
basal levels, and NO increase production, by the addition of MgA, reflecting the cell 
activation of iNOS. The addition of leishmanicidal drug suppresses the Leishmania 
immune silencing and TLR2 increased its expression in MgA treated KCs, 
accompanying the increase verified in IL-12 and TNF-α expression. Also TLR4 showed 
an increasing expression on KCs treated with MgA, attributing to these receptors a 
possible relevant role in activating KCs immune response in L. infantum infection. It is 
described the role of TLR4 in shaping the host immune response during Leishmania 
infection. Studies with TLR4
−/− 
mice demonstrate the role of TLR4 in the control of 
L. major infection (Kropf et al., 2004). Glyco-sphingophospholipid (GSPL) and 
proteoglycolipid complex (PGLC) from Leishmania are able to induce TLR4, 
promoting a strong antiparasitic immune response (Karmakar et al., 2012). As for 
TLR2, Leishmania has also devised mechanisms to alter TLR4 signaling pathways to 
favor the establishment of infection. During L. donovani infection, TLR4 mediated MØ 
activation is suppressed through the release of TGF-β that activates the ubiquitin editing 
enzyme A20 and Src homology 2 domain phosphotyrosine phosphatase 1 (SHP-1) (Das 
et al., 2012). L. major utilizes its inhibitors of serine protease (ISP) to prevent TLR4 
activation, inhibiting Leishmania uptake and killing by host MØs (Faria et al., 2011). 
As for TLR9, its role in Leishmania infection is poorly explored. TLR9 recognizes 
unmethylated CpG sequences in DNA molecules. CpG sites are relatively rare on 
vertebrate genomes in comparison to bacterial genomes or viral DNA. TLR9 is 
expressed intracellularly, within the endosomal compartments and is activated by the 
binding to DNA rich in CpG motifs, being essential in response against virus and 
bacteria (Krieg, 2008). As other TLRs, TLR9 signals lead to cell activation, initiating 
pro-inflammatory reactions that result in the production of cytokines such as TNF-α, 
IFN-γ and IL-12. In KCs treated with the leishmanicidal drug TLR9 does not register a 
significant increase, leading to the possibility of non-interaction of amastigotes antigens 
with this receptor. 
Although the role of these receptors in Leishmania infection is poorly known, it 
seems that NOD1 has a possible role in MØ activation. NODs can cooperate with TLRs 
and regulate inflammatory and apoptotic responses. NOD1 and NOD2 recognize 
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peptidoglycan motifs from bacterial cell which consists of N-acetylglucosamine and 
N-acetylmuramic acid. These sugar chains are cross-linked by peptide chains that can 
be sensed by NODs. NOD1 recognizes meso-diaminopimelic acid (meso-DAP) mostly 
found in Gram-negative bacteria. NOD2 can sense intracellular muramyl dipeptide 
(MDP) typical of bacteria, such as Streptococcus pneumoniae and Mycobacterium 
tuberculosis (Chen et al., 2009). The recognition of these ligands induced 
oligomerization of NACHT domain and CARD-CARD interaction with 
CARD-containing serine-threonin kinase RIP2, which leads to the activation of RIP2 
and a cascade of signaling proteins, culminating in the activation of the transcription 
factor NF-κB and expression of inflammatory cytokines (Hasegawa et al., 2008). In the 
present work, the increase in NOD1 expression after MgA treatment was transient and 
for NOD2 no major alterations were observed, leading to non-conclusive results on the 
implications of NODs receptors in L. infantum infected KCs. Further investigations are 
needed to clarify the implications of NODs and TLRs in Leishmania infection and to 
better understand how to explore these receptors for better therapeutic and prophylactic 
uses. 
The data presented suggest that MgA might exert an immune modulator effect 
and lead to the killing of intracellular amastigotes and to the activation of KCs. The 
activation of KCs in the liver is of critical importance to the resolution of the infection 
and granuloma formation, as this cellular structure is key to control the liver parasite 
progression. Although meglumine antimoniate is a drug with severe side effects its 
efficacy is high as demonstrated by several studies and also for the present data. A 
liposomic formulation is probably a good strategy to continue to use this drug and 
several authors have already described the use of liposomic formulations of meglumine 
antimoniate in VL and CL animal models, but not yet in human practice (da Silva et al., 
2012; Kalat et al., 2014). 
The co-culture of infected KCs with hepatocytes, revealed a vital role of these 
cells in the activation of KCs in response to L. infantum parasites. Hepatocytes play a 
key role in controlling systemic innate immunity via production of secreted PRRs and 
complement components found in plasma. Expression of the genes encoding these 
proteins is controlled by liver-specific transcription factors, such as hepatocyte nuclear 
factors, nuclear factor-1, and CCAAT-enhancer-binding protein, which account for their 
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liver-specific expression. During an acute phase or systemic inflammatory response, a 
variety of pro-inflammatory cytokines, such as IL-6, IL-1, TNF-α, and IFN-γ, can 
stimulate hepatocytes to produce high levels of complements and secreted PRRs. After 
activation, the complement system generates a wide range of biologic activities such as 
opsonic, inflammatory, and cytotoxic functions. The liver, and hepatocytes in particular, 
is a major site of complement components biosynthesis. These include C1r/s, C2, C4, 
and Cbp of the classical pathway, C3 and factor B of the alternative pathway, 
mannan-binding lectin, mannan-binding lectin-associated serine proteases 1-3, and 
mannan-binding lectin-associated protein 19 of the lectin pathway, and terminal 
components C5, C6, C8, and C9 (Qin and Gao 2006; Gao et al., 2008). Hepatocytes, not 
only are the major source of secreted PRRs, but also expresses membrane-bound PRRs, 
such as TLRs and NODs. Hepatocytes were found to express messenger RNAs for all 
other TLRs, but the functions of which on hepatocytes remain to be determined and the 
role of PRRs in host defenses against invading pathogens are less clear (Gustot et al., 
2006). As discussed previously, TLR2 functional expression has been reported in KCs, 
stellate cells, and sinusoidal endothelial cells, and activation of TLR2 leads to the 
production of pro-inflammatory cytokines, but is repressed in L. infantum KCs 
infection. In co-culture with hepatocytes it was verified a transient increase in TLR2 
expression, probably from hepatocytes activation, as KCs were previously infected with 
L. infantum amastigotes that repress TLR2 activation. Curiously, this transient increase 
was coincident with an increase in TNF-α expression. Suggesting that hepatocytes were 
able to sense KCs infection and react to it leading to the activation of pro-inflammatory 
cytokines. However, hepatocytes activation was progressively diminished with 
incubation time, probably related to an increase in anti-inflammatory cytokine gene 
expression that reduce TLRs and the generation of pro-inflammatory cytokines. The 
liver is the major metabolic organ and an extensive inflammatory response may have 
serious consequences to the host. So, hepatocytes, although transiently activate rapidly 
return to a more permissive state, inducing immune tolerance in order to avoid major 
damage to the organ and to the host. 
Recently, several other cytoplasmic PRRs have been identified in hepatocytes, 
including NOD-like receptors and the RIG-like helicases (Meylan et al., 2006). NOD1 
and NOD2 expression were assessed in the co-culture and interestingly, NOD1 did 
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register an increase in co-culture. NODs activation also leads to the production of 
pro-inflammatory cytokines, using a different activation mechanism from TLRs. So 
hepatocytes are able to sense the infection on KCs and to be activated (by innate 
immune receptors TLR2 and NOD1), producing a burst of Th1 inflammatory cytokines, 
but the strong immune modulator effected exerted by L. infantum parasite conjugated 
with the tendency of liver cells to avoid inflammation, rapidly down regulate the 
inflammatory signals to induce immunological permissiveness/tolerance. However, the 
initial inflammatory burst might be enough to call neutrophils, lymphocytes and other 
MØs from bloodstream into the liver and resolve the infection and in the case of 
Leishmania infection, create the resistance-associated liver structure: the granuloma. 
Hepatocytes might start to reveal their potential in immune regulatory mechanisms. 
Since KCs are silenced by the parasite, hepatocytes are able to be activated and induce 
the recruitment of other circulating cells to contain and resolve the infection. 
Regarding the comparison of the immune response exhibited against L. infantum 
by two different types of MØs, the blood derived MØs and the liver resident MØs 
(KCs), some interesting differences were found. Blood MØs are the primary host cells 
of L. infantum and is inside the circulating MØs that the parasite is transported into the 
inner organs, as is the case of the spleen and liver. Tissues MØs, as KCs, have their 
precursors in non-differentiated monocytes circulating in the bloodstream after be 
recruited to the tissues, maturing as tissue MØs (Gordon and Taylor, 2005). The 
constant exposure of liver cells to various gut-derived commensal microbes and 
food-borne antigens from the portal circulation has led to the concept that the liver is 
immunologically tolerant under steady-state conditions in the absence of pathogenic 
challenge (Gorczynski, 1992). To maintain this tolerance, KCs are considered to play an 
important role by creating an immunosuppressive local environment in the liver. Under 
steady-state conditions, KCs can produce IL-10, TGF-β and prostaglandins in 
spontaneous or induced ways, promoting a micro environment of immune suppression 
(Knolle et al., 1995; Roth et al., 1998). In addition to their scavenger function, MØs in 
vitro differentiated from bone marrow or obtained from the mouse peritoneal cavity 
have been shown to be highly responsive to pathogens or pathogen-derived products, 
such as the TLR ligands (Kawai and Akira 2010). However, in an apparent contrast to 
their supposed tolerogenic features KCs express distinct TLRs and upon TLR 
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triggering, have been reported to produce pro-inflammatory mediators (Wu et al., 
2010). TLR4 signaling by LPS renders stimulated KCs, producing the pro-inflammatory 
cytokines TNF, IL-1β, IL-6, IL-12 and IL-18 and, the anti-inflammatory cytokine 
IL-10. Besides, it was described that KCs express TLR 1–9 and are highly responsive to 
all TLR ligands, inducing the production of pro-inflammatory cytokines (Kinoshita et 
al., 2010) they seem to be weak producers of cytokines in contrast to peritoneal MØs 
(Movita et al., 2012). However, KCs exhibit potent phagocytic activity, whereas 
TLR-induced cytokine production is minimal despite the TLR gene expression and 
display relatively high basal levels of ROS compared with splenic and peritoneal MØs, 
demonstrating that the function of murine KCs is highly specialized and distinct from 
that of MØs from other anatomical sites. Although these findings indicate that KCs 
exert equilibrium, favor non-specific endocytic activity and eliminate foreign bodies 
and debris from blood circulation can also be activated, became highly immunoactive, 
eliciting potent pro-inflammatory responses. Blood MØs result from the monocyte 
immune activation and constitute immune active cells. KCs and MØs present different 
reactions to infection with L. infantum, reflecting the cytokine and cellular environment. 
MØs are rapidly activated by the parasite, with increased expression of NODs and 
TLRs innate immune receptors, accompanied by the generation of pro- and 
anti-inflammatory cytokines. However, this burst of activity associated with amastigote 
early infection (until ≈3 h) immediately (5 h) decay to low values. As discussed 
previously, Leishmania can exert immunomodulator functions that led to the 
deactivation of pro-inflammatory activated MØs and of parasite killing mechanisms. 
TLR2, TLR4 and TLR9 and also NOD1 and NOD2 registered augments of gene 
expression, indicating parasite sensing and MØs activation accompanied by increases in 
cytokine gene expression. However, L. infantum promastigotes rapidly subvert MØs 
activation by decreasing PRRs and cytokine levels. KCs are immunologically more 
permissive, probably favoring amastigotes phagocytosis. Being less activated, since the 
micro-environment of the liver favors the immune tolerance, KCs express lower 
cytokine levels compared to MØs. However, is curious to notice that even after be 
isolated from the liver and be maintained in culture, KCs retained the immune tolerance 
primed by their location. 
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In addition, the present study also evidences that there were some dogs 
registering values distant from the majority of the other animals throughout the several 
assessed parameters. These atypical values, always reflecting elevate amounts were 
indicated as outliers. In a small sample, like the sample used in this study constituted by 
12 dogs, the possible explanation for these outliers might be related to the genetic 
diversity of a natural canine population. For the present study, the dogs were collected 
from a dog population with no restrictions on breed and sex, in order to reflect the 
natural diversity of the population. It is interesting to notice, that it is well described that 
some dogs are more resistant to L. infantum infection than others. Still, the genetic 
associations are not yet defined. Altet et al. (2002) suggested that similar to the mouse 
model, a mutation on the canine NRAMP1 gene might be linked to increased 
susceptibility. Polymorphism associated with the MHC II was also investigated and 
some alleles were related to increase susceptibility to canine VL (Quinnell et al., 2003). 
As the dog constitutes the main reservoir for human infection, the identification of 
genetic factors influencing canine resistance or susceptibility to VL may provide 









The objective of this chapter was to investigate how liver resident macrophages – 
Kupffer cells (KCs) – sense and react to L. infantum presence. Taking together the 
results obtained in this chapter, the main conclusions are:  
 
– To the best of our knowledge, it is the first time that canine KCs are 
investigated for their role in L. infantum infection. It is also the first report of 
innate immune receptors NOD1 NOD2, TLR2, TLR4 and TLR9 gene 
expression on KCs in the context of L. infantum infection; 
 
– KCs are susceptible to both parasite forms – amastigote and promastigote – 
and no major differences were found in KC response to both parasite forms. 
However, amastigotes are more efficient on infecting KCs, reflecting how 
well the parasite is adapted to intra-macrophage life; 
 
– L. infantum is able to control KCs leishmanicidal mechanisms, avoiding 
cellular activation, by decreasing nitric oxide production and increasing urea 
levels, promoting its own survival. The presence of L. infantum induces an 
anergic state in KCs, limiting IL-12 and TNF-α pro-inflammatory cytokine 
expression; 
 
– L. infantum parasites seem to interact with KCs innate immune receptors 
TLR2 and NOD1 expression; 
 
– The addition of a leishmanicidal compound – meglumine antimoniate – is 
able to break the parasite imposed silencing and activate infected KCs to 
produce pro-inflammatory cytokines; 
 
– The addition of L. infantum infected KCs to canine hepatocytes in a 
co-culture, is able to activate cells innate immunity. Hepatocyte seems to 
have an interesting role in orchestrating a synergistic the immune response 
against L. infantum parasites; 




– There were found major differences in the immune response exhibited by 
blood derivate macrophages (MØ) facing and infection by L. infantum and 
liver resident macrophages (Kupffer cells) facing the same parasite. MØ 
reacted exuberantly to the presence of the parasite, with PRRs and Th1 
cytokine expression, but were rapidly silenced by the parasite. KCs were 
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6 Chapter 3: Immunological memory in the liver 
6.1. Introduction 
6.1.1. Liver infection in leishmaniasis-murine model  
The liver carries out a number of vital functions of metabolism and of innate and 
adaptive immunity. Contributions to the innate immune system include production of 
acute phase proteins, nonspecific phagocytosis and pinocytosis, and nonspecific cell 
killing. Hepatic involvement in innate immunity contributes to the systemic response to 
major threats and also to local inflammation, clearance of pathogens and of pathogen 
related molecules. Hepatic involvement in adaptive immunity allows the clearance of 
activated T cells and of signaling molecules followed by inflammatory reactions, 
promoting immunologic tolerance towards potentially antigenic proteins (Parker and 
Picut 2005). In the more recent years, the liver was recognized as an important 
immunological organ, with major regulatory functions and with a new discovery as a 
memory organ. 
In VL, evidences from experimental infections indicate that immune responses 
can be organ-specific. The liver is the compartment of acute resolving infection, with 
minimal tissue damage and resistance to reinfection, whereas the spleen is the 
compartment of parasite persistence. Control of hepatic infection in mice requires a 
coordinated immune response that  involves the development of cellular infiltrates 
around infected macrophages known as inflammatory granulomas (Murray et al., 1992). 
This granulomatous immune response is analogous to the protective granulomatous 
response seen in the majority of L. donovani infected patients that remain subclinically 
and observed in asymptomatic dogs (el Hag et al., 1994; Sanchez at al., 2004). To 
elucidate the mechanisms by which immunity develops in the liver, including the 
granuloma structure and function, many studies using VL murine models were done, 
using gene-targeted mice or in vivo administration of neutralizing or depleting 
antibodies. In contrast to the self-containing infection in the liver the spleen and bone 
marrow become chronically infected, involving mechanisms that are less well known. 
In the mouse, the spleen becomes grossly enlarged within 6–8 weeks post-infection and 
parasite persistence is accompanied by fail of granulomatous formation, splenomegaly, 
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disruption of lymphoid tissue microarchitecture, which includes disruption of B-cell 
follicles and of the marginal zone (Stanley and Engwerda, 2007). In the liver, the 
process of granuloma formation, crucial to efficient immune responses to infection by 
L. donovani and L. infantum (L. chagasi) depends on chemokine production, subsequent 
recruitment of monocytes, neutrophils, CD4
+
 T cells and CD8
+
 T cells, production of 
inflammatory cytokines and activation of infected cells. Kupffer cells (KC) are the 
major tissue macrophage found in the liver lining the sinusoids, and are a major target 
for Leishmania infection. There are a number of key pro-inflammatory cytokines 
required for efficient granulomatous formation, including IL-12, IFN-γ, TNF, 
granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-2. These pro-
inflammatory cytokines are required for chemokine production and for generation of 
leishmanicidal molecules by infected KC (Kaye et al., 2004). According to Stager et al. 
(2003), the anti-inflammatory cytokine IL-4 is also required for the resolution of hepatic 
infection and for the priming of CD8
+
 T cells that are critical for long-term protection. 
After infection, all these cytokines are rapidly secreted, possibly by the infected KC, 
resulting in the initial recruitment of monocytes and neutrophils, both critical for the 
effective control of parasite growth. Initial chemokine induction occurs in a T-cell 
independent manner, but studies have shown that sustained chemokine production 
requires hepatic lymphocytes. It is likely that also other cells of the innate immune 
system such as NK cells and NKT cells are also important in the early stages of 
granuloma formation due to their ability to rapidly produce large quantities of pro-
inflammatory cytokines such as IFN-γ. Studies in CD1d knockout mice (that lack NKT 
cell population) have shown the importance of NKT cells in the early control of parasite 
growth (Amprey et al., 2004). The fusion of some infected KC with other KC to form 
multinucleate cells is also evident during these early stages of granuloma formation. T 
cells required for the resolution of L. donovani infection in the liver are recruited for the 
developing granuloma in response to chemokines and cytokine stimuli, following 




 T cells is 
increased in the first week post-infection, probably reflecting both local expansion and 
recruitment from the spleen (Kaye et al., 2004). Studies have shown that the 
development of hepatic immunity can be manipulated by the administration of 
neutralizing antibodies or recombinant cytokines, or by manipulating co-stimulatory 
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pathways, indicating that T-cell responses are continually generated during infection 
(Stanley and Engwerda, 2007). Curiously, B cells appear to have a regulatory role in 
granuloma formation. Studies using B-cell deficient mice have shown that these mice 
rapidly clear L. donovani parasites from the liver, accelerate granuloma formation and 
markedly reduce spleen parasite burden. However, they also present signs of destructive 
pathology associated with increased number of neutrophils (Smelt et al., 2000). The 
participation of T lymphocytes in the control of Leishmania spp. infection has been 
recognized and many studies with experimental models of cutaneous leishmaniasis and 
VL have demonstrated the importance of T cells in granuloma formation. In naturally 
infected and asymptomatic dogs, the presence of well-defined hepatic granulomas with 
activated effector T cells, macrophages and dendritic cells and, the prominent 
expression of adhesion molecules and of inflammation mediators indicate the 
establishment of an efficient cell-mediated immunity, probably allowing the animals to 
remain chronically infected with a low parasite burden and undetectable clinical sings. 
In contrast, the lack of mature hepatic granulomas, the marked decreased of infiltrating 
T cells and of inflammation mediators in symptomatic dogs represents an unstructured 
and non-functional granuloma, such as those observed in T cell-deficient mice, 
highlighting the similarities in between dogs and VL murine models (Sanchez et al., 
2004). 
6.1.2. Liver as immunological memory organ   
Immunological memory is commonly believed to be a hallmark of the adaptive 
immune system, providing the organism with long-lasting and robust protection against 
reinfection. Memory cells are populations of prolonged life lymphocytes with self-
renewing properties capable of Ag-specific recognition. The liver is a solid organ, and 
immune cells in the liver can be divided into resident cells and passer-by cells. Resident 
cells, either come from other organs or develop in the liver. They exist in a stable state 
in the hepatic sinusoid and do not spontaneously leave. Passer-by cells go through the 
liver via the bloodstream like travelers. Taking together the unique characteristic of the 
liver environment and also the liver hematopoietic ability, maintained to some extent 
until adulthood, the developmental pathway for hepatic lymphocytes may be unique 
(Jiang et al., 2013). The initial recognition of the liver as an important immunological 
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memory organ was initiated with the Sun et al. (2009), that discovered that NK cells 
also have memory characteristics and that this particular population resides in the liver. 
NK cells were considered to have a short lifespan and lack the capacity of self-renewal. 
The fact that memory NK cells reside in the liver suggests that may be able to recognize 
certain Ag, which means that the receptor repertoire of hepatic NK cells is different 
from that of conventional NK cells. It is probably that owing a unique cytokine 
microenvironment the liver might be a place for cell reprogramming. The importance 
and role of this memory NK cells are still under investigation. Other evidences of liver 
importance in the immunological memory are the priming of CD8
+
 cells by liver 
sinusoidal endothelial cells (LSECs), during non-inflammatory conditions and the 
differentiation of liver-primed T cells into effector cells upon Ag re-encounter presented 
by mature DC, even after prolonged Ag absence (Bottcher et al., 2013). This recent new 
data are changing the traditional view of the liver as a major metabolic organ to the 
discovery that the unique immunological environment in the liver has a major 
contribution to the immune response to Ag and self-protection as well as maintaining 
immune tolerance.  
6.1.3. Immunological memory: effector and central memory cells 
Immunity is the balanced state of having adequate protection against infection, 
while maintaining adequate tolerance to avoid excessive inflammation, allergy, and 
autoimmune diseases. In most vertebrates, including humans, the immune system is 
composed of two principal components: innate and adaptive. Innate immune provides 
immediate protection against invading microbes, although in not specific way. 
However, a more directed, long-lasting and robust protective response is needed. The 
adaptive immune system generates immunological memory after an initial response to a 
pathogen or non-self-molecules (alloantigens). Immunological memory provides the 
organism with a faster and stronger protective response to an infection with an agent 
which had previous contact with, avoiding disease. This system is maintained 
through-out life in some cases, allowing a life-long immunity. Memory lymphocytes 
confer immediate protection in peripheral tissues and mount recall responses to antigens 
in secondary lymphoid organs. In the B cell system these functions are carried out by 
distinct cell types. Protective memory is mediated by plasma cells that secrete 
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antibodies, whereas reactive memory is mediated by memory B cells that proliferate and 
differentiate to plasma cells in response to secondary antigenic stimulation. A similar 
division has recently emerged in the T cell system. According to the model proposed by 
Lanzavecchia and Sallusto (2000), protective memory is mediated by effector memory 
T cells (Tem) that migrate to inflamed peripheral tissues and display immediate effector 
function, whereas reactive memory is mediated by central memory T cells (Tcm) that 
home to T cell areas of secondary lymphoid organs, have little or no effector function, 
but readily proliferate and differentiate to effector cells in response to antigenic 
stimulation (Figure 86) (Sallusto et al., 2004). 
 
Figure 86: Formation of central (Tcm) and effector (Tem) memory. 
Naïve T cells recognize and activate in the presence of an antigen, originating effector T cells. After the 
infection is controlled some of the effector T cells generated are transformed into central and effector 
memory cells 
Tcm and Tem were initially defined in humans based on two distinct 
characteristics: the presence or absence of immediate effector function and the 
expression of homing receptors that allow cells to migrate to secondary lymphoid 
organs versus non-lymphoid tissues. A fraction of primed T lymphocytes persists as 
circulating memory cells that can confer protection, upon secondary challenge, giving a 
qualitatively different and quantitatively enhanced response. Sallusto et al., (1999) 
showed that expression of CCR7, a chemokine receptor that controls homing to 
secondary lymphoid organs, divides human memory T cells into two functionally 
distinct subsets. CCR7
-
 memory cells express receptors for migration to inflamed 
tissues and display immediate effector function and CCR7
+
 memory cells expressing the 
lymph-node homing receptors and lack immediate effector function, but efficiently 
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stimulate dendritic cells and differentiate into CCR7
-





 T cells, which have been named central memory 
(Tcm) and effector memory (Tem) respectively, are differentiate from naive T cells and 
may persist for years after immunization and allow a division of work in the memory 
response. 
Later, human Tcm cells were described as CD45R0
+
 and constitutively express 
CCR7 and CD62L, two receptors that are also characteristic of naıve T cells, which are 
required for cell extravasation through endothelial venulesand migration to T cell areas 
of secondary lymphoid organs (Forster et al., 1999). When compared with naıve T cells, 
Tcm have higher sensitivity to antigenic stimulation, are less dependent on 
costimulation, and upregulate CD40L to a greater extent, thus providing more effective 
stimulatory feedback to dendritic cells and B cells. Following activation, Tcm produce 
mainly IL-2, but after proliferation they efficiently differentiate to effector cells and 
produce large amounts of IFN-γ or IL-4. CCR7
−
 memory T cells express low levels of 
the CD62L molecule, migrate to inflamed non-lymphoid tissues, and display immediate 
effector function such as IFN-γ production. This population of cells constitutes the 
effector memory (Tem). When compared with Tcm, Tem is characterized by rapid effector 
function. CD8
+





produce IFN-γ, IL-4, and IL-5 within hours following antigenic stimulation (Sallusto et 
al., 2004). The relative proportions of Tcm and Tem in blood vary in the CD4 and CD8 
compartments: Tcm is predominant in CD4
+
 and Tem in CD8
+
. Within the tissues, 
however, Tcm and Tem show characteristic patterns of distributions. Tcm are enriched in 
lymph nodes and tonsils, whereas lung, liver, and gut contain greater proportions of Tem 
(Campbell et al., 2001). The presence of memory T cells with different migratory 
capacity and effector function was also documented in mice. Two populations of 
memory CD4
+
 T cells survive for months after immunization with antigen in adjuvant. 
One was primarily found in the lymph nodes, produces IL-2 and the other larger 
population was found in non-lymphoid tissues produces IFN-γ (Reinhardt et al., 2001). 
Similarly, two populations of antigen-specific memory CD8
+
 T cells are present 
following viral or bacterial infection (Masopust et al., 2001). Whereas CD8
+
 memory T 
cells isolated from non-lymphoid tissues exhibit lytic activity directly ex vivo, their 
splenic counterparts do not. These results extended the Tcm /Tem paradigms to the mouse 
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system. A more recent study indicated much of the fundamental mechanisms of T cell 
memory in humans and mice are shared. Thus, significant findings in mouse memory 
studies may have the potential to be rapid translated to non-human primates and 
humans, as the knowledge acquired in mouse models studies appears to be 
interchangeable (Zhang and Lakkis, 2015). 
More recently, in-depth studies on local immunity identified a new memory T 
cell subset, tissue-resident memory (TRM), which resides in peripheral non-lymphoid 
tissues long after the initial infection has cleared. TRM provide a local protective 
immunity when the same pathogen is reencountered at the entry site. Although they 
express low levels of CCR7 and CD62L as do Tem, TRM express high levels of local 
non-lymphoid tissue-homing molecules such as CD103 and CD69, making these cells 
no-migratory (Gebhardt et al., 2009). CD69 acts to maintain TRM cells at tissue sites by 
antagonizing the SIPR1 receptor, which promotes the exit of T cells from tissue sites 
(Ledgerwood et al., 2008). CD103, which is induced by TGF-β, promotes interactions 
between TRM cells and local epithelial cells, thereby supporting tissue retention (Zhang 
and Bevan, 2013). TRM do not routinely recirculate and mix with memory subsets in 
other tissues, being that the probable reason why TRM was initially missed in studies 
investigating the peripheral blood or secondary lymph organs memory cells populations. 
In summary, the three described memory subsets (Tem, Tcm, and TRM) have distinct 
circulation patterns as a result of their distinct surface chemokine receptor and adhesion 
molecule expression. Tcm mainly circulate in lymphoid tissues (lymph nodes, spleen, 
and bone marrow) and blood; Tem can circulate between lymphoid tissues and non-
lymphoid tissues during steady state conditions (although they are largely excluded 
from lymph nodes) and TRM only reside in peripheral non-lymphoid tissues and do not 
circulate. Besides, as current methods to dissociate memory T cells in peripheral organs 
underestimate the numbers of TRM cells, our current knowledge on the presence and 
activities of these cells is still limited (Steinert et al., 2015). 
The heterogeneity of the called T cell memory population was further increases 
with the description by Gattinoni et al., (2011) of a long-lived human memory T cell 
population that has an enhanced capacity for self-renewal and a multipotent ability to 
derive central memory, effector memory and effector T cells (Figure 87). 




Figure 87: Heterogeneity in memory T cells. 
Memory T cells can be found in lymphoid organs, blood, and at tissues. Stem cell memory T cells (Tscm) 
and central memory T (Tcm) cells are found in lymphoid organs and in the blood. Effector memory (Tem) 
and tissue resident memory T (TRM) cells can both be found in peripheral tissues. Tem are migratory, 
passing through tissues and the blood, while TRM are restricted to tissues. Both populations can respond 
rapidly to tissue invading pathogens (Adapted from Jaigirdar and MacLeod, 2015). 
These memory stem T cells (Tscm), specific to multiple viral and self-tumor 















 T cell compartment characteristic of naive T cells. However, they 
expressed large amounts of CD95, IL-2Rβ, CXCR3, and LFA-1, and showed numerous 
functional attributes distinctive of memory cells. Compared with known memory 
populations, these lymphocytes had increased proliferative capacity and more 
efficiently reconstituted immunodeficient hosts, and they mediated superior anti-tumor 
responses in a humanized mouse model. Analysis of antigen-specific CD8 Tscm 
demonstrates that these cells have previously responded to antigen, can self-renew, and 
rapidly differentiate into cytokine producing effector cells upon reactivation. 
Transcriptional analysis of human CD4
+
 T cell populations identified using CD45RO, 
CCR7, and CD95, has positioned Tscm as a distinct population with a profile between 
naive and Tcm cells (Takeshita et al., 2015). Memory stem T cells have also been 
described in non-human primates, where Tscm are found in peripheral blood, secondary 
lymphoid organs, and the bone marrow (Lugli et al., 2013). Tscm cells in mice have 
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proven harder to track down, although cells with a similar profile to human Tscm, can 
be generated in vitro or in vivo in a model of graft versus host disease.  
6.1.4. Guiding immunological memory: the development of 
vaccines  
The ability to induce an immunological response to an Ag during a primary Ag 
presentation in safe, controlled conditions and allowing the generation of immune 
memory cells that will ensure the individual immunity in a future encounter with the 
same Ag is the base of any vaccine. In VL case, the necessity of induction a protective 
cellular response, able to break the immune silencing imposed by the parasite, is the 
major challenge in a search for a vaccine for humans and dogs. Host resistance to 
Leishmania spp. infection is mediated by cellular immune responses leading to 
macrophage activation and parasite killing. Antileishmanial immunity is mediated by 
both innate and adaptive immune responses which require effective activation of 




 T cells (Stanley and 
Engwerda, 2007). Effector CD4
+
 T (TE) cells are responsible for the production of 
cytokines critical for the activation of macrophages and are required for optimal host 
response to infection. Cytotoxic CD8
+
 T cells also play a role in host protection and are 
required for the effective clearance of parasites and the generation of memory responses 
(Kharazmi et al., 1999). Experimental infection models are used to screen and evaluate 
Leishmania vaccines, and several animal species have been used, including mice, 
hamsters, monkeys, and dogs. Currently there are three available vaccines with different 
origins and efficacies against CanL, Leishmune® and Leish-Tec® available in Brazil 
and CaniLeish® accessible in Europe. Although there have been numerous attempts, 
there is no licensed vaccine against any form of leishmaniasis for human use. 
Development of vaccines can be divided into five different stages: discovery, pre-
clinical development, clinical development, registration, and post-marketing evaluation. 
For leishmaniasis vaccines, there has been much activity in the discovery area, leading 
to many candidates of second generation vaccines. The leishmaniasis vaccines in 
development can be divided into various categories, including: (i) Live vaccine 
(leishmanization); (ii) Vaccines of first generation consisting of whole killed 
Leishmania or fractions of the parasite; (iii) Vaccines of second generation constituted 
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of recombinant proteins, DNA vaccines and combinations of both; (iv) Live-attenuated 
vaccines using molecular engineered parasites (Mutiso et al., 2013). Leishmune® and 
Leish-Tec® are considered vaccines of second generation constituted of parasite 
proteins. Leishmune® consists of the fucose mannose ligand isolated from L. donovani 
plus a saponin adjuvant. Leish-Tec® is based on an amastigote specific Ag, the 
recombinant A2 Ag and CaniLeish®, is constituted by excreted/secreted Ag purified 
from the culture supernatant of L. infantum promastigotes (LiESAP) with muramyl 
dipeptide (MDP) as adjuvant (LiESP/QA-21). Although several studies on the vaccine 
efficacy have been done consistent field results are not yet released. In the present study 
the hepatic lymphocyte memory, recovered by stimulation with three recombinant L. 
infantum proteins, was accessed. The recombinant proteinsLirCyP1, LirSOD and 
LirAMP were obtained of excreted/secreted Ag purified from the culture supernatant of 
L. infantum promastigotes. The levels of LirCyP1 (L. infantum recombinant cyclophilin 
protein 1) immunogenicity in the ZVL murine model were described in Santos-Gomes 
et al. (2014). Cyclophilins, a class of proteins found in several intracellular 
compartments and also extracellular, own peptidyl-prolyl cis-trans isomerase activity 
and can perform different functions. These proteins are well known for operating as 
cyclosporine receptors, a drug with immune suppression and antimicrobial functions 
towards different pathogens, including Leishmania. LirSOD (L. infantum recombinant 
superoxide dismutase) is an enzyme that detoxifies reactive superoxide radicals 
produced by activated macrophages essential for parasite survival (Ghosh et al., 2003). 
The third protein, LirAMP, corresponds to a L. infantum recombinant aminopeptidase. 
These proteins catalyze the removal of N-terminal amino acid residues from peptides 
and proteins are now being to be exploited as drug targets and vaccine candidates for 
parasitic diseases, as their potentials important virulence factors is recognized (Morty 
and Morehead, 2002). Gupta et al., (2012) exploited the immunogenic potential of a 
recombinant L. donovani methionine aminopeptidase, which was able to generate 
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6.2. Chapter objectives 
In this chapter, the role of the liver as an immunological memory organ was 
addressed, particularly in the context of L. infantum infection. This study was performed 
using a murine model mainly for immunoreagents availability reasons. Four groups of 
mice were established and the population of liver resident lymphocytes was isolated and 
phenotypic screened.  
The specific objectives are: 
 Provide evidence of the presence of L. infantum in the liver tissue, to ensure 
that isolated cells had a previous contact with the parasite antigen (Ag) in an 
in vivo infection environment; 
 Characterize phenotypically liver T lymphocytes, using markers for effector 
cells, effector memory cells and central memory cells; 
 Evaluate the dynamics of memory T cells in L. infantum infected mice vs 
non-infected mice; 
 Assess the effect of a leishmanicidal treatment (with meglumine 
antimoniate) in the differentiation of memory cell subsets;  
 Investigate the potential induction of resistance genes in L. infantum 
parasites potentiated by an exposition to the leishmanicidal treatment; 
 Explore the effect of an infection with L. infantum less susceptible to the 
leishmanicidal drug in the differentiation of memory cell subsets followed by 
a treatment with the same leishmanicidal compound; 
 Investigate the potential of recognition and activation of effector T cells and 
of recognition, differentiation and selection of memory T cells by three  
L. infantum recombinant proteins, LirCyP1, LirSOD and LirAMP. 
The present results obtained from non-infected (group 1) and infected (group 2) 
mice were performed by the MSc student Mafalda Claro with my technical and 
scientific support and are described in her Master thesis “Análise da memória cellular 
hepatica na infeção por Leishmania infantum”. 




6.3.1. Experimental design 
The liver is a very complex metabolic organ with immune functions that only 
now are starting to be explored and understood. The liver-immune memory was also 
evaluated in the present work. What is the role of the liver-immune memory during 
L. infantum infection and how this cellular compartment is influenced by a treatment 
with a leishmanicidal drug was addressed in this chapter. This study was performed in 
BALB/c mice purchased from Harlan laboratories (Horst, Holland) and maintained at 
the Instituto de Higiene e Medicina Tropical (IHMT) animal facility. All the 
experiments were conducted according to EU requirements and the Portuguese law (DR 
DL129/92, Law 1005/92). A total of 27 BALB/c mice were randomly distributed in four 
groups as follows: non-infected animals (group 1); L. infantum infected animals (group 
2); L. infantum infected animals treated with meglumine antimoniate (MgA, group 3) 
and, MgA pre-exposed L. infantum parasites infected mice treated with MgA (group 4) 
(Figure 88). 
 
Figure 88: Schematic representation of the experimental design used to evaluate the immune 
memory cells of the liver. 
After necropsy infected, treated and non-infected BALB/c mice were used for the isolation of hepatic 
resident lymphocytes. 
(Pre-exposed to Meglumineantimoniate) 
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Liver resident leukocytes isolated from mice of the four experimental groups 
were cultured and stimulated with L. infantum recombinant proteins: cyclophilin 
protein 1 (LirCyP1), superoxide dismutase (LirSOD) and aminopeptidase (LirAMP). A 
flow cytometry analysis of the expression of memory markers CD127 and CD62L was 








memory cell was accessed. 
6.3.2. Mice infection  
Each mouse of groups 2 and 3 was intraperitoneally infected with 5x10
6
 virulent 
promastigotes in a final volume of 100 μl of sterile saline solution [NaCl 0.9% (m/v)]. 
L. infantum virulent promastigotes were obtained as described in General Methods 
(section 3.3.1) of the general methods chapter. Mice of group 4 were infected with 
virulent L. infantum promastigotes previously isolated from mouse spleen of group 3, 
which received antileishmanial MgA treatment. To minimize the adaptation of the 
parasite to culture conditions, the inocula used were obtained from P1 cultures (the first 
in vitro passage after parasite isolation). Thirty days after the beginning of the study, 
mice of groups 1 and 2 were sacrificed by administration of a lethal dose of anesthetic 
solution (ketamine/Xylazine). After one month of infection, mice of groups 3 and 4 
were treated with a commercial leishmanicidal drug (see section 6.3.3) during five 
consecutive days and then sacrificed as described above.  
6.3.2.1. L. infantum genes associated with resistance 
The amplification of resistant associated genes in L. infantum P1 promastigotes 
isolated from mice treated with MgA (group 3) and from mice infected with MgA 
pre-exposed parasites and then treated with the same compound (group 4), were 
analyzed by real-time PCR. In parallel, wild type L. infantum promastigotes were also 
evaluated. 
Promastigotes were collected from the culture medium and washed with PBS 1x 
by centrifugation at 1800 xg, 10 min at room temperature. Pellets were processed for 
DNA extraction using the innuPREP DNA Mini Kit (Analytik Jena AG), according to 
the manufacturer’s protocol and stored at -20 ºC for posterior use. The number of copies 
of ABC-thiol transporter MRPA, P-glycoprotein MDR1, gamma-glutamylcysteine 
synthase (GSH1) and pteridinereductase (PTR1) were determined by real time PCR. 
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The design of primers and the optimization of real time PCR conditions are described in 
Santos-Mateus (2014). The process of plasmid production to obtain the standards used 
for absolute quantification of the gene copy number is described in General Methods 
(section 3.4), as well the real-time PCR protocol. Annealing temperature and fragment 
size for each of the genes assessed is described in Table 8. 
 
Table 8: List of forward (FW) and reverse (RV) primers, length of amplified fragment and primer 









FW - 5' CCGCTCGCGGACCACATTGT 3' 
RV - 5' TCGCCGCAAAGGCAGCGTAA 3' 
76 62 
MDR1 
FW - 5' GGAGGGTGACACAAGCGACACG 3' 
RV - 5' CGACGCGATCCGCCTTCATGTT 3' 
89 62 
GSH1 
FW - 5' CCCGGCATTTCTGGCTCTCAGC 3' 
RV - 5' GCGATAGTCAGCCAGCGCACAT 3' 
84 63.5 
PTR1 
FW - 5' ACGTGCTCGTGAACAACGCCTC 3' 
RV - 5' ATCTCCGACACAGGGCACGTGG 3' 
86 65.5 
 
6.3.3. Treatment  
Meglumine antimoniate commercially available as glucantime® (Merial) is a 
drug conventionally used for treating leishmaniasis and formulated with a solution of 
81 mg.ml
-1
 of MgA. It belongs to a group of compounds known as the pentavalent 
antimonials and it is used in human and veterinarian medicine. Thirteen days 
post-infection, animals of groups 3 and 4 were treated with 15 mg MgA/kg/day, injected 
subcutaneously for 5 consecutive days. Three days after the ending of the treatment, 
mice were sacrificed by administration of a lethal dose of anesthetic solution 
(ketamine/Xylazine).  
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6.3.4. Isolation of hepatic leukocytes  
The protocol used to isolate hepatic leukocytes was adapted from the works of 
Faure et al. (1994) and Gomes-Pereira et al. (2004). To isolate hepatic leukocytes, mice 
were anesthetized with a lethal concentration of a solution of ketamine/Xylazine in 
phosphate buffer saline (PBS 1x) (BioWhittaker, Lonza). Liver portal vein was exposed 
and perfusion with sterile Hanks Balanced Salt Solution (HBSS) (Sigma-Aldrich) was 
performed to clean peripheral blood from the liver (Figure 89A).  
 
Figure 89: Isolation of liver resident lymphocytes.. 
After the necropsy, liver perfusion through the portal vein was done to eliminate the peripheral blood (A). 
The liver was then homogenized and cell suspension overlaid onto a percoll gradient. After centrifugation 
it is possible to identify: 1 – culture medium; 2 – Percoll (40%); 3 – ring of hepatic leukocytes; 
4 – Percoll (70%) (B). 
Liver was excised, weighted and homogenized with a tissue disruptor 
(Medicons, Syntec International) with a 0.5 μm pore in order to obtain a single cell 
suspension. The cell suspension was washed with cold HBSS and centrifuged at 400xg 
during 10 min at 4 ºC. The pelleted cells were then resuspended in 5 ml of 40% 
Percoll® (GE Healthcare Life Sciences) in PBS 1x, carefully overlaid onto 3 ml of a 
70% Percoll® solution in PBS 1x and centrifuged at 850 xg during 25 min (Figure 89B). 
Mononuclear cells at the interface of the two gradients were collected, washed with cold 
PBS 1x and counted in a Neubauer chamber with trypan blue exclusion dye to 
determine viability and concentration as previously described (see Chapter 1 – 4.3.1).  




 in 150 μl RPMI medium 
supplemented with 10% (v/v) FBS were plated. Cells were maintained in a cell 
incubator at 37 ºC in a humidified atmosphere with 5% CO2. 
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6.3.5. Hepatic leukocyte stimulation  
6.3.5.1. L. infantum total antigen 
After isolation, hepatic leukocytes were stimulated with 40 μg.ml
-1 
of soluble 
L. infantum Ag for 72 h, at 37 ºC, in a humidified atmosphere with 5% CO2. Total 
soluble L. infantum Ag was obtained from a L. infantum culture with 1x10
8 
promastigotes/ml. The culture was centrifuged at 1800 xg, for 10 min at room 
temperature and the sediment washed in PBS 1x with 2 mM ethylenediaminetetraacetic 
acid (EDTA) (Sigma-Adrich). Parasites were then subjected to six freeze-thaw cycles 
(-20 ºC vs room temperature) to lyse cells. The obtained parasite extracts were 
quantified in a Nanodrop 1000 Spectrophotometer (Thermo Fisher Scientific) and the 
concentration adjusted to 40 μg.ml
-1
 in PBS. Aliquots of this extract were prepared and 
stored at -20 ºC until use.  
6.3.5.2. L. infantum recombinant proteins 
Three recombinant L. infantum proteins, previously obtained as described in 
Santos-Gomes et al. (2014), were used in this study. Proteins were kindly given by 
Professor Ana Tomás from Instituto de Biologia Molecular e Celular (IBMC), 
Universidade do Porto, Portugal. Briefly, full length open reading frame of cyclophilin 
protein 1 (LirCyP1), superoxide dismutase (LirSOD) and aminopeptidase (LirAMP) 
were amplified. The PCR product was digested and cloned into pET28a plasmid 
(Novagen). Escherichia coli BL21 were transformed with the constructed plasmid and 
recombinant proteins were obtained from purified bacteria cultures. Bacteria were 
pelleted, suspended in 500 mM NaCl, 20 mM Tris–HCl buffer and disrupted by 
sonication. The supernatant was then applied to a His Bin resin (Novagen) column and 
the recombinant protein eluted trough an imidazole gradient. Fractions confirmed to 
contain the protein by SDS-PAGE were pooled, applied to PD-10 columns (Amersham 
Biosciences) and eluted with PBS. Previously to be used in stimulation assays, 
recombinant proteins were further purified using Detoxi-Gel™ Endotoxin Removing 
Gel (Pierce Biotechnology), to remove any bacterial contaminant. Isolated hepatic 
leukocytes were stimulated with each one of the three described recombinant proteins 
(25 μg.ml
-1
) for 72 h, at 37 ºC in a humidified atmosphere with 5% CO2.  
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6.3.5.3. Limiting dilution Assay (LDA) 
To ensure that mice were infected, the viable parasite load was estimated in the 
liver by limiting dilution assay (LDA). Liver homogenate was diluted at 1:3 followed 
by a 1:10 dilution in SCH medium. In a sterile 96 well plate, 200 µl of the 1:10 dilution 
was placed into the first well and a fourfold serial dilution was made. After 15 days at 
24 ºC, a sample from each well was examined under light microscopy and presence 
(positive) or absence (negative) of promastigotes was registered. The final titer was set 
as the highest dilution for which the well contained at least one parasite and the number 
of parasites per gram of homogenized organ was calculated. All the samples were 
evaluated in triplicate. 
Viable parasite load (VPL), expressed as the number of promastigotes per gram 
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6.3.6. Flow cytometry 
After 72 h in culture, hepatic leukocytes were collected, washed with PBS and 
divided into two sample groups. One sample was marked for CD4 and the other for 
CD8. Cells were incubated in PBS with 2% (v/v) FBS, for 30 min at 4 ºC with the 
following fluorochrome-conjugated anti-mouse monoclonal antibodies: PE anti-mouse 
CD3 (clone 17A2, Biolegend), Alexa Fluor®647anti-mouse CD62L (clone MEL-14, 
BioLegend) and PerCP-Cy5.5 anti-mouse CD127 (clone A7R34, eBioscience), FITC 
anti-mouse CD4 (clone GK1.5, eBioscience) and FITC anti-mouse CD8a (clone 53-6.7, 
eBioscience). The antibody dilutions used are presented in Table 9. After incubation, 
cells were fixed with a 2% (m/v) paraformaldehyde in PBS 1x and stored at 4 ºC in the 
dark until further analysis. Hepatic lymphocytes become marked according with their 
characteristics. Monoclonal antibody CD3 binds to a molecular complex associated with 
TCR that is exclusive of lymphocytes. The flow cytometry analysis included a first 
CD3
+
 cell gating in order to ensure that only lymphocytes were analyzed. Next, CD4
+
 or 









 T cells to be 
registered. CD62L and CD127 allow the differentiation between central memory and 
effector cell memory. CD62L is an L-selectin, a cell adhesion molecule found on 
lymphocytes, favoring the cell retention within the organ. CD127 is the interleukin-7 
(IL-7) receptor, normally associated with cell survival. Together, these receptors allow 













). Thus, the 
frequencies of hepatic memory cell in the four groups of mice were estimated. Cell 
acquisition was performed on a FACSCalibur flow cytometer (BD Biosciences) and 
analyzed in triplicate to allow future statistical analysis. The flow cytometry analysis in 
this study is the fruit of a generous association with Professor Graça Alexandre-Pires of 
the Faculdade de Medicina Veterinária da Universidade de Lisboa. 
 
Table 9: List of mouse monoclonal antibodies used to analyze hepatic leukocyte memory cell 
population, respective concentration and the volume applied to each sample. 
 
Monoclonal antibody Concentration 
Volume per 
sample (µl) 
FITC Anti-mouse CD8a 0.5 µg.100µl
-1
 1.0 
FITC Anti-mouse CD4 0.25 µg.100µl
-1
 0.5 
PerCPCy5.5 anti-mouse CD127 0.25 µg.100µl
-1
 0.16 
PE anti-mouse CD3 0.25µg.100µl
-1
 0.42 




6.3.7. Histological analysis  
After liver perfusion, a small portion of the organ was excised and prepared for 
histological processing in order to evaluate granuloma formation. Granulomas, 
defensive structures that correspond to alteration on normal tissue morphology, are 
constituted when the immune system attempts to isolate substances or pathogens that 
are perceived as foreign but is unable to eliminate them. The excised tissue was 
conserved in 2% (m/v) paraformaldehyde in PBS 1x and stored at 4 ºC until further 
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processing. Samples were processed at Laboratório de Histopatologia, na Universidade 
Lusófona de Humanidades e Tecnologias (ULHT), in an automatic tissue sample 
processor (Spin Tissue Processor 120, Thermo Scientific), under the supervision of Dr. 
Pedro Faísca and of Dr. Susana Silva. Tissue samples were dehydrated in ethanol 
gradients [70% (v/v) during 110 min, 96% (v/v) for 110 min and in immersion at 100% 
during 4 h] and then immersed in a Clear-Rite® solution for 4 h to extract lipids and 
prepare the tissue to paraffin inclusion (3.5 h). Samples were conserved at 4 ºC until 
further processing. The sectioning of the paraffin embed tissue blocks were made at the 
Hospital Santa Cruz (Centro Hospitalar de Lisboa Ocidental, E.P.E), at Anatomia 
Patológica service under the technical guidance of Dr. Armandina Manuel. The sections 
were performed in a rotary automatic micrometer Leica DSC-1 (Leica Microsystems 
GmbH) programmed to execute cuts of 3µm thick. Cuts were unfolded in cold water 
and adhered to a glass slide and left to rest into a stove at 60 ºC to increase slide 
adherence. Then, the slides were stained with hematoxylin and eosin (HE). These are 
the most widely used dyes in medical diagnosis and are often the gold standardin 
histology. Hematoxylin has a deep blue-purple color and stains nucleic acids and eosin 
is pink colored and stains nonspecifically proteins. In a typical tissue, nuclei are blue 
stained, whereas the cytoplasm and the extracellular matrix shown different degrees of 
pink.  
Before starting with coloration it was necessary to remove the paraffin. This was 
performed in an automatic processor for coloration of slides Sakura tissue-Tek DRS 
(Sakura Finetek). Slides were immersed in xylol for 10 min to complete remove the 
paraffin and hydrated by immersion in decreasing ethanol proportions: 96% (v/v) 2 min, 
70% (v/v) 2 min and finally washed in water. Slides were immersed in hematoxylin 
(Merk) and then in 0.5% (v/v) HCL to remove the exceeding dye, stained with 1% (v/v) 
eosin (Surgipath) for 3 min and washed with water. Tissue samples were again 
dehydrated in crescent ethanol gradients, to remove all the water from the tissue, and 
immersed in xylol. Coverslip were added in an automatic coverslip mounter Sakura 
Tissue-Tek GLC (Sakura Finetek) and then covered with resin to permanently fix the 
coverslip. Obtained slides were observed under an optical microscopy (Motic Digital 
Microscope (B1-223 ASC, Motic) and digital image acquisition were performed by a 
camera and software Motic Images Plus 2.0 M.L and treated with ImageJ free software.  
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6.3.8. Statistical analysis 
To explore the differences between the experimental groups it was used a non-
parametrical Mann-Whitney test for two independent samples. To analyze intra-group 
results with the different stimulations applied to the isolated cells (total L. infantumAg 
or recombinant protein) it was used a non-parametric Wilcoxon test for two related 
samples. All the data analysis was performed using the software IBM SPSS Statist ics 
version 16.0 (IBM, USA). A significance level of 5% (p≤0.05) was used to evaluate the 
significance of the data analyzed. 
 
 




6.4.1. L. infantum parasites in the liver trigger a local immune 
response 
In order to ensure that after 30 days post L. infantum infection the mice had 
parasites in the liver tissue, granuloma formation and the viable parasitic load was 
accessed.  
Infected mice presented several granulomas in liver identifiable on liver 
histological preparations, as a macrophage infiltrate (Figure 90A-D). Granulomas 
appear well defined with considerable infiltration of macrophages and apparent absence 
of necrosis. However, granulomas were variable in shape, size and complexity through 
the liver tissue.  
Granuloma formation is a typical marker of an established L. infantum liver 
infection, in which the host intends to circumscribe parasite dissemination. It is also 
indicative of an inflammatory response, pointing to the development of an unspecific 
immune response of the liver directed by the parasite 
Total viable parasitic load was estimated in the liver of infected mice (groups 2, 
3 and 4) through LDA (Figure 90E). L. infantum infected animals (group 2) had a 
parasitic load of 1.3x10
5
 promastigotes/g of liver. However, in both groups of treated 
mice (groups 3 and 4) it was possible to isolate viable parasites. Treatment with MgA 
seems to leave residual viable parasites in the liver. The treatment of infected animals 
with MgA resulted in an 83 % reduction in the liver parasitic load. However the MGA 
treatment of mice infected with MgA pre-exposed L. infantum parasites only caused a 
reduction of 78% in parasite load.  
These results point out that a total L. infantum clearing is difficult even with 
treatment and that a previous contact with the drug, albeit briefly (only five days) has 
consequences. In fact, by reducing the parasitic sensitivity to MgA the residual parasitic 
load of the liver had increased.  
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From the analysis of these results it was concluded that the mice had a well-
established L. infantum liver infection, which allow continuing to further immune 
memory studies.  
 
Figure 90: BALB/c mouse liver infected by L. infantum. 
A) arrow pointing to a granuloma in the normal surrounding liver tissue (black bar 100 µm, 200x 
magnification). B) to D) examples of liver granulomas found in the mice after 30 days post-infection 
(black bar 50µm, 400x magnification). E) Viable parasitic load in the liver of mice infected with L. 
infantum promastigotes (Group 2), infected and treated with MgA (Group 3) and mice infected with MgA 
pre-exposed L. infantum parasites and MgA treated (Group 4). Results are expressed as a mean and 
standard deviation of three independent experiments. 
6.4.2. Phenotypic characterization of liver resident lymphocytes 
Liver resident lymphocytes were discriminated into effector T cells (TE), central 
(TCM) and effector memory T (TEM) cells according with CD127 and CD62L levels of 
fluorescence (Figure 91). Using CD3 cellular marker it was possible to isolate 





 gating, it was analyzed CD62L and CD127 expression. The different 














). These cell populations were present in all four experimental 
groups with different representation.  




Figure 91: Representative histograms and plots of flow cytometry analysis of liver resident 
lymphocytes. 
A) Histogram representing a CD3+ cell population. B) Histogram showing a CD3+CD4+ cell subset. C) 
Histogram presenting a CD3+CD8+ population. D) Histogram showing a CD127+ cell subset of low 
fluorescence (CD127low at the left side of the vertical line) and of high fluorescence (CD127high at the right 
side of the vertical line). E) Histogram presenting a CD62L+ cell subset of reduced fluorescence 
(CD62Llow at the left side of the vertical line) and of high fluorescence (CD62Lhigh at the right side of the 
vertical line).  Dot-plots of liver resident lymphocytes isolated from non-infected mice (group 1, F), 
L. infantum infected mice (group 2, G), L. infantum infected mice treated with MgA (group 3, H) and of 
MgA pre-exposed L. infantum infected mice followed by a MgA treatment (group 4, I). R1- TEcells 
(CD62low CD127low); R2-TEM cells (CD62L
low CD127high); R3-TCMcells (CD62L
high CD127high). 
6.4.2.1. L. infantum exert a silencing effect on memory hepatic T cells 
The levels of hepatic T cell memory in the liver of non-infected animals 
(group 1) and of mice infected with L. infantum (group 2) was compared to elicit the 
effect of the presence of the parasite in the differentiation of a subpopulation of resident 
memory T cells. 




TEM cell subsets were 











) population (P=0.0237) comparing with non-
infected mice (group 1). Even with the addition of an antigenic stimulus, total 
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L. infantum Ag, TEM cells were able to expand very little, indicating a suppressive effect 











) of non-infected animals were 
able to expand significantly (P=0.0098) when stimulated with total L. infantum Ag. 
However, cells from infected animals did not expand even in the  





















) TCM cells showed similar tendencies (Figure 92C and 
D). Although differences were statistically not significant, non-infected mice had higher 
cell percentages when compared with infected animals. L. infantum parasites appear to 
exert a silencing effect, preventing differentiation and activation of memory cells.  
 
Figure 92: Levels of hepatic memory T cells in non-infected and in L. infantum infected mice. 
Unexposed (W/o stim) and parasite Ag exposed (Ag.T) leukocytes were evaluated by flow cytometry.  A) 
CD3+CD4+ effector memory subset. B) CD3+CD8+ effector memory subset. C) CD3+CD4+ central 
memory subset. D) CD3+CD8+ central memory subset. Results are represented as whisker box-plot and 
(minimum to maximum) including values from three independent experiments and triplicates per each 
sample.* represent significant differences (P<0.05), resulting from the comparison of group 1 with group 
2 mice. # represent significant differences (P<0.05), resulting from the comparison within an 
experimental group with different types of stimulation (non-stimulated or Ag.T). 
 







 TE cells are relatively short-lived activated cells that display a 
specific immune response (Figure 93). Activated CD4
+
 T helper cells and cytotoxic 
CD8
+
 T cells are the main responsible for cell-mediated immune responses.  
In non-infected animals, the CD4
+
TE cell population has a higher dispersion 
compared to infected mice. The addition of total L. infantum Ag did not induce 
proliferation of effector cells in infected animals, as the dispersion of the T cell 
populations is higher than in non-stimulated cells. This indicates a possible silencing 
effect of parasitic Ag over cell proliferation. A similar effect is observed in CD8
+
T 
cells, the stimulation of effector cells from infected mice with total parasite Ag results 
in a cell population dispersion, indicating poor cell activation and proliferation.  
 
Figure 93: Hepatic TE cell subsets from non-infected mice and L. infantum infected mice. 
Leukocytes were stimulated with L. infantum total Ag (Ag.T) or unstimulated (W/o stim.) for 72 h and 
evaluated by flow cytometry. A) CD4+ TE cells. B) CD8
+ TE cells. Results are represented as whisker 
box-plot (minimum to maximum) including results from three independent experiments and triplicates 
per each sample. 
6.4.3. Recombinant L. infantum proteins do not overcome the 
silencing imposed by the parasite infection 
The capacity of liver isolated leukocytes from non-infected and L. infantum 
infected mice to recognize and expand in the presence of L. infantum proteins was 
accessed for three recombinant proteins, LirCyP1, LirSOD and LirAMP. These are 
soluble proteins that can be found in the total parasite Ag. Memory cell subpopulations 
from non-infected (group 1) and from L. infantum infected (group 2) mice were cultured 
with the recombinant proteins (Figure 94).  













) from non-infected animals 
were able to expand with the incubation with the three recombinant proteins. There are 
differences in pattern selection induced by LirAMP (P=0.0137) when comparing with 
the other two proteins. In this case, LirAMP is the protein that less stimulates the 
expansion of cell populations. CD4
+
 TEM cells of infected animals also recognize the 
tested proteins and stimulation with LirCyP1 is significantly different (P=0.0421) 
between the two experimental groups. 
 
Figure 94: Levels of hepatic memory T cell subsets selected by L. infantum recombinant proteins, 
LirCyP1, LirSOD and LirAMP. 
Comparison was performed between infected (group 2) and non-infected mice (group 1). A) CD4+ TEM 
cells. B) CD8+ TEM cells. C) CD4
+ TCM cells. D) CD8
+ TCMcells. Results are represented as whisker 
box-plot (minimum to maximum) comprising results from three independent experiments and triplicates 
per each sample.* represents statistical significance (P<0.05), resulting of a comparison of group 1 with 
group 2 mice. # represents statistical significance (P<0.05), resulting from the comparison within an 
experimental group with different types of stimulation (LirCyP1, LirSOD orLirAMP). 
In CD8
+
T cells from non-infected animals, it is evident a different stimulation 
pattern for each protein, being again LirAMP the less stimulatory protein (P=0.001, 
compared to LirSOD and P=0.0244, compared to LirCyP1). Infected animals expand 
less to the proteins when compared to non-infected animals, especially with LirSOD 





TCM cells are also able to recognize the recombinant proteins. Infected 
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animals seem to recognize the recombinant proteins expanding, although without 
statistics significance. 
The effector cell population was also accessed after 72 h of stimulation with the 
recombinant proteins. In non-infected animals, the CD4
+
TE cells did not proliferate with 
any of the recombinant proteins (Figure 95). However, LirAMP stimulation of cells 
from the liver of infected mice presented a contraction of cell dispersion, possible 
indicating some proliferation, although not statistically significant. As for CD8
+ 
TE cells, 
a similar pattern was obtained with cells from infected and non-infected mice presenting 
a wide dispersion. Only cells from non-infected mice stimulated with LirAMP showed a 
proliferation profile different from the stimulation with LirCyP1 or LirSOD (P=0.0244). 
This is a possible indicator that LirAMP stimulates the proliferation of TE cells, 
eventually giving origin to a cytotoxic immune response.  
 
Figure 95: The frequency of hepatic TE cells stimulated by recombinant L. infantum proteins. 
Leukocytes isolated from non-infected and L. infantum infected mice were stimulated with LirCyP1, 
LirSOD and LirAMP for 72 h and analyzed by flow cytometry. A) CD4+ TE cells. B) CD8
+ TE cells. 
Results are represented as whisker box-plot (minimum to maximum) comprising results from three 
independent experiments and triplicates per each sample. # represents statistical significance (P<0.05), 
resulting from the comparison within an experimental group with different types of stimulation (LirCyP1, 
LirSOD orLirAMP). 
6.4.4. Leishmanicidal treatment favors the differentiation of 
hepatic CD4
+
TEM subset and the proliferation of CD8
+
TE 
The effect of treatment with a leishmanicidal drug that can kill intracellular 
amastigotes and possible release parasite Ag in T cell memory was also investigated. 
The third experimental group was included L. infantum infected and treated animals. 
The treatment was performed with the commercial leishmanicidal drug, MgA, during 
five consecutive days. When compared with infected mice (group 2), CD4
+ 
T cell 
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population isolated from the liver of treated mice (group 3) presented higher levels of 
effector memory cells, particularly when exposed to total L. infantum Ag (P=0.0126) 
(Figure 96A). However, the subset of CD8
+
 T cells with the effector memory phenotype 
showed a significant contraction (P=0.0048) (Figure 96B). 
 
Figure 96: Levels of hepatic memory T cell in infected mice and in treated mice. 
Leukocytes isolated from infected (group 2) and treated mice (group 3) were exposed to L. infantum total 
Ag (Ag.T) for 72 h. Parallel unexposed (W/o stim.) cells were also left to incubate for 72 h. Cells were 
marked and the magnitude of TEM and TCM cell subsets determined by flow cytometry. A) CD4
+ TEM cells. 
B) CD8+ TEM cells. C) CD4
+ TCM cells. D) CD8
+ TCM cells. Results are represented as whisker box-plot 
(minimum to maximum) comprising results from three independent experiments and triplicates per each 
sample. * represents statistical significance (P<0.05), resulting of a comparison of group 2 with group 3 
mice. # represents statistical significance (P<0.05), resulting from the comparison within an experimental 
group with different types of stimulation (non-stimulated or Ag.T). 
Exposition of liver leukocytes from treated mice to the parasite total Ag caused a 
slight increase of CD8
+
 T cells with effector memory phenotype, although not 
statistically significant. When compared with infected mice (group 2), central memory 
CD4
+
 T cell subset evidence a strong contraction in treated mice (group 3) (P=0.0048). 
The treated mice group also exhibited lower differentiation of CD8
+
 TCM cells 
(P=0.0048) in comparison with infected mice. This cell subset still remained low, even 
when exposed to the L. infantum Ag (P=0.0059). Furthermore, exposition to parasite Ag 
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caused a strong contraction of CD8
+
 TCM cell subset when compared with unexposed 
cells (P=0.0313). 
It is interesting to notice that the CD8
+ 
TE cells originated from treated mice 
were significantly higher (P=0.0048) when compared with infected mice (Figure 97). 
This high proliferation stays elevated when stimulated by parasite Ag (P=0.0013), 
achieving a frequency of near 100%. This elevated frequency might be related to the 
low memory levels (booth effector and central) observed in the treated animals, 
suggesting that memory cell subpopulations are a dynamic system with cells being able 
to be transformed into others cell subset as needed, and in this particular case into 
effector cells. 
 
Figure 97: Hepatic TE cell subsets of infected and treated mice. 
Leukocytes isolated from livers of infected (group 2) and treated mice (group 3) were stimulated by 
L. infantum total Ag (Ag.T) for 72 h. Parallel unstimulated cells (W/o stim.) were also left to incubate for 
72 h. Cells were marked and the frequency of effector cells determined by flow cytometry. A) CD4+ TE 
cells. B) CD8+ TE cells. Results are represented as whisker box-plot (minimum to maximum) comprising 
results from three independent experiments and triplicates per each sample. * represents statistical 
significance (P<0.05), resulting of a comparison of group 2 with group 3 mice. 
6.4.4.1. Recombinant L. infantum proteins induce the proliferation of 
hepatic CD8
+
TE cell subset 
The ability to recognize and expand in the presence of L. infantum recombinant 
proteins LirCyP1, LirSOD and LirAMP by liver resident lymphocytes of treated mice 
was also analyzed. The presence of a leishmanicidal drug, MgA, may lead to the killing 
of intracellular amastigotes and the exposition and presentation of parasite Ag leading 
to cell activation and proliferation. CD4
+ 
TEM cells from the liver of treated mice 
(group 3) recognize and expand when exposed to recombinant proteins, particularly in 
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the presence of LirCyP1 (P=0.0262) and LirSOD (P=0.0101), achieving a higher 
proliferation than the cells from L. infantum infected mice (group 2) (Figure 98A), that 
probably were subjected to a silencing effect induced by the parasite. CD8
+
 TEM did not 





 TCM cell subpopulations of treated mice showed an 
accentuated reduction when exposed to recombinant proteins (Figure 98C and D). CD4
+
 
central memory TCM cells from treated mice differ significantly from infected mice, 
presenting a contraction of the subpopulation (PLirCyP1=0.0007, PLirSOD=0.0023 and 
PLirAMP=0.0014). Exposition to LirSOD was significantly different from LirCyP1 
(P=0.0313).  
 
Figure 98: Hepatic memory T cells of infected and treated mice selected by L. infantum 
recombinant proteins. 
Leukocytes isolated from infected (group 2) and treated (group 3) mice were exposed to LirCyP1, 
LirSOD and LirAMP. A) CD4+ TEM cells. B) CD8
+ TEM cells. C) CD4
+ TCM cells. D) CD8
+TCM cells. 
Results are represented as whisker box-plot (minimum to maximum) comprising results from three 
independent experiments and triplicates per each sample. * represents statistical significance (P<0.05), 
resulting of a comparison of group 2 with group 3 mice. # represents significant differences (P<0.05), 
when comparing exposition to different recombinant proteins within the same experimental mice group. 
The subpopulation of CD4
+
 TE cells that comes from the livers of treated mice 
(group 3) evidenced some proliferation when stimulated with LirAMP (P=0.0003) in 
comparison to infected mice (group 2). Furthermore, stimulation with LirSOD had a 
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different effect than LirCyP1 (P=0.0313) (Figure 99A). Stimulation with LirCyP1 
(P=0.0027), LirSOD (P=0.0012) and LirAMP (P=0.0262) caused higher proliferation of 
CD8
+
 TE cell subset from treated mice than the cells isolated from infected mice. Also 
the stimulation with LirSOD has a different effect than the stimulation with LIrCyP1 
(P=0.0313). The increase of CD8
+
TEcell subpopulation derived from liver of treated 
mice is associated with the significant reduction of both CD8
+
 memory T cell subsets 
(effector and central) (Figure 99B), suggesting that memory cell subpopulations are a 
dynamic system in which the cells are able to exhibit different phenotypes as necessary 
in order to react to the presence of not self Ag.  
 
Figure 99: Hepatic TE cells of infected mice (group 2) and treated mice (group 3) stimulated by 
L. infantum recombinant proteins. 
Liver resident leukocyte cells were stimulated by LirCyP1, LirSOD and LirAMP, and analyzed in a flow 
cytometer. A) CD4+ TE cells. B) CD8
+ TE cells. Results are represented as whisker box-plot (minimum to 
maximum) comprising results from three independent experiments and triplicates per each sample. * 
represent statistical significance (P<0.05), resulting of a comparison of infected with treated mice. # 
represents significant differences (P<0.05), when comparing exposition to different recombinant proteins 
within the same experimental mice group. 
6.4.5. Liver residual L. infantum parasites exhibit different 
sensitivity to MgA 
The parasites isolated from the liver of mice infected with L. infantum virulent 
promastigotes and treated with MgA (group 3) were analyzed by real-time PCR to 
screen for resistance associated gene amplification. The analyzed genes were MRPA, 
MDR1, GSH1 and PTR1 (Figure 100). All analyzed genes, except MDR1 exhibited an 
increase in gene copy number when compared with wild type L. infantum 
promastigotes. MRPA in group 3 (treated mice) isolated parasites registered an increase 
in gene copy numbers equivalent at 6 times the WT (P=0.0044) and group 4 (mice 
infected with less MgA susceptible L. infantum parasites) isolated parasites registered a 
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10 fold increase compared to WT (P= 0.0012). As for GSH1 a similar tendency was 
observed. Parasites isolated from group 3 mice increased GSH1 copy number 5 times 
(P=0.0044) and group 4 isolated parasite revealed an fold increase of 11 times when 
compared with the WT copy number (P=0.0012). Curiously, MDR1 gene exhibited a 
decrease in copy numbers in group 3 isolated parasites (P=0.0044) and in group 4 
isolated promastigotes the MDR1 copy presented levels similar of WT. PTR1 also 
presented a major increase in copy number of promastigotes isolated from group 3 mice 
(P=0.0044) and group 4 mice (P= 0.0009). The increases in PTR1 gene copy numbers 
observed were 13 and 20 times when compared with the WT promastigotes. These 
results evidence that parasites twice exposed to MgA had not a yet fully resistant 
genotype, but had acquired a decreased sensitivity to the leishmanicidal drug.  
 
Figure 100: Amplification of MRPA, GSH1, MDR1 and PTR1 from L. infantum parasites that were 
under drug pressure. 
Parasite DNA was amplified by real time PCR and the copy number determined. WT- DNA isolated from 
wild type L. infantum parasites were also evaluated. Group 3 - DNA of L. infantum parasites isolated 
from MgA treated mice. Group 4 – DNA of parasites isolated from treated mice previously infected with 
L. infantum parasites pre-exposed to MgA. Results of three independent experiments and triplicates per 
sample are represented as whisker box-plot (minimum to maximum). * represent statistical significant 
differences (P<0.05) when comparing WT parasites vs parasites exposed to leishmanicidal drug. 
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6.4.6. Total parasite Ag favors the expansion of hepatic CD8+T 
memory cells driving from mice infected with less MgA 
susceptible parasites  
The impact of less susceptible MgA-parasites in the liver memory T cells was 
analyzed. When compared with group 3 (treated mice), CD4
+
 TEM cell subset of group 4 
(mice infected with less MgA susceptible L .infantum parasites) presented a contraction. 
This contraction is also observed even when exposed to parasite Ag (Figure 101). 
However, the difference was not statistically significant. CD8
+
 TEM cell subset 
originated from group 4 exposed to parasite Ag, expanded significantly more than group 
3 (P=0.0037), indicating that liver resident leukocytes, previously sensitized by less 
MgA susceptible parasites, differentiate a higher subset of CD8
+
 T cells with effector 
memory phenotype when exposed to parasite antigen. Also, there is a statistically 
significant difference when comparing the CD8
+
 TEM cell subset from group 4 
stimulated exposed to total antigen with the non-exposed cells (P=0.0025).  
CD4
+
TCM cell subset, originating from mice of group 4, exposed to L. infantum 
Ag exhibited an important contraction when compared with unexposed cells (P=0.0313) 
(Figure 101C). By the contrary, when in contact with L. infantum Ag CD8
+
 TCM cell 
subset (group 4) significantly expanded when compared with cells isolated from mice of 
group 3 (P=0.0006) (Figure 101D).  




Figure 101: Levels of hepatic memory T cell of mice infected with less MgA susceptible L. infantum 
parasites. 
Resident hepatic leukocytes exposed to L. infantum total Ag (Ag.T) were evaluated by flow cytometry 
and the results compared with group 3. Parallel unexposed cells (W/o stim.) were also analyzed. A) CD4+ 
TEM cells. B) CD8
+ TEM cells. C) CD4
+ TCM cells. D) CD8
+ TCM cells. Results are represented as whisker 
box-plot (minimum to maximum) comprising results from three independent experiments and triplicates 
per each sample. * represent significant differences (P<0.05), when comparing group 3 with group 4 
mice. # represents significant differences (P<0.05), when comparing different stimulation (without 
stimulation or Ag.T) within the same experimental group. 
CD4
+ 
TE cell subpopulation originated from the livers of mice from group 4 
exhibited a significant expansion (P=0.0379) when compared with animals of group 2 
(Figure 102A). Curiously, CD8
+ 
TEM cell subset, in the same experimental conditions, 
reveals a significant reduction in cell proliferation in comparison with group 3 
(P=0.003). This reduction was accompanied by a significant increase of CD8
+
 TEM and 









Figure 102: Hepatic TE cell subsets of mice infected with less MgA susceptible L. infantum 
parasites. 
Leukocytes isolated mice of group 3 were stimulated by L. infantum total Ag (Ag.T) for 72 h. Parallel 
unstimulated cells (W/o stim.) were also left to incubate for 72 h. Stimulated and unstimulated (W/o 
stim.) hepatic leukocytes were evaluated by flow cytometry and the results compared with mice of group 
3. A) CD4+ TE cells. B) Effector CD8
+ TE cells. Results are represented as whisker box-plot (minimum to 
maximum) comprising results from three independent experiments and triplicates per each sample.  
* represent statistical significance (P<0.05), resulting of a comparison of group 3 with group 4 mice. 
6.4.6.1. LirCyP1 triggers the expansion of hepatic CD8+TEM cells and 
LirSOD promotes the expansion of CD4
+
TCM cells originating in 
mice infected with less susceptible MgA parasites  
Resident hepatic leukocytes isolated from mice of group 4 were exposed to 
L. infantum recombinant proteins, LirCyP1, LirSOD and LirAMP, and memory T cell 
subsets were assessed and compared with group 3. CD4
+
 TEM cell subpopulation from 
experimental group 4 expanded less than group 3 (Figure 103). This retraction is 
particularly visible in cells exposed to LirSOD (P=0.0317). LirCyP1 promoted and 
accentuated expansion of CD8
+
 TEM cells (P=0.0387) but, the contact with LirAMP 
leaded to a contraction of the cell sub population (P=0.0012). When exposed to LirSOD 
CD4
+
 TCM cells from mice of group 4 exhibit an accentuated expansion (P=0.0087). 
Furthermore, the contact with recombinant proteins did not induce significant changes 
in CD8
+
TCM cell subpopulation when compared with group 3.  
 




Figure 103: Hepatic memory T cells of mice infected with less MgA susceptible L. infantum 
parasites selected by L. infantum recombinant proteins. 
Resident hepatic leukocytes isolated mice of group 4were exposed to LirCyP1, LirSOD and LirAMP were 
evaluated by flow cytometry and the results compared with mice of group 3. A) CD4+ TEM cells. B) CD8
+ 
TEM cells. C) CD4
+ TCM cells. D) CD8
+ TCM cells. Results are represented as whisker box-plot (minimum 
to maximum) comprising results from three independent experiments and triplicates per each sample. * 
represent significance differences (P<0.05) when comparing group 3 with group 4 mice. # represents 
significant differences (P<0.05) when comparing different stimulation (LirCyP1, LirSOD and LirAMP) 
within the same experimental group. 
CD4
+
TE cells from mice of group 4 proliferated more than group 3, in particular 
when stimulated by LirCyP1 (P= 0.0200) (Figure 104). CD8
+
 TE cells from mice of 
group 4 evidenced lower proliferations, above all when stimulated with LirCyP1 
(P=0.0237) or LirSOD (P=0.0173). The stimulation with LirAMP is statistically 
different from LirCyP1 stimulation (P=0.00313). These subset reductions are probably 
related to the increase of TEM and TCM cells, suggesting that these cell subpopulations 
are able to interchange as needed.  




Figure 104: Hepatic TE cells of mice infected with less MgA susceptible parasites stimulated by 
L. infantum recombinant proteins. 
Liver resident leukocytes were stimulated by LirCyP1, LirSOD and LirAMP and analyzed by flow 
cytometry and compared with mice or group 3. A) CD4+ TE cells. B) CD8
+ TE cells. Results are 
represented as whisker box-plot (minimum to maximum) comprising results from three independent 
experiments and triplicates per each sample. * represent statistical differences (P<0.05) when comparing 
group 3 with group 4 mice. # represents significant differences (P<0.05), when comparing different 
stimulation (LirCyP1, LirSOD and LirAMP) within the same experimental group. 
 
. 




In this chapter, the role of the liver as an immunological memory organ was 
analyzed during the outcome of L. infantum infection. During the past 40 years, murine 
models of leishmaniasis have been extensively employed to elucidate parasite immune 
interactions, including cell types, cytokines, signal transduction cascades and receptors 
involved in infection constrain, in clinical resolution of disease, resistance to a 
secondary infection and in vaccine development. Although, the domestic dog is the 
main reservoir of L. infantum and is of the highest importance to study their immune 
response to the parasite, the mouse model has several important practical advantages 
over the canine model. Mice have long been established as model of the disease. Since 
different mouse strains are genetically identical it is possible to collect and combine 
biological data obtained over time from several different sources, resulting in a depth 
characterization rarely achieved in other mammalian models (Loría-Cervera and 
Andrade-Narváez, 2014). Another major advantage of working with the murine model 
when compared with the canine model is related to the simplicity of keeping, breeding 
and reproducing, as well as the superior availability of commercial reagents for 
molecular and cellular studies. Taking into account the above considerations, the 
present study used the susceptible BALB/c mouse strain as a VL mouse model in order 
to ensure a stable genetic background and eliminate possible genetic influences in the 
development of immune memory, as well as the use of careful germ-controlled mice 
reduces the possibility of cross-reactions with other Ag from previous infections. The 
superior availability of commercial reagents, namely monoclonal antibodies for mouse 
cell receptors was also taken in consideration in the choice of the murine model.  
In mouse models, the infection outcome is genetically determined, being 
BALB/c mice considered susceptible to VL. Following Leishmania infection, BALB/c 
mice develop an organ-specific immune response. During the first weeks of infection, 
the parasites multiply rapidly in the liver. But about four weeks later, effective Th1 
immune response is developed and parasites are cleared, becoming resistant to 
re-infection (Murray et al., 1987). Similarly to what is observed in the canine model, the 
hepatic resistance to Leishmania infection is associated with the development of a 
granulomatous reaction in the liver. Also in human VL, hepatic granulomas appears to 
6 | Chapter 3 
 
378 
correlate with spontaneous control and maintenance of subclinical infections (Murray, 
2001).  
While pathology in the liver is limited (although hepatomegalia is verified), 
parasites persist in the spleen and the infection progresses. Under optimal conditions, 
granulomas provide anatomically circumscribed, functional structures in which it is 
possible to limit infection, kill and remove the microbial target, and then repair any 
associated tissue injury. Intracellular infections associated with the development of 
granulomatous inflammation include those caused by mycobacteria, bacteria, fungi and 
certain protozoa such as Leishmania (Murray, 2001). In the present work, it was 
identified several liver granulomas with the typical macrophage infiltrate. As BALB/c 
mice are susceptible to L. infantum infection this observation was expected, given 
evidence of a well succeeded experimental L. infantum infection. The isolation of viable 
parasites from the liver of infected mice (group 2), infected and treated mice (group 3) 
and also from treated mice previously infected with less MgA susceptible L. infantum 
(group 4) indicates that despite the granulomatous immune response viable parasite 
persist, even after treatment with a leishmanicidal drug. This observation may raise the 
following question: are the granulomas ensuring the persistence of the parasite in the 
host, difficulty the access of the drug to the parasite? Murray (2001) describes the 
typical structure of a liver granuloma in Leishmania infection as a cellular infiltrate rich 
in macrophages. Monocytes and T lymphocytes from the circulating blood are recruited 
and move into the mononuclear mantle, which slowly evolves to surround infected 
macrophages. In some cases, B cells, plasma cells, some neutrophils and eosinophils are 
also present. The evolution around the core of infected macrophages in the liver was 
also observed in this experimental work, suggesting mature and active granulomas. 
According to many authors, granulomas represent a successful T cell-dependent 
immune response (Sheffield 1990; Murray and Nathan, 1999; Hernandez-Pando et al., 
2000). To be assembled, granulomas typically require an Ag-specific immune response 
mediated by mononuclear cells. Have a relatively slow development and persist for 
extended periods (McElrath et al., 1988). This is particularly important, as the present 
study aims to analyses the immune memory generated during L. infantum infection in 
the liver, it is mandatory that the resident hepatic lymphocytes had previous contact 
with the parasite Ag naturally presented in the context of the organ infection, proven by 
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the presence of granulomas. Curiously, the overall antimicrobial efficacy of the 
granulomatous response appears to be variable, depending upon host determinants, the 
pathogen and the criteria used to define efficacy. Although microbial eradication is the 
ideal outcome in infections, which trigger granuloma assembly, it is not clear how often 
this objective is actually achieved. In mice and dog the formation of granulomas, leads 
to a resistant phenotype and animals are able to control infection progression, at least 
for a longer period of time, remaining asymptomatic. But, after an initially intense 
granulomatous response, a number of pathogens, including L. donovani and L. infantum 
establish a state of chronic intra-granuloma parasitism and survive at low levels 
lifelong. Although might allow parasite survival in the host granuloma also requires a 
constant immune pressure to preserve and renewal the multi-cellular structure, 
preventing the recrudescence of a latent infection (Murray, 2001). However, this state of 
concomitant immunity, in which pathogen resistance is dependent on viable pathogen 
persistence, may be key to delay disease progression. What happens in a lifelong 
granuloma is still debated, as it may relapse and the parasite may invade out of the 
granuloma and infect other tissues. 
The cellular markers used in the present study for the assessment of memory T 
cells were the CD127 and CD62L. CD127 is the interleukin-7 receptor (IL7R) and T 
cells are dependent upon IL-7 for their survival since signaling through the IL7R 
promotes cell survival via the upregulation of anti-apoptotic proteins, such as Bcl-2, and 
the glucose transporter, Glut. The IL7R is expressed on naive T cells and is 
downregulated following TCR engagement. T cells then have the capacity to upregulate 
the IL7R for their continued preservation (Schluns et al., 2000). Huster et al. (2004) 
showed for the first time the use of IL7R as a marker for memory T cells in mice, 
allowing the distinction of effector (TEM) and central memory T (TCM) cells from TE 
cells together with the use of CD62L cell marker. CD62L is an L-selectin, which 
mediates T cell migration into lymphoid organs and has long been used as a marker to 
distinguish TCM from TEM. In the present study the use of these two cellular markers 
allowed the identification of three distinct subpopulations: TE, TCM and TEM in 
accordance with the previously described.  
The infection of an individual with a new pathogenic agent leads to the 
activation of innate, followed by adaptive immunity and the generation of memory cells 
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that will persist and assure future immunity and protection. In VL little is described 
about the formation, activation and maintenance of these cells. Following L. infantum 
infection in the liver, granuloma assembling takes place and an immune active cellular 
response is generated. The memory levels induced by the infection of mice (group 2) 
with L. infantum virulent promastigotes did not induce major changes compared to the 
natural memory levels present in the healthy mice (group 1). This situation may be due 
to the parasite silencing effect and is altered when the mice are treated (group 3) with a 
commercial leishmanicidal drug, meglumine antimoniate. Leishmania has several 
intrinsic factors described to downregulate the host immune response. The most known 
and described virulence factors from Leishmania include glicoinositolphospholipids 
(GIPL), lipophosphoglycan (LPG), proteophosphoglycan (PPG), an 11kDa 
kinetoplastid membrane protein (KMP-11), several proteinases and metalloproteinases. 
Although the exact impact of these macro molecules in the immune system of 
mammalian host is not yet totally clarified there is evidence that these macromolecules 
modulate the interactions between parasite and host immune cells, favoring the 
establishment of infection (Silva-Almeida et al., 2012). For example, it was shown that 
LPG inhibit the nuclear translocation of monocytes NF-κB, leading to a subsequent 
diminution in IL-12 production (Argueta-Donohué et al., 2008) and also influences the 
host’s early immune responses by modulating the activity of dendritic cells, inhibiting 
Ag presentation and promoting an early IL-4 response (Liu et al., 2009). All together, 
these actions favor parasite establishment and survival. Also, parasite proteases are 
important virulence factors, as they are enzymes that hydrolyze peptide bonds and have 
the potential to degrade peptides and proteins. Leishmania has several proteases that 
participate in host pathogenesis. Proteases are crucial in parasite invasion and migration 
through host tissues, degradation of immune related proteins, immune evasion and 
activation of the inflammation pathways (McKerrow et al., 2006). More recently, Marr 
et al. (2014) suggested a new paradigm in host-pathogen interactions. Upon infection 
Leishmania induces epigenetic changes in the host genome able to direct the 
downregulation of innate immunity, thereby enabling pathogen survival and replication. 
The mechanisms by which Leishmania spp. evade the host immune response are now to 
start to be better understood and explored, as the parasite has several strategies to evade 
the host immune system.  
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In L. infantum infected mice MgA treated (group 3), the effect of the silence 
imposed by the parasite is overlapped and a more robust memory T cell population is 
differentiated, in particularly the CD4
+




 TEM cells can be 
recalled when stimulated with L. infantum total Ag, which is in fact a typical 
characteristic of TEM cells, the fast Ag recognition and differentiation in TE cell followed 




 phenotype can produce effector 
cytokines, as IFN-γ but are less proliferative than TCM cells that produce IL-2 and 
proliferate extensively (Mueller et al., 2012). There was also a major increase in the 
CD8
+
TE cell population, indicating that CD8
+
 cytotoxic T cells are highly important in 
parasite killing and controlling the infection. Interestingly, this increase reflects an 
accentuated decrease of CD8
+
 TCM cells, suggesting that central memory is activated in 
treated mice and transformed into intermediate stage, and from there to TE cells, capable 
of delivering cytotoxicity. The differentiation pathways and lineage relationship 
between naive, TE, TEM, and TCM cells is still a matter of debate. The more consensual 
model is a linear differentiation of naive into TE, TEM, and TCM. According to this 
model, the majority of Ag-specific TCM and TEM cells derived from one original T cell 
clone that, upon secondary encounter with Ag, a fraction of TCM cells differentiated into 
TEM cells. In the absence of a secondary antigenic challenge, some TEM cells 
re-expressed CD62L (Schluns et al., 2005). Bachmann et al (2005) proposed a model in 
which naive CD8
+





) and arrest at this stage. If Ag stimulation is not 
sufficient, an abortive T cell process is initiated. But, if Ag exposure is sufficient, this 




 cell (TEM phenotype) 
with effector function and gain the potential to significantly clonal expansion. Further 
Ag contact induces CD127 down-regulation (TE phenotype), and a majority of these 
cells will not develop into long-lived memory cells, but will eventually die due to 
activation-induced cell death or to lack of response to homeostatic signals such as IL-7. 
In Ag absence, at least some TE cells can re-express CD127, adopting a TEM phenotype, 
and later on, some cells can re-express CD62L, becoming TCM cells. Such dynamic 
lineage relationships allow the development of CD8
+
 TEM cells with different 
anatomical localization and different recall capabilities. As it is the effector cells that are 
active and have cytotoxic properties, MgA treatment does increase the immune 
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activation of the liver resident lymphocytes, probably due to its leishmanicidal effect, 
providing new antigens for T cell presentation and macrophage activation. This is 
particular evident in the increase of CD8
+
TEcells, resulting from an activation of the 
CD8
+
TCMand in the augment of CD4
+
 TEM cell that represent a potential for posterior 
differentiation into CD4
+
TEcells and in itself constitute a cellular population already 
with effector potential for secret inflammatory th1 cytokines. This situation is not 
observed in the infected animals, leading to the hypothesis that treatment increases 
leishmanicidal immune activity.  
These results may reflect the rapid interchange of some memory populations into 
others and may also reflect the presence of tissue-resident memory cells (TRM). These 
not so well described cell population is resident in several tissues and does not re-
circulate in the blood. It has a similar phenotype with effector cells with low expression 
of CD62L and CD127. It is also not clear yet in each degree are memory cells resident 
in the tissue or transiting through it. These non-recirculating memory T cells are found 
in the brain, in the salivary glands, in the vagina, and in the stomach, lungs, kidney, 
pancreas, and heart. TRM is maintained within non-lymphoid tissues in the absence of 
significant external replenishment and with minimal turnover. These memory T cells 
appear to be terminally differentiated because they do not expand significantly and 
survive poorly upon introduction into the circulation. Nevertheless, TRM provides site-
specific protection against infection, suggesting that when present, representing the first 
line of defense. TRM expresses different integrins, such as CD103 and CD69 that are 
involved in the interaction with epithelial cells by binding the ligand E-cadherin, being 
responsible for the retention of these cells in the tissues (Park and Kupper, 2015). 
However, TRM cells were only described in the liver following malaria infection (Tse et 
al., 2013). This cell subset is normally associated with mucosal and frontline tissues, but 
being the liver the major organ in close contact with the digestive tract Ag it is possible 
that this resident population is yet to be signalized. However, in the present work, with 
the used cellular markers, it is not possible to isolate these cells, but they might be 
present and included in the effector cell phenotype. In future study it would be 
interesting to include integrins markers, such as CD103 and CD69, to signalize this cell 
population and understand better its role in the outcome of liver infection by 
L. infantum.  
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The recognition of L. infantum recombinant proteins was achieved in infected 
mice (group 2) although without particular relevance when compared to non-infected 
mice (group 1). This situation may be related to the immune modulation that the 
parasite exert over cells from the host immune system, leading to decrease in 
recognition of Ag and reaction to them. However, when compared with the expansion 
observed in cells from L. infantum infected and MgA treated mice (group 3), the 
stimulation with LirSOD leads to the expansion of the CD4
+
 TEM in a notable way. 
Superoxide dismutase (SOD) is a detoxify enzyme that removes reactive superoxide 
radicals produced by activated macrophages. This enzyme, present in the cytosol and in 
the microsomal fractions of several Leishmania species, such as L. donovani, L. 
infantum or L. tropica, are essential to ensure intra-macrophage Leishmania survival 
(Ghosh et al., 2003). The treatment of mice with a leishmanicidal drug leads to the 
killing of intracellular amastigotes and to the release of antigens that were previously 
not accessible due to intracellular localization, may facilitate the recognition of LirSOD 
by CD4
+
 TEM cells. Curiously, TCM cells were not particularly stimulated by any of the 
recombinant proteins, but the CD8
+
 TE cells presented higher levels of proliferation 
when stimulated with LirCyP1 or LirSOD. This might be related to a rapid activation of 
the CD8
+
 TCM cells and a differentiation into effector memory and effector cells, 
illustrating again the flexibility of the memory cell compartment. LirCyp1 is a 
recombinant L. infantum cyclophilin. Cyclophilins are a class of proteins found in 
several intracellular compartments and also extracellular that possesses 
peptidylprolylcis–trans isomerase activity and can perform different functions, ranging 
from cell division, receptor maturation and protein folding (Roy et al., 2014). However, 
even with at extracellular localization LirCyP1 is not as immunogenic as LirSOD. The 
ability of memory cells from treated mice recognize recombinant L. infantum proteins, 
with different cellular localizations in the amastigote and probable different abundance, 
indicates that the leishmanicidal activity of the drug is crucial for antigen presentation 
process, since memory cells from infected (not treated) mice recognize and react to 
these proteins in a lesser extent. LirSOD was the more efficient recombinant protein to 
recall and activate memory cells, making of this protein a potential candidate to be 
incorporated into a vaccine against VL.  
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The exposition of parasites to a leishmanicidal drug, MgA (group 3) and a 
posterior re-exposition to the same drug, in a newer infection followed by a treatment in 
the same conditions (group 4) decreased the drug sensitivity and induced the 
amplification of MRPA, GSH1 and PTR1genes that are known to be associated to 
parasite resistance. ATP-binding cassette (ABC) transporters have been associated with 
drug resistance in various diseases. In Leishmania, the first ABC protein identified was 
MRPA (Ouellette et al., 1990) which is a member of the ABCC subfamily able to 
confer resistance to antimonials by sequestering metal-thiol conjugates into an 
intracellular vesicle (Légaré et al., 2001). The treatment of choice for leishmaniasis are 
the pentavalent antimony [Sb(V)] drugs such as meglumine antimoniate (Glucantime®) 
and sodium stibogluconate (Pentostam®). Despite the clinical use of these 
antileishmanial agents for several years, their mechanism of action and the basis for 
their selective toxicity remain poorly known. The most accepted hypothesis is that 
Sb(V) acts as a pro-drug, then converted into the more toxic trivalent antimony [Sb(III)] 
by cellular enzymes (Goodwin and Page, 1943). This hypothesis was further supported 
by the observations that Sb(III) is more toxic than Sb(V) against both parasite stages of 
different Leishmania species (Roberts et al., 1995; Sereno and Lemesre, 1997) and that 
mutants of L. infantum amastigotes selected for resistance to Sb(III) were cross-resistant 
to Sb(V) (Sereno et al., 1998). Frézard et al. (2001) showed that reduced glutathione 
(GSH) promotes the reduction of Sb(V) to Sb(III) greatly favored by an acidic pH 
environment and an elevated temperature. Thus, conversion should not occur in the host 
cell cytosol due to its neutral pH, but in the macrophage acidic organelles, such as 
lysosomes and endosomes, and also in the parasitophorous vacuole, whose pH lies 
between 4.7 and 5.2, and in which Leishmania resides. The resistance to pentavalent 
antimonials have been related to antimony conjugation to the parasite-specific 
glutathione-spermidine conjugate trypanothione [T(SH)2] (Fairlamb and Cerami, 1992). 
Trypanothione is thought to bind to metals in susceptible isolates and is increased in 
Sb(III)-resistant parasites (Haimeur et al., 2000). Metal-trypanothione conjugates are 
either sequestered into an intracellular organelle by the ABC transporter MRPA or 
extruded outside the cell by an efflux pump (Légaré et al., 2001). Therefore, in the 
present study it was found increased copy numbers of MRPA gene as part of the 
response exhibited by L. infantum to the stress imposed by the treatment with MgA. 
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However, other MgA resistance related genes were found with increased copy number 
in isolated parasites that were under under drug pressure, leading to the hypothesis that 
MgA perform more than one effect on parasite cell. MgA mechanism of action, 
although not yet fully understood suggested that antimonials inhibit the biosynthesis of 
macromolecules in the amastigote, possibly by perturbing the energy metabolism 
caused by the inhibition of glycolysis and fatty acid beta-oxidation. Sodium 
stibogluconate, another antimonial formulation, specifically inhibits type I DNA 
topoisomerase, thus reducing unwinding and cleavage. A similar mechanism is also 
described for MgA (Lucumi et al., 1998). To counterpart other effects on amastigote it 
is possible that L. infantum increases the expression of other resistance related genes as 
GSH1 and PTR1. Gamma-glutamylcysteine synthetase (γ-GCS), encoded by the GSH1 
gene, is the rate-limiting enzyme in the biosynthesis of glutathione and of trypanothione 
in Leishmania. Mukherjee et al. (2009) assessed the importance of GSH1 in L. infantum 
by generating GSH1 null mutant. Removal of even a single wild-type allelic copy of 
GSH1 invariably led to the generation of an extra copy of GSH1, maintaining intact 
wild-type alleles and revealing the crucial importance of this gene for parasite survival. 
Hydrogen peroxide detoxification in trypanosomatids relies on a cascade of reactions 
orchestrated by trypanothione [T(SH)2], a bis-glutathione-spermidine conjugate, that 
consists in a series of reduction reactions culminating on glutathione peroxidase type 
enzymes and detoxification of reactive hydrogen peroxide. The T(SH)2 system has been 
implicated in the resistance against antimonial-containing drugs through various 
mechanisms (Mandal et al., 2007; Mittal et al., 2007;Wyllie et al., 2008). Amplification 
of GSH1or overexpression was observed in Leishmania in which resistance to 
antimonials was induced in vitro (Haimeur et al., 2000) or in resistant field isolates 
(Mukherjee et al., 2007). PTR1 is responsible for pteridines rescue and for the 
resistance to the antifolate drug methotrexate (Nare et al., 1997). Therefore, the 
amplification of PTR1 suggests that less sensitivity to MgA can be also associated with 
the folate metabolic pathway. Leishmania and other trypanosomatid protozoa require 
reduced pteridines (pterins and folates) for growth, suggesting that inhibition of these 
pathways could be targeted for effective chemotherapy. Requisition of an exogenous 
source of folate and of unconjugate pteridines is essential for Leishmania survival, 
replication and, also important in the infection process of the vertebrate host. The 
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enzyme PTR1 is responsible for the reduction of biopterin into H4-biopterin, which was 
shown to play a key role in the biosynthesis of nitric oxide (NO) and to be connected 
with the Leishmania sensitivity to oxidants (Nare et al., 2009). PTR1 amplification may 
decrease the efficacy of MgA by reducing the reactive oxygen and nitrogen 
intermediates, making the inhibition of trypanothione reductase less relevant and 
assuring that folate metabolism is not affected, allowing the parasite survival in the 
presence of the drug. Curiously, it was observed that MDR1, a gene associated with 
resistance had decreased the copy number in parasites that were under drug pressure. 
MDR1-derived permeases belong to the ABC-B sub-family and contribute to the 
parasite's survival by extruding the drug from its place of action (Katakura et al., 2005), 
most likely by both decreasing the initial accumulation (Callahan et al., 1994) and 
increasing the drug efflux. In Leishmania, MRP confers multi-drug-resistance 
phenotype, although this cannot be reversed by conventional MDR modulators. The 
Leishmania MDR1 confers resistance to drugs such as daunorubicin and vinblastine, but 
there is no evidence of a relationship between the MDR1 protein and antimony 
resistance (Klokouzas et al., 2003). In the present study no evidence of increased MDR1 
copy number was found, indicating that probably this gene is not related to MgA 
resistance. Together, these results indicate that L. infantum under MgA pressure 
increases MRPA gene copies to better release the drug from the amastigote cell, 
increases GSH1 and PTR1 gene copies to improve resistance to the oxidative stress of 
the host cell. However, amplification of these genes did not reflect a complete resistant 
phenotype, since parasites under different levels of drug pressure evidence similar 
values of viable parasitic load on the liver. This situation highlights the parasite easy 
acquisition of a less sensitive phenotype that in a continued process might lead to the 
development of fully MgA resistant parasites.  
The levels of CD8
+
 TEM and TCM were found higher in group 4 compared with 
group 3 and TE, which are the cells that effective kill the parasite were diminished in 
group 4. Studies of murine VL infections, in L. donovani infected BALB/c mice, have 
established that an intact T cell population, in particular the Th1 cell subset is required 
for antimoniates to produce a curative antileishmanial effect (Murray et al., 1991). By 
itself, MgA has leishmanicidal activity in vitro and in vivo, however complete cure, in 
vivo, is not achieved without a host concomitant Th1 immune response. Haldar et al., 
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(2011) observed that the treatment with sodium antimony gluconate, another antimonial 
formulation, enhances the expression of MHCI on the macrophage surface, promoting 
antigen presentation, but not the antigen presentation by MHCII. This might be a 
mechanism by which the drug can enhance antileishmanial cytotoxic T lymphocyte 
response. As discussed above, TE cell proliferation observed in the treated mice 
(group 3) may in fact be a key activation to enhance Ag presentation, leading to 
macrophage activation. But in the presence of parasites that are less susceptible to MgA 
leishmanicidal activity, there is a less efficient immune response with less effector T 
cells, particularly cytotoxic T cells, easing parasite survival even in the presence of a 
leishmanicidal drug. 
The recognition of recombinant proteins is affected by drug less sensitive 
parasites (group 4), reducing CD4
+
 TEM cells and increasing CD4
+
 TE cells. Curiously 
the situation is the inverse of what was observed in treating mice (group 3). In this case, 
the levels of CD8
+
 TCM cells were low and CD8
+
 TE cells were increased, leading to a 
crescent cytotoxic immune response. In group 4, the immune response is dominated by 
CD4
+
 T cells and in the group 3 a CD8
+
 T cell predominating response was generated. 
In group 4, the presence of a parasite that is less sensitive to the drug that was used in 
the treatment, lead to less parasite killing and less Ag exposure and, in consequence, 
less immune activation. In this case, parasite seem to be able to silencing the 
differentiation of CD8
+
 TCM cells into TE cells, leading to a decrease in this population 
to levels similar to what was observed in infected mice (group 2). The effect of an 
infection with parasites less susceptible to a drug (but yet fully resistant) is seriously as 
the reduction in parasite killing may delay the activation of a CD8
+
 T cell mediated 
immune response, allowing parasite survival. In consequence survival parasites may be 
able to control the host immune response to a silencing state similar to what was 
observed in not treated infected mice (group 2), favoring parasite survival and treatment 
failure.  
Only the stimulation with LirCyP1 and LirSOD were able to induce some 
expansion of memory T cells. As discussed previously, these proteins are located inside 
the amastigote and the killing of the parasite by MgA addition may lead to exposure of 
new parasite antigens and making possible recognition. Taking together, these results 
indicate that LirCyP1 and LirSOD, may be included in future vaccine for VL. The 
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vaccine might be preventive or therapeutic improving Ag presentation and the 














In summary, the present study demonstrates that:  
 
– For the first time the generation of memory T cells in the resident liver 
lymphocytes following an L. infantum infection is accessed, as well after 
treatment; 
 
– The infection with L. infantum generates memory T cells, which can be 
accessed with the cellular markers CD127 and CD62L; 
 
– The treatment with a leishmanicidal drug (antimoniate meglumine) increases 
the levels of memory and effector T cells, indicating a more robust immune 
response, possibly due to the exposition to parasite Ag released as a 
consequence of parasite killing. Thus, the treatment with a leishmanicidal 
drug enhances the liver immune response; 
 
– The re-exposition of L. infantum parasites to a leishmanicidal drug for short 
periods of time has potential to decrease parasite sensitivity and may lead to 
the development of resistant phenotypes; 
 
– The recombinant proteins LirCyp1 and LirSOD are strongly recognized by 
memory cells from infected and treated mice, indicating these proteins might 
be used in a prophylactic or therapeutic vaccine formulation; 
 
– The liver has higher levels of immune memory T cells, and the role of the 
liver as an immunological organ is flourishing, but it still is necessary to 
perform more studies. 
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7 Final remarks  
This study aimed to elucidate on the natural mechanisms elicited by the liver of 
the dog, the main reservoir for L. infantum, to control the infection. In chapter 2 and 3 
of the present dissertation, the role of hepatocytes and KCs isolated from canine livers 
was assessed in the framework of a L. infantum infection. To the best of our knowledge, 
this report constitutes the first in vitro description of immune response exhibited against 
L. infantum parasites by dog hepatocytes as well as the first time that innate immune 
receptors NOD1, NOD2, TLR2, TLR4 and TLR9 of dog KCs were investigated for 
their role in L. infantum infection. 
Hepatocytes constitute rich metabolic cells and their role as immune active cells 
represent a recent discovery. In the context of L. infantum infection, parasites exhibited 
a strong tropism to cells and a close interaction between hepatocytes and parasites were 
observed. In some cases, a possible internalization by hepatocytes was considered, 
however, in a not conclusive way. In culture, the close interaction between hepatocyte’s 
membrane and parasite increased the expression of innate immune receptors NOD1 and 
NOD2 as well as TLR2, suggesting that these receptors were activated by the parasite 
antigens, and in the case of NODs, by a close interaction with the hepatocyte 
membrane. A possible role for TLR9 was also evidenced but not in a conclusive form. 
The parasite presence induced a mix immune response from hepatocytes. These cells 
are able to produce several different cytokines and also acute phase proteins that impact 
on the host immune defense. In contact with L. infantum, hepatocytes produced 
pro-inflammatory TNF-α, the pleiotropic IL-6 and the anti-inflammatory IL-10. 
Hepatocytes are known for inducing immune tolerance and, naturally do not activate a 
strong anti-inflammatory Th1 response in order to avoid major damage to the tissue. 
However, the production of inflammatory cytokines also influenced metabolic 
pathways. Decrease of CYPs450 and phase II enzyme activities might lead to increased 
toxicity by the accumulation of non-metabolized drugs or xenobiotics. 
The search for new leishmanicidal compounds constitutes an important quest, as 
many of the used drugs present several side effects. Three new leishmanicidal drugs, 
ursolic acid, chalcone-8 and quercetin, were tested in hepatocytes exposed to 




L. infantum amastigotes in comparison with the classic meglumine antimoniate, all 
revealing good leishmanicidal activity and low cell toxicity. The addition of drugs 
induced the CYPs450 metabolism, indicating that these compounds may be metabolized 
by the assessed CYPs. The knowledge of the metabolization path and the enzyme used 
for each drug is very useful to predict efficacy and avoid drug-to-drug interaction and 
should be evaluated since the initial process of drug development. 
In the future, it would be of interest to clarify whether L. infantum parasites can 
enter the hepatocyte cell in vitro and in vivo. The clarification of this point might impact 
in the role of hepatocytes in canine leishmaniasis from classically considered 
side-performers to target cells and possible silent reservoir. Also the described evidence 
that NODs and TLR2 are activated by the parasite could be explored in vitro and in vivo 
as therapeutic or vaccine adjuvants to improve response to treatment. Likewise, would 
be of great interest to progress the evaluation of the new leishmanicidal compounds 
with studies in vitro using canine infection model and in vivo, in dogs naturally infected. 
KCs, the liver resident macrophages, constitute the main target cells of the liver 
and form the core of the granulomas in infected animals. Although KCs sense and react 
to the parasite presence these cells are susceptible to both parasite forms, but 
amastigotes are more efficient at infecting KCs. L. infantum promastigotes and 
amastigotes exerted immune regulation on infected KCs, avoiding cellular activation, 
downregulation of NO production. Instead L. infantum induces urea production and an 
anergic response from infected KCs. The innate immune receptors TLR2 and NOD1 
seem to be activated on infected KCs, but little effect on Th1 cytokine production was 
observed. L. infantum is able to modulate KCs leishmanicidal mechanisms promoting 
parasite survival. Curiously, co-culture of infected KCs with hepatocytes was able to 
create an inflammatory response, activating the innate immune receptors NOD1 and 
TLR2 and pro-inflammatory TNF-α cytokine expression. Revealing that KCs alone are 
subverted by the parasite silencing effect, but when in contact with hepatocyte, the 
cellular crosstalk seems to have an interesting role in orchestrating a synergistic 
immune response against L. infantum parasites. The addition of a leishmanicidal drug to 
infected KCs obtained a similar effect, with activation of innate immune receptors 
TLR4 and TLR2 and generation of TNF-α. Again, a role for TLR2 seems evident in 
canine leishmaniasis, which may be exploited for therapeutic ends. Interestingly, there 




were found important differences in the immune response against L. infantum displayed 
by blood derived macrophages (MØs) when compared with liver resident macrophages 
(KCs). Liver macrophages were anergic and more tolerant to the parasite in comparison 
with the early active response exhibited by MØs. Even so, L. infantum seem to have the 
ability to exert a negative regulation on MØ activity. The localization of MØs and the 
respective environment seem to induce a regulation in the potential level of activation. 
In chapter 3, the role of the liver as an immunological memory organ was 
investigated in the framework of an L. infantum infection. For this study the model of 
murine visceral leishmaniasis was used due to practical reasons. To our best knowledge, 
this chapter also constitutes the first description of local memory generation by liver 
resident T cells following an L. infantum infection and after treatment. Animals treated 
with antimoniate meglumine increases the levels of memory and of effector T cells, 
enhancing the liver immune response, highlighting the impact of treatment application 
on recovery from this parasitic infection. Also was found evidence that re-exposition of 
L. infantum parasites to antimoniate meglumine for short periods of time has potential 
to decrease parasite sensitivity and may lead to the development of resistant phenotypes, 
emphasizing the importance of treatment compliance. LirCyp1 and LirSOD, L. infantum 
recombinant proteins were found to be strongly recognized by memory cells from 
infected and treated mice, indicating that these proteins might be used in a prophylactic 
or therapeutic vaccine formulation. 
In the future, it would be of interest to perform a similar study in dogs naturally 
infected and after treatment to understand whether parasite specific immune memory 
can be established and if confers protection against re-infection. Testing the potential 
for use of the selected recombinant proteins as therapeutic vaccines in naturally infected 
dogs might also be of interest. Likewise, testing the selected proteins with adjuvants for 
TLR2 or NOD1 and NOD2 could also lead to interesting results on exploration of the 
innate immune response. 
The liver is, in fact, a very complex organ with unique metabolic functions and 
newly discovered immune implications. During L. infantum infection and visceral 
disease, the liver executes unique functions on signaling the infection, produce acute 
phase proteins and inflammatory cytokines initiating a general inflammatory response, 




isolate the parasite in a granuloma assembly and ensuring balancing of the immune 
response to avoid damage to the host. The present work attributes an active role to 
hepatocytes in an active L. infantum infection. 
 
 
 
 
